0001829126-24-001462.txt : 20240308 0001829126-24-001462.hdr.sgml : 20240308 20240308093343 ACCESSION NUMBER: 0001829126-24-001462 CONFORMED SUBMISSION TYPE: N-CSR PUBLIC DOCUMENT COUNT: 24 CONFORMED PERIOD OF REPORT: 20231231 FILED AS OF DATE: 20240308 DATE AS OF CHANGE: 20240308 EFFECTIVENESS DATE: 20240308 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Gabelli Healthcare & WellnessRx Trust CENTRAL INDEX KEY: 0001391437 ORGANIZATION NAME: IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: N-CSR SEC ACT: 1940 Act SEC FILE NUMBER: 811-22021 FILM NUMBER: 24732568 BUSINESS ADDRESS: STREET 1: ONE CORPORATE CENTER CITY: RYE STATE: NY ZIP: 10580-1422 BUSINESS PHONE: 914-921-5100 MAIL ADDRESS: STREET 1: ONE CORPORATE CENTER CITY: RYE STATE: NY ZIP: 10580-1422 FORMER COMPANY: FORMER CONFORMED NAME: Gabelli Global Healthcare & WellnessRx Trust DATE OF NAME CHANGE: 20070227 N-CSR 1 grx_ncsr.htm N-CSR

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM N-CSR

CERTIFIED SHAREHOLDER REPORT OF REGISTERED
MANAGEMENT INVESTMENT COMPANIES

Investment Company Act file number 811-22021

The Gabelli Healthcare & Wellness^Rx Trust

(Exact name of registrant as specified in charter)

One Corporate Center
Rye, New York 10580-1422

(Address of principal executive offices) (Zip code)

John C. Ball
Gabelli Funds, LLC
One Corporate Center
Rye, New York 10580-1422

(Name and address of agent for service)

Registrant’s telephone number, including area code: 1-800-422-3554

Date of fiscal year end: December 31

Date of reporting period: December 31, 2023

Form N-CSR is to be used by management investment companies to file reports with the Commission not later than 10 days after the transmission to stockholders of any report that is required to be transmitted to stockholders under Rule 30e-1 under the Investment Company Act of 1940 (17 CFR 270.30e-1). The Commission may use the information provided on Form N-CSR in its regulatory, disclosure review, inspection, and policymaking roles.

A registrant is required to disclose the information specified by Form N-CSR, and the Commission will make this information public. A registrant is not required to respond to the collection of information contained in Form N-CSR unless the Form displays a currently valid Office of Management and Budget (“OMB”) control number. Please direct comments concerning the accuracy of the information collection burden estimate and any suggestions for reducing the burden to Secretary, Securities and Exchange Commission, 450 Fifth Street, NW, Washington, DC 20549-0609. The OMB has reviewed this collection of information under the clearance requirements of 44 U.S.C. § 3507.

Item 1.

Reports to Stockholders.

(a)

The Report to Shareholders is attached herewith.

The Gabelli Healthcare & Wellness^Rx Trust

Annual Report — December 31, 2023

To Our Shareholders,

For the year ended December 31, 2023, the net asset value (NAV) total return of The Gabelli Healthcare & Wellness^Rx Trust (the Fund) was 1.6%, compared with a total return of 2.1% for the Standard & Poor’s (S&P) 500 Health Care Index. The total return for the Fund’s publicly traded shares was (3.4)%. The Fund’s NAV per share was $11.58, while the price of the publicly traded shares closed at $9.33 on the New York Stock Exchange (NYSE). See page 4 for additional performance information.

Enclosed are the financial statements, including the schedule of investments, as of December 31, 2023.

Investment Objective and Strategy (Unaudited)

The Fund’s investment objective is long term growth of capital. Under normal market conditions, the Fund will invest at least 80% of its net assets (plus borrowings made for investment purposes) in equity securities (such as common stock and preferred stock) and income producing securities (such as fixed income debt securities and securities convertible into common stock) of domestic and foreign companies in the healthcare and wellness industries. Companies in the healthcare and wellness industries are defined as those companies which are primarily engaged in providing products, services and/or equipment related to healthcare, medical, or lifestyle needs (i.e., nutrition, weight management, and food and beverage companies primarily engaged in healthcare and wellness). “Primarily engaged,” as defined in this registration statement, means a company that derives at least 50% of its revenues or earnings from, or devotes at least 50% of its assets to, the indicated business. The above 80% policy includes investments in derivatives that have similar economic characteristics to the securities included in the 80% policy. The Fund values derivatives at market value for purposes of the 80% policy. Specific sector investments for the Fund will include, but are not limited to, dental, orthopedics, cardiology, hearing aid, life science, in-vitro diagnostics, medical supplies and products, aesthetics and plastic surgery, veterinary, pharmacy benefits management, healthcare distribution, healthcare imaging, pharmaceuticals, biotechnology, healthcare plans, healthcare services, and healthcare equipment, as well as food, beverages, nutrition and weight management. The Fund will focus on companies that are growing globally due to favorable demographic trends and may invest without limitation in securities of foreign issuers, including issuers in emerging markets.

As permitted by regulations adopted by the Securities and Exchange Commission, paper copies of the Fund’s annual and semiannual shareholder reports will no longer be sent by mail, unless you specifically request paper copies of the reports. Instead, the reports will be made available on the Fund’s website (www.gabelli.com), and you will be notified by mail each time a report is posted and provided with a website link to access the report. If you already elected to receive shareholder reports electronically, you will not be affected by this change and you need not take any action. To elect to receive all future reports on paper free of charge, please contact your financial intermediary, or, if you invest directly with the Fund, you may call 800-422-3554 or send an email request to info@gabelli.com.

Performance Discussion (Unaudited)

During the first quarter 2023, Hospitals continued to recover from COVID-19 disruptions and last year’s labor shortages. HCA Healthcare (+10%) and Tenet Healthcare (+22%) are seeing strong admissions and are beginning to clear the backlog of deferred surgical volumes, especially orthopedic cases. This benefits many of the medical device companies who supply them, including Stryker (+17%), Integer Holdings (+13%), and Boston Scientific (+8%). Insurance companies Cigna (-23%) and CVS Health (-20%) were some of our best performers last year, but sold off this quarter on concerns around Medicare Advantage reimbursement rates and potential Pharmacy Benefits Manager (PBM) regulation out of Congress. After the quarter ended, the Centers for Medicare Services (CMS) announced an improved Medicare Advantage rate for 2024.The Fund’s consumer holdings were mostly higher in the quarter.

The healthcare system has continued to return to normal- in the second quarter 2023, addressing the backlog of deferred care from the COVID-19 pandemic and last year’s labor shortages. Surgeries continue to shift to outpatient surgery centers, but hospital chains HCA Healthcare (+15%) and Tenet Healthcare (+37%) have been building out their networks of these facilities for years. Their medical device suppliers continue to benefit from this pent-up demand, most notably orthopedic companies Zimmer Biomet (+13%), Stryker (+7%), and Boston Scientific (+8%). However, this strong demand is finally starting to impact health insurance companies such as UnitedHealth (+2%), most notably in their Medicare Advantage business. On the negative side, drug manufacturer Catalent (-34%) fired their chief financial officer after finding accounting and forecasting problems, forcing them to cut guidance for the year and make a small financial restatement. The decline in COVID-19 drug and vaccine manufacturing has been a headwind for Bio-Rad (-21%) and ThermoFisher Scientific (-9%).

As a traditionally defensive sector, healthcare stocks were down during the third quarter slightly less than the overall market. As we move beyond COVID-19, there will be less demand for diagnostic tests from Abbott Labs (-11%) and QuidelOrtho (-12%). After a very strong first half of the year, hospitals HCA Healthcare (-19%) and Tenet Healthcare (-18%) gave back some of their gains on fears of tougher comparisons going forward. Smaller cap growth stocks sold off once again, including medical device companies Silk Road Medical (-54%) and Treace Medical (-49%). Pharmaceutical company AbbVie (+12%) is successfully defending its biggest drug HUMIRA against biosimilar competition. Health insurance companies Cigna (0%), CVS Health (+2%), and UnitedHealth (+4%) continue to adapt well to the current environment.

Healthcare stocks were down for most of the year, but did participate in the fourth quarter rally. Hospitals HCA Health (+10%) and Tenet Healthcare (+15%) rose for the quarter and the year, buoyed by an improving labor market and steady procedure volume growth. ThermoFisher Scientific (+5%) began to move beyond its difficult COVID-19 testing and vaccine comparisons and is looking forward to a better 2024. ZimVie (+89%) almost doubled after agreeing to sell its struggling spine business for a good price in order to pay down debt and focus on its more attractive dental implant business. After a difficult year, shares of most of the Fund’s consumer holdings rebounded in the fourth quarter as investors began looking to 2024.

Our top contributors to the portfolio during the calendar year included BellRing Brands Inc. (2.9% of total investments as of December 31, 2023), together with its subsidiaries, provides various nutrition products in the United States; Tenet Healthcare Corp (2.6%), which operates as a diversified healthcare services company. The company operates through three segments: Hospital Operations, Ambulatory Care, and Conifer; and Cencora Inc.(2.0%), which sources and distributes pharmaceutical products. The company’s U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services.

Detractors to performance for the year included pharmaceutical manufacturer CVS Health Corp. (3.3%), which provides health services in the United States. It operates through Health Care Benefits, Pharmacy Services, and Retail/LTC segments; The J.M. Smucker Co. (1.5%), which manufactures and markets branded food and beverage products worldwide. It operates in three segments: U.S. Retail Pet Foods, U.S. Retail Coffee, and U.S. Retail Consumer Foods; and Bristol Myers Squibb Co.(1.4%), which discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide.

Thank you for your investment in The Gabelli Healthcare & Wellness^Rx Trust.

The views expressed reflect the opinions of the Fund’s portfolio managers and Gabelli Funds, LLC, the Adviser, as of the date of this report and are subject to change without notice based on changes in market, economic, or other conditions. These views are not intended to be a forecast of future events and are no guarantee of future results.

Comparative Results

Average Annual Returns through December 31, 2023 (a) (Unaudited)

	1 Year			3 Year			5 Year			10 Year			15 Year			Since Inception (6/28/07)
The Gabelli Healthcare & Wellness^Rx Trust (GRX)
NAV Total Return (b)		1.56	%		(0.44	)%		6.49	%		5.91	%		10.58	%		7.99	%
Investment Total Return (c)		(3.36	)		(1.90	)		6.36			5.00			10.63			6.66
S&P 500 Health Care Index		2.06			8.07			11.59			11.35			13.62			10.59
S&P 500 Consumer Staples Index		0.52			5.82			10.86			8.54			10.93			9.33
50% S&P 500 Health Care Index and 50% S&P 500 Consumer Staples Index		1.29			6.95			11.23			9.95			12.28			9.96

(a)	Returns represent past performance and do not guarantee future results. Investment returns and the principal value of an investment will fluctuate. The Fund’s use of leverage may magnify the volatility of net asset value changes versus funds that do not employ leverage. When shares are sold, they may be worth more or less than their original cost. Current performance may be lower or higher than the performance data presented. Visit www.gabelli.com for performance information as of the most recent month end. The S&P 500 Health Care Index is an unmanaged indicator of health care equipment and services, pharmaceuticals, biotechnology, and life sciences stock performance. The S&P 500 Consumer Staples Index is an unmanaged indicator of food and staples retailing, food, beverage and tobacco, and household and personal products stock performance. Dividends are considered reinvested. You cannot invest directly in an index.
(b)	Total returns and average annual returns reflect changes in the NAV per share, reinvestment of distributions at NAV on the ex-dividend date, and adjustments for rights offerings and are net of expenses. Since inception return is based on an initial NAV of $8.00.
(c)	Total returns and average annual returns reflect changes in closing market values on the NYSE, reinvestment of distributions, and adjustments for rights offerings. Since inception return is based on an initial offering price of $8.00.

Investors should carefully consider the investment objectives, risks, charges, and expenses of the Fund before investing.

COMPARISON OF CHANGE IN VALUE OF A $10,000 INVESTMENT IN

THE GABELLI HEALTHCARE & WELLNESS^Rx TRUST (INVESTMENT TOTAL RETURN) and S&P 500

HEALTH CARE INDEX (Unaudited)

Average Annual Total Returns*
	1 Year	5 Year	10 Year
Investment	(3.36)%	6.36%	5.00%

* Past performance is not predictive of future results. The performance tables and graph do not reflect the deduction of taxes that a shareholder would pay on Fund distributions or the sale of Fund shares.

Summary of Portfolio Holdings (Unaudited)

The following table presents portfolio holdings as a percent of total investments as of December 31, 2023:

The Gabelli Healthcare & Wellness^Rx Trust

Health Care Providers and Services	21.1	%
Health Care Equipment and Supplies	20.5	%
Food	18.5	%
Pharmaceuticals	17.1	%
Food and Staples Retailing	8.8	%
Biotechnology	3.8	%
U.S. Government Obligations	3.0	%

Beverages	2.4	%
Household and Personal Products	2.3	%
Electronics	1.8	%
Equipment and Supplies	0.7	%
Specialty Chemicals	0.0	%*
	100.0	%

Amount represents less than 0.05%.

The Fund files a complete schedule of portfolio holdings with the Securities and Exchange Commission (the SEC) for the first and third quarters of each fiscal year on Form N-PORT. Shareholders may obtain this information at www.gabelli.com or by calling the Fund at 800-GABELLI (800-422-3554). The Fund’s Form N-PORT is available on the SEC’s website at www.sec.gov and may also be reviewed and copied at the SEC’s Public Reference Room in Washington, DC. Information on the operation of the Public Reference Room may be obtained by calling 800-SEC-0330.

Proxy Voting

The Fund files Form N-PX with its complete proxy voting record for the twelve months ended June 30, no later than August 31 of each year. A description of the Fund’s proxy voting policies, procedures, and how each Fund voted proxies relating to portfolio securities is available without charge, upon request, by (i) calling 800-GABELLI (800-422-3554); (ii) writing to The Gabelli Funds at One Corporate Center, Rye, NY 10580-1422; or (iii) visiting the SEC’s website at www.sec.gov.

The Gabelli Healthcare & Wellness^Rx Trust
Schedule of Investments — December 31, 2023

Shares			Cost		Market Value
		COMMON STOCKS — 96.9%
		Beverages — 2.4%
	60,000	China Mengniu Dairy Co. Ltd.	$	134,296	$	161,363
	26,743	Danone SA		1,503,013		1,732,406
	40,000	ITO EN Ltd.		954,106		1,214,752
	14,000	Morinaga Milk Industry Co. Ltd.		121,875		270,865
	5,000	PepsiCo Inc.		423,100		849,200
	30,000	Suntory Beverage & Food Ltd.		1,001,275		989,362
	424,000	Vitasoy International Holdings Ltd.		253,570		422,452
				4,391,235		5,640,400
		Biotechnology — 3.7%
	7,500	Bio-Rad Laboratories Inc., Cl. A†		3,215,659		2,421,675
	55,000	Catalent Inc.†		4,544,462		2,471,150
	8,300	Charles River Laboratories International Inc.†		1,759,702		1,962,120
	3,000	Idorsia Ltd.†		39,699		7,540
	3,600	Illumina Inc.†		272,208		501,264
	700	Incyte Corp.†		56,772		43,953
	1,200	Regeneron Pharmaceuticals Inc.†		452,649		1,053,948
	800	Waters Corp.†		144,196		263,384
				10,485,347		8,725,034
		Electronics — 1.8%
	8,150	Thermo Fisher Scientific Inc.		1,414,351		4,325,938

		Equipment and Supplies — 0.7%
	90,000	Owens & Minor Inc.†		1,740,172		1,734,300

		Food — 18.5%
	10,000	Calavo Growers Inc.		321,804		294,100
	40,000	Campbell Soup Co.		1,959,380		1,729,200
	15,000	Conagra Brands Inc.		422,042		429,900
	45,000	Flowers Foods Inc.		454,258		1,012,950
	15,000	General Mills Inc.		1,097,474		977,100
	25,000	Kellanova		1,277,740		1,397,750
	34,000	Kerry Group plc, Cl. A		1,304,283		2,968,963
	80,200	Kikkoman Corp.		986,007		4,910,970
	15,000	Lamb Weston Holdings Inc.		1,149,351		1,621,350
	10,000	Maple Leaf Foods Inc.		169,092		190,484
	30,000	MEIJI Holdings Co. Ltd.		310,384		712,553
	45,000	Mondelēz International Inc., Cl. A		1,824,489		3,259,350
	46,500	Nestlé SA		3,311,457		5,391,136
	45,000	Nomad Foods Ltd.†		831,419		762,750
	40,000	Post Holdings Inc.†		1,092,790		3,522,400

Shares			Cost		Market Value
	10,000	Sovos Brands Inc.†	$	124,309	$	220,300
	27,500	The J.M. Smucker Co.		2,572,692		3,475,450
	90,000	The Kraft Heinz Co.		3,566,885		3,328,200
	120,000	Tingyi (Cayman Islands) Holding Corp.		196,545		146,302
	45,000	TreeHouse Foods Inc.†		2,058,341		1,865,250
	60,000	Unilever plc, ADR		2,212,942		2,908,800
	10,550	WK Kellogg Co.		125,527		138,627
	124,000	Yakult Honsha Co. Ltd.		1,837,085		2,785,163
				29,206,296		44,049,048
		Food and Staples Retailing — 8.8%
	4,000	BARK Inc.†		30,439		3,222
	125,000	BellRing Brands Inc.†		2,219,020		6,928,750
	99,400	CVS Health Corp.		4,375,338		7,848,624
	30,000	Ingles Markets Inc., Cl. A		454,430		2,591,100
	13,000	Pets at Home Group plc		72,880		52,727
	20,000	Sprouts Farmers Market Inc.†		403,296		962,200
	50,000	The Kroger Co.		791,123		2,285,500
	6,000	United Natural Foods Inc.†		48,857		97,380
	9,000	Walgreens Boots Alliance Inc.		243,607		234,990
				8,638,990		21,004,493
		Health Care Equipment and Supplies — 20.5%
	500	Agilent Technologies Inc.		64,443		69,515
	130,000	Bausch + Lomb Corp.†		2,234,262		2,217,800
	55,000	Baxter International Inc.		2,881,159		2,126,300
	2,200	Becton Dickinson & Co.		524,122		536,426
	15,500	Boston Scientific Corp.†		89,110		896,055
	75,000	DENTSPLY SIRONA Inc.		3,404,577		2,669,250
	15,867	Electromed Inc.†		150,549		173,109
	800	Exact Sciences Corp.†		48,049		59,184
	7,000	Gerresheimer AG		298,976		729,104
	22,975	Globus Medical Inc., Cl. A†		844,937		1,224,338
	60,000	Halozyme Therapeutics Inc.†		2,884,105		2,217,600
	45,000	Henry Schein Inc.†		2,763,324		3,406,950
	800	Hologic Inc.†		57,920		57,160
	7,000	ICU Medical Inc.†		1,522,402		698,180
	182,000	InfuSystem Holdings Inc.†		1,422,953		1,918,280
	40,000	Integer Holdings Corp.†		2,193,700		3,963,200
	200	Intuitive Surgical Inc.†		65,290		67,472
	45,000	Lantheus Holdings Inc.†		2,627,940		2,790,000
	23,000	Medtronic plc		1,777,226		1,894,740
	15,000	Merit Medical Systems Inc.†		957,300		1,139,400
	1,400	Neogen Corp.†		33,155		28,154
	23,200	QuidelOrtho Corp.†		2,035,198		1,709,840
	500	Revvity Inc.		84,547		54,655
	30,473	Semler Scientific Inc.†		1,463,878		1,349,649
	46,392	Silk Road Medical Inc.†		1,272,545		569,230

See accompanying notes to financial statements.

The Gabelli Healthcare & Wellness^Rx Trust

Schedule of Investments (Continued) — December 31, 2023

Shares			Cost		Market Value
		COMMON STOCKS (Continued)
		Health Care Equipment and Supplies (Continued)
	25,000	Stericycle Inc.†	$	1,294,786	$	1,239,000
	14,000	Stryker Corp.		1,517,787		4,192,440
	17,000	SurModics Inc.†		478,044		617,950
	12,000	The Cooper Companies Inc.		1,891,881		4,541,280
	112,107	Treace Medical Concepts Inc.†		2,157,764		1,429,364
	34,400	Zimmer Biomet Holdings Inc.		3,541,576		4,186,480
				42,583,505		48,772,105
		Health Care Providers and Services — 21.1%
	160,000	Avantor Inc.†		3,693,338		3,652,800
	56,726	CareCloud Inc.†		388,986		86,224
	23,000	Cencora Inc.		3,108,625		4,723,740
	5,000	Chemed Corp.		2,255,276		2,923,750
	15,000	DaVita Inc.†		971,199		1,571,400
	5,551	DLH Holdings Corp.†		44,536		87,428
	11,200	Elevance Health Inc.		2,626,272		5,281,472
	192,500	Evolent Health Inc., Cl. A†		2,634,469		6,358,275
	15,585	Fortrea Holdings Inc.†		249,268		543,916
	20,300	HCA Healthcare Inc.		4,021,605		5,494,804
	500	IQVIA Holdings Inc.†		101,974		115,690
	15,985	Laboratory Corp. of America Holdings		1,562,078		3,633,231
	5,000	McKesson Corp.		311,487		2,314,900
	100	Medpace Holdings Inc.†		16,071		30,653
	170,603	Option Care Health Inc.†		1,730,793		5,747,615
	9,500	Orthofix Medical Inc.†		191,196		128,060
	55,053	PetIQ Inc.†		1,195,570		1,087,297
	500	Quest Diagnostics Inc.		75,022		68,940
	80,800	Tenet Healthcare Corp.†		2,108,126		6,106,056
	400	UnitedHealth Group Inc.		49,112		210,588
				27,335,003		50,166,839
		Household and Personal Products — 2.3%
	12,000	Church & Dwight Co. Inc.		774,331		1,134,720
	10,000	Colgate-Palmolive Co.		646,459		797,100
	60,000	Edgewell Personal Care Co.		1,794,131		2,197,800
	10,000	The Procter & Gamble Co.		770,075		1,465,400
				3,984,996		5,595,020
		Pharmaceuticals — 17.1%
	21,900	Abbott Laboratories		992,108		2,410,533
	47,000	AbbVie Inc.		5,241,350		7,283,590
	25,000	Achaogen Inc.†(a)		360		0
	35,611	AstraZeneca plc, ADR		1,946,881		2,398,401
	18,000	Bausch Health Cos. Inc.†		143,699		144,360
	66,800	Bristol-Myers Squibb Co.		3,094,045		3,427,508
	70,000	Elanco Animal Health Inc.†		1,913,398		1,043,000
	47,400	Johnson & Johnson		5,832,432		7,429,476
	19,500	Merck & Co. Inc.		756,044		2,125,890

Shares			Cost		Market Value
	65,000	Perrigo Co. plc	$	2,324,628	$	2,091,700
	71,625	Pfizer Inc.		2,172,170		2,062,084
	12,000	Roche Holding AG, ADR		250,095		434,760
	25,000	Teva Pharmaceutical Industries Ltd., ADR†		278,115		261,000
	20,400	The Cigna Group		2,983,524		6,108,780
	7,808	Vertex Pharmaceuticals Inc.†		1,761,477		3,176,997
	6,000	Viatris Inc.		88,320		64,980
	10,000	Zimvie Inc.†		78,840		177,500
	200	Zoetis Inc.		34,626		39,474
				29,892,112		40,680,033
		Specialty Chemicals — 0.0%
	700	International Flavors & Fragrances Inc.		60,637		56,679

		TOTAL COMMON STOCKS		159,732,644		230,749,889

		PREFERRED STOCKS — 0.1%
		Biotechnology — 0.1%
	5,600	XOMA Corp., Ser. A, 8.625%		127,311		142,800

		RIGHTS — 0.0%
		Biotechnology — 0.0%
	6,907	Tobira Therapeutics Inc., CVR†(a)		414		0

		Health Care Providers and Services — 0.0%
	38,284	Chinook Therapeutics Inc., CVR†		0		15,314

		Pharmaceuticals — 0.0%
	3,500	Ipsen SA/Clementia, CVR†(a)		4,725		0
	13,000	Paratek Pharmaceuticals Inc., CVR†		0		260
				4,725		260
		TOTAL RIGHTS		5,139		15,574

		WARRANTS — 0.0%
		Health Care Providers and Services — 0.0%
	420	Option Care Health Inc., Cl. A, expire 07/27/25†		384		1,549
	420	Option Care Health Inc., Cl. B, expire 07/27/25†		363		1,090
				747		2,639

See accompanying notes to financial statements.

The Gabelli Healthcare & Wellness^Rx Trust

Schedule of Investments (Continued) — December 31, 2023

Principal					Market
Amount			Cost		Value
		U.S. GOVERNMENT OBLIGATIONS — 3.0%
$	7,250,000	U.S. Treasury Bills, 5.244% to 5.414%††, 01/11/24 to 03/28/24	$	7,195,155	$	7,196,289

TOTAL INVESTMENTS — 100.0%			$	167,060,996		238,107,191

Other Assets and Liabilities (Net)						22,782

PREFERRED SHAREHOLDERS (5,332,000 preferred shares outstanding)						(53,320,000	)

NET ASSETS — COMMON SHAREHOLDERS (15,956,278 common shares outstanding)					$	184,809,973

NET ASSET VALUE PER COMMON SHARE ($184,809,973 ÷ 15,956,278 shares outstanding)					$	11.58

	(a)	Security is valued using significant unobservable inputs and is classified as Level 3 in the fair value hierarchy.
	†	Non-income producing security.
	††	Represents annualized yields at dates of purchase.

ADR

American Depositary Receipt

CVR

Contingent Value Right

Geographic Diversification	% of Total Investments			Market Value
North America		86.0	%	$	204,859,381
Europe		9.1			21,634,028
Japan		4.6			10,883,665
Asia/Pacific		0.3			730,117
Total Investments		100.0	%	$	238,107,191

See accompanying notes to financial statements.

The Gabelli Healthcare & Wellness^Rx Trust

Statement of Assets and Liabilities

December 31, 2023

Assets:
Investments, at value (cost $167,060,996)	$	238,107,191
Cash		2,368
Receivable for investments sold		336,120
Dividends receivable		436,130
Deferred offering expense		155,475
Prepaid expenses		6,470
Total Assets		239,043,754
Liabilities:
Foreign currency overdraft, at value (cost $384)		384
Distributions payable		31,842
Payable for Fund shares repurchased		179,767
Payable for investment advisory fees		208,112
Payable for payroll expenses		85,334
Payable for offering costs		42,593
Payable for accounting fees		3,750
Payable for preferred offering expenses		109,482
Series E Cumulative Preferred Stock, callable and mandatory redemption 12/26/25 (See Notes 2 and 6)		40,000,000
Series G Cumulative Preferred Shares, callable and mandatory redemption 06/26/25 (See Notes 2 and 6)		13,320,000
Other accrued expenses		252,517
Total Liabilities		54,233,781
Net Assets Attributable to Common Shareholders	$	184,809,973

Net Assets Attributable to Common Shareholders Consist of:
Paid-in capital	$	114,340,710
Total distributable earnings		70,469,263
Net Assets	$	184,809,973

Net Asset Value per Common Share:
($184,809,973 ÷ 15,956,278 shares outstanding at $0.001 par value; unlimited number of shares authorized)	$	11.58

Statement of Operations

For the Year Ended December 31, 2023

Investment Income:
Dividends (net of foreign withholding taxes of $77,882)	$	3,346,510
Interest		636,613
Total Investment Income		3,983,123
Expenses:
Investment advisory fees		2,559,266
Interest expense on preferred shares		2,774,044
Shareholder communications expenses		180,514
Payroll expenses		171,061
Shareholder services fees		105,945
Legal and audit fees		95,586
Trustees’ fees		80,450
Accounting fees		45,000
Custodian fees		27,444
Offering expense for issuance of preferred shares		23,809
Interest expense		388
Miscellaneous expenses		89,841
Total Expenses		6,153,348
Less:
Expenses paid indirectly by broker (See Note 5)		(2,369	)
Net Expenses		6,150,979
Net Investment Loss		(2,167,856	)

Net Realized and Unrealized Gain/(Loss) on Investments and Foreign Currency:
Net realized gain on investments		11,678,006
Net realized loss on foreign currency transactions		(1,358	)
Net realized gain on investments and foreign currency transactions		11,676,648
Net change in unrealized appreciation/depreciation:
on investments		(9,104,160	)
on foreign currency translations		18,170
Net change in unrealized appreciation/depreciation on investments and foreign currency translations		(9,085,990	)
Net Realized and Unrealized Gain/(Loss) on Investments and Foreign Currency		2,590,658
Net Increase in Net Assets Attributable to Common Shareholders Resulting from Operations	$	422,802

See accompanying notes to financial statements.

The Gabelli Healthcare & Wellness^Rx Trust

Statement of Changes in Net Assets Attributable to Common Shareholders

	Year Ended			Year Ended
	December 31, 2023			December 31, 2022
Operations:
Net investment loss	$	(2,167,856	)	$	(2,873,611	)
Net realized gain on investments and foreign currency transactions		11,676,648			11,529,079
Net change in unrealized appreciation/depreciation on investments and foreign currency translations		(9,085,990	)		(56,097,958	)
Net Increase/(Decrease) in Net Assets Attributable to Common Shareholders Resulting from Operations		422,802			(47,442,490	)

Distributions to Common Shareholders:
Accumulated earnings		(9,537,495	)		(10,190,611	)
Return of capital		(409,628	)		(69,324	)
Total Distributions to Common Shareholders		(9,947,123	)		(10,259,935	)

Fund Share Transactions:
Net decrease from repurchase of common shares		(10,118,752	)		(1,596,912	)
Offering costs for preferred shares charged to paid-in capital		(200,000	)		–
Net Decrease in Net Assets from Fund Share Transactions		(10,318,752	)		(1,596,912	)

Net Decrease in Net Assets Attributable to Common Shareholders		(19,843,073	)		(59,299,337	)

Net Assets Attributable to Common Shareholders:
Beginning of year		204,653,046			263,952,383
End of year	$	184,809,973		$	204,653,046

See accompanying notes to financial statements.

The Gabelli Healthcare & Wellness^Rx Trust

Statement of Cash Flows

December 31, 2023

Net increase in net assets attributable to common shareholders resulting from operations	$	422,802

Adjustments to Reconcile Net Increase in Net Assets Resulting from Operations to Net Cash from Operating Activities:
Purchase of long term investment securities		(50,469,871	)
Proceeds from sales of long term investment securities		50,401,906
Net sales of short term investment securities		7,031,375
Net realized gain on investments		(11,678,006	)
Net change in unrealized depreciation on investments		9,104,160
Net amortization of discount		(636,449	)
Decrease in receivable for investments sold		5,870,442
Increase in dividends receivable		(16,024	)
Increase in prepaid expenses		(2,739	)
Decrease in payable for investments purchased		(3,505,373	)
Increase in payable for offering costs		23,809
Decrease in payable for investment advisory fees		(32,652	)
Increase in payable for payroll expenses		40,625
Decrease in payable for accounting fees		(7,500	)
Increase in other accrued expenses		60,428
Net cash provided by operating activities		6,606,933

Net decrease in net assets resulting from financing activities:		(6,655,435	)
Issuance of Series G 5.200% Cumulative Preferred Stock		13,320,000
Offering costs for preferred shares charged to paid-in capital		(98,947	)
Distributions to common shareholders		(9,937,503	)
Repurchase of common shares		(9,938,985	)
Net cash used in financing activities		(6,655,435	)
Net decrease in cash		(48,502	)
Cash (including foreign currency):
Beginning of year		50,486
End of year	$	1,984

Supplemental disclosure of cash flow information and non-cash activities:
Interest paid on preferred shares	$	2,774,044
Interest paid on bank overdrafts		388

The following table provides a reconciliation of cash and foreign currency reported within the Statement of Assets and Liabilities that sum to the total of the same amount above at December 31, 2023:

Cash	$	2,368
Foreign currency overdraft, at value		(384	)
	$	1,984

See accompanying notes to financial statements.

The Gabelli Healthcare & Wellness^Rx Trust

Financial Highlights

Selected data for a common share of beneficial interest outstanding throughout each year:

	Year Ended December 31,
	2023			2022			2021			2020			2019
Operating Performance:
Net asset value, beginning of year	$	12.01		$	15.36		$	13.81		$	13.10		$	10.95
Net investment income/(loss)		(0.14	)		(0.17	)		(0.13	)		(0.00	)(a)		0.02
Net realized and unrealized gain/(loss) on investments and foreign currency transactions		0.22			(2.59	)		2.61			1.38			2.87
Total from investment operations		0.08			(2.76	)		2.48			1.38			2.89

Distributions to Preferred Shareholders: (b)
Net investment income		—			—			—			(0.00	)(a)		(0.01	)
Net realized gain		—			—			—			(0.14	)		(0.20	)
Total distributions to preferred shareholders		—			—			—			(0.14	)		(0.21	)

Net Increase/(Decrease) in Net Assets Attributable to Common Shareholders Resulting from Operations		0.08			(2.76	)		2.48			1.24			2.68

Distributions to Common Shareholders:
Net investment income		(0.04	)		(0.02	)		—			(0.01	)		(0.02	)
Net realized gain		(0.54	)		(0.57	)		(0.96	)		(0.57	)		(0.53	)
Return of capital		(0.02	)		(0.01	)		—			—			(0.01	)
Total distributions to common shareholders		(0.60	)		(0.60	)		(0.96	)		(0.58	)		(0.56	)

Fund Share Transactions:
Increase in net asset value from repurchase of common shares		0.10			0.01			0.03			0.06			0.03
Offering costs for preferred shares charged to paid-in capital		(0.01	)		—			—			—			—
Offering costs and adjustment to offering costs for common shares charged to paid-in capital		—			—			(0.00	)(a)		(0.01	)		—
Total Fund share transactions		0.09			0.01			0.03			0.05			0.03

Net Asset Value Attributable to Common Shareholders, End of Year	$	11.58		$	12.01		$	15.36		$	13.81		$	13.10
NAV total return †		1.56	%		(17.98	)%		18.47	%		10.82	%		25.22	%
Market value, end of year	$	9.33		$	10.28		$	13.57		$	11.95		$	11.52
Investment total return ††		(3.36	)%		(19.96	)%		22.04	%		9.94	%		31.16	%

Ratios to Average Net Assets and Supplemental Data:
Net assets including liquidation value of preferred shares, end of year (in 000’s)	$	238,130		$	244,653		$	343,952		$	282,174		$	305,775
Net assets attributable to common shares, end of year (in 000’s)	$	184,810		$	204,653		$	263,952		$	242,174		$	238,739
Ratio of net investment income/(loss) to average net assets attributable to common shares before preferred share distributions		(1.12	)%		(1.29	)%		(0.86	)%		(0.02	)%		0.20	%
Ratio of operating expenses to average net assets attributable to common shares (c)(d)		3.18	%		3.11	%		2.24	%		1.60	%		1.57	%
Portfolio turnover rate		21	%		14	%		29	%		15	%		25	%

See accompanying notes to financial statements.

The Gabelli Healthcare & Wellness^Rx Trust

Financial Highlights (Continued)

Selected data for a common share of beneficial interest outstanding throughout each year:


	Year Ended December 31,
	2023			2022			2021			2020			2019
Cumulative Preferred Shareholders:
5.760% Series A Preferred
Liquidation value, end of year (in 000’s)		—			—			—			—		$	30,000
Total shares outstanding (in 000’s)		—			—			—			—			1,200
Liquidation preference per share		—			—			—			—		$	25.00
Average market value (e)		—			—			—			—		$	25.86
Asset coverage per share (f)		—			—			—			—		$	114.03

5.875% Series B Preferred
Liquidation value, end of year (in 000’s)		—			—			—			—		$	37,036
Total shares outstanding (in 000’s)		—			—			—			—			1,481
Liquidation preference per share		—			—			—			—		$	25.00
Average market value (e)		—			—			—			—		$	26.03
Asset coverage per share (f)		—			—			—			—		$	114.03

4.000% Series C Preferred(g)
Liquidation value, end of year (in 000’s)		—			—		$	40,000		$	40,000			—
Total shares outstanding (in 000’s)		—			—			2,000			2,000			—
Liquidation preference per share		—			—		$	20.00		$	20.00			—
Average market value (e)		—			—		$	20.00		$	20.00			—
Asset coverage per share (f)		—			—		$	85.99		$	141.08			—

4.000% Series E Preferred
Liquidation value, end of year (in 000’s)	$	40,000		$	40,000		$	40,000			—			—
Total shares outstanding (in 000’s)		4,000			4,000			4,000			—			—
Liquidation preference per share	$	10.00		$	10.00		$	10.00			—			—
Average market value (e)	$	10.00		$	10.00		$	10.00			—			—
Asset coverage per share (f)	$	44.66		$	61.16		$	42.99			—			—

5.200% Series G Preferred
Liquidation value, end of year (in 000’s)	$	13,320			—			—			—			—
Total shares outstanding (in 000’s)		1,332			—			—			—			—
Liquidation preference per share	$	10.00			—			—			—			—
Average market value (e)	$	10.00			—			—			—			—
Asset coverage per share (f)	$	44.66			—			—			—			—
Asset Coverage (h)		447	%		612	%		430	%		705	%		456	%

	†	Based on net asset value per share, adjusted for reinvestment of distributions at the net asset value per share on ex-dividend dates including the effect of shares issued pursuant to the rights offerings, assuming full subscription by shareholders.
	††	Based on market value per share, adjusted for reinvestment of distributions at prices determined under the Fund’s dividend reinvestment plan including the effect of shares issued pursuant to the rights offerings, assuming full subscription by shareholders.
	(a)	Amount represents less than $0.005 per share.
	(b)	Calculated based on average common shares outstanding on the record dates throughout the years.
	(c)	The Fund received credits from a designated broker who agreed to pay certain Fund operating expenses. For all years presented, there was no impact on the expense ratios.
	(d)	Ratio of operating expenses to average net assets including liquidation value of preferred shares for the years ended December 31, 2023, 2022, 2021, 2020, and 2019 would have been 2.40%, 2.29%, 1.88%, 1.33%, and 1.21%, respectively.
	(e)	Based on weekly prices.
	(f)	Asset coverage per share is calculated by combining all series of preferred shares.
	(g)	The Fund redeemed and retired all of the 2,000,000 Shares of Series C Preferred on December 26, 2022.
	(h)	Asset coverage is calculated by combining all series of preferred shares.

See accompanying notes to financial statements.

The Gabelli Healthcare & Wellness^Rx Trust

Notes to Financial Statements

1. Organization. The Gabelli Healthcare & Wellness^Rx Trust (the Fund) was organized on February 20, 2007 as a Delaware statutory trust. The Fund is a diversified closed-end management investment company registered under the Investment Company Act of 1940, as amended (the 1940 Act). The Fund commenced investment operations on June 28, 2007.

The Fund’s investment objective is long term growth of capital. The Fund will invest at least 80% of its assets, under normal market conditions, in equity securities and income producing securities of domestic and foreign companies in the healthcare and wellness industries. As a result, the Fund may be more susceptible to economic, political, and regulatory developments in this particular sector of the market, positive or negative, and may experience increased volatility to the Fund’s NAV and a magnified effect in its total return.

2. Significant Accounting Policies. As an investment company, the Fund follows the investment company accounting and reporting guidance, which is part of U.S. generally accepted accounting principles (GAAP) that may require the use of management estimates and assumptions in the preparation of its financial statements. Actual results could differ from those estimates. The following is a summary of significant accounting policies followed by the Fund in the preparation of its financial statements.

Security Valuation. Portfolio securities listed or traded on a nationally recognized securities exchange or traded in the U.S. over-the-counter market for which market quotations are readily available are valued at the last quoted sale price or a market’s official closing price as of the close of business on the day the securities are being valued. If there were no sales that day, the security is valued at the average of the closing bid and asked prices or, if there were no asked prices quoted on that day, then the security is valued at the closing bid price on that day. If no bid or asked prices are quoted on such day, the security is valued at the most recently available price or, if the Board of Trustees (the Board) so determines, by such other method as the Board shall determine in good faith to reflect its fair market value. Portfolio securities traded on more than one national securities exchange or market are valued according to the broadest and most representative market, as determined by Gabelli Funds, LLC (the Adviser).

Portfolio securities primarily traded on a foreign market are generally valued at the preceding closing values of such securities on the relevant market, but may be fair valued pursuant to procedures established by the Board if market conditions change significantly after the close of the foreign market, but prior to the close of business on the day the securities are being valued. Debt obligations for which market quotations are readily available are valued at the average of the latest bid and asked prices. If there were no asked prices quoted on such day, the securities are valued using the closing bid price, unless the Board determines such amount does not reflect the securities’ fair value, in which case these securities will be fair valued as determined by the Board. Certain securities are valued principally using dealer quotations. Futures contracts are valued at the closing settlement price of the exchange or board of trade on which the applicable contract is traded. OTC futures and options on futures for which market quotations are readily available will be valued by quotations received from a pricing service or, if no quotations are available from a pricing service, by quotations obtained from one or more dealers in the instrument in question by the Adviser.

Securities and assets for which market quotations are not readily available are fair valued as determined by the Board. Fair valuation methodologies and procedures may include, but are not limited to: analysis and review of available financial and non-financial information about the company; comparisons with the valuation and changes in valuation of similar securities, including a comparison of foreign securities with the equivalent U.S.

The Gabelli Healthcare & Wellness^RxTrust

Notes to Financial Statements (Continued)

dollar value American Depositary Receipt securities at the close of the U.S. exchange; and evaluation of any other information that could be indicative of the value of the security.

The inputs and valuation techniques used to measure fair value of the Fund’s investments are summarized into three levels as described in the hierarchy below:

●

Level 1 — quoted prices in active markets for identical securities;

●

Level 2 — other significant observable inputs (including quoted prices for similar securities, interest rates, prepayment speeds, credit risk, etc.); and

●

Level 3 — significant unobservable inputs (including the Board’s determinations as to the fair value of investments).

A financial instrument’s level within the fair value hierarchy is based on the lowest level of any input both individually and in the aggregate that is significant to the fair value measurement. The inputs or methodology used for valuing securities are not necessarily an indication of the risk associated with investing in those securities. The summary of the Fund’s investments in securities by inputs used to value the Fund’s investments as of December 31, 2023 is as follows:

	Valuation Inputs
	Level 1 Quoted Prices		Level 2 Other Significant Observable Inputs		Level 3 Significant Unobservable Inputs (a)		Total Market Value at 12/31/23
INVESTMENTS IN SECURITIES:
ASSETS (Market Value):
Common Stocks:
Pharmaceuticals	$	40,680,033		—		—	$	40,680,033
Other Industries (b)		190,069,856		—		—		190,069,856
Total Common Stocks		230,749,889		—		—		230,749,889
Preferred Stocks (b)		142,800		—		—		142,800
Rights (b)		—	$	15,574	$	0		15,574
Warrants (b)		—		2,639		—		2,639
U.S. Government Obligations		—		7,196,289		—		7,196,289
TOTAL INVESTMENTS IN SECURITIES – ASSETS	$	230,892,689	$	7,214,502	$	0	$	238,107,191

	(a)	The inputs for these securities are not readily available and are derived based on the judgment of the Adviser according to procedures approved by the Board.
	(b)	Please refer to the Schedule of Investments for the industry classifications of these portfolio holdings.

During the year ended December 31, 2023, the Fund did not have material transfers into or out of Level 3. The Fund’s policy is to recognize transfers among Levels as of the beginning of the reporting period.

The Gabelli Healthcare & Wellness^Rx Trust

Notes to Financial Statements (Continued)

Additional Information to Evaluate Qualitative Information.

General. The Fund uses recognized industry pricing services – approved by the Board and unaffiliated with the Adviser – to value most of its securities, and uses broker quotes provided by market makers of securities not valued by these and other recognized pricing sources. Several different pricing feeds are received to value domestic equity securities, international equity securities, preferred equity securities, and fixed income securities. The data within these feeds are ultimately sourced from major stock exchanges and trading systems where these securities trade. The prices supplied by external sources are checked by obtaining quotations or actual transaction prices from market participants. If a price obtained from the pricing source is deemed unreliable, prices will be sought from another pricing service or from a broker/dealer that trades that security or similar securities.

Fair Valuation. Fair valued securities may be common or preferred equities, warrants, options, rights, or fixed income obligations. Where appropriate, Level 3 securities are those for which market quotations are not available, such as securities not traded for several days, or for which current bids are not available, or which are restricted as to transfer. When fair valuing a security, factors to consider include recent prices of comparable securities that are publicly traded, reliable prices of securities not publicly traded, the use of valuation models, current analyst reports, valuing the income or cash flow of the issuer, or cost if the preceding factors do not apply. A significant change in the unobservable inputs could result in a lower or higher value in Level 3 securities. The circumstances of Level 3 securities are frequently monitored to determine if fair valuation measures continue to apply.

The Adviser reports quarterly to the Board the results of the application of fair valuation policies and procedures. These may include backtesting the prices realized in subsequent trades of these fair valued securities to fair values previously recognized.

Series E and Series G Cumulative Preferred Stock. For financial reporting purposes only, the liquidation value of preferred stock that has a mandatory call date is classified as a liability within the Statement of Assets and Liabilities and the dividends paid on this preferred stock are included as a component of “Interest expense on preferred stock” within the Statement of Operations. Offering costs are amortized over the life of the preferred stock.

Investments in Other Investment Companies. The Fund may invest, from time to time, in shares of other investment companies (or entities that would be considered investment companies but are excluded from the definition pursuant to certain exceptions under the 1940 Act) (the Acquired Funds) in accordance with the 1940 Act and related rules. Shareholders in the Fund would bear the pro rata portion of the periodic expenses of the Acquired Funds in addition to the Fund’s expenses.

Foreign Currency Translations. The books and records of the Fund are maintained in U.S. dollars. Foreign currencies, investments, and other assets and liabilities are translated into U.S. dollars at current exchange rates. Purchases and sales of investment securities, income, and expenses are translated at the exchange rate prevailing on the respective dates of such transactions. Unrealized gains and losses that result from changes in foreign exchange rates and/or changes in market prices of securities have been included in unrealized appreciation/depreciation on investments and foreign currency translations. Net realized foreign currency gains and losses resulting from changes in exchange rates include foreign currency gains and losses between trade date and settlement date on investment securities transactions, foreign currency transactions, and the difference

The Gabelli Healthcare & Wellness^Rx Trust

Notes to Financial Statements (Continued)

between the amounts of interest and dividends recorded on the books of the Fund and the amounts actually received. The portion of foreign currency gains and losses related to fluctuation in exchange rates between the initial purchase trade date and subsequent sale trade date is included in realized gain/(loss) on investments.

Foreign Securities. The Fund may directly purchase securities of foreign issuers. Investing in securities of foreign issuers involves special risks not typically associated with investing in securities of U.S. issuers. The risks include possible revaluation of currencies, the inability to repatriate funds, less complete financial information about companies, and possible future adverse political and economic developments. Moreover, securities of many foreign issuers and their markets may be less liquid and their prices more volatile than securities of comparable U.S. issuers.

Foreign Taxes. The Fund may be subject to foreign taxes on income, gains on investments, or currency repatriation, a portion of which may be recoverable. The Fund will accrue such taxes and recoveries as applicable, based upon its current interpretation of tax rules and regulations that exist in the markets in which it invests.

Securities Transactions and Investment Income. Securities transactions are accounted for on the trade date with realized gain/(loss) on investments determined by using the identified cost method. Interest income (including amortization of premium and accretion of discount) is recorded on an accrual basis. Premiums and discounts on debt securities are amortized using the effective yield to maturity method or amortized to earliest call date, if applicable. Dividend income is recorded on the ex-dividend date, except for certain dividends from foreign securities that are recorded as soon after the ex-dividend date as the Fund becomes aware of such dividends.

Custodian Fee Credits and Interest Expense. When cash balances are maintained in the custody account, the Fund receives credits which are used to offset custodian fees. The gross expenses paid under the custody arrangement are included in custodian fees in the Statement of Operations with the corresponding expense offset, if any, shown as “Custodian fee credits.” When cash balances are overdrawn, the Fund is charged an overdraft fee of 110% of the 90 day U.S. Treasury Bill rate on outstanding balances. This amount, if any, would be included in the Statement of Operations.

Distributions to Stockholders. Distributions to common shareholders are recorded on the ex-dividend date. Distributions to shareholders are based on income and capital gains as determined in accordance with federal income tax regulations, which may differ from income and capital gains as determined under GAAP. These differences are primarily due to differing treatments of income and gains on various investment securities and foreign currency transactions held by the Fund, timing differences, and differing characterizations of distributions made by the Fund. Distributions from net investment income for federal income tax purposes include net realized gains on foreign currency transactions. These book/tax differences are either temporary or permanent in nature. To the extent these differences are permanent, adjustments are made to the appropriate capital accounts in the period when the differences arise. Permanent differences were primarily due to the redesignation of dividends paid and disallowed expenses. These reclassifications have no impact on the NAV of the Fund. For the year ended December 31, 2023, reclassifications were made to decrease paid-in capital by $34,590, with an offsetting adjustment to total distributable earnings.

Distributions to shareholders of the Fund’s Series E Cumulative Preferred Shares and Series G Cumulative Preferred Shares (Series E Preferred and Series G Preferred) are recorded on a daily basis and are determined as described in Note 6.

The Gabelli Healthcare & Wellness^Rx Trust

Notes to Financial Statements (Continued)

The Fund declares and pays quarterly distributions from net investment income, capital gains, and paid-in capital. The actual source of the distribution is determined after the end of the year. Distributions during the year may be made in excess of required distributions. To the extent such distributions are made from current earnings and profits, they are considered ordinary income or long term capital gains. Distributions sourced from paid-in capital should not be considered as dividend yield or the total return from an investment in the Fund. The Board will continue to monitor the Fund’s distribution level, taking into consideration the Fund’s NAV and the financial market environment. The Fund’s distribution policy is subject to modification by the Board at any time.

The tax character of distributions paid during the years ended December 31, 2023 and 2022 was as follows:

	Year Ended December 31, 2023		Year Ended December 31, 2022
	Common		Common
Distributions paid from:
Ordinary income (inclusive of short term capital gains)	$	651,310	$	—
Net long term capital gains		8,886,185		10,190,611
Return of capital		409,628		69,324
Total distributions paid	$	9,947,123	$	10,259,935

Provision for Income Taxes. The Fund intends to continue to qualify as a regulated investment company under Subchapter M of the Internal Revenue Code of 1986, as amended (the Code). It is the policy of the Fund to comply with the requirements of the Code applicable to regulated investment companies and to distribute substantially all of its net investment company taxable income and net capital gains. Therefore, no provision for federal income taxes is required.

At December 31, 2023, the components of accumulated earnings/losses on a tax basis were as follows:

Net unrealized appreciation on investments and foreign currency translations	$	70,501,105
Other temporary differences*		(31,842	)
Total	$	70,469,263

Other temporary differences are due to preferred share class distributions payable.

At December 31, 2023, the temporary differences between book basis and tax basis net unrealized appreciation on investments were primarily due to deferral of losses on wash sales for tax purposes.

The following summarizes the tax cost of investments and the related net unrealized appreciation at December 31, 2023:

Cost

Gross
Unrealized
Appreciation

Gross
Unrealized
Depreciation

Net

Unrealized
Appreciation

Investments

167,626,191

83,212,312

(12,731,312

)

70,481,000

The Fund is required to evaluate tax positions taken or expected to be taken in the course of preparing the Fund’s tax returns to determine whether the tax positions are “more-likely-than-not” of being sustained by the applicable tax authority. Income tax and related interest and penalties would be recognized by the Fund as tax

The Gabelli Healthcare & Wellness^Rx Trust

Notes to Financial Statements (Continued)

expense in the Statement of Operations if the tax positions were deemed not to meet the more-likely-than-not threshold. As of December 31, 2023, the Adviser has reviewed all open tax years and concluded that there was no impact to the Fund’s net assets or results of operations. The Fund’s federal and state tax returns for the prior three fiscal years remain open, subject to examination. On an ongoing basis, the Adviser will monitor the Fund’s tax positions to determine if adjustments to this conclusion are necessary.

3. Investment Advisory Agreement and Other Transactions. The Fund has entered into an investment advisory agreement (the Advisory Agreement) with the Adviser which provides that the Fund will pay the Adviser a fee, computed weekly and paid monthly, equal on an annual basis to 1.00% of the value of the Fund’s average weekly net assets including the liquidation value of preferred shares. In accordance with the Advisory Agreement, the Adviser provides a continuous investment program for the Fund’s portfolio and oversees the administration of all aspects of the Fund’s business and affairs.

4. Portfolio Securities. Purchases and sales of securities during the year ended December 31, 2023, other than short term securities and U.S. Government obligations, aggregated to $50,481,592 and $50,239,850, respectively. Purchases and sales of U.S. Government obligations for the year ended December 31, 2023, aggregated $106,687,503 and $113,718,878, respectively.

5. Transactions with Affiliates and Other Arrangements. During the year ended December 31, 2023, the Fund paid $1,686 in brokerage commissions on security trades to G.research, LLC, an affiliate of the Adviser.

During the year ended December 31, 2023, the Fund received credits from a designated broker who agreed to pay certain Fund operating expenses. The amount of such expenses paid through this directed brokerage arrangement during this period was $2,369.

The cost of calculating the Fund’s NAV per share is a Fund expense pursuant to the Advisory Agreement. Under the sub-administration agreement with Bank of New York Mellon, the fees paid include the cost of calculating the Fund’s NAV. The Fund reimburses the Adviser for this service. During the year ended December 31, 2023, the Fund accrued $45,000 in accounting fees in the Statement of Operations.

As per the approval of the Board, the Fund compensates officers of the Fund, who are employed by the Fund and are not employed by the Adviser (although the officers may receive incentive based variable compensation from affiliates of the Adviser). During the year ended December 31, 2023, the Fund accrued $171,061 in payroll expenses in the Statement of Operations.

The Fund pays retainer and per meeting fees to Trustees not affiliated with the Adviser, plus specified amounts to the Lead Trustee and Audit Committee Chairman. Trustees are also reimbursed for out of pocket expenses incurred in attending meetings. Trustees who are directors or employees of the Adviser or an affiliated company receive no compensation or expense reimbursement from the Fund.

6. Capital. The Fund is authorized to issue an unlimited number of shares of beneficial interest (par value $0.001). The Board has authorized the repurchase of its shares on the open market when the shares are trading on the NYSE at a discount of 10% or more (or such other percentage as the Board may determine from time to time) from the NAV of the shares. During the years ended December 31, 2023 and December 31, 2022, the Fund repurchased and retired 1,081,299 and 143,380 common shares in the open market at investments of $10,118,752 and $1,596,912, respectively, at average discounts of approximately 18.00% and 13.02% from its NAV.

The Gabelli Healthcare & Wellness^Rx Trust

Notes to Financial Statements (Continued)

Transactions in shares of beneficial interest were as follows:

	Year Ended December 31, 2023						Year Ended December 31, 2022
	Shares			Amount			Shares			Amount
Net decrease from repurchase of common shares		(1,081,299	)	$	(10,118,752	)		(143,380	)	$	(1,596,912	)

The Fund’s Declaration of Trust, as amended, authorizes the issuance of an unlimited number of shares of $0.001 par value Preferred Shares. The Preferred Shares are senior to the common shares and result in the financial leveraging of the common shares. Such leveraging tends to magnify both the risks and opportunities to common shareholders. Dividends on Preferred Shares are cumulative. The Fund is required by the 1940 Act and by the Statement of Preferences to meet certain asset coverage tests with respect to the Preferred Shares. If the Fund fails to meet these requirements and does not correct such failure, the Fund may be required to redeem, in part or in full, the Preferred Shares at their liquidation preference plus an amount equal to the accumulated and unpaid dividends whether or not declared on such shares in order to meet these requirements. Additionally, failure to meet the foregoing asset coverage requirements could restrict the Fund’s ability to pay dividends to common shareholders and could lead to sales of portfolio securities at inopportune times. The income received on the Fund’s assets may vary in a manner unrelated to the fixed rates, which could have either a beneficial or detrimental impact on net investment income and gains available to common shareholders.

As of December 31, 2023 the Fund had an effective shelf registration authorizing the issuance of $200 million in common or preferred shares.

On December 18, 2020, the Fund issued 2,000,000 shares of Series C 4.00% Cumulative Preferred Shares receiving $39,841,048 after the deduction of offering expenses of $158,952. The Series C Preferred had a liquidation value of $20 per share, an annual dividend rate of 4.00%, and was subject to mandatory redemption by the Fund on December 18, 2024.

On December 26, 2022, 2,000,000 Shares of the Series C were put back to the Fund at their liquidation preference of $20 per share plus accrued and unpaid dividends.

On October 15, 2021, the Fund issued 4,000,000 shares of Series E 4.00% Cumulative Preferred Shares receiving $39,875,000 after the deduction of actual offering expenses of $100,000. The Series E Preferred has a liquidation value of $10 per share and an annual dividend rate of 4.00%. The Series E Preferred Shares are callable at the Fund’s option at any time commencing on December 26, 2024 and thereafter. The Series E Preferred Shares are puttable on June 26, 2024. The Series E Preferred is subject to mandatory redemption by the Fund on December 26, 2025. At December 31, 2023, 4,000,000 shares of Series E Preferred were outstanding and accrued dividends amounted to $22,222.

On January 18, 2023, and February 1, 2023, the Fund issued 2,100,000 shares and 295,500 shares, respectively, of Series G 5.20% Cumulative Preferred Shares receiving $23,755,000 after the deduction of actual offering expenses of $200,000. The Series G Preferred has a liquidation value of $10 per share and an annual dividend rate of 5.20%. The Series G Preferred Shares are puttable on June 26, 2024 and December 26,

The Gabelli Healthcare & Wellness^Rx Trust

Notes to Financial Statements (Continued)

2024. On December 26, 2023, 1,098,500 shares were put back to the Fund at their liquidation preference plus accumulated and unpaid dividends, leaving 1,297,000 shares. The Fund issued 35,000 shares on December 26, 2023, receiving $345,000 after the deduction of estimated offering expenses. The Series G Preferred is subject to mandatory redemption by the Fund on June 26, 2025. At December 31, 2023, 1,332,000 shares of Series G Preferred were outstanding and accrued dividends amounted to $9,620.

Series	Issue Date	Authorized		Number of Shares Outstanding at 12/31/2023		Net Proceeds		2023 Dividend Rate Range	Dividend Rate at 12/31/2023			Accrued Dividends at 12/31/2023
E 4.000%	October 15, 2021		4,000,000		4,000,000	$	39,875,000	Fixed Rate		4.000	%	$	22,222
G 5.200%	Various		2,395,500		1,332,000	$	23,755,000	Fixed Rate		5.200	%	$	9,620

The holders of Preferred Shares generally are entitled to one vote per share held on each matter submitted to a vote of shareholders of the Fund and will vote together with holders of common stock as a single class. The holders of Preferred Shares voting together as a single class also have the right currently to elect two Trustees and under certain circumstances are entitled to elect a majority of the Board. In addition, the affirmative vote of a majority of the votes entitled to be cast by holders of all outstanding shares of the Preferred Shares, voting as a single class, will be required to approve any plan of reorganization adversely affecting the Preferred Shares, and the approval of two-thirds of each class, voting separately, of the Fund’s outstanding voting stock must approve the conversion of the Fund from a closed-end to an open-end investment company. The approval of a majority (as defined in the 1940 Act) of the outstanding Preferred Shares and a majority (as defined in the 1940 Act) of the Fund’s outstanding voting securities are required to approve certain other actions, including changes in the Fund’s investment objectives or fundamental investment policies.

7. Industry Concentration. Because the Fund primarily invests in common stocks and other securities of foreign and domestic companies in the health care, pharmaceuticals, and food and beverage industries, its portfolio may be subject to greater risk and market fluctuations than a portfolio of securities representing a broad range of investments.

8. Indemnifications. The Fund enters into contracts that contain a variety of indemnifications. The Fund’s maximum exposure under these arrangements is unknown. However, the Fund has not had prior claims or losses pursuant to these contracts. Management has reviewed the Fund’s existing contracts and expects the risk of loss to be remote.

9. Subsequent Events. On January 6, 2024 and on February 29, 2024, the Fund issued 100,000 shares of Series G Preferred and 810,000 shares of Series G Preferred, respectively, receiving $990,000 and $8,080,000, respectively, after deduction of estimated offering expenses.

Effective February 12, 2024, the dividend rate on GRX Preferred E shares increased to 5.200%. Management has evaluated the impact on the Fund of all other subsequent events occurring through the date the financial statements were issued and has determined that there were no other subsequent events requiring recognition or disclosure in the financial statements.

The Gabelli Healthcare & Wellness^Rx Trust

Report of Independent Registered Public Accounting Firm

To the Board of Trustees and Shareholders of

The Gabelli Healthcare & Wellness^Rx Trust

Opinion on the Financial Statements

We have audited the accompanying statement of assets and liabilities, including the schedule of investments, of The Gabelli Healthcare & Wellness^Rx Trust (the “Fund”) as of December 31, 2023, the related statements of operations and cash flows for the year ended December 31, 2023, the statement of changes in net assets attributable to common shareholders for each of the two years in the period ended December 31, 2023, including the related notes, and the financial highlights for each of the five years in the period ended December 31, 2023 (collectively referred to as the “financial statements”). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Fund as of December 31, 2023, the results of its operations and its cash flows for the year then ended, the changes in its net assets attributable to common shareholders for each of the two years in the period ended December 31, 2023, and the financial highlights for each of the five years in the period ended December 31, 2023 in conformity with accounting principles generally accepted in the United States of America.

Basis for Opinion

These financial statements are the responsibility of the Fund’s management. Our responsibility is to express an opinion on the Fund’s financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (“PCAOB”) and are required to be independent with respect to the Fund in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audits of these financial statements in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud.

Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. Our procedures included confirmation of securities owned as of December 31, 2023, by correspondence with the custodian. We believe that our audits provide a reasonable basis for our opinion.

/s/ PricewaterhouseCoopers LLP

New York, New York

February 29, 2024

We have served as the auditor of one or more investment companies in the Gabelli Fund Complex since 1986.

The Gabelli Healthcare & Wellness^Rx Trust

Additional Fund Information (Unaudited)

Summary of Updated Information Regarding the Fund

The following includes information that is incorporated by reference in the Fund’s Registration Statement and is also a summary of certain changes during the most recent fiscal year ended December 31, 2023. This information may not reflect all of the changes that have occurred since you purchased shares of the Fund.

Investment Objective and Strategies

During the Fund’s most recent fiscal year, there were no material changes to the Fund’s investment objectives or policies that have not been approved by shareholders or in the principal risk factors associated with an investment in the Fund.

Investment Objective

The Fund will invest primarily in equity securities of companies in the healthcare and wellness industries. However, the Fund may also invest in debt securities of any quality, any maturity and any duration of such companies when it appears that the Fund will be better able to achieve its investment objective through investments in such securities or when the Fund is temporarily in a defensive position. The remaining 20% of the Fund’s assets may be invested in other securities, including stocks, debt obligations (such as U.S. Treasury securities) and money market instruments, as well as certain derivative instruments. Moreover, should extraordinary conditions affecting such sectors or securities markets as a whole warrant, the Fund may temporarily be primarily invested in money market instruments. These factors may change rapidly. The Fund emphasizes quality in selecting healthcare and wellness investments, and looks for companies that have sound financial structures and

The Gabelli Healthcare & Wellness^Rx Trust

Additional Fund Information (Continued) (Unaudited)

identifiable growth prospects. Believing that demographic trends will affect global market opportunities, the Fund intends to position itself to take advantage of these trends.

The Fund may invest up to 10% of its total assets in fixed-income securities rated below investment grade by recognized statistical rating agencies or unrated securities of comparable quality. These securities, which may be preferred stock or debt, are predominantly speculative and involve major risk exposure to adverse conditions. Debt securities that are not rated or that are rated lower than “BBB” by Standard & Poor’s Ratings Services, a Division of The McGraw-Hill Companies, Inc., or lower than “Baa” by Moody’s Investors Services, Inc. are referred to in the financial press as “junk bonds.”

The Fund may invest without limitation in securities of foreign issuers, which generally are denominated in foreign currencies, and may include issuers in emerging markets. Foreign investments may involve certain risk and opportunity considerations not typically associated with investing in domestic issuers and could cause the Fund to be affected favorably or unfavorably by changes in currency exchange rates and revaluations of currencies.

The average duration and average maturity of the Fund’s investments in debt securities will vary from time to time depending on the views of Gabelli Funds, LLC (the “Investment Adviser”). Duration is a mathematical calculation of the average life of a bond that serves as a measure of its price risk. Each year of duration represents an expected 1% change in the value of a debt security for every 1% immediate change in interest rates. See “Risk Factors and Special Considerations — Fixed Income Securities — Duration and Maturity Risk.”

No assurance can be given that the Fund’s investment objective will be achieved.

Investment Methodology of the Fund

In selecting securities for the Fund, the Investment Adviser normally will consider the following factors, among others:

●

the Investment Adviser’s own evaluations of the private market value (as defined below), cash flow, earnings per share and other fundamental aspects of the underlying assets and business of the company;

●

the potential for capital appreciation of the securities;

●

the interest or dividend income generated by the securities;

●

the prices of the securities relative to other comparable securities;

●

whether the securities are entitled to the benefits of call protection or other protective covenants;

●

the existence of any anti-dilution protections or guarantees of the security; and

●

the diversification of the portfolio of the Fund as to issuers.

The Investment Adviser’s investment philosophy with respect to equity securities is to identify assets that are selling in the public market at a discount to their private market value. The Investment Adviser defines private market value as the value informed purchasers are willing to pay to acquire assets with similar characteristics. The Investment Adviser also normally evaluates an issuer’s free cash flow and long-term earnings trends. Finally, the Investment Adviser looks for a catalyst, something indigenous to the company, its industry or country, that will surface additional value.

The Gabelli Healthcare & Wellness^Rx Trust

Additional Fund Information (Continued) (Unaudited)

The Fund’s investment objective of long term growth of capital is a fundamental policy of the Fund. The Fund’s policy of concentration in companies in the healthcare and wellness industries is also a fundamental policy of the Fund. Under the 1940 Act, a fundamental policy may not be changed without the vote of a majority, as defined in the 1940 Act, of the outstanding voting securities of the Fund (voting together as a single class).

Certain Investment Practices

Special Situations. Although the Fund typically invests in the securities of companies on the basis of fundamental value, the Fund from time to time may, as a non-principal investment strategy, invest in companies that are determined by the Investment Adviser to possess “special situation” characteristics. In general, a special situation company is a company whose securities are expected to increase in value solely by reason of a development particularly or uniquely applicable to the company. Developments that may create special situations include, among others, a liquidation, reorganization, recapitalization or merger, material litigation, technological breakthrough or new management or management policies. The principal risk associated with investments in special situation companies is that the anticipated development thought to create the special situation may not occur and the investment therefore may not appreciate in value or may decline in value.

Temporary Investments. Subject to the Fund’s investment restrictions, when a temporary defensive period is believed by the Investment Adviser to be warranted (“temporary defensive periods”), the Fund may, without limitation, hold cash or invest its assets in securities of United States government sponsored instrumentalities, including U.S. Treasury securities, in repurchase agreements in respect of those instruments, and in certain high-grade commercial paper instruments. During temporary defensive periods, the Fund may also invest in money market mutual funds that invest primarily in securities of United States government sponsored instrumentalities and repurchase agreements in respect of those instruments. Obligations of certain agencies and instrumentalities of the United States government, such as the Government National Mortgage Association, are supported by the “full faith and credit” of the United States government; others, such as those of the Export-Import Bank of the United States, are supported by the right of the issuer to borrow from the United States Treasury; others, such as those of the Federal National Mortgage Association, are supported by the discretionary authority of the United States government to purchase the agency’s obligations; and still others, such as those of the Student Loan Marketing Association, are supported only by the credit of the instrumentality. No assurance can be given that the United States government would provide financial support to United States government sponsored instrumentalities if it is not obligated to do so by law. During temporary defensive periods, the Fund may not achieve its investment objective.

Options. On behalf of the Fund, the Investment Adviser may, subject to the guidelines of the Board and Securities and Exchange Commission (“SEC”) or staff guidance and any other applicable regulatory authority, purchase or sell (i.e., write) options on securities, securities indices and foreign currencies which are listed on a national securities exchange or in the U.S. over-the-counter (“OTC”) markets as a means of achieving additional return or of hedging the value of the Fund’s portfolio.

The Fund may write covered call options on common stocks that it owns or has an immediate right to acquire through conversion or exchange of other securities in an amount not to exceed 25% of its total assets or invest up to 10% of its total assets in the purchase of put options on common stocks that the Fund owns or may acquire through the conversion or exchange of other securities that it owns.

The Gabelli Healthcare & Wellness^Rx Trust

Additional Fund Information (Continued) (Unaudited)

A call option is a contract that gives the holder of the option the right to buy from the writer (seller) of the call option, in return for a premium paid, the security underlying the option at a specified exercise price at any time during the term of the option. The writer of the call option has the obligation, upon exercise of the option, to deliver the underlying security upon payment of the exercise price during the option period.

A put option is a contract that gives the holder of the option the right to sell to the writer (seller), in return for the premium, the underlying security at a specified price during the term of the option. The writer of the put, who receives the premium, has the obligation to buy the underlying security upon exercise, at the exercise price during the option period.

If the Fund has written an option, it may terminate its obligation by effecting a closing purchase transaction. This is accomplished by purchasing an option of the same series as the option previously written. There can be no assurance that a closing purchase transaction can be effected when the Fund so desires.

An exchange-traded option may be closed out only on an exchange which provides a secondary market for an option of the same series. Although the Fund will generally purchase or write only those options for which there appears to be an active secondary market, there is no assurance that a liquid secondary market on an exchange will exist for any particular option.

A call option is “covered” if the Fund owns the underlying instrument covered by the call or has an absolute and immediate right to acquire that instrument without additional cash consideration upon conversion or exchange of another instrument held in its portfolio (or for additional cash consideration held in a segregated account by its custodian). A call option is also covered if the Fund holds a call on the same instrument as the call written where the exercise price of the call held is (i) equal to or less than the exercise price of the call written or (ii) greater than the exercise price of the call written if the difference is maintained by the Fund in cash, U.S. government obligations or other high-grade short term obligations in a segregated account with its custodian. A put option is “covered” if the Fund maintains cash or other high-grade short term obligations with a value equal to the exercise price in a segregated account with its custodian, or else holds a put on the same instrument as the put written where the exercise price of the put held is equal to or greater than the exercise price of the put written. If the Fund has written an option, it may terminate its obligation by effecting a closing purchase transaction. This is accomplished by purchasing an option of the same series as the option previously written. However, once the Fund has been assigned an exercise notice, it will be unable to effect a closing purchase transaction. Similarly, if the Fund is the holder of an option, it may liquidate its position by effecting a closing sale transaction. This is accomplished by selling an option with the same terms as the option previously purchased. There can be no assurance that either a closing purchase or sale transaction can be effected when the Fund so desires.

The Fund will realize a profit from a closing transaction if the price of the transaction is less than the premium it received from writing the option or is more than the premium it paid to purchase the option; the Fund will realize a loss from a closing transaction if the price of the transaction is more than the premium it received from writing the option or is less than the premium it paid to purchase the option. Since call option prices generally reflect increases in the price of the underlying security, any loss resulting from the repurchase of a call option may also be wholly or partially offset by unrealized appreciation of the underlying security. Other principal factors affecting the market value of a put or a call option include supply and demand, interest rates, the current market price and price volatility of the underlying security and the time remaining until the expiration date. Gains and losses

The Gabelli Healthcare & Wellness^Rx Trust

Additional Fund Information (Continued) (Unaudited)

on investments in options depend, in part, on the ability of the Investment Adviser to predict correctly the effect of these factors. The use of options cannot serve as a complete hedge since the price movement of securities underlying the options will not necessarily follow the price movements of the portfolio securities subject to the hedge.

An option position may be closed out only on an exchange that provides a secondary market for an option with the same terms or in a private transaction. Although the Fund will generally purchase or write only those options for which there appears to be an active secondary market, there is no assurance that a liquid secondary market on an exchange will exist for any particular option. In such event, it might not be possible to effect closing transactions in particular options, so that the Fund would have to exercise its options in order to realize any profit and would incur brokerage commissions upon the exercise of call options and upon the subsequent disposition of underlying securities for the exercise of put options. If the Fund, as a covered call option writer, is unable to effect a closing purchase transaction in a secondary market, it will not be able to sell the underlying security until the option expires or it delivers the underlying security upon exercise or otherwise covers the position.

In addition to options on securities, the Fund may also purchase and sell call and put options on securities indices. A stock index reflects in a single number the market value of many different stocks. Relative values are assigned to the stocks included in an index and the index fluctuates with changes in the market values of the stocks. The options give the holder the right to receive a cash settlement during the term of the option based on the difference between the exercise price and the value of the index. By writing a put or call option on a securities index, the Fund is obligated, in return for the premium received, to make delivery of this amount. The Fund may offset its position in the stock index options prior to expiration by entering into a closing transaction on an exchange or it may let the option expire unexercised.

The Fund may also buy or sell put and call options on foreign currencies. A put option on a foreign currency gives the purchaser of the option the right to sell a foreign currency at the exercise price until the option expires. A call option on a foreign currency gives the purchaser of the option the right to purchase the currency at the exercise price until the option expires. Currency options traded on U.S. or other exchanges may be subject to position limits which may limit the ability of the Fund to reduce foreign currency risk using such options. OTC options differ from exchange-traded options in that they are two-party contracts with price and other terms negotiated between buyer and seller and generally do not have as much market liquidity as exchange-traded options. OTC options are considered illiquid securities.

Use of options on securities indices entails the risk that trading in the options may be interrupted if trading in certain securities included in the index is interrupted. The Fund will not purchase these options unless the Investment Adviser is satisfied with the development, depth and liquidity of the market and the Investment Adviser believes the options can be closed out.

Price movements in the portfolio of the Fund may not correlate precisely with the movements in the level of an index and, therefore, the use of options on indices cannot serve as a complete hedge and will depend, in part, on the ability of the Investment Adviser to predict correctly movements in the direction of the stock market generally or of a particular industry. Because options on securities indices require settlement in cash, the Fund may be forced to liquidate portfolio securities to meet settlement obligations.

The Gabelli Healthcare & Wellness^Rx Trust

Additional Fund Information (Continued) (Unaudited)

Although the Investment Adviser will attempt to take appropriate measures to minimize the risks relating to the Fund’s writing of put and call options, there can be no assurance that the Fund will succeed in any option writing program it undertakes.

Futures Contracts and Options on Futures. A “sale” of a futures contract (or a “short” futures position) means the assumption of a contractual obligation to deliver the assets underlying the contract at a specified price at a specified future time. A “purchase” of a futures contract (or a “long” futures position) means the assumption of a contractual obligation to acquire the assets underlying the contract at a specified price at a specified future time. Certain futures contracts, including stock and bond index futures, are settled on a net cash payment basis rather than by the sale and delivery of the assets underlying the futures contracts. No consideration will be paid or received by the Fund upon the purchase or sale of a futures contract. Initially, the Fund will be required to deposit with the broker an amount of cash or cash equivalents equal to approximately 1% to 10% of the contract amount (this amount is subject to change by the exchange or board of trade on which the contract is traded and brokers or members of such board of trade may charge a higher amount). This amount is known as “initial margin” and is in the nature of a performance bond or good faith deposit on the contract. Subsequent payments, known as “variation margin,” to and from the broker will be made daily as the price of the index or security underlying the futures contract fluctuates. At any time prior to the expiration of a futures contract, the Fund may close the position by taking an opposite position, which will operate to terminate its existing position in the contract.

An option on a futures contract gives the purchaser the right, in return for the premium paid, to assume a position in a futures contract at a specified exercise price at any time prior to the expiration of the option. Upon exercise of an option, the delivery of the futures position by the writer of the option to the holder of the option will be accompanied by delivery of the accumulated balance in the writer’s futures margin account attributable to that contract, which represents the amount by which the market price of the futures contract exceeds, in the case of a call option, or is less than, in the case of a put option, the exercise price of the option on the futures contract. The potential loss related to the purchase of an option on a futures contract is limited to the premium paid for the option (plus transaction costs). Because the value of the option purchased is fixed at the point of sale, there are no daily cash payments by the purchaser to reflect changes in the value of the underlying contract; however, the value of the option does change daily and that change would be reflected in the net assets of the Fund.

Futures and options on futures entail certain risks, including but not limited to the following: no assurance that futures contracts or options on futures can be offset at favorable prices, possible reduction of the yield of the Fund due to the use of hedging, possible reduction in value of both the securities hedged and the hedging instrument, possible lack of liquidity due to daily limits on price fluctuations, imperfect correlation between the contracts and the securities being hedged and losses from investing in futures transactions that are potentially unlimited.

The Investment Adviser has claimed an exclusion, granted to operators of registered investment companies like the Fund, from registration as a commodity pool operator (“CPO”) with respect to the Fund under the Commodity Exchange Act (the “CEA”), and, therefore, is not subject to registration or regulation with respect to the Fund under the CEA. As a result, the Fund is limited in its ability to use commodity futures (which include futures on broad-based securities indices and interest rate futures) or options on commodity futures, engage in certain swaps transactions or make certain other investments (whether directly or indirectly through investments in

The Gabelli Healthcare & Wellness^Rx Trust

Additional Fund Information (Continued) (Unaudited)

other investment vehicles) for purposes other than “bona fide hedging,” as defined in the rules of the Commodity Futures Trading Commission. With respect to transactions other than for bona fide hedging purposes, either: (1) the aggregate initial margin and premiums required to establish the Fund’s positions in such investments may not exceed 5% of the liquidation value of its portfolio (after accounting for unrealized profits and unrealized losses on any such investments); or (2) the aggregate net notional value of such instruments, determined at the time the most recent position was established, may not exceed 100% of the liquidation value of its portfolio (after accounting for unrealized profits and unrealized losses on any such positions). In addition to meeting one of the foregoing trading limitations, the Fund may not market itself as a commodity pool or otherwise as a vehicle for trading in the futures, options or swaps markets. If the Investment Adviser were required to register as a CPO with respect to the Fund, compliance with additional registration and regulatory requirements would increase Fund expenses. Other potentially adverse regulatory initiatives could also develop.

Interest Rate Futures Contracts and Options Thereon. The Fund may purchase or sell interest rate futures contracts to take advantage of, or to protect against, fluctuations in interest rates affecting the value of debt securities which the Fund holds or intends to acquire. For example, if interest rates are expected to increase, the Fund might sell futures contracts on debt securities, the values of which historically have a high degree of positive correlation to the values of the Fund’s portfolio securities. Such a sale would have an effect similar to selling an equivalent value of the Fund’s portfolio securities. If interest rates increase, the value of the Fund’s portfolio securities will decline, but the value of the futures contracts to the Fund will increase at approximately an equivalent rate, thereby keeping the net asset value (“NAV”) of the Fund from declining as much as it otherwise would have. The Fund could accomplish similar results by selling debt securities with longer maturities and investing in debt securities with shorter maturities when interest rates are expected to increase. However, since the futures market may be more liquid than the cash market, the use of futures contracts as a risk management technique allows the Fund to maintain a defensive position without having to sell its portfolio securities.

Similarly, the Fund may purchase interest rate futures contracts when it is expected that interest rates may decline. The purchase of futures contracts for this purpose constitutes a hedge against increases in the price of debt securities (caused by declining interest rates) which the Fund intends to acquire. Since fluctuations in the value of appropriately selected futures contracts should approximate that of the debt securities that will be purchased, the Fund can take advantage of the anticipated rise in the cost of the debt securities without actually buying them. Subsequently, the Fund can make its intended purchase of the debt securities in the cash market and concurrently liquidate its futures position.

The purchase of a call option on a futures contract is similar in some respects to the purchase of a call option on an individual security. Depending on the pricing of the option compared to either the price of the futures contract upon which it is based or the price of the underlying debt securities, it may or may not be less risky than ownership of the futures contract or underlying debt securities. As with the purchase of futures contracts, when the Fund is not fully invested it may purchase a call option on a futures contract to hedge against a market advance due to declining interest rates.

The purchase of a put option on a futures contract is similar to the purchase of protective put options on portfolio securities. The Fund will purchase a put option on a futures contract to hedge the Fund’s portfolio against the risk of rising interest rates and a consequent reduction in the value of portfolio securities.

The Gabelli Healthcare & Wellness^Rx Trust

Additional Fund Information (Continued) (Unaudited)

The writing of a call option on a futures contract constitutes a partial hedge against declining prices of the securities that are deliverable upon exercise of the futures contract. If the futures price at expiration of the option is below the exercise price, the Fund will retain the full amount of the option premium, which provides a partial hedge against any decline that may have occurred in the Fund’s portfolio holdings. The writing of a put option on a futures contract constitutes a partial hedge against increasing prices of the securities that are deliverable upon exercise of the futures contract. If the futures price at expiration of the option is higher than the exercise price, the Fund will retain the full amount of the option premium, which provides a partial hedge against any increase in the price of debt securities that the Fund intends to purchase. If a put or call option the Fund has written is exercised, the Fund will incur a loss which will be reduced by the amount of the premium it received. Depending on the degree of correlation between changes in the value of its portfolio securities and changes in the value of its futures positions, losses of the Fund from options on futures it has written may to some extent be reduced or increased by changes in the value of its portfolio securities.

Swaps. The Fund may enter into total rate of return, credit default, interest rate or other types of swaps and related derivatives for various purposes, including to gain economic exposure to an asset or group of assets that may be difficult or impractical to acquire or for hedging and risk management. These transactions generally provide for the transfer from one counterparty to another of certain risks inherent in the ownership of a financial asset such as a common stock or debt instrument. Such risks include, among other things, the risk of default and insolvency of the obligor of such asset, the risk that the credit of the obligor or the underlying collateral will decline or the risk that the underlying collateral will decline. The transfer of risk pursuant to a derivative of this type may be complete or partial, and may be for the life of the related asset or for a shorter period. These derivatives may be used as a risk management tool for a pool of financial assets, providing the Fund with the opportunity to gain or reduce exposure to one or more reference securities or other financial assets (each, a“Reference Asset”) without actually owning or selling such assets in order, for example, to increase or reduce a concentration risk or to diversify a portfolio. Conversely, these derivatives may be used by the Fund to reduce exposure to an owned asset without selling it.

Because the Fund would not own the Reference Assets, the Fund may not have any voting rights with respect to the Reference Assets, and in such cases will not be able to vote on matters related to the obligors or issuers of the Reference Assets, including whether to exercise certain remedies.

Total rate of return swaps and similar derivatives are subject to many risks, including the possibility that the market will move in a manner or direction that would have resulted in gain for the Fund had the swap or other derivative not been utilized (in which case it would have been better had the Fund not engaged in the transactions), nearly unlimited exposure to changes in the value of the Reference Assets, total loss to the Fund of the entire notional amount of the swap, the risk of imperfect correlation between the risk sought to be hedged and the derivative transactions utilized, the possible inability of the counterparty to fulfill its obligations under the swap and potential illiquidity of the instrument utilized, which may make it difficult for the Fund to close out or unwind one or more transactions.

Total rate of return swaps and related derivatives are a relatively recent development in the financial markets. Consequently, there are certain legal, tax and market uncertainties that present risks in entering into such an arrangement. There is currently little or no case law or litigation characterizing total rate of return swaps or related derivatives, interpreting their provisions, or characterizing their tax treatment. In addition, additional

The Gabelli Healthcare & Wellness^Rx Trust

Additional Fund Information (Continued) (Unaudited)

regulations and laws may apply to these types of derivatives that have not previously been applied. There can be no assurance that future decisions constructing similar provisions to those in any swap agreement or other related documents or additional regulations and laws will not have an adverse effect on the Fund that utilizes these instruments. The Fund will monitor these risks and seek to utilize these instruments in a manner that does not lead to undue risk regarding the tax or other structural elements of the Fund. The Fund will not invest in these types of instruments if the Reference Assets are commodities except for bona fide hedging or risk management purposes.

Currency Futures and Options Thereon. Generally, foreign currency futures contracts and options thereon are similar to the interest rate futures contracts and options thereon discussed previously. By entering into currency futures and options thereon, the Fund will seek to establish the rate at which it will be entitled to exchange U.S. dollars for another currency at a future time. By selling currency futures, the Fund will seek to establish the number of dollars it will receive at delivery for a certain amount of a foreign currency. In this way, whenever the Fund anticipates a decline in the value of a foreign currency against the U.S. dollar, the Fund can attempt to “lock in” the U.S. dollar value of some or all of the securities held in its portfolio that are denominated in that currency. By purchasing currency futures, the Fund can establish the number of dollars it will be required to pay for a specified amount of a foreign currency in a future month. Thus, if the Fund intends to buy securities in the future and expects the U.S. dollar to decline against the relevant foreign currency during the period before the purchase is effected, the Fund can attempt to “lock in” the price in U.S. dollars of the securities it intends to acquire.

The purchase of options on currency futures will allow the Fund, for the price of the premium and related transaction costs it must pay for the option, to decide whether or not to buy (in the case of a call option) or to sell (in the case of a put option) a futures contract at a specified price at any time during the period before the option expires. If the Investment Adviser, in purchasing an option, has been correct in its judgment concerning the direction in which the price of a foreign currency would move as against the U.S. dollar, the Fund may exercise the option and thereby take a futures position to hedge against the risk it had correctly anticipated or close out the option position at a gain that will offset, to some extent, currency exchange losses otherwise suffered by the Fund. If exchange rates move in a way the Fund did not anticipate, however, the Fund will have incurred the expense of the option without obtaining the expected benefit; any such movement in exchange rates may also thereby reduce, rather than enhance, the Fund’s profits on its underlying securities transactions.

Securities Index Futures Contracts and Options Thereon. Purchases or sales of securities index futures contracts are used for hedging purposes to attempt to protect the Fund’s current or intended investments from broad fluctuations in stock or bond prices. For example, the Fund may sell securities index futures contracts in anticipation of or during a market decline to attempt to offset the decrease in market value of its securities portfolio that might otherwise result. If such decline occurs, the loss in value of portfolio securities may be offset, in whole or part, by gains on the futures position. When the Fund is not fully invested in the securities market and anticipates a significant market advance, it may purchase securities index futures contracts in order to gain rapid market exposure that may, in part or entirely, offset increases in the cost of securities that it intends to purchase. As such purchases are made, the corresponding positions in securities index futures contracts will be closed out. The Fund may write put and call options on securities index futures contracts for hedging purposes.

The Gabelli Healthcare & Wellness^Rx Trust

Additional Fund Information (Continued) (Unaudited)

Forward Currency Exchange Contracts. The Fund may engage in currency transactions other than on futures exchanges to protect against future changes in the level of future currency exchange rates. The Fund will conduct such currency exchange transactions either on a spot, i.e., cash, basis at the rate then prevailing in the currency exchange market or on a forward basis, by entering into forward contracts to purchase or sell currency. A forward contract on foreign currency involves an obligation to purchase or sell a specific currency at a future date, which may be any fixed number of days agreed upon by the parties from the date of the contract, at a price set on the date of the contract. Dealing in forward currency exchange by the Fund will be limited to hedging involving either specific transactions or portfolio positions. Transaction hedging is the purchase or sale of forward currency with respect to specific receivables or payables of the Fund generally arising in connection with the purchase or sale of its portfolio securities and accruals of interest receivable and fund expenses. Position hedging is the forward sale of currency with respect to portfolio security positions denominated or quoted in that currency or in a currency bearing a high degree of positive correlation to the value of that currency.

The Fund may not position hedge with respect to a particular currency for an amount greater than the aggregate market value (determined at the time of making any sale of forward currency) of the securities held in its portfolio denominated or quoted in, or currently convertible into, such currency.

At or before the maturity of a forward sale contract, the Fund may either sell a portfolio security and make delivery of the currency, or retain the security and offset its contractual obligations to deliver the currency by purchasing a second contract pursuant to which the Fund will obtain, on the same maturity date, the same amount of the currency which it is obligated to deliver. If the Fund retains the portfolio security and engages in an offsetting transaction, the Fund, at the time of execution of the offsetting transaction, will incur a gain or a loss to the extent that movement has occurred in forward contract prices. Should forward prices decline during the period between entering into a forward contract by the Fund for the sale of a currency and the date it enters into an offsetting contract for the purchase of the currency, the Fund will realize a gain to the extent the price of the currency it has agreed to purchase is less than the price of the currency it has agreed to sell. Should forward prices increase, the Fund will suffer a loss to the extent the price of the currency it has agreed to purchase exceeds the price of the currency it has agreed to sell. Closing out forward purchase contracts involves similar offsetting transactions.

The cost to the Fund of engaging in currency transactions varies with factors such as the currency involved, the length of the contract period and the market conditions then prevailing. Because forward transactions in currency exchange are usually conducted on a principal basis, no fees or commissions are involved. The use of foreign currency contracts does not eliminate fluctuations in the underlying prices of the securities, but it does establish a rate of exchange that can be achieved in the future. In addition, although forward currency contracts limit the risk of loss due to a decline in the value of the hedged currency, they also limit any potential gain that might result if the value of the currency increases.

If a decline in any currency is generally anticipated by the Investment Adviser, the Fund may not be able to contract to sell the currency at a price above the level to which the currency is anticipated to decline.

When Issued, Delayed Delivery Securities and Forward Commitments. The Fund may enter into forward commitments for the purchase or sale of securities, including on a “when issued” or “delayed delivery” basis, in excess of customary settlement periods for the type of security involved. In some cases, a forward commitment

The Gabelli Healthcare & Wellness^Rx Trust

Additional Fund Information (Continued) (Unaudited)

may be conditioned upon the occurrence of a subsequent event, such as approval and consummation of a merger, corporate reorganization or debt restructuring, i.e., a when, as and if issued security. When such transactions are negotiated, the price is fixed at the time of the commitment, with payment and delivery taking place in the future, generally a month or more after the date of the commitment. While it will only enter into a forward commitment with the intention of actually acquiring the security, the Fund may sell the security before the settlement date if it is deemed advisable.

Securities purchased under a forward commitment are subject to market fluctuation, and no interest (or dividends) accrues to the Fund prior to the settlement date.

Restricted and Illiquid Securities. The Fund may invest without limit in illiquid securities. Illiquid securities include securities the disposition of which is subject to substantial legal or contractual restrictions. The sale of illiquid securities often requires more time and results in higher brokerage charges or dealer discounts and other selling expenses than does the sale of securities eligible for trading on national securities exchanges or in the OTC markets. Restricted securities may sell at a price lower than similar securities that are not subject to restrictions on resale. Unseasoned issuers are companies (including predecessors) that have operated less than three years. The continued liquidity of such securities may not be as well assured as that of publicly traded securities, and accordingly the Board will monitor their liquidity. The Board will review pertinent factors such as trading activity, reliability of price information and trading patterns of comparable securities in determining whether to treat any such security as liquid. To the extent the Board treats such securities as liquid, temporary impairments to trading patterns of such securities may adversely affect the liquidity of the Fund.

The Board has adopted guidelines and delegated to the Investment Adviser, subject to the supervision of the Board, the function of determining and monitoring the liquidity of particular Rule 144A securities under the Securities Act of 1933 Act, as amended (the “Securities Act”).

Leverage. As provided in the 1940 Act, and subject to compliance with the Fund’s investment limitations, the Fund may issue senior securities representing (i) shares, such as preferred shares, so long as immediately following such issuance of stock, its total assets exceed 200% of the amount of such shares and (ii) indebtedness, such as notes, so long as immediately following such issuance of indebtedness, its total assets exceed 300% of the amount of such indebtedness. The use of leverage magnifies the impact of changes in NAV. For example, a fund that uses 33% leverage will show a 1.5% increase or decline in NAV for each 1% increase or decline in the value of its total assets. In addition, if the cost of leverage exceeds the return on the securities acquired with the proceeds of leverage, the use of leverage will diminish, rather than enhance, the return to the Fund. The use of leverage generally increases the volatility of returns to the Fund.

Additionally, the Fund may enter into derivative transactions that have economic leverage embedded in them. Derivative transactions that the Fund may enter into and the risks associated with them are described herein. The Fund cannot assure you that investments in derivative transactions that have economic leverage embedded in them will result in a higher return on its common shares. Under Rule 18f-4 under the 1940 Act, among other things, the Fund must either use derivatives in a limited manner or comply with an outer limit on fund leverage risk based on value-at-risk. See “Risk Factors and Special Considerations—Special Risks of Derivative Transactions—Derivatives Transactions Subject to Rule 18f-4 Under the 1940 Act.”

The Gabelli Healthcare & Wellness^Rx Trust

Additional Fund Information (Continued) (Unaudited)

Investment Restrictions. The Fund has adopted certain investment restrictions as fundamental policies of the Fund. Under the 1940 Act, a fundamental policy may not be changed without the vote of a majority, as defined in the 1940 Act, of the outstanding voting securities of the Fund (voting together as a single class). The Fund’s fundamental investment restrictions prohibit the Fund from: (1) concentrating its investments (i.e., investing more than 25% of the Fund’s total assets) in securities of issuers in any industry other than the healthcare and wellness industries; (2) purchasing or selling commodities or commodity contracts, except that the Fund may purchase or sell futures contracts and related options thereon if certain conditions are met, and purchasing or selling sell real estate, provided that the Fund may invest in securities secured by real estate or interests therein or issued by companies which invest in real estate or interests therein; (3) making loans of money, except by the purchase of a portion of private or publicly distributed debt obligations or the entering into of repurchase agreements, and the Fund reserves the authority to make loans of its portfolio securities to financial intermediaries in an aggregate amount not exceeding 20% of its total assets; (4) borrowing money, except to the extent permitted by applicable law (i.e., the Fund generally may borrow money in amounts of up to one-third of the Fund’s total assets for any purpose, subject to the requirement that the Fund have asset coverage of at least 300% of the amount of its borrowings at the time the borrowing is incurred, and may borrow up to 5% of the Fund’s total assets for temporary purposes (for up to 60 days) without maintaining such 300% asset coverage); (5) issuing senior securities, except to the extent permitted by applicable law (i.e., the Fund may issue senior securities (which may be stock, such as preferred shares, and/or securities representing debt, such as notes), subject to the requirement that the Fund maintain asset coverage as required by the 1940 Act); and (6) underwriting securities of other issuers except insofar as the Fund may be deemed an underwriter under the Securities Act of 1933, as amended, in selling portfolio securities. See also “Leverage Risk — Portfolio Guidelines of Rating Agencies for Preferred Shares and/or Credit Facility.”

Portfolio Turnover. The Fund will buy and sell securities to accomplish its investment objective. The investment policies of the Fund may lead to frequent changes in investments, particularly in periods of rapidly fluctuating interest or currency exchange rates. The portfolio turnover may be higher than that of other investment companies.

Portfolio turnover generally involves some expense to the Fund, including brokerage commissions or dealer mark-ups and other transaction costs on the sale of securities and reinvestment in other securities. The portfolio turnover rate is computed by dividing the lesser of the amount of the securities purchased or securities sold by the average monthly value of securities owned during the year (excluding securities whose maturities at acquisition were one year or less). High portfolio turnover may also result in the realization of substantial net short term capital gains and any distributions resulting from such gains will be taxable at ordinary income rates for United States federal income tax purposes. The Fund’s portfolio turnover rates for the fiscal years ended December 31, 2023 and 2022 were 21% and 14%, respectively.

Borrowing. The Fund may borrow money in accordance with its investment restrictions, including as a temporary measure for extraordinary or emergency purposes.

The Gabelli Healthcare & Wellness^Rx Trust

Additional Fund Information (Continued) (Unaudited)

RISK FACTORS AND SPECIAL CONSIDERATIONS

Investors should consider the following risk factors and special considerations associated with investing in the Fund:

Industry Concentration Risks

The Fund is concentrated in the healthcare and wellness industries. Under normal market conditions, the Fund will invest at least 80% of its net assets (plus borrowings made for investment purposes) in equity securities (such as common stock and preferred stock) and income producing securities (such as fixed income debt securities and securities convertible into common stock) of domestic and foreign companies in the healthcare and wellness industries. As a result of investing a significant portion of its assets in companies in the healthcare and wellness industries, the value of the Fund’s shares will be more susceptible to factors affecting those particular types of companies, which may include, among others, governmental regulation, changes in government subsidy and reimbursement levels, the governmental approval process, rapid obsolescence of products and services and patent expirations. The Investment Adviser believes that certain healthcare and wellness related companies could experience growth as a result of demographic changes and the Fund intends to focus on companies that will benefit from these demographic trends. However, certain of these companies may be less able to anticipate demographic trends and investments in these companies would not be likely to perform as well as investments in those that do.

Long Term Objective

The Fund seeks long term growth of capital. The Fund is not meant to provide a vehicle for those who wish to exploit short term swings in the stock market. An investment in shares of the Fund should not be considered a complete investment program. Each shareholder should take into account the shareholder’s investment objectives when considering an investment in the Fund.

Tax Status

To qualify as a “regulated investment company,” or “RIC,” for purposes of the Internal Revenue Code of 1986, as amended (the “Code”), the Fund has in the past conducted and intends to conduct its operations in a manner that will relieve it of any liability for federal income tax to the extent its earnings are distributed to shareholders. To so qualify as a “regulated investment company,” among other requirements, the Fund will limit its investments so that, at the close of each quarter of the taxable year:

●

not more than 25% of the market value of its total assets will be invested in the securities (other than United States government securities or the securities of other RICs) of a single issuer, any two or more issuers in which the Fund owns 20% or more of the voting securities and which are determined to be engaged in the same, similar or related trades or businesses or in the securities of one or more qualified publicly traded partnerships (as defined in the Code); and

●

at least 50% of the market value of the Fund’s assets will be represented by cash, securities of other RICs, United States government securities and other securities, with such other securities limited in re-

The Gabelli Healthcare & Wellness^Rx Trust

Additional Fund Information (Continued) (Unaudited)

spect of any one issuer to an amount not greater than 5% of the value of the Fund’s total assets and not more than 10% of the outstanding voting securities of such issuer.

Market Value and Net Asset Value

The Fund is a diversified, closed-end management investment company. Shares of closed-end funds are bought and sold in the securities markets and may trade at either a premium to or discount from NAV. Listed shares of closed-end investment companies often trade at discounts from NAV. This characteristic of shares of a closed-end fund is a risk separate and distinct from the risk that its NAV may decrease. The Fund cannot predict whether its listed shares will trade at, below or above NAV. The risk of holding shares of a closed-end fund that might trade at a discount is more pronounced for shareholders who wish to sell their shares in a relatively short period of time after acquiring them because, for those investors, realization of a gain or loss on their investments is likely to be more dependent upon the existence of a premium or discount than upon portfolio performance. The Fund’s shares are not subject to redemption. Shareholders desiring liquidity may, subject to applicable securities laws, trade their Fund shares on the New York Stock Exchange (“NYSE”) or other markets on which such shares may trade at the then-current market value, which may differ from the then current NAV. Shareholders will incur brokerage or other transaction costs to sell shares.

Equity Risk

Investing in the Fund involves equity risk, which is the risk that the securities held by the Fund will fall in market value due to adverse market and economic conditions, perceptions regarding the industries in which the issuers of securities held by the Fund participate and the particular circumstances and performance of particular companies whose securities the Fund holds. An investment in the Fund represents an indirect economic stake in the securities owned by the Fund, which are for the most part traded on securities exchanges or in the OTC markets. The market value of these securities, like other market investments, may move up or down, sometimes rapidly and unpredictably. The NAV of the Fund may at any point in time be worth less than the amount at the time the shareholder invested in the Fund, even after taking into account any reinvestment of distributions.

Foreign Securities

There is no limitation on the amount of foreign securities, including emerging market securities, in which the Fund may invest. Investments in the securities of foreign issuers involve certain considerations and risks not ordinarily associated with investments in securities of domestic issuers and such securities may be more volatile than those of issuers in the United States. Foreign companies are not generally subject to uniform accounting, auditing and financial standards and requirements comparable to those applicable to United States companies. Foreign securities exchanges, brokers and listed companies may be subject to less government supervision and regulation than exists in the United States. Dividend and interest income may be subject to withholding and other foreign taxes, which may adversely affect the net return on such investments. There may be difficulty in obtaining or enforcing a court judgment abroad. In addition, it may be difficult to effect repatriation of capital invested in certain countries. Also, with respect to certain countries, there are risks of expropriation, confiscatory taxation, political or social instability or diplomatic developments that could affect assets of the Fund held in foreign countries. Dividend income that the Fund receives from foreign securities may not be eligible for the special tax treatment applicable to qualified dividend income. Moreover, certain equity investments in foreign issuers classified as passive foreign investment companies may be subject to additional taxation risk.

The Gabelli Healthcare & Wellness^Rx Trust

Additional Fund Information (Continued) (Unaudited)

There may be less publicly available information about a foreign company than a United States company. Foreign securities markets may have substantially less volume than United States securities markets and some foreign company securities are less liquid than securities of otherwise comparable United States companies. A portfolio of foreign securities may also be adversely affected by fluctuations in the rates of exchange between the currencies of different nations and by exchange control regulations. Foreign markets also have different clearance and settlement procedures that could cause the Fund to encounter difficulties in purchasing and selling securities on such markets and may result in the Fund missing attractive investment opportunities or experiencing loss. In addition, a portfolio that includes foreign securities can expect to have a higher expense ratio because of the increased transaction costs on non-United States securities markets and the increased costs of maintaining the custody of foreign securities.

The Fund also may purchase sponsored American Depositary Receipts (“ADRs”) or United States dollar denominated securities of foreign issuers, including emerging market issuers. ADRs are receipts issued by United States banks or trust companies in respect of securities of foreign issuers held on deposit for use in the United States securities markets. While ADRs may not necessarily be denominated in the same currency as the securities into which they may be converted, many of the risks associated with foreign securities may also apply to ADRs. In addition, the underlying issuers of certain depositary receipts, particularly unsponsored or unregistered depositary receipts, are under no obligation to distribute shareholder communications to the holders of such receipts, or to pass through to them any voting rights with respect to the deposited securities.

Emerging Markets

The Fund may invest in securities of issuers whose primary operations or principal trading market is in an “emerging market.” An “emerging market” country is any country that is considered to be an emerging or developing country by the International Bank for Reconstruction and Development (the “World Bank”). Investing in securities of companies in emerging markets may entail special risks relating to potential political and economic instability and the risks of expropriation, nationalization, confiscation or the imposition of restrictions on foreign investment, the lack of hedging instruments and restrictions on repatriation of capital invested. Emerging securities markets are substantially smaller, less developed, less liquid and more volatile than the major securities markets. The limited size of emerging securities markets and limited trading value compared to the volume of trading in U.S. securities could cause prices to be erratic for reasons apart from factors that affect the quality of the securities. For example, limited market size may cause prices to be unduly influenced by traders who control large positions. Adverse publicity and investors’ perceptions, whether or not based on fundamental analysis, may decrease the value and liquidity of portfolio securities, especially in these markets. Other risks include high concentration of market capitalization and trading volume in a small number of issuers representing a limited number of industries, as well as a high concentration of investors and financial intermediaries; overdependence on exports, including gold and natural resources exports, making these economies vulnerable to changes in commodity prices; overburdened infrastructure and obsolete or unseasoned financial systems; environmental problems; potential for sanctions; less developed legal systems, and deficiencies in regulatory oversight, market infrastructure, shareholder protections; differences in regulatory, accounting, auditing and financial reporting and recordkeeping standards; and less reliable securities custodial services and settlement practices.

The Gabelli Healthcare & Wellness^Rx Trust

Additional Fund Information (Continued) (Unaudited)

Value Investing Risk

The Fund focuses its investments on the securities of companies that the Investment Adviser believes to be undervalued or inexpensive relative to other investments. These types of securities may present risks in addition to the general risks associated with investing in common and preferred stocks. These securities generally are selected on the basis of an issuer’s fundamentals relative to current market price. Such securities are subject to the risk of mis-estimation of certain fundamental factors. In addition, during certain time periods market dynamics may strongly favor “growth” stocks of issuers that do not display strong fundamentals relative to market price based upon positive price momentum and other factors. Disciplined adherence to a “value” investment mandate during such periods can result in significant underperformance relative to overall market indices and other managed investment vehicles that pursue growth style investments and/or flexible equity style mandates.

Smaller Companies

The Fund may invest in smaller companies that may benefit from the development of new products and services. These smaller companies may present greater opportunities for capital appreciation, and may also involve greater investment risk than larger, more established companies. For example, smaller companies may have more limited product lines, market, or financial resources, and their securities may trade less frequently and in lower volume than the securities of larger, more established companies. As a result, the prices of the securities of such smaller companies may fluctuate to a greater degree than the prices of securities of other issuers.

Fixed Income Securities

Fixed income securities in which the Fund may invest are generally subject to the following risks:

●

Interest Rate Risk. The market value of bonds and other fixed-income or dividend paying securities changes in response to interest rate changes and other factors. Interest rate risk is the risk that prices of bonds and other income or dividend paying securities will increase as interest rates fall and decrease as interest rates rise. The Fund may be subject to a greater risk of rising interest rates due to the recent period of historically low interest rates. The Federal Reserve began raising the federal funds rate in March 2022 as part of its efforts to address rising inflation. There is a risk that interest rates will continue to rise, which will likely drive down prices of bonds and other fixed-income securities. The magnitude of these price reductions in the market price of bonds and other fixed-income securities is generally greater for those securities with longer maturities. Fluctuations in the market price of the Fund’s investments will not affect interest income derived from instruments already owned by the Fund, but will be reflected in the Fund’s NAV. The Fund may lose money if short-term or long-term interest rates rise sharply in a manner not anticipated by the Investment Adviser.

●

Issuer Risk. Issuer risk is the risk that the value of an income or dividend paying security may decline for a number of reasons which directly relate to the issuer, such as management performance, financial leverage, reduced demand for the issuer’s goods and services, historical and prospective earnings of the issuer, and the value of the assets of the issuer.

●

Credit Risk. Credit risk is the risk that one or more income or dividend paying securities in the Fund’s portfolio will decline in price or fail to pay interest/distributions or principal when due because the issuer

The Gabelli Healthcare & Wellness^Rx Trust

Additional Fund Information (Continued) (Unaudited)

of the security experiences a decline in its financial status. Credit risk is increased when a portfolio security is downgraded or the perceived creditworthiness of the issuer deteriorates.

●

Prepayment Risk. Prepayment risk is the risk that during periods of declining interest rates, borrowers may exercise their option to prepay principal earlier than scheduled. For income or dividend paying securities, such payments often occur during periods of declining interest rates, forcing the Fund to reinvest in lower yielding securities, resulting in a possible decline in the Fund’s income and distributions to shareholders.

●

Reinvestment Risk. Reinvestment risk is the risk that income from the Fund’s portfolio will decline if the Fund invests the proceeds from matured, traded or called fixed income securities at market interest rates that are below the Fund portfolio’s current earnings rate.

●

Duration and Maturity Risk. The Fund may incur costs in seeking to adjust the portfolio average duration or maturity. In comparison to maturity (which is the date on which the issuer of a debt instrument is obligated to repay the principal amount), duration is a measure of the price volatility of a debt instrument as a result in changes in market rates of interest, based on the weighted average timing of the instrument’s expected principal and interest payments. Specifically, duration measures the anticipated percentage change in NAV that is expected for every percentage point change in interest rates. The two have an inverse relationship. For example, a duration of five years means that a 1% decrease in interest rates will increase the NAV of the portfolio by approximately 5%; if interest rates increase by 1%, the NAV will decrease by 5%. However, in a managed portfolio of fixed income securities having differing interest or dividend rates or payment schedules, maturities, redemption provisions, call or prepayment provisions and credit qualities, actual price changes in response to changes in interest rates may differ significantly from a duration-based estimate at any given time. Actual price movements experienced by a portfolio of fixed income securities will be affected by how interest rates move (i.e., changes in the relationship of long term interest rates to short term interest rates), the magnitude of any move in interest rates, actual and anticipated prepayments of principal through call or redemption features, the extension of maturities through restructuring, the sale of securities for portfolio management purposes, the reinvestment of proceeds from prepayments on and from sales of securities, and credit quality-related considerations whether associated with financing costs to lower credit quality borrowers or otherwise, as well as other factors. Accordingly, while duration maybe a useful tool to estimate potential price movements in relation to changes in interest rates, investors are cautioned that duration alone will not predict actual changes in the net asset or market value of the Fund’s shares and that actual price movements in the Fund’s portfolio may differ significantly from duration-based estimates. Duration differs from maturity in that it takes into account a security’s yield, coupon payments and its principal payments in addition to the amount of time until the security matures. As the value of a security changes over time, so will its duration. There can be no assurance that the Investment Adviser’s assessment of current and projected market conditions will be correct or that any strategy to adjust duration or maturity will be successful at any given time.

●

Liquidity Risk. Certain fixed income securities in which the Fund invests may be or become illiquid. See “Certain Investment Practices – Restricted and Illiquid Securities.”

The Gabelli Healthcare & Wellness^Rx Trust

Additional Fund Information (Continued) (Unaudited)

Lower Grade Securities

Generally, lower grade securities and unrated securities of comparable quality offer a higher current yield than is offered by higher rated securities, but also (i) will likely have some quality and protective characteristics that, in the judgment of the rating organizations, are outweighed by large uncertainties or major risk exposures to adverse conditions and (ii) are predominantly speculative with respect to the issuer’s capacity to pay interest and repay principal in accordance with the terms of the obligation. The market values of certain of these securities also tend to be more sensitive to individual corporate developments and changes in economic conditions than higher quality securities. In addition, such securities generally present a higher degree of credit risk. The risk of loss due to default by these issuers is significantly greater because such lower grade securities and unrated securities of comparable quality generally are unsecured and frequently are subordinated to the prior payment of senior indebtedness. In light of these risks, the Investment Adviser, in evaluating the creditworthiness of an issue, whether rated or unrated, will take various factors into consideration, which may include, as applicable, the issuer’s operating history, financial resources and its sensitivity to economic conditions and trends, the market support for the facility financed by the issue, the perceived ability and integrity of the issuer’s management, and regulatory matters.

In addition, the market value of lower securities is more volatile than that of higher quality securities, and the markets in which such lower grade or unrated securities are traded are more limited than those in which higher rated securities are traded. The existence of limited markets may make it more difficult for the Fund to obtain accurate market quotations for purposes of valuing its portfolio and calculating its NAV. Moreover, the lack of a liquid trading market may restrict the availability of securities for the Fund to purchase and may also have the effect of limiting the ability of the Fund to sell securities at their fair value in response to changes in the economy or the financial markets.

Lower grade securities also present risks based on payment expectations. If an issuer calls the obligation for redemption (often a feature of fixed income securities), the Fund may have to replace the security with a lower yielding security, resulting in a decreased return for investors. Also, as the principal value of nonconvertible bonds and preferred stocks moves inversely with movements in interest rates, in the event of rising interest rates the value of the securities held by the Fund may decline proportionately more than a portfolio consisting of higher rated securities. Investments in zero coupon bonds may be more speculative and subject to greater fluctuations in value due to changes in interest rates than bonds that pay regular income streams. See “—Fixed Income Securities—Interest Rate Risk” above.

As part of its investment in lower grade securities, the Fund may invest in securities of issuers in default. The Fund will make an investment in securities of issuers in default only when the Investment Adviser believes that such issuers will honor their obligations or emerge from bankruptcy protection under a plan pursuant to which the securities received by the Fund in exchange for its defaulted securities will have a value in excess of the Fund’s investment. By investing in securities of issuers in default, the Fund bears the risk that these issuers will not continue to honor their obligations or emerge from bankruptcy protection or that the value of the securities will not otherwise appreciate.

The Gabelli Healthcare & Wellness^Rx Trust

Additional Fund Information (Continued) (Unaudited)

In addition to using recognized rating agencies and other sources, the Investment Adviser also performs its own analysis of issues in seeking investments that it believes to be underrated (and thus higher yielding) in light of the financial condition of the issuer. Its analysis of securities of issuers may include, among other things, current and anticipated cash flow and borrowing requirements, value of assets in relation to historical cost, strength of management, responsiveness to business conditions, credit standing, and current anticipated results of operations. In selecting investments for the Fund, the Investment Adviser may also consider general business conditions, anticipated changes in interest rates, and the outlook for specific industries.

Subsequent to its purchase by the Fund, an issuer of securities may cease to be rated or its rating may be reduced. In addition, it is possible that statistical rating agencies may change their ratings of a particular issuer to reflect subsequent events. Moreover, such ratings do not assess the risk of a decline in market value. None of these events will require the sale of the securities by the Fund, although the Investment Adviser will consider these events in determining whether the Fund should continue to hold the securities.

The market for lower grade and comparable unrated securities has experienced several periods of significantly adverse price and liquidity, particularly at or around times of economic recessions. Past market recessions have adversely affected the value of such securities as well as the ability of certain issuers of such securities to repay principal and pay interest thereon or to refinance such securities. The market for those securities may react in a similar fashion in the future.

Special Risks of Derivative Transactions

The Fund may participate in derivative transactions. Such transactions entail certain execution, market, liquidity, hedging and tax risks. Participation in the options, futures or swaps markets and in currency exchange transactions involves investment risks and transaction costs to which the Fund would not be subject absent the use of these strategies. If the Investment Adviser’s prediction of movements in the direction of the securities, foreign currency and interest rate markets are inaccurate, the consequences to the Fund may leave the Fund in a worse position than if such strategies were not used. Risks inherent in the use of options, foreign currency, swaps contracts, futures contracts and options on futures contracts, swap contracts, securities indices and foreign currencies include:

●

dependence on the Investment Adviser’s ability to predict correctly movements in the direction of interest rates, securities prices and currency markets;

●

imperfect correlation between the price of options and futures contracts and options thereon and movements in the prices of the securities or currencies being hedged;

●

the fact that skills needed to use these strategies are different from those needed to select portfolio securities;

●

the possible absence of a liquid secondary market for any particular instrument at any time;

●

the possible need to defer closing out certain hedged positions to avoid adverse tax consequences;

●

the possible inability of the Fund to purchase or sell a security at a time that otherwise would be favorable for it to do so; and

●

the creditworthiness of counterparties.

The Gabelli Healthcare & Wellness^Rx Trust

Additional Fund Information (Continued) (Unaudited)

Options, futures contracts, swaps contracts and options thereon and forward contracts on securities and currencies may be traded on foreign exchanges. Such transactions may not be regulated as effectively as similar transactions in the United States, may not involve a clearing mechanism and related guarantees, and are subject to the risk of governmental actions affecting trading in, or the prices of, foreign securities. The value of such positions also could be adversely affected by (i) other complex foreign political, legal and economic factors, (ii) lesser availability than in the United States of data on which to make trading decisions, (iii) delays in the ability of the Fund to act upon economic events occurring in the foreign markets during non-business hours in the United States, (iv) the imposition of different exercise and settlement terms and procedures and margin requirements than in the United States and (v) less trading volume. Exchanges on which options, futures, swaps and options on futures or swaps are traded may impose limits on the positions that the Fund may take in certain circumstances.

Many OTC derivatives are valued on the basis of dealers’ pricing of these instruments. However, the price at which dealers value a particular derivative and the price which the same dealers would actually be willing to pay for such derivative should the Fund wish or be forced to sell such position may be materially different. Such differences can result in an overstatement of the Fund’s NAV and may materially adversely affect the Fund in situations in which the Fund is required to sell derivative instruments. Exchange-traded derivatives and OTC derivative transactions submitted for clearing through a central counterparty have become subject to minimum initial and variation margin requirements set by the relevant clearinghouse, as well as possible margin requirements mandated by the SEC or the Commodity Futures Trading Commission. These regulators also have broad discretion to impose margin requirements on non-cleared OTC derivatives. These margin requirements will increase the overall costs for the Fund.

While hedging can reduce or eliminate losses, it can also reduce or eliminate gains. Hedges are sometimes subject to imperfect matching between the derivative and the underlying security, and there can be no assurance that the Fund’s hedging transactions will be effective.

Derivatives may give rise to a form of leverage and may expose the Fund to greater risk and increase its costs.

Under Rule 18f-4 under the 1940 Act, among other things, the Fund must either use derivatives in a limited manner or comply with an outer limit on fund leverage risk based on value-at-risk. See “—Derivatives Transactions Subject to Rule18f-4 Under the 1940 Act” below.

Special Risk Considerations Relating to Futures and Options Thereon. The Fund’s ability to establish and close out positions in futures contracts and options thereon will be subject to the development and maintenance of liquid markets. Although the Fund generally will purchase or sell only those futures contracts and options thereon for which there appears to be a liquid market, there is no assurance that a liquid market on an exchange will exist for any particular futures contract or option thereon at any particular time.

In the event no liquid market exists for a particular futures contract or option thereon in which the Fund maintains a position, it may not be possible to effect a closing transaction in that contract or to do so at a satisfactory price and the Fund may have to either make or take delivery under the futures contract or, in the case of a written option, wait to sell the underlying securities until the option expires or is exercised or, in the case of a purchased option, exercise the option. In the case of a futures contract or an option thereon which the Fund has written

The Gabelli Healthcare & Wellness^Rx Trust

Additional Fund Information (Continued) (Unaudited)

and which the Fund is unable to close, the Fund would be required to maintain margin deposits on the futures contract or option thereon and to make variation margin payments until the contract is closed.

Successful use of futures contracts and options thereon and forward contracts by the Fund is subject to the ability of the Investment Adviser to predict correctly movements in the direction of interest and foreign currency rates. If the Investment Adviser’s expectations are not met, the Fund will be in a worse position than if a hedging strategy had not been pursued. For example, if the Fund has hedged against the possibility of an increase in interest rates that would adversely affect the price of securities in its portfolio and the price of such securities increases instead, the Fund will lose part or all of the benefit of the increased value of its securities because it will have offsetting losses in its futures positions. In addition, in such situations, if the Fund has insufficient cash to meet daily variation margin requirements, it may have to sell securities to meet the requirements. These sales may be, but will not necessarily be, at increased prices that reflect the rising market. The Fund may have to sell securities at a time when it is disadvantageous to do so.

Additional Risks of Foreign Options, Futures Contracts, Swaps Contracts, Options on Futures Contracts and Forward Contracts. Options, futures contracts, swaps contracts and options thereon and forward contracts on securities and currencies may be traded on foreign exchanges. Such transactions may not be regulated as effectively as similar transactions in the United States, may not involve a clearing mechanism and related guarantees, and are subject to the risk of governmental actions affecting trading in, or the prices of, foreign securities. The value of such positions also could be adversely affected by (i) other complex foreign political, legal and economic factors, (ii) lesser availability than in the United States of data on which to make trading decisions, (iii) delays in the ability of the Fund to act upon economic events occurring in the foreign markets during non-business hours in the United States, (iv) the imposition of different exercise and settlement terms and procedures and margin requirements than in the United States and (v) less trading volume.

Exchanges on which options, futures, swaps and options on futures or swaps are traded may impose limits on the positions that the Fund may take in certain circumstances.

See “Risk Factors and Special Considerations – Futures Transactions.”

Derivatives Transactions Subject to Rule 18f-4 Under the 1940 Act. Rule 18f-4 under the 1940 Act governs the Fund’s use of derivative instruments and certain other transactions that create future payment and/or delivery obligations by the Fund. Rule 18f-4 permits the Fund to enter into Derivatives Transactions (as defined below) and certain other transactions notwithstanding the restrictions on the issuance of “senior securities” under Section 18 of the 1940 Act. Section 18 of the Investment Company Act, among other things, prohibits closed-end funds, including the Trust, from issuing or selling any “senior security” representing indebtedness (unless the fund maintains 300% “asset coverage”) or any senior security representing stock (unless the fund maintains 200% “asset coverage”). In connection with the adoption of Rule 18f-4, the SEC eliminated the asset segregation framework arising from prior SEC guidance for covering Derivatives Transactions and certain financial instruments.

Under Rule 18f-4, “Derivatives Transactions” include the following: (i) any swap, security-based swap (including a contract for differences), futures contract, forward contract, option (excluding purchased options), any combination of the foregoing, or any similar instrument, under which the Fund is or may be required to make any payment or delivery of cash or other assets during the life of the instrument or at maturity or early termination,

The Gabelli Healthcare & Wellness^Rx Trust

Additional Fund Information (Continued) (Unaudited)

whether as margin or settlement payment or otherwise; (ii) any short sale borrowing; (iii) reverse repurchase agreements and similar financing transactions, if the Fund elects to treat these transactions as Derivatives Transactions under Rule 18f-4; and (iv) when-issued or forward-settling securities (e.g., firm and standby commitments, including to-be-announced (“TBA”) commitments, and dollar rolls) and non-standard settlement cycle securities, unless the Fund intends to physically settle the transaction and the transaction will settle within 35 days of its trade date.

Unless the Fund is relying on the Limited Derivatives User Exception (as defined below), the Fund must comply with Rule 18f-4 with respect to its Derivatives Transactions. Rule 18f-4, among other things, requires the Fund to (i) appoint a Derivatives Risk Manager, (ii) maintain a Derivatives Risk Management Program designed to identify, assess, and reasonably manage the risks associated with Derivatives Transactions; (iii) comply with certain value-at-risk (VaR)-based leverage limits (VaR is an estimate of an instrument’s or portfolio’s potential losses over a given time horizon and at a specified confidence level); and (iv) comply with certain Board reporting and recordkeeping requirements.

Rule 18f-4 provides an exception from the requirements to appoint a Derivatives Risk Manager, adopt a Derivatives Risk Management Program, comply with certain VaR-based leverage limits, and comply with certain Board oversight and reporting requirements if the Fund’s “derivatives exposure” (as defined in Rule 18f-4) is limited to 10% of its net assets (as calculated in accordance with Rule 18f-4) and the Fund adopts and implements written policies and procedures reasonably designed to manage its derivatives risks (the “Limited Derivatives User Exception”).

Pursuant to Rule 18f-4, if the Fund enters into reverse repurchase agreements or similar financing transactions, the Fund will (i) aggregate the amount of indebtedness associated with all of its reverse repurchase agreements or similar financing transactions with the amount of any other “senior securities” representing indebtedness (e.g., bank borrowings, if applicable) when calculating the Fund’s asset coverage ratio or (ii) treat all such transactions as Derivatives Transactions.

The requirements of Rule 18f-4 may limit the Fund’s ability to engage in Derivatives Transactions as part of its investment strategies. These requirements may also increase the cost of the Fund’s investments and cost of doing business, which could adversely affect the value of the Fund’s investments and/or the performance of the Fund.

The Gabelli Healthcare & Wellness^Rx Trust

Additional Fund Information (Continued) (Unaudited)

Futures Transactions

The Fund may make investments in futures and options on futures. Risks include, but are not limited to, the following:

●

no assurance that futures contracts or options on futures can be offset at favorable prices;

●

possible reduction of the yield of the Fund due to the use of hedging;

●

possible reduction in value of both the securities hedged and the hedging instrument;

●

possible lack of liquidity due to daily limits or price fluctuations;

●

imperfect correlation between the contracts and the securities being hedged; and

●

losses from investing in futures transactions that are potentially unlimited.

Swap Agreements

Swap agreements involve the risk that the party with whom the Fund has entered into the swap will default on its obligation to pay the Fund and the risk that the Fund will not be able to meet its obligations to pay the other party to the agreement. Whether the Fund’s use of swap agreements will be successful in furthering its investment objective will depend on the Investment Adviser’s ability to correctly predict whether certain types of investments are likely to produce greater returns than other investments. Because they are two party contracts and because they may have terms of greater than seven days, some swap agreements may be considered by the Fund to be illiquid. Restrictions imposed by the tax rules applicable to regulated investment companies may limit the Fund’s ability to use swap agreements. The swap market currently is largely unregulated. It is possible that developments in the swap market, including potential significant government regulation as a result of the Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010 (the “Dodd-Frank Act”) or otherwise, could adversely affect the Fund’s ability to enter into or terminate swap agreements or to realize amounts to be received under these agreements. Swap transactions may involve substantial leverage.

Forward Currency Exchange Contracts

The use of forward currency exchange contracts may involve certain risks, including the failure of the counterparty to perform its obligations under the contract and that the use of forward contracts may not serve as a complete hedge because of an imperfect correlation between movements in the prices of the contracts and the prices of the currencies hedged or used for cover.

Risks of Currency Transactions. Currency transactions are also subject to risks different from those of other portfolio transactions. Because currency control is of great importance to the issuing governments and influences economic planning and policy, purchases and sales of currency and related instruments can be adversely affected by government exchange controls, limitations or restrictions on repatriation of currency, and manipulation, or exchange restrictions imposed by governments. These forms of governmental action can result in losses to the Fund if it is unable to deliver or receive currency or monies in settlement of obligations and could also cause hedges it has entered into to be rendered useless, resulting in full currency exposure as well as incurring transaction costs.

The Gabelli Healthcare & Wellness^Rx Trust

Additional Fund Information (Continued) (Unaudited)

Interest Rate Transactions

The Fund may enter into an interest rate swap or cap transaction. The use of interest rate swaps and caps is a highly specialized activity that involves certain risks to the Fund including, among others, counterparty risk and early termination risk.

Counterparty Risk

The Fund will be subject to credit risk with respect to the counterparties to the derivative contracts purchased by the Fund. If a counterparty becomes bankrupt or otherwise fails to perform its obligations under a derivative contract due to financial difficulties, the Fund may experience significant delays in obtaining any recovery under the derivative contract in bankruptcy or other reorganization proceeding. The Fund may obtain only a limited recovery or may obtain no recovery in such circumstances.

Dodd-Frank Act Risk

Title VII of the Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010 (the “Dodd-Frank Act”) (the “Derivatives Title”) imposed a substantially new regulatory structure on derivatives markets, with particular emphasis on swaps (which are subject to oversight by the CFTC) and security-based swaps (which are subject to oversight by the SEC). The regulatory framework covers a broad range of swap market participants, including banks, non-banks, credit unions, insurance companies, broker-dealers and investment advisers. Prudential regulators were granted authority to regulate margining of swaps and security-based swaps of banks and bank-related entities.

Current regulations for swaps require the mandatory central clearing and mandatory exchange trading of particular types of interest rate swaps and index credit default swaps (together, “Covered Swaps”). The Fund is required to clear its Covered Swaps through a clearing broker, which requires, among other things, posting initial margin and variation margin to the Fund’s clearing broker in order to enter into and maintain positions in Covered Swaps. Covered Swaps generally are required to be executed through a swap execution facility (“SEF”), which can involve additional transaction fees.

Additionally, under the Dodd-Frank Act, with respect to uncleared swaps (both uncleared swaps and uncleared security-based swaps entered into with banks), swap dealers are required to collect from the Fund both initial and variation margin (comprised of specified liquid instruments and subject to a required haircut). Shares of investment companies (other than certain money market funds) may not be posted as collateral under applicable regulations. As capital and margin requirements for swap dealers and capital and margin requirements for security-based swaps are implemented, such requirements may make certain types of trades and/or trading strategies more costly. There may be market dislocations due to uncertainty during the implementation period of any new regulation and the Investment Adviser cannot know how the derivatives market will adjust to such new regulations.

In addition, regulations adopted by global prudential regulators that are now in effect require certain bank-regulated counterparties and certain of their affiliates to include in “qualified financial contracts,” including many derivatives contracts as well as repurchase agreements and securities lending agreements, terms that delay or

The Gabelli Healthcare & Wellness^Rx Trust

Additional Fund Information (Continued) (Unaudited)

restrict the rights of counterparties to terminate such contracts, foreclose upon collateral, exercise other default rights or restrict transfers of affiliate credit enhancements (such as guarantees) in the event that the bank-regulated counterparty and/or its affiliates are subject to certain types of resolution or insolvency proceedings.

Special Risks Related to Fund Investments in Preferred Securities

There are special risks associated with the Fund’s investing in preferred securities, including:

●

Deferral. Preferred securities may include provisions that permit the issuer, at its discretion, to defer dividends or distributions for a stated period without any adverse consequences to the issuer. If the Fund owns a preferred security that is deferring its dividends or distributions, the Fund may be required to report income for tax purposes although it has not yet received such income.

●

Non-Cumulative Dividends. Some preferred securities are non-cumulative, meaning that the dividends do not accumulate and need not ever be paid. A portion of the portfolio may include investments in non-cumulative preferred securities, whereby the issuer does not have an obligation to make up any arrearages to its shareholders. Should an issuer of a non-cumulative preferred security held by the Fund determine not to pay dividends or distributions on such security, the Fund’s return from that security may be adversely affected. There is no assurance that dividends or distributions on non-cumulative preferred securities in which the Fund invests will be declared or otherwise made payable.

●

Subordination. Preferred securities are subordinated to bonds and other debt instruments in an issuer’s capital structure in terms of priority to corporate income and liquidation payments, and therefore will be subject to greater credit risk than more senior debt security instruments.

●

Liquidity. Preferred securities may be substantially less liquid than many other securities, such as common stocks or U.S. government securities.

●

Limited Voting Rights. Generally, preferred security holders (such as the Fund) have no voting rights with respect to the issuing company unless preferred dividends have been in arrears for a specified number of periods, at which time the preferred security holders may be entitled to elect a number of directors to the issuer’s board. Generally, once all the arrearages have been paid, the preferred security holders no longer have voting rights.

●

Special Redemption Rights. In certain varying circumstances, an issuer of preferred securities may redeem the securities prior to a specified date. For instance, for certain types of preferred securities, a redemption may be triggered by a change in federal income tax or securities laws. A redemption by the issuer may negatively impact the return of the security held by the Fund.

●

Phantom Income. Some preferred securities are classified as debt for U.S. federal income tax purposes. If a debt instrument is issued with original issue discount, the Fund could recognize taxable income in advance of the receipt of cash on the investment. This “phantom income” may require the Fund to liquidate other investments (including when it is not advantageous to do so) to meet its distribution requirements or otherwise qualify for treatment as a RIC.

Special Risks for Holders of Subscription Rights

The issuance of subscription rights to purchase our common shares may substantially dilute the aggregate NAV of the common shares owned by shareholders who do not fully exercise their rights in the offering. Shareholders who do not exercise their rights to purchase common stock will own a smaller proportional interest in the Fund

The Gabelli Healthcare & Wellness^Rx Trust

Additional Fund Information (Continued) (Unaudited)

than they did before the offering. In the case of subscription rights for preferred shares, there is a risk that changes in yield or changes in the credit quality of the Fund may result in the underlying preferred shares purchasable upon exercise of the subscription rights being less attractive to investors at the conclusion of the subscription period. This may reduce or eliminate the value of the subscription rights for the preferred shares. Investors who receive subscription rights may find that there is no market to sell rights they do not wish to exercise. If investors exercise only a portion of the rights, the number of preferred shares or common shares issued may be reduced, and the preferred shares or common shares may trade at less favorable prices than larger offerings for similar securities.

Management Risk

The Fund is subject to management risk because it is an actively managed portfolio. The Investment Adviser applies investment techniques and risk analyses in making investment decisions for the Fund, but there can be no guarantee that these will produce the desired results.

Portfolio Turnover

The Fund may have a high turnover ratio which may result in higher expenses and lower after-tax return to shareholders than if the Fund had a lower turnover ratio.

Dependence on Key Personnel

Mr. Mario J. Gabelli is a portfolio manager of the Fund. The Investment Adviser is dependent upon the expertise of Mr. Gabelli in providing advisory services with respect to the Fund’s investments. If the Investment Adviser were to lose the services of Mr. Gabelli, its ability to service the Fund could be adversely affected. There can be no assurance that a suitable replacement could be found for Mr. Gabelli in the event of his death, resignation, retirement or inability to act on behalf of the Investment Adviser.

Coronavirus (“COVID-19”) and Global Health Event Risk

An outbreak of a highly contagious novel coronavirus known as “COVID 19” that was first declared in December 2019 developed into a global pandemic that had a devastating impact on the global economy, including the U.S. economy, and resulted in a global economic recession. Many states issued orders requiring the closure of non-essential businesses and/or requiring residents to stay at home. The COVID 19 pandemic and preventative measures taken to contain or mitigate its spread caused business shutdowns, cancellations of events and travel, significant reductions in demand for certain goods and services, reductions in business activity and financial transactions, supply chain interruptions and overall economic and financial market instability both globally and in the United States. The U.S. economy and most other major global economies may continue to experience a substantial economic downturn or recession, and our business and operations, as well as the business and operations of our portfolio companies, could be materially adversely affected by a prolonged economic downturn or recession in the United States and other major markets.

The impact of this coronavirus, and other epidemics and pandemics that may arise in the future, could affect the economies of many nations, individual companies and the market in general ways that cannot necessarily be foreseen at the present time. These events could have a significant impact on the Fund’s performance, NAV,

The Gabelli Healthcare & Wellness^Rx Trust

Additional Fund Information (Continued) (Unaudited)

income, operating results and ability to pay distributions, as well as the performance, income, operating results and viability of issuers in which it invests.

Market Disruption and Geopolitical Risk

The consequences of the conflict between Russia and Ukraine, including international sanctions, further impact on inflation and increased disruption to supply chains may impact our portfolio companies, result in an economic downturn or recession either globally or locally in the U.S. or other economies, reduce business activity, spawn additional conflicts (whether in the form of traditional military action, reignited “cold” wars or in the form of virtual warfare such as cyberattacks) with similar and perhaps wider ranging impacts and consequences and have an adverse impact on the Fund’s returns and NAV.

The occurrence of events similar to those in recent years, such as localized wars, instability, new and ongoing pandemics (such as COVID-19), epidemics or outbreaks of infectious diseases in certain parts of the world, natural/environmental disasters, terrorist attacks in the United States and around the world, social and political discord, debt crises sovereign debt downgrades, increasingly strained relations between the United States and a number of foreign countries, new and continued political unrest in various countries, the exit or potential exit of one or more countries from the European Union (“EU”) or the Economic and Monetary Union, continued changes in the balance of political power among and within the branches of the U.S. government, government shutdowns, among others, may result in market volatility, may have long term effects on the U.S. and worldwide financial markets, and may cause further economic uncertainties in the United States and worldwide. The current contentious domestic political environment, as well as political and diplomatic events within the United States and abroad, such as the U.S. government’s inability at times to agree on a long-term budget and deficit reduction plan, may in the future result in government shutdowns, which could have a material adverse effect on the Fund’s investments and operations. In addition, the Fund’s ability to raise additional capital in the future through the sale of securities could be materially affected by a government shutdown. Additional and/ or prolonged U.S. government shutdowns may affect investor and consumer confidence and may adversely impact financial markets and the broader economy, perhaps suddenly and to a significant degree. In particular, the escalation of the conflict between Russia and Ukraine, including international sanctions, further impact on inflation and increased disruption to supply chains may impact our portfolio companies. Such unfavorable economic conditions also may also be expected to increase our funding costs, limit our access to the capital markets or result in a decision by lenders not to extend credit to us. The current political climate has intensified concerns about a potential trade war between China and the United States, as each country has recently imposed tariffs on the other country’s products. These actions may trigger a significant reduction in international trade, the oversupply of certain manufactured goods, substantial price reductions of goods and possible failure of individual companies and/or large segments of China’s export industry, which could have a negative impact on our performance. U.S. companies that source material and goods from China and those that make large amounts of sales in China would be particularly vulnerable to an escalation of trade tensions. Uncertainty regarding the outcome of the trade tensions and the potential for a trade war could cause the U.S. dollar to decline against safe haven currencies, such as the Japanese yen and the euro. Events such as these and their consequences are difficult to predict and it is unclear whether further tariffs may be imposed or other escalating actions may be taken in the future. Any of these effects could have a material adverse effect on our business, financial condition and results of operations.

The Gabelli Healthcare & Wellness^Rx Trust

Additional Fund Information (Continued) (Unaudited)

On January 31, 2020, the United Kingdom officially left the European Union (“Brexit”), subject to a transitional period that ended December 31, 2020. The United Kingdom and European Union have reached an agreement on the terms of their future trading relationship effective January 1, 2021, which principally relates to the trading of goods rather than services, including financial services. Further discussions are to be held between the United Kingdom and the European Union in relation to matters not covered by the trade agreement, such as financial services. The Fund faces risks associated with the potential uncertainty and consequences that may follow Brexit, including with respect to volatility in exchange rates and interest rates. Brexit could adversely affect European or worldwide political, regulatory, economic or market conditions and could contribute to instability in global political institutions, regulatory agencies and financial markets. Brexit has also led to legal uncertainty and could lead to politically divergent national laws and regulations as a new relationship between the United Kingdom and European Union is defined and the United Kingdom determines which European Union laws to replace or replicate. Any of these effects of Brexit could adversely affect any of the companies to which the Fund has exposure and any other assets that the Fund invests in. The political, economic and legal consequences of Brexit are not yet known. In the short term, financial markets may experience heightened volatility, particularly those in the United Kingdom and Europe, but possibly worldwide. The United Kingdom and Europe may be less stable than they have been in recent years, and investments in the United Kingdom and the European Union may be difficult to value or subject to greater or more frequent volatility. In the longer term, there is likely to be a period of significant political, regulatory and commercial uncertainty as the United Kingdom continues to negotiate the terms of its future trading relationship with the European Union.

While the extreme volatility and disruption that U.S. and global markets experienced for an extended period of time beginning in 2007 and 2008 had, until the recent coronavirus (COVID-19) outbreak, generally subsided, uncertainty and periods of volatility still remain, and risks to a robust resumption of growth persist. Federal Reserve policy, including with respect to certain interest rates, may adversely affect the value, volatility and liquidity of dividend and interest paying securities. Market volatility, dramatic changes to interest rates and/or a return to unfavorable economic conditions may lower the Fund’s performance or impair the Fund’s ability to achieve its investment objective.

Cybersecurity incidents affecting particular companies or industries may adversely affect the economies of particular countries, regions or parts of the work in which the Fund invests.

The occurrence of any of these above events could have a significant adverse impact on the value and risk profile of the Fund’s portfolio. The Fund does not know how long the securities markets may be affected by similar events and cannot predict the effects of similar events in the future on the U.S. economy and securities markets. There can be no assurance that similar events and other market disruptions will not have other material and adverse implications.

Economic Events and Market Risk

Periods of market volatility may continue to occur in the future, in response to various political, social and economic events both within and outside of the United States. These conditions have resulted in, and in many cases continue to result in, greater price volatility, less liquidity, widening credit spreads and a lack of price transparency, with many securities remaining illiquid and of uncertain value. Such market conditions may adversely affect the Fund, including by making valuation of some of the Fund’s securities uncertain and/or result

The Gabelli Healthcare & Wellness^Rx Trust

Additional Fund Information (Continued) (Unaudited)

in sudden and significant valuation increases or declines in the Fund’s holdings. If there is a significant decline in the value of the Fund’s portfolio, this may impact the asset coverage levels for the Fund’s outstanding leverage.

Risks resulting from any future debt or other economic crisis could also have a detrimental impact on the global economic recovery, the financial condition of financial institutions and our business, financial condition and results of operation. Market and economic disruptions have affected, and may in the future affect, consumer confidence levels and spending, personal bankruptcy rates, levels of incurrence and default on consumer debt and home prices, among other factors. To the extent uncertainty regarding the U.S. or global economy negatively impacts consumer confidence and consumer credit factors, our business, financial condition and results of operations could be significantly and adversely affected. Downgrades to the credit ratings of major banks could result in increased borrowing costs for such banks and negatively affect the broader economy. Moreover, Federal Reserve policy, including with respect to certain interest rates, may also adversely affect the value, volatility and liquidity of dividend- and interest-paying securities. Market volatility, rising interest rates and/ or a return to unfavorable economic conditions could impair the Fund’s ability to achieve its investment objective.

Regulation and Government Intervention Risk

Federal, state, and other governments, their regulatory agencies or self-regulatory organizations may take actions that affect the regulation of the issuers in which the Fund invests in ways that are unforeseeable. Legislation or regulation may also change the way in which the Fund is regulated. Such legislation or regulation could limit or preclude the Fund’s ability to achieve its investment objective.

In light of popular, political and judicial focus on finance related consumer protection, financial institution practices are also subject to greater scrutiny and criticism generally. In the case of transactions between financial institutions and the general public, there may be a greater tendency toward strict interpretation of terms and legal rights in favor of the consuming public, particularly where there is a real or perceived disparity in risk allocation and/or where consumers are perceived as not having had an opportunity to exercise informed consent to the transaction. In the event of conflicting interests between retail investors holding common shares of a closed-end investment company such as the Fund and a large financial institution, a court may similarly seek to strictly interpret terms and legal rights in favor of retail investors.

The Fund may be affected by governmental action in ways that are not foreseeable, and there is a possibility that such actions could have a significant adverse effect on the Fund and its ability to achieve its investment objective.

Inflation Risk

Inflation risk is the risk that the value of assets or income from investments will be worth less in the future as inflation decreases the value of money. Inflation rates may change frequently and drastically as a result of various factors, including unexpected shifts in the domestic or global economy. As inflation increases, the real value of the Fund’s shares and distributions therefore may decline. In addition, during any periods of rising inflation, dividend rates of any debt securities issued by the Fund would likely increase, which would tend to further reduce returns to common shareholders.

The Gabelli Healthcare & Wellness^Rx Trust

Additional Fund Information (Continued) (Unaudited)

Deflation Risk

Deflation risk is the risk that prices throughout the economy decline over time, which may have an adverse effect on the market valuation of companies, their assets and their revenues. In addition, deflation may have an adverse effect on the creditworthiness of issuers and may make issuer default more likely, which may result in a decline in the value of the Fund’s portfolio.

Leverage Risk

The Fund currently uses, and intends to continue to use, leverage for investment purposes by issuing preferred shares. “Leverage” for these purposes means the ratio by which the aggregate amount of senior securities representing indebtedness of the Fund plus the aggregate involuntary liquidation preference of the Fund’s preferred shares bears to the Fund’s total assets. As of December 31, 2023, the amount of leverage represented approximately 22% of the Fund’s total assets. All series of the Fund’s preferred shares have the same seniority with respect to distributions and liquidation preference. Preferred shares have seniority over common shares with respect to distributions and upon liquidation of the Fund.

The Fund’s leveraged capital structure creates special risks not associated with unleveraged funds having similar investment objectives and policies. The Fund’s use of leverage, which can be described as exposure to changes in price at a ratio greater than the amount of equity invested, either through the issuance of preferred shares, borrowing or other forms of market exposure, magnifies both the favorable and unfavorable effects of price movements in the investments made by the Fund. The Fund’s leveraged capital structure creates special risks not associated with unleveraged funds having similar investment objectives and policies. The Fund cannot assure that the issuance of preferred shares will result in a higher yield or return to the holders of the common shares. Also, as the Fund is utilizing leverage, a decline in NAV could affect the ability of the Fund to make common share distributions and such a failure to pay dividends or make distributions could result in the Fund ceasing to qualify as a regulated investment company under the Code.

●

Preferred Share Risk. The issuance of preferred shares causes the NAV and market value of the common shares to become more volatile. If the dividend rate on the preferred shares approaches the net rate of return on the Fund’s investment portfolio, the benefit of leverage to the holders of the common shares would be reduced. If the dividend rate on the preferred shares plus the management fee annual rate of 1.00% (as applicable) exceeds the net rate of return on the Fund’s portfolio, the leverage will result in a lower rate of return to the holders of common shares than if the Fund had not issued preferred shares.

Any decline in the NAV of the Fund’s investments would be borne entirely by the holders of common shares. Therefore, if the market value of the Fund’s portfolio declines, the leverage will result in a greater decrease in NAV to the holders of common shares than if the Fund were not leveraged. This greater NAV decrease will also tend to cause a greater decline in the market price for the common shares. In such a case, the Fund might be in danger of failing to maintain the required asset coverage of the preferred shares or of losing its ratings (if any) on the preferred shares or, in an extreme case, the Fund’s current investment income might not be sufficient to meet the dividend requirements on the preferred shares. In order to counteract such an event, the Fund might need to liquidate investments in order to fund a redemption of some or all of the preferred shares.

The Gabelli Healthcare & Wellness^Rx Trust

Additional Fund Information (Continued) (Unaudited)

In addition, the Fund would pay (and the holders of common shares will bear) all costs and expenses relating to the issuance and ongoing maintenance of the preferred shares, including the advisory fees on the incremental assets attributable to such shares.

Holders of preferred shares may have different interests than holders of common shares and may at times have disproportionate influence over the Fund’s affairs. Holders of preferred shares, voting separately as a single class, have the right to elect two members of the Board at all times and in the event dividends become two full years in arrears have the right to elect a majority of the Trustees until such arrearage is completely eliminated. In addition, preferred shareholders have class voting rights on certain matters, including changes in fundamental investment restrictions and conversion of the Fund to open-end status, and accordingly can veto any such changes.

Restrictions imposed on the declarations and payment of dividends or other distributions to the holders of the Fund’s common shares and preferred shares, both by the 1940 Act and by requirements imposed by any rating agencies, might impair the Fund’s ability to maintain its qualification as a regulated investment company for federal income tax purposes. While the Fund intends to redeem its preferred shares to the extent necessary to enable the Fund to distribute its income as required to maintain its qualification as a regulated investment company under the Code, there can be no assurance that such actions can be effected in time to meet the Code requirements.

●

Special Risks to Holders of Fixed Rate Preferred Shares

Illiquidity. Prior to the offering, there will be no public market for any additional series of Fixed Rate Preferred Shares. In the event any additional series of Fixed Rate Preferred Shares are issued, prior application may have been, but is not required to be, made to list such shares on a national securities exchange, which would be expected to be the NYSE. If no such application is made, there can be no assurances that any additional series of Fixed Rate Preferred Shares would be liquid at any time. If any additional series of Fixed Rate Preferred Shares are to be listed, during an initial period prior to listing, which would not be expected to exceed 30 days after the date of initial issuance, such shares may not be listed on any securities exchange. During such period, the underwriters may make a market in such shares, though, they will have no obligation to do so. Consequently, an investment in such shares may be illiquid during such period.

Market Price Fluctuation. Fixed Rate Preferred Shares that are listed on a national securities exchange may trade at a premium to or discount from liquidation value for various reasons, including changes in interest rates.

●

Special Risks to Holders of Notes. There may not be an established market for our notes. To the extent that our notes trade, they may trade at a price either higher or lower than their principal amount depending on interest rates, the rating (if any) on such notes and other factors.

●

Special Risks to Holders of Notes and Preferred Shares

The Gabelli Healthcare & Wellness^Rx Trust

Additional Fund Information (Continued) (Unaudited)

Common Share Repurchases. Repurchases of common shares by the Fund may reduce the net asset coverage of the notes and preferred shares, which could adversely affect their liquidity or market prices, if such noted or preferred shares are listed on a national securities exchange.

Common Share Distribution Policy. In the event the Fund does not generate a total return from dividends and interest received and net realized capital gains in an amount at least equal to its distributions for a given year, the Fund may return capital as part of its distribution. This would decrease the asset coverage per share with respect to the Fund’s notes or preferred shares, which could adversely affect their liquidity or market prices, if such notes or preferred shares are listed on a national securities exchange. See “Risk Factors and Special Considerations — Common Share Distribution Policy Risk.”

Credit Quality Ratings. The Fund may obtain credit quality ratings for its preferred shares or notes, if desired; however, it is not required to do so and may issue preferred shares or notes without any rating. If rated, the Fund does not impose any minimum rating necessary to issue such preferred shares or notes. In order to obtain and maintain attractive credit quality ratings for preferred shares or borrowings, if desired, the Fund’s portfolio must satisfy over-collateralization tests established by the relevant rating agencies. These tests are more difficult to satisfy to the extent the Fund’s portfolio securities are of lower credit quality, longer maturity or not diversified by issuer and industry within the meaning of such rating agencies’ over-collateralization tests. These guidelines could affect portfolio decisions and may be more stringent than those imposed by the 1940 Act. With respect to ratings (if any) of the notes or preferred shares, a rating by a ratings agency does not eliminate or necessarily mitigate the risks of investing in our preferred shares or notes, and a rating may not fully or accurately reflect all of the securities’ credit risks. A rating does not address the liquidity or any other market risks of the securities being rated. A rating agency could downgrade the rating of our notes or preferred shares, which may make such securities less liquid in the secondary market. If a rating agency downgrades the rating assigned to our preferred shares or notes, we may alter our portfolio or redeem all or a portion of the preferred shares or notes that are then redeemable under certain circumstances.

●

Special Risks of Notes to Holders of Common Shares. If the interest rate on the notes approaches the net rate of return on the Fund’s investment portfolio, the benefit of leverage to the holders of the common shares would be reduced. Any decline in the NAV of the Fund’s investments would be borne entirely by the holders of common shares. Therefore, if the market value of the Fund’s portfolio declines, the leverage will result in a greater decrease in NAV to the holders of common shares than if the Fund were not leveraged. This greater NAV decrease will also tend to cause a greater decline in the market price for the common shares. The Fund might be in danger of failing to maintain the required asset coverage of the notes. Holders of notes may have different interests than holders of common shares and at times may have disproportionate influence over the Fund’s affairs. In the event the Fund fails to maintain the specified level of asset coverage of any notes outstanding, the holders of the notes will have the right to elect a majority of the Fund’s trustees.

The Gabelli Healthcare & Wellness^Rx Trust

Additional Fund Information (Continued) (Unaudited)

●

Portfolio Guidelines of Rating Agencies for Preferred Shares and/or Credit Facility. In order to obtain and maintain attractive credit quality ratings for preferred shares or borrowings, if desired, the Fund must comply with investment quality, diversification and other guidelines established by the relevant rating agencies. These tests tend to require over-collateralization and may be more difficult to satisfy to the extent the Fund’s portfolio securities are of lower credit quality, longer maturity or not diversified by issuer and industry within the meaning of such rating agencies’ collateralization tests. These guidelines could affect portfolio decisions and may be more stringent than those imposed by the 1940 Act. In the event that a rating on the Fund’s preferred shares or notes is lowered or withdrawn by the relevant rating agency, the Fund may also be required to redeem all or part of its outstanding preferred shares or notes, and the common shares of the Fund will lose the potential benefits associated with a leveraged capital structure.

●

Impact on Common Shares. Assuming that leverage will (1) be equal in amount to approximately 22% of the Fund’s total net assets, and (2) charge interest or involve dividend payments at a projected blended annual average leverage dividend or interest rate of 4.32%, then the annual return generated by the Fund’s portfolio (net of estimated expenses) must exceed approximately 1.01% of the Fund’s total net assets in order to cover such interest or dividend payments and other expenses specifically related to leverage. These numbers are merely estimates, used for illustration. Actual dividend rates, interest or payment rates may vary frequently and may be significantly higher or lower than the rate estimated above. The following table is furnished in response to requirements of the SEC. It is designed to illustrate the effect of leverage on common share total return, assuming investment portfolio total returns (comprised of net investment income of the Fund, realized gains or losses of the Fund and changes in the value of the securities held in the Fund’s portfolio) of –10%, –5%, 0%, 5% and 10%. These assumed investment portfolio returns are hypothetical figures and are not necessarily indicative of the investment portfolio returns experienced or expected to be experienced by the Fund. See “Risks.” The table further reflects leverage representing 22% of the Fund’s total assets, the Fund’s current projected blended an-nual average leverage dividend or interest rate of 4.32%, a management fee at an annual rate of 1.00% of the liquidation preference of any outstanding preferred shares and estimated annual incremental expenses attributable to any outstanding preferred shares of 0.04% of the Fund’s net assets attributable to common shares.

Assumed Return on Portfolio (Net of Expenses)			(10	)%			(5	)%			0	%			5	%			10	%
Common Shares Total Return			(14.51	)%			(8.05	)%			(1.58	)%			4.89	%			11.36	%

Common share total return is composed of two elements — the common share distributions paid by the Fund (the amount of which is largely determined by the taxable income of the Fund (including realized gains or losses) after paying interest on any debt and/or dividends on any preferred shares) and unrealized gains or

The Gabelli Healthcare & Wellness^Rx Trust

Additional Fund Information (Continued) (Unaudited)

losses on the value of the securities the Fund owns. As required by SEC rules, the table assumes that the Fund is more likely to suffer capital losses than to enjoy total return. For example, to assume a total return of 0% the Fund must assume that the income it receives on its investments is entirely offset by expenses and losses in the value of those investments. The Fund’s shares are leveraged and the risks and special considerations related to leverage described in this prospectus apply. Such leveraging of the shares cannot be fully achieved until the proceeds resulting from the use of leverage have been invested in accordance with the Fund’s investment objectives and policies.

Potential Dilution in Rights Offerings

To the extent that the Fund engages in a rights offering, shareholders who do not exercise their subscription rights may, at the completion of such an offering, own a smaller proportional interest in the Fund than if they exercised their subscription rights. As a result of such an offering, a shareholder also may experience dilution in NAV per share if the subscription price per share is below the NAV per share on the expiration date. Specifically, if the subscription price per share is below the NAV per share of the Fund’s shares on the expiration date of the rights offering, a shareholder will experience an immediate dilution of the aggregate NAV of their shares if the shareholder does not participate in the offering and the shareholder will experience a reduction in the NAV per share of their shares whether or not the shareholder participates in the offering. The Fund cannot state precisely the extent of this dilution (if any) if the shareholder does not exercise his or her subscription rights because the Fund does not know what the NAV per share will be when a rights offering expires or what proportion of the rights will be exercised.

There is also a risk that the Fund’s largest shareholders, record date shareholders of more than 5% of the outstanding common shares of the Fund, may increase their percentage ownership of the Fund through the exercise of the primary subscription and any over-subscription privilege.

Common Share Distribution Policy Risk

The Fund has adopted a policy, which may be changed at any time by the Board, of paying distributions on its common shares of $0.15 per share per quarter. In the event the Fund does not generate a total return from dividends and interest received and net realized capital gains in an amount equal to or in excess of its stated distribution in a given year, the Fund may return capital as part of such distribution, which may have the effect of decreasing the asset coverage per share with respect to the Fund’s preferred shares. Any return of capital should not be considered by investors as yield or total return on their investment in the Fund. Shareholders should not assume that a distribution from the Fund is comprised exclusively of net profits. For the fiscal year ended December 31, 2023, the Fund made distributions of $0.60 per common share, approximately $0.02 of which was deemed a return of capital. The Fund has made quarterly distributions with respect to its common shares since June 2012. A portion of the distributions to holders of common shares during four of the sixteen fiscal years since the Fund’s inception has constituted a return of capital. The composition of each distribution is estimated based on the earnings of the Fund as of the record date for each distribution. The actual composition of each of the current year’s distributions will be based on the Fund’s investment activity through the end of the calendar year.

The Gabelli Healthcare & Wellness^Rx Trust

Additional Fund Information (Continued) (Unaudited)

Legislation Risk

At any time after the date of this report, legislation may be enacted that could negatively affect the assets of the Fund. Legislation or regulation may change the way in which the Fund itself is regulated. The Investment Adviser cannot predict the effects of any new governmental regulation that may be implemented and there can be no assurance that any new governmental regulation will not adversely affect the Fund’s ability to achieve its investment objective.

Reliance on Service Providers Risk

The Fund must rely upon the performance of service providers to perform certain functions, which may include functions that are integral to the Fund’s operations and financial performance. Failure by any service provider to carry out its obligations to the Fund in accordance with the terms of its appointment, to exercise due care and skill or to perform its obligations to the Fund at all as a result of insolvency, bankruptcy or other causes could have a material adverse effect on the Fund’s performance and returns to shareholders. The termination of the Fund’s relationship with any service provider, or any delay in appointing a replacement for such service provider, could materially disrupt the business of the Fund and could have a material adverse effect on the Fund’s performance and returns to shareholders.

Cyber Security Risk

The Fund and its service providers are susceptible to cyber security risks that include, among other things, theft, unauthorized monitoring, release, misuse, loss, destruction or corruption of confidential and highly restricted data; denial of service attacks; unauthorized access to relevant systems, compromises to networks or devices that the Fund and its service providers use to service the Fund’s operations; or operational disruption or failures in the physical infrastructure or operating systems that support the Fund and its service providers. Cyber attacks against or security breakdowns of the Fund or its service providers may adversely impact the Fund and its shareholders, potentially resulting in, among other things, financial losses; the inability of Fund shareholders to transact business and the Fund to process transactions; inability to calculate the Fund’s NAV; violations of applicable privacy and other laws; regulatory fines, penalties, reputational damage, reimbursement or other compensation costs; and/or additional compliance costs. The Fund may incur additional costs for cyber security risk management and remediation purposes. In addition, cyber security risks may also impact issuers of securities in which the Fund invests, which may cause the Fund’s investment in such issuers to lose value. There can be no assurance that the Fund or its service providers will not suffer losses relating to cyber attacks or other information security breaches in the future.

Misconduct of Employees and of Service Providers Risk

Misconduct or misrepresentations by employees of the Investment Adviser or the Fund’s service providers could cause significant losses to the Fund. Employee misconduct may include binding the Fund to transactions that exceed authorized limits or present unacceptable risks and unauthorized trading activities, concealing unsuccessful trading activities (which, in any case, may result in unknown and unmanaged risks or losses)

The Gabelli Healthcare & Wellness^Rx Trust

Additional Fund Information (Continued) (Unaudited)

or making misrepresentations regarding any of the foregoing. Losses could also result from actions by the Fund’s service providers, including, without limitation, failing to recognize trades and misappropriating assets. In addition, employees and service providers may improperly use or disclose confidential information, which could result in litigation or serious financial harm, including limiting the Fund’s business prospects or future marketing activities. Despite the Investment Adviser’s due diligence efforts, misconduct and intentional misrepresentations may be undetected or not fully comprehended, thereby potentially undermining the Investment Adviser’s due diligence efforts. As a result, no assurances can be given that the due diligence performed by the Investment Adviser will identify or prevent any such misconduct.

Anti-Takeover Provisions of the Fund’s Governing Documents

The Fund’s Agreement and Declaration of Trust as amended and supplemented (including the statements of preferences thereto) and bylaws, as amended from time to time, include provisions that could limit the ability of other entities or persons to acquire control of the Fund or convert the Fund to an open-end fund.

Status as a Regulated Investment Company

The Fund has qualified, and intends to remain qualified, for federal income tax purposes as a regulated investment company under Subchapter M of the Code. Qualification requires, among other things, compliance by the Fund with certain distribution requirements. Statutory limitations on distributions on the common shares if the Fund fails to satisfy the 1940 Act’s asset coverage requirements could jeopardize the Fund’s ability to meet such distribution requirements. The Fund presently intends, however, to purchase or redeem preferred shares to the extent necessary in order to maintain compliance with such asset coverage requirements.

Temporary Investments

During temporary defensive periods and during inopportune periods to be fully invested, the Fund may invest in U.S. government securities, including U.S. Treasury securities, and in money market mutual funds that invest in those securities. Obligations of certain agencies and instrumentalities of the U.S. government, such as the Government National Mortgage Association, are supported by the “full faith and credit” of the U.S. government; others, such as those of the Export-Import Bank of the United States, are supported by the right of the issuer to borrow from the U.S. Treasury; others, such as those of the Federal National Mortgage Association, are supported by the discretionary authority of the U.S. government to purchase the agency’s obligations; and still others, such as those of the Student Loan Marketing Association, are supported only by the credit of the instrumentality. No assurance can be given that the U.S. government would provide financial support to U.S. government-sponsored instrumentalities if it is not obligated to do so by law.

Investment Restrictions

The Fund has adopted certain investment limitations designed to limit investment risk and maintain portfolio diversification. These limitations are fundamental and may not be changed without the approval of the holders of a majority, as defined in the 1940 Act, of the outstanding common shares and preferred shares voting together as a single class. The Fund may become subject to guidelines that are more limiting than the investment restrictions set forth above in order to obtain and maintain ratings from a credit rating agency on its preferred

The Gabelli Healthcare & Wellness^Rx Trust

Additional Fund Information (Continued) (Unaudited)

shares. See “Leverage Risk — Portfolio Guidelines of Rating Agencies for Preferred Shares and/or Credit Facility.”

INVESTMENT RESTRICTIONS

Senior Securities / leverage

As of December 31, 2023, the Fund uses leverage through the issuance of preferred shares.

Effects of Leverage

The following information is furnished in response to requirements of the SEC. It is designed to, among other things, illustrate the effects of leverage through the use of senior securities, as that term is defined under Section 18 of the 1940 Act, on Common Share total return, assuming investment portfolio total returns (consisting of income and changes in the value of investments held in a Fund’s portfolio) of -10%, -5%, 0%, 5% and 10%. The table below reflects the Fund’s continued use of preferred shares, as of December 31, 2023 as a percentage of total managed assets (including assets attributable to such leverage), the estimated annual effective preferred shares dividend rate and interest expense rate payable by the Fund on such instruments (based on market conditions as of December 31, 2023), and the annual return that the Fund’s portfolio must experience (net of expenses) in order to cover such costs. The information below does not reflect the Fund’s use of certain other forms of economic leverage achieved through the use of other instruments or transactions not considered to be senior securities under the 1940 Act, such as derivative instruments.

The assumed investment portfolio returns in the table below are hypothetical figures and are not necessarily indicative of the investment portfolio returns experienced or expected to be experienced by the Fund. Your actual returns may be greater or less than those appearing below.

Preferred Shares as a Percentage of Total Managed Assets (Including Assets Attributable to Preferred Shares)	22	%
Estimated Annual Effective Preferred Share Dividend Rate	4.32	%
Annual Return Fund Portfolio Must Experience (net of expenses) to Cover Estimated Annual Effective Preferred Share Dividend Rate	1.01	%
Common Share Total Return for (10.00)% Assumed Portfolio Total Return	(14.51	)%
Common Share Total Return for (5.00)% Assumed Portfolio Total Return	(8.05	)%
Common Share Total Return for 0.00% Assumed Portfolio Total Return	(1.58	)%
Common Share Total Return for 5.00% Assumed Portfolio Total Return	4.89	%
Common Share Total Return for 10.00% Assumed Portfolio Total Return	11.36	%

The Gabelli Healthcare & Wellness^Rx Trust

Additional Fund Information (Continued) (Unaudited)

Common shares total return is composed of two elements — the distributions paid by a Fund to holders of common shares (the amount of which is largely determined by the net investment income of the Fund after paying dividend payments on any preferred shares issued by the Fund and expenses on any forms of leverage outstanding) and gains or losses on the value of the securities and other instruments the Fund owns. As required by SEC rules, the table assumes that a Fund is more likely to suffer capital losses than to enjoy capital appreciation. For example, to assume a total return of 0%, a Fund must assume that the income it receives on its investments is entirely offset by losses in the value of those investments. This table reflects hypothetical performance of the Fund’s portfolio and not the actual performance of the Fund’s common shares, the value of which is determined by market forces and other factors. Should the Fund elect to add additional leverage to its portfolio, any benefits of such additional leverage cannot be fully achieved until the proceeds resulting from the use of such leverage have been received by the Fund and invested in accordance with the Fund’s investment objectives and policies. As noted above, the Fund’s willingness to use additional leverage, and the extent to which leverage is used at any time, will depend on many factors, including, among other things, the Fund’s assessment of the yield curve environment, interest rate trends, market conditions and other factors.

SUMMARY OF FUND EXPENSES

The following table shows the Fund’s expenses, which are borne directly or indirectly by holders of the Fund’s common shares, including preferred shares offering expenses, as a percentage of net assets attributable to common shares. All expenses of the Fund will be borne, directly or indirectly, by the common shareholders. Amounts are for the current fiscal year.

Annual Expenses	Percentages of Net Assets Attributable to Common Shares
Management Fees(a)	1.29	%
Interest Expense(b)	1.27	%
Other Expenses(c)	0.44	%
Total Annual Expenses	3.00	%
Total Annual Expenses and Dividends on Preferred Shares(d)	3.00	%

	(a)	The Investment Adviser’s fee is 1.00% annually of the Fund’s average weekly net assets. The Fund’s average weekly net assets will be deemed to be the average weekly value of the Fund’s total assets minus the sum of the Fund’s liabilities (such liabilities exclude (i) the aggregate liquidation preference of outstanding shares of preferred stock and accumulated dividends, if any, on those shares and (ii) the liabilities for any money borrowed). Consequently, because the Fund has preferred stock outstanding, the investment management fees and other expenses as a percentage of net assets attributable to common stock will be higher than if the Fund did not utilize a leveraged capital structure.
	(b)	The Series E Preferred Shares have a mandatory redemption date of December 26, 2025 and the Series G Preferred Shares have a mandatory redemption date of June 26, 2025. Therefore, for financial reporting purposes only, the dividends paid on the Series E Preferred Shares and Series G Preferred Shares are included as a component of “Interest Expense.”

The Gabelli Healthcare & Wellness^Rx Trust

Additional Fund Information (Continued) (Unaudited)

	(c)	“Other Expenses” are based on amounts for the year ended December 31, 2023.
	(d)	Dividends on Preferred Stock represent the estimated annual distributions on the existing preferred stock outstanding.

The following example illustrates the expenses you would pay on a $1,000 investment in common shares, assuming a 5% annual portfolio total return.*

		1 Year		3 Year		5 Year		10 Year
Total Expenses Incurred		$30		$93		$158		$332

The example should not be considered a representation of future expenses. The example is based on Total Annual Expenses and Dividends on Preferred Shares shown in the table above and assumes that the amounts set forth in the table do not change and that all distributions are reinvested at NAV. Actual expenses may be greater or less than those assumed. Moreover, the Fund’s actual rate of return may be greater or less than the hypothetical 5% return shown in the example.

The above example includes Dividends on Preferred Shares. If Dividends on Preferred Shares were not included in the example calculation, the expenses would be as follows (based on the same assumptions as above).

		1 Year		3 Year		5 Year		10 Year
Total Expenses Incurred		$18		$55		$94		$205

Share Price Data

The following table sets forth for the quarters indicated, the high and low closing prices on the NYSE per share of the Fund’s common shares and the NAV and the premium or discount from NAV at which the common shares was trading, expressed as a percentage of NAV, at each of the high and low NYSE closing prices provided.

The Gabelli Healthcare & Wellness^Rx Trust

Additional Fund Information (Continued) (Unaudited)


	Common Share Market Price		Corresponding Net Asset Value (“NAV”) Per Share		Corresponding Premium or Discount as a % of NAV
Quarter Ended	High	Low	High	Low	High	Low
March 31, 2022	$13.68	$12.00	$15.34	$13.96	(10.82)%	(14.04)%
June 30, 2022	$13.19	$9.84	$14.94	$11.56	(11.71)%	(14.88)%
September 30, 2022	$12.27	$9.50	$13.38	$10.99	(8.30)%	(13.56)%
December 31, 2022	$10.65	$9.50	$12.53	$11.00	(15.00)%	(13.64)%
March 31, 2023	$10.56	$9.49	$12.47	$11.38	(15.32)%	(16.61)%
June 30, 2023	$10.34	$9.50	$12.55	$11.46	(17.61)%	(17.10)%
September 30, 2023	$10.12	$8.57	$12.28	$10.70	(17.59)%	(19.91)%
December 31, 2023	$9.35	$7.74	$11.49	$9.81	(18.62)%	(21.10)%

Portfolio Managers

Effective July 17, 2023, Jennie Tsai no longer serves as a portfolio manager of the Fund.

Unresolved Staff Comments

The Fund does not believe that there are any material unresolved written comments, received 180 days or more before December 31, 2023 from the Staff of the SEC regarding any of the Fund’s periodic or current reports under the Securities Exchange Act or the Investment Company Act, or its registration statement.

The Gabelli Healthcare & Wellness^Rx Trust

Additional Fund Information (Continued) (Unaudited)

Selected data for a common share of beneficial interest outstanding throughout each year:

	Year Ended December 31,
	2018			2017			2016			2015			2014
Operating Performance:
Net asset value, beginning of year	$	11.74		$	10.86		$	11.79		$	11.76		$	11.33
Net investment income/(loss)		0.07			(0.01	)		(0.02	)		(0.03	)		0.01
Net realized and unrealized gain/(loss) on investments, and foreign currency transactions		(0.23	)		1.61			(0.21	)		0.75			2.04
Total from investment operations		(0.16	)		1.60			(0.23	)		0.72			2.05

Distributions to Preferred Shareholders:(a)
Net investment income		(0.02	)		(0.01	)		—			—			—
Net realized short term/long term gain		(0.18	)		(0.19	)		(0.19	)		(0.19	)		(0.13	)
Total distributions to preferred shareholders		(0.20	)		(0.20	)		(0.19	)		(0.19	)		(0.13	)

Net Increase in Net Assets Attributable to Common Shareholders Resulting from Operations		(0.36	)		1.40			(0.42	)		0.53			1.92

Distributions to Common Shareholders:
Net investment income		(0.05	)		(0.00	)(b)		—			—			—
Net realized short term/long term gain		(0.47	)		(0.51	)		(0.52	)		(0.51	)		(0.62	)
Return of capital		—			(0.01	)		—			—			—
Total distributions to common shareholders		(0.52	)		(0.52	)		(0.52	)		(0.51	)		(0.62	)

Fund Share Transactions:
Increase in net asset value from repurchase of common shares		0.09			0.00	(b)		—			0.01			—
Decrease in net asset value from common shares issued in rights offering		—			—			—			—			(0.77	)
Offering costs for preferred shares charged to paid-in capital		—			—			—			—			(0.08	)
Offering costs and adjustment to offering costs for common shares charged to paid-in capital		0.00	(b)		—			—			(0.00	)(b)		(0.02	)
Increase in net asset value from offering of preferred shares		—			—			0.01			—			—
Total Fund share transactions		0.09			0.00	(b)		0.01			0.01			(0.87	)

Net Asset Value Attributable to Common Shareholders, End of Year	$	10.95		$	11.74		$	10.86		$	11.79		$	11.76
NAV total return †		(2.65	)%		13.02	%		(3.63	)%		4.55	%		16.98	%
Market value, end of year	$	9.25		$	10.33		$	9.43		$	10.25		$	10.42
Investment total return ††		(5.78	)%		15.17	%		(3.15	)%		3.14	%		10.39	%

The Gabelli Healthcare & Wellness^Rx Trust

Additional Fund Information (Continued) (Unaudited)

Selected data for a common share of beneficial interest outstanding throughout each year:


	Year Ended December 31,
	2018			2017			2016			2015			2014
Ratios to Average Net Assets and Supplemental Data:
Net assets including liquidation value of preferred shares, end of year (in 000’s)	$	271,649		$	299,680		$	282,611		$	299,097		$	299,595
Net assets attributable to common shares, end of year (in 000’s)	$	204,613		$	232,644		$	215,575		$	234,097		$	234,595
Ratio of net investment income/(loss) to average net assets attributable to common shares before preferred share distributions		0.60	%		(0.07	)%		(0.20	)%		(0.22	)%		(0.27	)%
Ratio of operating expenses to average net assets attributable to common shares (c)		1.61	%(d)		1.65	%(d)		1.62	%(d)		1.60	%(d)		1.63	%
Portfolio turnover rate		32.4	%		34.3	%		31.7	%		52.4	%		43.5	%

Cumulative Preferred Shares:
5.760% Series A Preferred
Liquidation value, end of year (in 000’s)	$	30,000		$	30,000		$	30,000		$	30,000		$	30,000
Total shares outstanding (in 000’s)		1,200			1,200			1,200			1,200			1,200
Liquidation preference per share	$	25.00		$	25.00		$	25.00		$	25.00		$	25.00
Average market value (e)	$	25.43		$	25.89		$	26.12		$	25.96		$	25.85
Asset coverage per share (f)	$	101.31		$	111.76		$	105.40		$	115.04		$	115.23

5.875% Series B Preferred
Liquidation value, end of year (in 000’s)	$	37,036		$	37,036		$	37,036		$	35,000		$	35,000
Total shares outstanding (in 000’s)		1,481			1,481			1,481			1,400			1,400
Liquidation preference per share	$	25.00		$	25.00		$	25.00		$	25.00		$	25.00
Average market value (e)	$	25.83		$	26.67		$	26.76		$	26.09		$	25.37
Asset coverage per share (f)	$	101.31		$	111.76		$	105.40		$	115.04		$	115.23
Asset Coverage (g)		405	%		447	%		422	%		460	%		461	%

	†	Based on net asset value per share at commencement of operations of $8.00 per share, adjusted for reinvestment of distributions at the net asset value per share on ex-dividend dates including the effect of shares issued pursuant to the rights offerings, assuming full subscription by shareholders.
	††	Based on market value per share at initial public offering of $8.00 per share, adjusted for reinvestment of distributions at prices determined under the Fund’s dividend reinvestment plan including the effect of shares issued pursuant to the rights offerings, assuming full subscription by shareholders.
	(a)	Calculated based on average common shares outstanding on the record dates throughout the years.
	(b)	Amount represents less than $0.005 per share.
	(c)	Ratio of operating expenses to average net assets including liquidation value of preferred shares for the years ended December 31, 2018, 2017, 2016, 2015, and 2014 would have been 1.25%, 1.27%, 1.26%, 1.26%, and 1.36%, respectively.
	(d)	The Fund received credits from a designated broker who agreed to pay certain Fund operating expenses. Had such payments not been made, this expense ratio for the year ended December 31, 2015 would have been 1.27%. For the years ended December 31, 2018, 2017, and 2016, there was no impact on the expense ratios.
	(e)	Based on weekly prices.
	(f)	Asset coverage per share is calculated by combining all series of preferred shares.
	(g)	Asset coverage is calculated by combining all series of preferred shares.

The Gabelli Healthcare & Wellness^Rx Trust

Additional Fund Information (Continued) (Unaudited)

AUTOMATIC DIVIDEND REINVESTMENT AND VOLUNTARY CASH PURCHASE PLAN

Under the Fund’s Automatic Dividend Reinvestment Plan and Voluntary Cash Purchase Plan (the “Plan”), a shareholder whose shares of common stock are registered in his or her own name will have all distributions reinvested automatically by Computershare Trust Company, N.A. (“Computershare”), which is an agent under the Plan, unless the shareholder elects to receive cash. Distributions with respect to shares registered in the name of a broker-dealer or other nominee (that is, in “street name”) will be reinvested by the broker or nominee in additional shares under the Plan, unless the service is not provided by the broker or nominee or the shareholder elects to receive distributions in cash. Investors who own shares of common stock registered in street name should consult their broker-dealers for details regarding reinvestment. All distributions to investors who do not participate in the Plan will be paid by check mailed directly to the record holder by Computershare as dividend-disbursing agent.

Enrollment in the Plan

It is the policy of The Gabelli Healthcare & WellnessRx Trust (the “Fund”) to automatically reinvest dividends. As a “registered” shareholder you automatically become a participant in the Fund’s Automatic Dividend Reinvestment Plan (the “Plan”). The Plan authorizes the Fund to credit common shares to participants upon an income dividend or a capital gains distribution regardless of whether the shares are trading at a discount or a premium to net asset value. All distributions to shareholders whose shares are registered in their own names will be automatically reinvested pursuant to the Plan in additional shares of the Fund. Plan participants may send their shares certificates to Computershare Trust Company, N.A. (“Computershare”) to be held in their dividend reinvestment account. Registered shareholders wishing to receive their distribution in cash may submit this request through the Internet, by telephone or in writing to:

The Gabelli Healthcare & Wellness^Rx Trust

c/o Computershare

P.O. Box 43006

Providence, RI 02940-3006

Telephone: (800) 336-6983

Website: www.computershare.com/investor

Shareholders requesting this cash election must include the shareholder’s name and address as they appear on the share certificate. Shareholders with additional questions regarding the Plan requesting a copy of the terms of the Plan, may contact Computershare at the website or telephone number above.

If your shares are held in the name of a broker, bank, or nominee, you should contact such institution. If such institution is not participating in the Plan, your account will be credited with a cash dividend. In order to participate in the Plan through such institution, it may be necessary for you to have your shares taken out of

The Gabelli Healthcare & Wellness^Rx Trust

Additional Fund Information (Continued) (Unaudited)

“street name” and re-registered in your own name. Once registered in your own name your dividends will be automatically reinvested. Certain brokers participate in the Plan. Shareholders holding shares in “street name” at participating institutions will have dividends automatically reinvested. Shareholders wishing a cash dividend at such institution must contact their broker to make this change.

The number of common shares distributed to participants in the Plan in lieu of cash dividends is determined in the following manner. Under the Plan, whenever the market price of the Fund’s common shares is equal to or exceeds net asset value at the time shares are valued for purposes of determining the number of shares equivalent to the cash dividends or capital gains distribution, participants are issued common shares valued at the greater of (i) the net asset value as most recently determined or (ii) 95% of the then current market price of the Fund’s common shares. The valuation date is the dividend or distribution payment date or, if that date is not a NYSE trading day, the next trading day. If the net asset value of the common shares at the time of valuation exceeds the market price of the common shares, participants will receive shares from the Fund valued at market price. If the Fund should declare a dividend or capital gains distribution payable only in cash, Computershare will buy common shares in the open market, or on the NYSE or elsewhere, for the participants’ accounts, except that Computershare will endeavor to terminate purchases in the open market and cause the Fund to issue shares at net asset value if, following the commencement of such purchases, the market value of the common shares exceeds the then current net asset value.

The automatic reinvestment of dividends and capital gains distributions will not relieve participants of any income tax which may be payable on such distributions. A participant in the Plan will be treated for federal income tax purposes as having received, on a dividend payment date, a dividend or distribution in an amount equal to the cash the participant could have received instead of shares.

Voluntary Cash Purchase Plan

The Voluntary Cash Purchase Plan is yet another vehicle for our shareholders to increase their investment in the Fund. In order to participate in the Voluntary Cash Purchase Plan, shareholders must have their shares registered in their own name.

Participants in the Voluntary Cash Purchase Plan have the option of making additional cash payments to Computershare for investments in the Fund’s shares at the then current market price. Shareholders may send an amount from $250 to $10,000. Computershare will use these funds to purchase shares in the open market on or about the 1st and 15th of each month. Computershare will charge each shareholder who participates $0.75, plus a per share fee (currently $0.02 per share). Per share fees include any applicable brokerage commissions Computershare is required to pay and fees for such purchases are expected to be less than the usual fees for such transactions. It is suggested that any voluntary cash payments be sent to Computershare, P.O. Box 6006, Carol Stream, IL 60197-6006 such that Computershare receives such payments approximately three business days before the 1st and 15th of the month. Funds not received at least three business days before the investment date shall be held for investment until the next purchase date. Computershare will wait up to three business days after receipt of a check to ensure it receives good funds and will then seek to purchase shares for voluntary cash payments on the voluntary cash payment date. A payment may be withdrawn without charge if notice is received by Computershare at least two business days before such payment is to be invested.

The Gabelli Healthcare & Wellness^Rx Trust

Additional Fund Information (Continued) (Unaudited)

Shareholders wishing to liquidate shares held at Computershare may do so through the Internet, in writing or by telephone to the above-mentioned website, address or telephone number. Include in your request your name, address, and account number. Computershare will sell such shares through a broker-dealer selected by Computershare within 5 business days of receipt of the request. The sale price will equal the weighted average price of all shares sold through the Plan on the day of the sale, less applicable fees. Participants should note that Computershare is unable to accept instructions to sell on a specific date or at a specific price. The cost to liquidate shares is $2.50 per transaction as well as the per share fee (currently $0.10 per share) Per share fees include any applicable brokerage commissions Computershare is required to pay and are expected to be less than the usual fees for such transactions.

For more information regarding the Dividend Reinvestment Plan and Voluntary Cash Purchase Plan, brochures are available by calling (914) 921-5070 or by writing directly to the Fund.

The Fund reserves the right to amend or terminate the Plans as applied to any voluntary cash payments made and any dividend or distribution paid subsequent to written notice of the change sent to the members of the Plan at least 30 days before the record date for such dividend or distribution. The Plan also may be amended or terminated by Computershare on at least 30 days written notice to participants in the Plan.

The Gabelli Healthcare & Wellness^Rx Trust

Additional Fund Information (Unaudited) (Continued)

MANAGEMENT OF THE FUND

Trustees and Officers

The business and affairs of the Fund are managed under the direction of the Fund’s Board of Trustees. Information pertaining to the Trustees and Officers of the Fund is set forth below. The Fund’s Statement of Additional Information includes additional information about the Fund Trustees and is available without charge, upon request, by calling 800-GABELLI (800-422-3554) or by writing to The Gabelli Healthcare & Wellness^Rx Trust at One Corporate Center, Rye, NY 10580-1422.

Name, Position(s) Address¹ and Year of Birth	Term of Office and Length of Time Served²	Number of Funds in Fund Complex Overseen by Trustee³	Principal Occupation(s) During Past Five Years	Other Directorships Held by Trustee³

INTERESTED TRUSTEES⁴:

Mario J. Gabelli, CFA Chairman and Chief Investment Officer 1942	Since 2007***	31	Chairman, Co-Chief Executive Officer, and Chief Investment Officer– Value Portfolios of GAMCO Investors, Inc. and Chief Investment Officer – Value Portfolios of Gabelli Funds, LLC and GAMCO Asset Management, Inc.; Director/Trustee or Chief Investment Officer of other registered investment companies within the Gabelli Fund Complex; Chief Executive Officer of GGCP, Inc.; Executive Chair of Associated Capital Group, Inc.	Director of Morgan Group Holding Co. (holding company) (2001-2019); Chairman of the Board and Chief Executive Officer of LICT Corp. (multimedia and communication services company); Director of CIBL, Inc. (broadcasting and wireless communications); Director of ICTC Group Inc. (communications) (2013-2018)

Jeffrey J. Jonas Trustee 1981	Since 2016**	1	Portfolio Manager for Gabelli Funds, LLC, GAMCO Asset Management Inc., and Gabelli & Company Investment Advisers, Inc.	—

Agnes Mullady Trustee 1958	Since 2021***	14	Senior Vice President of GAMCO Investors, Inc. (2008 - 2019); Executive Vice President of Associated Capital Group, Inc. (November 2016 - 2019); President and Chief Operating Officer of the Fund Division of Gabelli Funds, LLC (2010 - 2019); Vice President of Gabelli Funds, LLC (2006 - 2019); Chief Executive Officer of G.distributors, LLC (2011 - 2019); and an officer of all of the Gabelli/ Teton Funds (2006 - 2019)	GAMCO Investors, Inc.

INDEPENDENT TRUSTEES⁵:

Calgary Avansino Trustee 1975	Since 2021*	5	Chief Executive Officer, Glamcam (2018- 2020)	Trustee, Cate School; Trustee, the E.L. Wiegand Foundation; Member, the Common Sense Media Advisory Council

The Gabelli Healthcare & Wellness^Rx Trust

Additional Fund Information (Unaudited) (Continued)

Name, Position(s) Address¹ and Year of Birth	Term of Office and Length of Time Served²	Number of Funds in Fund Complex Overseen by Trustee³	Principal Occupation(s) During Past Five Years	Other Directorships Held by Trustee³
James P. Conn⁶ Trustee 1938	Since 2007**	23	Former Managing Director and Chief Investment Officer of Financial Security Assurance Holdings Ltd. (1992-1998)	—

Vincent D. Enright^6,7 Trustee 1943	Since 2007***	17	Former Senior Vice President and Chief Financial Officer of KeySpan Corp. (public utility) (1994-1998)	Director of Echo Therapeutics, Inc. (therapeutics and diagnostics) (2008-2014); Director of The LGL Group, Inc. (diversified manufacturing) (2011-2014)

Leslie F. Foley⁸ Trustee 1968	Since 2017*	16	Attorney; Serves on the Board of the Addison Gallery of American Art at Phillips Academy Andover; Vice President, Global Ethics & Compliance and Associate General Counsel for News Corporation (2008-2010)	—

Robert C. Kolodny⁹Trustee 1944	Since 2007*	2	Physician; Medical Director and Chairman of the Board of the Behavioral Medicine Institute; Managing Member of KBS Management LLC (investment adviser); Managing General Partner of KBS Partnership, KBS III Investment Partnership, KBS IV Limited Partnership (1990-2016), KBS New Dimensions, L.P. (1993-2015), Kolodny Family Limited Partnership (private investment partnerships)	—

Anthonie C. van Ekris⁷ Trustee 1934	Since 2007***	23	Chairman and Chief Executive Officer of BALMAC International, Inc. (global import/ export company)	—

Salvatore J. Zizza¹⁰ Trustee 1945	Since 2007*	35	President, Zizza & Associates Corp. (private holding company); Chairman of Bergen Cove Realty Inc. (residential real estate)	Director and Chairman of Trans-Lux Corporation (business services); Director and Chairman of Harbor Diversified Inc. (pharmaceuticals) (2009-2018); Retired Chairman of BAM (semiconductor and aerospace manufacturing); Director of Bion Environmental Technologies, Inc.

The Gabelli Healthcare & Wellness^Rx Trust

Additional Fund Information (Unaudited) (Continued)

Name, Position(s) Address¹ and Year of Birth	Term of Office and Length of Time Served²	Principal Occupation(s) During Past Five Years

OFFICERS:

John C. Ball President, Treasurer, Principal Financial & Accounting Officer 1976	Since 2017	Senior Vice President (since 2018) of GAMCO Investors, Inc.; Chief Executive Officer, G. distributors, LLC since 2020; Officer of registered investment companies within the Gabelli Fund Complex since 2017

Peter Goldstein Secretary & Vice President 1953	Since 2020	General Counsel, GAMCO Investors, Inc. and Chief Legal Officer, Associated Capital Group, Inc. since 2021; General Counsel and Chief Compliance Officer, Buckingham Capital Management, Inc. (2012-2020); Chief Legal Officer and Chief Compliance Officer, The Buckingham Research Group, Inc. (2012-2020)

Richard J. Walz Chief Compliance Officer 1959	Since 2013	Chief Compliance Officer of registered investment companies within the Gabelli Fund Complex since 2013

Bethany A. Uhlein Vice President and Ombudsman 1990	Since 2017	Vice President and/or Ombudsman of closed-end funds within the Gabelli Fund Complex since 2017; Senior Vice President (since 2021) of GAMCO Investors, Inc.

David I. Schachter Vice President 1953	Since 2007	Vice President and/or Ombudsman of closed-end funds within the Gabelli Fund Complex; Senior Vice President (since 2015) of G.research, LLC

Adam E. Tokar Vice President 1980	Since 2007	Vice President and/or Ombudsman of closed-end funds within the Gabelli Fund Complex

	¹	Address: One Corporate Center, Rye, NY 10580-1422, unless otherwise noted.
	²	The Fund’s Board of Trustees is divided into three classes, each class having a term of three years. Each year the term of office of one class expires and the successor or successors elected to such class serve for a three year term. The three year term for each class expires as follows:
	*	Term expires at the Fund’s 2024 Annual Meeting of Shareholders or until their successors are duly elected and qualified.
	**	Term expires at the Fund’s 2025 Annual Meeting of Shareholders or until their successors are duly elected and qualified.
	***	Term expires at the Fund’s 2026 Annual Meeting of Shareholders or until their successors are duly elected and qualified.

Each officer will hold office for an indefinite term until the date he or she resigns or retires or until his or her successor is elected and qualified.

	³	This column includes only directorships of companies required to report to the SEC under the Securities Exchange Act of 1934, as amended, i.e., public companies, or other investment companies registered under the 1940 Act.
	⁴	“Interested person” of the Fund as defined in the 1940 Act. Messrs. Gabelli, Jonas and Ms. Mullady are considered “interested persons” because of their affiliation with Gabelli Funds, LLC which acts as the Fund’s investment adviser.
	⁵	Trustees who are not considered to be “interested persons” of the Fund as defined in the 1940 Act are considered to be “Independent” Trustees.
	⁶	This Trustee is elected solely by and represents the shareholders of the preferred shares issued by the Fund.
	⁷	Mr. van Ekris is an independent director of Gabelli International Ltd., Gabelli Fund LDC, Gama Capital Opportunities Master Ltd., and

The Gabelli Healthcare & Wellness^Rx Trust

Additional Fund Information (Unaudited) (Continued)

		GAMCO International SICAV, Mr. Birch is an independent director of Gabelli Merger Plus+ Trust Plc and an independent director of the GAMCO International SICAV, and Mr. Enright is an independent director of The LGL Group, Inc., all of which may be deemed to be controlled by Mario J. Gabelli and/or affiliates and, in that event, would be deemed to be under common control with the Fund’s Adviser.
	⁸	Ms. Foley’s father, Frank J. Fahrenkopf, Jr., serve as directors of other funds in the Fund Complex.
	⁹	Dr. Kolodny is the managing general partner of the following private investment partnerships for which GAMCO Asset Management Inc. (GAMCO), a registered investment adviser under common control with the Manager, serves as an investment adviser providing portfolio management for these entities and receives an advisory fee: KBS Partnership (KBS) and KBS III Investment Partnership (KBS III). For the calendar years ended December 31, 2023 and 2022, GAMCO received the following amounts for the services it provided to these private investment partnerships: (i) KBS - $32,158 and $36,440 and (ii) KBS III - $64,336 and $71,364, respectively.
	¹⁰	Mr. Zizza is an independent director of Gabelli International Ltd., which may be deemed to be controlled by Mario J. Gabelli and/or affiliates and in that event would be deemed to be under common control with the Fund’s Adviser. On September 9, 2015, Mr. Zizza entered into a settlement with the SEC to resolve an inquiry relating to an alleged violation regarding the making of false statements or omissions to the accountants of a company concerning a related party transaction. The company in question is not an affiliate of, nor has any connection to, the Fund. Under the terms of the settlement, Mr. Zizza, without admitting or denying the SEC’s findings and allegation, paid $150,000 and agreed to cease and desist committing or causing any future violations of Rule 13b2-2 of the Securities Exchange Act of 1934, as amended. The Board has discussed this matter and has determined that it does not disqualify Mr. Zizza from serving as an independent director.

THE GABELLI HEALTHCARE & WELLNESS^RX TRUST

INCOME TAX INFORMATION (Unaudited)

December 31, 2023

Cash Dividends and Distributions

	Payable Date	Record Date	Ordinary Investment Income (a)		Long Term Capital Gains		Return of Capital (b)		Total Amount Paid Per Share (c)		Dividend Reinvestment Price
Common Stock
	03/24/23	03/17/23	$	0.00750	$	0.13700	$	0.00550	$	0.15000	$	9.92880
	06/23/23	06/15/23		0.00750		0.13700		0.00550		0.15000		9.95810
	09/22/23	09/15/23		0.00750		0.13700		0.00550		0.15000		8.81010
	12/22/23	12/15/23		0.00750		0.13700		0.00550		0.15000		9.32570
			$	0.03000	$	0.54800	$	0.02200	$	0.60000
4.000% Series E Cumulative Preferred Shares
	03/27/23	03/20/23	$	0.0052000	$	0.0948000		—	$	0.1000000
	06/26/23	06/16/23		0.0052000		0.0948000		—		0.1000000
	09/26/23	09/19/23		0.0052000		0.0948000		—		0.1000000
	12/26/23	12/18/23		0.0052000		0.0948000		—		0.1000000
			$	0.0208000	$	0.3792000		—	$	0.4000000
5.200% Series G Cumulative Preferred Shares
	06/26/23	06/16/23	$	0.0118550	$	0.2163670		—	$	0.2282220
	12/26/23	12/18/23		0.0135060		0.2464940		—		0.2600000
			$	0.0253610	$	0.4628610		—	$	0.4882220

A Form 1099-DIV has been mailed to all shareholders of record which sets forth specific amounts to be included in your 2023 tax returns. Ordinary distributions include net investment income and realized net short-term capital gains. Ordinary income is reported in box 1a of Form 1099- DIV. Capital gain distributions are reported in box 2a of Form 1099-DIV.

The long term gain distributions for the year ended December 31, 2023 were $8,886,185 or the maximum amount.

Corporate Dividends Received Deduction, Qualified Dividend Income, and U.S. Government Securities Income

In 2023, the Fund paid to common, 4.000% Series E Cumulative Preferred, and 5.200% Series G Cumulative Preferred Stock shareholders ordinary income dividends of $0.03000, $0.02080, and $0.02536 per share, respectively. For 2023, 100% of the ordinary dividend qualified for the dividend received deduction available to corporations, 100% of the ordinary income distribution was deemed qualified dividend income, and 15.80% of ordinary income distribution was qualified interest income. The percentage of ordinary income dividends paid by the Fund during 2023 derived from U.S. Government securities was 14.73%. Such income is exempt from state and local taxes in all states. However, many states, including New York and California, allow a tax exemption for a portion of the income earned only if a mutual fund has invested at least 50% of its assets at the end of each quarter of its fiscal year in U.S. Government securities. The Fund did not meet this strict requirement in 2023. The percentage of U.S. Government securities held as of December 31, 2023 was 3.0%.

THE GABELLI HEALTHCARE & WELLNESS^RX TRUST

INCOME TAX INFORMATION (Unaudited) (Continued)

December 31, 2023

Historical Distribution Summary

	Investment Income (a)		Short Term Capital Gains (a)		Long Term Capital Gains		Return of Capital (b)		Total Distributions (c)		Adjustment to Cost Basis (d)
Common Shares
2023	$	0.03000		—	$	0.54800	$	0.02200	$	0.60000	$	0.02200
2022		0.01575		—		0.57761		0.00664		0.60000		0.00664
2021		0.00240	$	0.01940		0.93820		—		0.96000		—
2020		0.00740		—		0.57260		—		0.58000		—
2019		0.01750		0.19070		0.34100		0.01080		0.56000		0.01080
2018		0.05004		0.23560		0.23436		—		0.52000		—
2017		0.00114		0.02873		0.48277		0.00736		0.52000		0.00736
2016		—		0.04890		0.47110		—		0.52000		—
2015		—		0.10070		0.40930		—		0.51000		—
2014(e)		—		0.11520		0.50480		—		0.62000		—
5.760% Series A Cumulative Preferred Shares
2020	$	0.00521		—	$	0.40679		—	$	0.41200		—
2019		0.04565	$	0.49990		0.89441		—		1.44000		—
2018		0.13856		0.65248		0.64896		—		1.44000		—
2017		0.00322		0.08075		1.35603		—		1.44000		—
2016		—		0.13560		1.30440		—		1.44000		—
2015		—		0.28380		1.15620		—		1.44000		—
2014		—		0.27160		1.16840		—		1.44000		—
5.875% Series B Cumulative Preferred Shares
2020	$	0.01844		—	$	1.44215		—	$	1.46059		—
2019		0.04655	$	0.50992		0.91228		—		1.46875		—
2018		0.14134		0.66550		0.66190		—		1.46875		—
2017		0.00327		0.08237		1.38311		—		1.46875		—
2016		—		0.13821		1.33054		—		1.46875		—
2015		—		0.28937		1.17938		—		1.46875		—
2014		—		0.07337		0.30198		—		0.37535		—
4.000% Series C Cumulative Preferred Shares
2022	$	0.02120		—	$	0.77880		—	$	0.80000		—
2021		0.00198	$	0.01628		0.79952		—		0.81778		—
4.000% Series E Cumulative Preferred Stock
2023	$	0.02080		—	$	0.37920		—	$	0.40000		—
2022		0.01060		—		0.38940		—		0.40000		—
2021		0.00020	$	0.00163		0.07706		—		0.07889		—
5.200% Series G Cumulative Preferred Stock
2023	$	0.02536		—	$	0.46286		—	$	0.48822		—

	(a)	Taxable as ordinary income for Federal tax purposes.
	(b)	Non-taxable.
	(c)	Total amounts may differ due to rounding.
	(d)	Decrease in cost basis.
	(e)	On May 22, 2014, the Fund also distributed Rights equivalent to $0.77 per common share based upon full subscription of all issued shares.

THE GABELLI HEALTHCARE & WELLNESS^RX TRUST

INCOME TAX INFORMATION (Unaudited) (Continued)

December 31, 2023

All designations are based on financial information available as of the date of this annual report and, accordingly, are subject to change. For each item, it is the intention of the Fund to designate the maximum amount permitted under the Internal Revenue Code and the regulations thereunder.

This page was intentionally left blank.

THE GABELLI HEALTHCARE & WELLNESS^Rx TRUST

One Corporate Center

Rye, NY 10580-1422

Portfolio Management Team Biographies

		Mario J. Gabelli, CFA, is Chairman, Chief Executive Officer, and Chief Investment Officer - Value Portfolios of GAMCO Investors, Inc. that he founded in 1977, and Chief Investment Officer - Value Portfolios of Gabelli Funds, LLC and GAMCO Asset Management, Inc. He is also Executive Chairman of Associated Capital Group, Inc. Mr. Gabelli is a summa cum laude graduate of Fordham University and holds an MBA degree from Columbia Business School and Honorary Doctorates from Fordham University and Roger Williams University.

		Kevin V. Dreyer joined Gabelli in 2005 as a research analyst covering companies within the consumer sector. Currently he is a Managing Director and Co-Chief Investment Officer for GAMCO Investors, Inc.’s Value team. In addition, he serves as a portfolio manager of Gabelli Funds, LLC and manages several funds within the Fund Complex. Mr. Dreyer received a BSE from the University of Pennsylvania and an MBA degree from Columbia Business School.

		Jeffrey J. Jonas, CFA, joined Gabelli in 2003 as a research analyst focusing on companies across the healthcare industry. In 2006, he began serving as a portfolio manager of Gabelli Funds, LLC and manages several funds within the Fund Complex. Mr. Jonas was a Presidential Scholar at Boston College, where he received a BS in Finance and Management Information Systems.

		Sara E. Wojda joined the Firm in 2014 as a research analyst and covers the Diagnostics and Life Sciences industries. Since moving to London in 2018, she has expanded the Firm’s global healthcare coverage and assisted with Gabelli’s UK based funds. Sara graduated summa cum laude from Babson College with a BS in Business Management, double majoring in Economics and Accounting.

The Net Asset Value per share appears in the Publicly Traded Funds column, under the heading “Specialized Equity Funds,” in Monday’s The Wall Street Journal. It is also listed in Barron’s Mutual Funds/Closed End Funds section under the heading “Specialized Equity Funds.”

The Net Asset Value per share may be obtained each day by calling (914) 921-5070 or visiting www.gabelli.com.

The NASDAQ symbol for the Net Asset Value is “XXGRX.”

Notice is hereby given in accordance with Section 23(c) of the Investment Company Act of 1940, as amended, that the Fund may, from time to time, purchase its common shares in the open market when the Fund’s shares are trading at a discount of 10% or more from the net asset value of the shares. The Fund may also, from time to time, purchase its preferred shares in the open market when the preferred shares are trading at a discount to the liquidation value.

(b)

Not applicable.

Item 2.

Code of Ethics.

(a)

The registrant, as of the end of the period covered by this report, has adopted a code of ethics that applies to the registrant’s principal executive officer, principal financial officer, principal accounting officer or controller, or persons performing similar functions, regardless of whether these individuals are employed by the registrant or a third party.

(c)

There have been no amendments, during the period covered by this report, to a provision of the code of ethics that applies to the registrant’s principal executive officer, principal financial officer, principal accounting officer or controller, or persons performing similar functions, regardless of whether these individuals are employed by the registrant or a third party, and that relates to any element of the code of ethics description.

(d)

The registrant has not granted any waivers, including an implicit waiver, from a provision of the code of ethics that applies to the registrant’s principal executive officer, principal financial officer, principal accounting officer or controller, or persons performing similar functions, regardless of whether these individuals are employed by the registrant or a third party, that relates to one or more of the items set forth in paragraph (b) of this item’s instructions.

Item 3.

Audit Committee Financial Expert.

As of the end of the period covered by the report, the registrant’s Board of Trustees has determined that Vincent D. Enright is qualified to serve as an audit committee financial expert serving on its audit committee and that he is “independent,” as defined by Item 3 of Form N-CSR.

Item 4.

Principal Accountant Fees and Services.

Audit Fees

(a)

The aggregate fees billed for each of the last two fiscal years for professional services rendered by the principal accountant for the audit of the registrant’s annual financial statements or services that are normally provided by the accountant in connection with statutory and regulatory filings or engagements for those fiscal years are $34,939 for 2022 and $35,638 for 2023.

Audit-Related Fees

(b)

The aggregate fees billed in each of the last two fiscal years for assurance and related services by the principal accountant that are reasonably related to the performance of the audit of the registrant’s financial statements and are not reported under paragraph (a) of this Item are $0 for 2022 and $0 for 2023.

Tax Fees

(c)

The aggregate fees billed in each of the last two fiscal years for professional services rendered by the principal accountant for tax compliance, tax advice, and tax planning are $4,070 for 2022 and $4,150 for 2023. Tax fees represent tax compliance services provided in connection with the review of the Registrant’s tax returns.

All Other Fees

(d)

The aggregate fees billed in each of the last two fiscal years for products and services provided by the principal accountant, other than the services reported in paragraphs (a) through (c) of this Item are $0 for 2022 and $0 for 2023. All other fees represent services provided in review of the registration statement.

	(e)(1)	Disclose the audit committee’s pre-approval policies and procedures described in paragraph (c)(7) of Rule 2-01 of Regulation S-X.

		Pre-Approval Policies and Procedures. The Audit Committee (“Committee”) of the registrant is responsible for pre-approving (i) all audit and permissible non-audit services to be provided by the independent registered public accounting firm to the registrant and (ii) all permissible non-audit services to be provided by the independent registered public accounting firm to the Adviser, Gabelli Funds, LLC, and any affiliate of Gabelli Funds, LLC (“Gabelli”) that provides services to the registrant (a “Covered Services Provider”) if the independent registered public accounting firm’s engagement related directly to the operations and financial reporting of the registrant. The Committee may delegate its responsibility to pre-approve any such audit and permissible non-audit services to the Chairperson of the Committee, and the Chairperson must report to the Committee, at its next regularly scheduled meeting after the Chairperson’s pre-approval of such services, his or her decision(s). The Committee may also establish detailed pre-approval policies and procedures for pre-approval of such services in accordance with applicable laws, including the delegation of some or all of the Committee’s pre-approval responsibilities to the other persons (other than Gabelli or the registrant’s officers). Pre-approval by the Committee of any permissible non-audit services is not required so long as: (i) the permissible non-audit services were not recognized by the registrant at the time of the engagement to be non-audit services; and (ii) such services are promptly brought to the attention of the Committee and approved by the Committee or Chairperson prior to the completion of the audit.

(e)(2)

The percentage of services described in each of paragraphs (b) through (d) of this Item that were approved by the audit committee pursuant to paragraph (c)(7)(i)(C) of Rule 2-01 of Regulation S-X are as follows:

(b) N/A

(d) 0%

No services described in paragraphs (b) through (d) were approved pursuant to paragraph (c)(7)(i)(C) of Rule 2-01 of Regulation S-X.

(f)

The percentage of hours expended on the principal accountant’s engagement to audit the registrant’s financial statements for the most recent fiscal year that were attributed to work performed by persons other than the principal accountant’s full-time, permanent employees was less than fifty percent.

(g)

The aggregate non-audit fees billed by the registrant’s accountant for services rendered to the registrant, and rendered to the registrant’s investment adviser (not including any sub-adviser whose role is primarily portfolio management and is subcontracted with or overseen by another investment adviser), and any entity controlling, controlled by, or under common control with the adviser that provides ongoing services to the registrant for each of the last two fiscal years of the registrant was $0 for 2022 and $0 for 2023.

(h)

The registrant’s audit committee of the board of directors has considered whether the provision of non-audit services that were rendered to the registrant’s investment adviser (not including any sub-adviser whose role is primarily portfolio management and is subcontracted with or overseen by another investment adviser), and any entity controlling, controlled by, or under common control with the investment adviser that provides ongoing services to the registrant that were not pre-approved pursuant to paragraph (c)(7)(ii) of Rule 2-01 of Regulation S-X is compatible with maintaining the principal accountant’s independence.

(i)

Not Applicable.

(j)

The registrant is not a foreign issuer.

Item 5.

Audit Committee of Listed Registrants.

(a)

The registrant has a separately designated audit committee consisting of the following members: James P. Conn, Vincent D. Enright, and Salvatore J. Zizza.

(b)

Not applicable.

Item 6.

Investments.

(a)

Schedule of Investments in securities of unaffiliated issuers as of the close of the reporting period is included as part of the report to shareholders filed under Item 1(a) of this form.

(b)

Not applicable due to no such divestments during the semi-annual period covered since the previous Form N-CSR filing.

Item 7.

Disclosure of Proxy Voting Policies and Procedures for Closed-End Management Investment Companies.

The Proxy Voting Policies are attached herewith.

SECTION HH

The Voting of Proxies on Behalf of Clients

(This section pertains to all affiliated SEC registered investment advisers)

Rule 206(4)-6 under the Investment Advisers Act of 1940 and Rule 30b1-4 under the Investment Company Act of 1940 require investment advisers to adopt written policies and procedures governing the voting of proxies on behalf of their clients.

These procedures will be used by GAMCO Asset Management Inc., Gabelli Funds, LLC, Gabelli & Company Investment Advisers, Inc., and Teton Advisors, Inc. (collectively, the “Advisers”) to determine how to vote proxies relating to portfolio securities held by their clients, including the procedures that the Advisers use when a vote presents a conflict between the interests of the shareholders of an investment company managed by one of the Advisers, on the one hand, and those of the Advisers; the principal underwriter; or any affiliated person of the investment company, the Advisers, or the principal underwriter. These procedures will not apply where the Advisers do not have voting discretion or where the Advisers have agreed to with a client to vote the client’s proxies in accordance with specific guidelines or procedures supplied by the client (to the extent permitted by ERISA).

Proxy Voting Committee

The Proxy Voting Committee was originally formed in April 1989 for the purpose of formulating guidelines and reviewing proxy statements within the parameters set by the substantive proxy voting guidelines originally published in 1988 and updated periodically, a copy of which are appended as Exhibit A. The Committee will include representatives of Research, Administration, Legal, and the Advisers. Additional or replacement members of the Committee will be nominated by the Chairman and voted upon by the entire Committee.

Meetings are held on an as needed basis to form views on the manner in which the Advisers should vote proxies on behalf of their clients.

In general, the Director of Proxy Voting Services, using the Proxy Guidelines, and the analysts of GAMCO Investors, Inc. (“GBL”), will determine how to vote on each issue. For non-controversial matters, the Director of Proxy Voting Services may vote the proxy if the vote is: (1) consistent with the recommendations of the issuer’s Board of Directors and not contrary to the Proxy Guidelines; (2) consistent with the recommendations of the issuer’s Board of Directors and is a non-controversial issue not covered by the Proxy Guidelines; or (3) the vote is contrary to the recommendations of the Board of Directors but is consistent with the Proxy Guidelines. In those instances, the Director of Proxy Voting Services or the Chairman of the Committee may sign and date the proxy statement indicating how each issue will be voted.

Revised: August 16, 2023

HH-1

INTERNAL USE ONLY

All matters identified by the Chairman of the Committee, the Director of Proxy Voting Services or the Legal Department as controversial, taking into account the recommendations of the analysts of GBL, will be presented to the Proxy Voting Committee. If the Chairman of the Committee, the Director of Proxy Voting Services or the Legal Department has identified the matter as one that (1) is controversial; (2) would benefit from deliberation by the Proxy Voting Committee; or (3) may give rise to a conflict of interest between the Advisers and their clients, the Chairman of the Committee will initially determine what vote to recommend that the Advisers should cast and the matter will go before the Committee.

Conflicts of Interest.

The Advisers have implemented these proxy voting procedures in order to prevent conflicts of interest from influencing their proxy voting decisions. By following the Proxy Guidelines and the analysts of GBL, the Advisers are able to avoid, wherever possible, the influence of potential conflicts of interest. Nevertheless, circumstances may arise in which one or more of the Advisers are faced with a conflict of interest or the appearance of a conflict of interest in connection with its vote. In general, a conflict of interest may arise when an Adviser knowingly does business with an issuer, and may appear to have a material conflict between its own interests and the interests of the shareholders of an investment company managed by one of the Advisers regarding how the proxy is to be voted. A conflict also may exist when an Adviser has actual knowledge of a material business arrangement between an issuer and an affiliate of the Adviser.

In practical terms, a conflict of interest may arise, for example, when a proxy is voted for a company that is a client of one of the Advisers, such as GAMCO Asset Management Inc. A conflict also may arise when a client of one of the Advisers has made a shareholder proposal in a proxy to be voted upon by one or more of the Advisers. The Director of Proxy Voting Services, together with the Legal Department, will scrutinize all proxies for these or other situations that may give rise to a conflict of interest with respect to the voting of proxies.

Operation of Proxy Voting Committee

For matters submitted to the Committee, each member of the Committee will receive, prior to the meeting, a copy of the proxy statement, a summary of any views provided by the Chief Investment Officer and any recommendations by GBL analysts. The Chief Investment Officer or the GBL analysts may be invited to present their viewpoints. If the Director of Proxy Voting Services or the Legal Department believe that the matter before the committee is one with respect to which a conflict of interest may exist between the Advisers and their clients, counsel may provide an

Revised: August 16, 2023

HH-2

INTERNAL USE ONLY

opinion to the Committee concerning the conflict. If the matter is one in which the interests of the clients of one or more of the Advisers may diverge, counsel may so advise and the Committee may make different recommendations as to different clients. For any matters where the recommendation may trigger appraisal rights, counsel may provide an opinion concerning the likely risks and merits of such an appraisal action.

Each matter submitted to the Committee will be determined by the vote of a majority of the members present at the meeting. Should the vote concerning one or more recommendations be tied in a vote of the Committee, the Chairman of the Committee will cast the deciding vote. The Committee will notify the proxy department of its decisions and the proxies will be voted accordingly.

Although the Proxy Guidelines express the normal preferences for the voting of any shares not covered by a contrary investment guideline provided by the client, the Committee is not bound by the preferences set forth in the Proxy Guidelines and will review each matter on its own merits. The Advisers subscribe to Institutional Shareholder Services Inc (“ISS”) and Glass Lewis & Co., LLC (“Glass Lewis”), which supply current information on companies, matters being voted on, regulations, trends in proxy voting and information on corporate governance issues. The information provided by ISS and GL is for informational purposes only.

If the vote cast either by the analyst or as a result of the deliberations of the Proxy Voting Committee runs contrary to the recommendation of the Board of Directors of the issuer, the matter may be referred to legal counsel to determine whether an amendment to the most recently filed Schedule 13D is appropriate.

II.

Social Issues and Other Client Guidelines

If a client has provided and the Advisers have accepted special instructions relating to the voting of proxies, they should be noted in the client’s account file and forwarded to the proxy department. This is the responsibility of the investment professional or sales assistant for the client. In accordance with Department of Labor guidelines, the Advisers’ policy is to vote on behalf of ERISA accounts in the best interest of the plan participants with regard to social issues that carry an economic impact. Where an account is not governed by ERISA, the Advisers will vote shares held on behalf of the client in a manner consistent with any individual investment/voting guidelines provided by the client. Otherwise the Advisers may abstain with respect to those shares.

Specific to the Gabelli SRI Fund and the Gabelli Love Our Planet & People ETF, the Proxy Voting Committee will rely on the advice of the portfolio managers of the Gabelli SRI Fund and the Gabelli Love Our Planet & People ETF to provide voting recommendations on the securities held in the portfolios.

Revised: August 16, 2023

HH-3

INTERNAL USE ONLY

III.

Client Retention of Voting Rights

If a client chooses to retain the right to vote proxies or if there is any change in voting authority, the following should be notified by the investment professional or sales assistant for the client.

- Operations

- Proxy Department

- Investment professional assigned to the account

In the event that the Board of Directors (or a Committee thereof) of one or more of the investment companies managed by one of the Advisers has retained direct voting control over any security, the Proxy Voting Department will provide each Board Member (or Committee member) with a copy of the proxy statement together with any other relevant information.

IV.

Proxies of Certain Non-U.S. Issuers

Proxy voting in certain countries requires “share-blocking.” Shareholders wishing to vote their proxies must deposit their shares shortly before the date of the meeting with a designated depository. During the period in which the shares are held with a depository, shares that will be voted at the meeting cannot be sold until the meeting has taken place and the shares are returned to the clients’ custodian. Absent a compelling reason to the contrary, the Advisers believe that the benefit to the client of exercising the vote is outweighed by the cost of voting and therefore, the Advisers will not typically vote the securities of non-U.S. issuers that require share-blocking.

In addition, voting proxies of issuers in non-U.S. markets may also give rise to a number of administrative issues or give rise to circumstances under which voting would impose a cost (real or implied) on its client which may cause the Advisers to abstain from voting such proxies. For example, the Advisers may receive the notices for shareholder meetings without adequate time to consider the proposals in the proxy or after the cut-off date for voting. Other markets require the Advisers to provide local agents with power of attorney prior to implementing their respective voting instructions on the proxy. Other markets may require disclosure of certain ownership information in excess of what is required to vote in the U.S. market. Although it is the Advisers’ policies to vote the proxies for its clients for which they have proxy voting authority, in the case of issuers in non-U.S. markets, we vote client proxies on a best efforts basis.

Voting Records

The Proxy Voting Department will retain a record of matters voted upon by the Advisers for their clients. The Advisers will supply information on how they voted a client’s proxy upon request from the client.

Revised: August 16, 2023

HH-4

INTERNAL USE ONLY

The complete voting records for each registered investment company (the “Fund”) that is managed by the Advisers will be filed on Form N-PX for the twelve months ended June 30th, no later than August 31st of each year. A description of the Fund’s proxy voting policies, procedures, and how the Fund voted proxies relating to portfolio securities is available without charge, upon request, by (i) calling 800-GABELLI (800-422-3554); (ii) writing to Gabelli Funds, LLC at One Corporate Center, Rye, NY 10580-1422; or (iii) visiting the SEC’s website at www.sec.gov.

The Advisers’ proxy voting records will be retained in compliance with Rule 204-2 under the Investment Advisers Act.

VI.

Voting Procedures

1. Custodian banks, outside brokerage firms and clearing firms are responsible for forwarding proxies directly to the Advisers.

Proxies are received in one of two forms:

●

Shareholder Vote Instruction Forms (“VIFs”) - Issued by Broadridge Financial Solutions, Inc. (“Broadridge”). Broadridge is an outside service contracted by the various institutions to issue proxy materials.

●

Proxy cards which may be voted directly.

2. Upon receipt of the proxy, the number of shares each form represents is logged into the proxy system, electronically or manually, according to security.

3. Upon receipt of instructions from the proxy committee, the votes are cast and recorded for each account.

Records have been maintained on the ProxyEdge system.

ProxyEdge records include:

Security Name and CUSIP Number

Date and Type of Meeting (Annual, Special, Contest)

Directors’ Recommendation (if any)

How the Adviser voted for the client on item

4. VIFs are kept alphabetically by security. Records for the current proxy season are located in the Proxy Voting Department office. In preparation for the upcoming season, files are transferred to an offsite storage facility during January/February.

5. If a proxy card or VIF is received too late to be voted in the conventional matter, every attempt is made to vote including:

Revised: August 16, 2023

HH-5

INTERNAL USE ONLY

●

When a solicitor has been retained, the solicitor is called. At the solicitor’s direction, the proxy is faxed or sent electronically.

●

In some circumstances VIFs can be faxed or sent electronically to Broadridge up until the time of the meeting.

6. In the case of a proxy contest, records are maintained for each opposing entity.

7. Voting in Person

a) At times it may be necessary to vote the shares in person. In this case, a “legal proxy” is obtained in the following manner:

●

Banks and brokerage firms using the services at Broadridge:

Broadridge is notified that we wish to vote in person. Broadridge issues individual legal proxies and sends them back via email or overnight (or the Adviser can pay messenger charges). A lead-time of at least two weeks prior to the meeting is needed to do this. Alternatively, the procedures detailed below for banks not using Broadridge may be implemented.

●

Banks and brokerage firms issuing proxies directly:

The bank is called and/or faxed and a legal proxy is requested.

All legal proxies should appoint:

“Representative of [Adviser name] with full power of substitution.”

b) The legal proxies are given to the person attending the meeting along with the limited power of attorney.

Revised: August 16, 2023

HH-6

INTERNAL USE ONLY

Appendix A

Proxy Guidelines

PROXY VOTING GUIDELINES

General Policy Statement

It is the policy of GAMCO Investors, Inc, and its affiliated advisers (collectively “the Advisers”) to vote in the best economic interests of our clients. As we state in our Magna Carta of Shareholders Rights, established in May 1988, we are neither for nor against management. We are for shareholders.

At our first proxy committee meeting in 1989, it was decided that each proxy statement should be evaluated on its own merits within the framework first established by our Magna Carta of Shareholders Rights. The attached guidelines serve to enhance that broad framework.

We do not consider any issue routine. We take into consideration all of our research on the company, its directors, and their short and long-term goals for the company. In cases where issues that we generally do not approve of are combined with other issues, the negative aspects of the issues will be factored into the evaluation of the overall proposals but will not necessitate a vote in opposition to the overall proposals.

Board of Directors

We do not consider the election of the Board of Directors a routine issue. Each slate of directors is evaluated on a case-by-case basis.

Factors taken into consideration include:

●

Historical responsiveness to shareholders

This may include such areas as:

- Paying greenmail

- Failure to adopt shareholder resolutions receiving a majority of shareholder votes

●

Qualifications

●

Nominating committee in place

●

Number of outside directors on the board

●

Attendance at meetings

●

Overall performance

Revised: August 16, 2023

HH-7

INTERNAL USE ONLY

Selection of Auditors

In general, we support the Board of Directors’ recommendation for auditors.

Blank Check Preferred Stock

We oppose the issuance of blank check preferred stock.

Blank check preferred stock allows the company to issue stock and establish dividends, voting rights, etc. without further shareholder approval.

Classified Board

A classified board is one where the directors are divided into classes with overlapping terms. A different class is elected at each annual meeting.

While a classified board promotes continuity of directors facilitating long range planning, we feel directors should be accountable to shareholders on an annual basis. We will look at this proposal on a case-by-case basis taking into consideration the board’s historical responsiveness to the rights of shareholders.

Where a classified board is in place we will generally not support attempts to change to an annually elected board.

When an annually elected board is in place, we generally will not support attempts to classify the board.

Increase Authorized Common Stock

The request to increase the amount of outstanding shares is considered on a case-by-case basis.

Factors taken into consideration include:

●

Future use of additional shares

- Stock split

- Stock option or other executive compensation plan

- Finance growth of company/strengthen balance sheet

- Aid in restructuring

- Improve credit rating

- Implement a poison pill or other takeover defense

●

Amount of stock currently authorized but not yet issued or reserved for stock option plans

Revised: August 16, 2023

HH-8

INTERNAL USE ONLY

●

Amount of additional stock to be authorized and its dilutive effect

We will support this proposal if a detailed and verifiable plan for the use of the additional shares is contained in the proxy statement.

Confidential Ballot

We support the idea that a shareholder’s identity and vote should be treated with confidentiality.

However, we look at this issue on a case-by-case basis.

In order to promote confidentiality in the voting process, we endorse the use of independent Inspectors of Election.

Cumulative Voting

In general, we support cumulative voting.

Cumulative voting is a process by which a shareholder may multiply the number of directors being elected by the number of shares held on record date and cast the total number for one candidate or allocate the voting among two or more candidates.

Where cumulative voting is in place, we will vote against any proposal to rescind this shareholder right.

Cumulative voting may result in a minority block of stock gaining representation on the board. When a proposal is made to institute cumulative voting, the proposal will be reviewed on a case-by-case basis. While we feel that each board member should represent all shareholders, cumulative voting provides minority shareholders an opportunity to have their views represented.

Director Liability and Indemnification

We support efforts to attract the best possible directors by limiting the liability and increasing the indemnification of directors, except in the case of insider dealing.

Revised: August 16, 2023

HH-9

INTERNAL USE ONLY

Equal Access to the Proxy

The SEC’s rules provide for shareholder resolutions. However, the resolutions are limited in scope and there is a 500 word limit on proponents’ written arguments. Management has no such limitations. While we support equal access to the proxy, we would look at such variables as length of time required to respond, percentage of ownership, etc.

Fair Price Provisions

Charter provisions requiring a bidder to pay all shareholders a fair price are intended to prevent two-tier tender offers that may be abusive. Typically, these provisions do not apply to board-approved transactions.

We support fair price provisions because we feel all shareholders should be entitled to receive the same benefits.

Reviewed on a case-by-case basis.

Golden Parachutes

Golden parachutes are severance payments to top executives who are terminated or demoted after a takeover.

We support any proposal that would assure management of its own welfare so that they may continue to make decisions in the best interest of the company and shareholders even if the decision results in them losing their job. We do not, however, support excessive golden parachutes. Therefore, each proposal will be decided on a case-by- case basis.

Anti-Greenmail Proposals

We do not support greenmail. An offer extended to one shareholder should be extended to all shareholders equally across the board.

Revised: August 16, 2023

HH-10

INTERNAL USE ONLY

Limit Shareholders’ Rights to Call Special Meetings

We support the right of shareholders to call a special meeting.

Reviewed on a case-by-case basis.

Consideration of Nonfinancial Effects of a Merger

This proposal releases the directors from only looking at the financial effects of a merger and allows them the opportunity to consider the merger’s effects on employees, the community, and consumers.

As a fiduciary, we are obligated to vote in the best economic interests of our clients. In general, this proposal does not allow us to do that. Therefore, we generally cannot support this proposal.

Reviewed on a case-by-case basis.

Mergers, Buyouts, Spin-Offs, Restructurings

Each of the above is considered on a case-by-case basis. According to the Department of Labor, we are not required to vote for a proposal simply because the offering price is at a premium to the current market price. We may take into consideration the long term interests of the shareholders.

Military Issues

Shareholder proposals regarding military production must be evaluated on a purely economic set of criteria for our ERISA clients. As such, decisions will be made on a case-by-case basis.

In voting on this proposal for our non-ERISA clients, we will vote according to the client’s direction when applicable. Where no direction has been given, we will vote in the best economic interests of our clients. It is not our duty to impose our social judgment on others.

Northern Ireland

Shareholder proposals requesting the signing of the MacBride principles for the purpose of countering the discrimination of Catholics in hiring practices must be evaluated on a purely economic set of criteria for our ERISA clients. As such, decisions will be made on a case-by-case basis.

Revised: August 16, 2023

HH-11

INTERNAL USE ONLY

In voting on this proposal for our non-ERISA clients, we will vote according to client direction when applicable. Where no direction has been given, we will vote in the best economic interests of our clients. It is not our duty to impose our social judgment on others.

Opt Out of State Anti-Takeover Law

This shareholder proposal requests that a company opt out of the coverage of the state’s takeover statutes. Example: Delaware law requires that a buyer must acquire at least 85% of the company’s stock before the buyer can exercise control unless the board approves.

We consider this on a case-by-case basis. Our decision will be based on the following:

●

State of Incorporation

●

Management history of responsiveness to shareholders

●

Other mitigating factors

Poison Pill

In general, we do not endorse poison pills.

In certain cases where management has a history of being responsive to the needs of shareholders and the stock is very liquid, we will reconsider this position.

Reincorporation

Generally, we support reincorporation for well-defined business reasons. We oppose reincorporation if proposed solely for the purpose of reincorporating in a state with more stringent anti-takeover statutes that may negatively impact the value of the stock.

Stock Incentive Plans

Director and Employee Stock incentive plans are an excellent way to attract, hold and motivate directors and employees. However, each incentive plan must be evaluated on its own merits, taking into consideration the following:

●

Dilution of voting power or earnings per share by more than 10%.

●

Kind of stock to be awarded, to whom, when and how much.

Revised: August 16, 2023

HH-12

INTERNAL USE ONLY

●

Method of payment.

●

Amount of stock already authorized but not yet issued under existing stock plans.

●

The successful steps taken by management to maximize shareholder value.

Supermajority Vote Requirements

Supermajority vote requirements in a company’s charter or bylaws require a level of voting approval in excess of a simple majority of the outstanding shares. In general, we oppose supermajority-voting requirements. Supermajority requirements often exceed the average level of shareholder participation. We support proposals’ approvals by a simple majority of the shares voting.

Reviewed on a case-by-case basis.

Limit Shareholders Right to Act by Written Consent

Written consent allows shareholders to initiate and carry on a shareholder action without having to wait until the next annual meeting or to call a special meeting. It permits action to be taken by the written consent of the same percentage of the shares that would be required to effect proposed action at a shareholder meeting.

Reviewed on a case-by-case basis.

“Say-on-Pay” / “Say-When-on-Pay” / “Say-on-Golden-Parachutes”

Required under the Dodd-Frank Act; these proposals are non-binding advisory votes on executive compensation. We will generally vote with the Board of Directors’ recommendation(s) on advisory votes on executive compensation (“Say-on-Pay”), advisory votes on the frequency of voting on executive compensation (“Say-When-on-Pay”) and advisory votes relating to extraordinary transaction executive compensation (“Say-on-Golden-Parachutes”). In those instances when we believe that it is in our clients’ best interest, we may abstain or vote against executive compensation and/or the frequency of votes on executive compensation and/or extraordinary transaction executive compensation advisory votes.

Proxy Access

Proxy access is a tool used to attempt to promote board accountability by requiring that a company’s proxy materials contain not only the names of management nominees, but also any candidates nominated by long-term shareholders holding at least a certain stake in the company. We will review proposals regarding proxy access on a case-by-case basis taking into account the provisions of the proposal, the company’s current governance structure, the successful steps taken by management to maximize shareholder value, as well as other applicable factors.

Revised: August 16, 2023

HH-13

INTERNAL USE ONLY

Item 8.

Portfolio Managers of Closed-End Management Investment Companies.

PORTFOLIO MANAGERS

Mario J. Gabelli, CFA, is Chairman, Chief Executive Officer, and Chief Investment Officer – Value Portfolios of GAMCO Investors, Inc. that he founded in 1977, and Chief Investment Officer – Value Portfolios of Gabelli Funds, LLC and GAMCO Asset Management Inc. He is also Executive Chairman of the Board of Directors of Associated Capital Group, Inc. Mr. Gabelli is a summa cum laude graduate of Fordham University and holds an MBA degree from Columbia Business School, and Honorary Doctorates from Fordham University and Roger Williams University.

Kevin V. Dreyer joined Gabelli in 2005 as a research analyst covering companies within the consumer sector. He currently serves as Co-Chief Investment Officer of GAMCO Investors, Inc.’s Value team and a portfolio manager of Gabelli Funds, LLC. He manages several funds within the Gabelli/GAMCO Fund Complex. Mr. Dreyer received a BSE from the University of Pennsylvania and an MBA from Columbia Business School.

Jeffrey J. Jonas, CFA, joined Gabelli in 2003 as a research analyst focusing on companies across the healthcare industry. In 2006, he began serving as a portfolio manager of Gabelli Funds, LLC and manages several funds within the Gabelli/GAMCO Fund Complex. Mr. Jonas was a Presidential Scholar at Boston College, where he received a BS in Finance and Management Information Systems.

Sara E. Wojda joined the firm in 2014 as a Research Analyst and covers the Diagnostics and Life Sciences industries. Since moving to London in 2018, she has expanded the firm’s global healthcare coverage and assisted with Gabelli’s UK-based funds. Sara graduated summa cum laude from Babson College with a BS in Business Management, double majoring in Economics and Accounting.

MANAGEMENT OF OTHER ACCOUNTS

The table below shows the number of other accounts managed by the portfolio managers and the total assets in each of the following categories: registered investment companies, other paid investment vehicles and other accounts as of December 31, 2023. For each category, the table also shows the number of accounts and the total assets in the accounts with respect to which the advisory fee is based on account performance.

Name of
Portfolio Manager or
Team Member

Type of Accounts

Total
No. of
Accounts
Managed

Total Assets

No. of
Accounts
where
Advisory Fee
is Based on
Performance

Total Assets in
Accounts where
Advisory Fee
is Based on
Performance

Mario J. Gabelli, CFA

Registered Investment Companies:

$16.2 billion

$5.3 billion

Other Pooled Investment Vehicles:

$895.8 million

$879 million

Other Accounts:

834

$6.5 billion

Kevin V. Dreyer

Registered Investment Companies:

$6.5 billion

$4.7 billion

Other Pooled Investment Vehicles:

$4.4 million

Other Accounts:

253

$692.8 million

Jeffrey J. Jonas, CFA

Registered Investment Companies:

$4.5 billion

$2.6 billion

Other Pooled Investment Vehicles:

$7.1 million

Other Accounts:

$11.2 million

Sara Wojda

Registered Investment Companies:

$2.0 billion

Other Pooled Investment Vehicles:

Other Accounts:

$0.2 million

POTENTIAL CONFLICTS OF INTEREST

Actual or apparent conflicts of interest may arise when a Portfolio Manager also has day to day management responsibilities with respect to one or more other accounts. These potential conflicts include:

ALLOCATION OF LIMITED TIME AND ATTENTION. Because the portfolio managers manage many accounts, they may not be able to formulate as complete a strategy or identify equally attractive investment opportunities for each of those accounts as might be the case if they were to devote all of their attention to the management of only a few accounts.

ALLOCATION OF LIMITED INVESTMENT OPPORTUNITIES. If the portfolio managers identify an investment opportunity that may be suitable for multiple accounts, the Fund may not be able to take full advantage of that opportunity because the opportunity may be allocated among all or many of these accounts or other accounts managed primarily by other portfolio managers of the Adviser, and their affiliates.

SELECTION OF BROKER/DEALERS. Because of Mr. Gabelli’s indirect majority ownership interest in G.research, LLC, he may have an incentive to use G.research to execute portfolio transactions for a Fund.

PURSUIT OF DIFFERING STRATEGIES. At times, the portfolio managers may determine that an investment opportunity may be appropriate for only some of the accounts for which they exercises investment responsibility, or may decide that certain of these accounts should take differing positions with respect to a particular security. In these cases, the portfolio managers may execute differing or opposite transactions for one or more accounts which may affect the market price of the security or the execution of the transaction, or both, to the detriment of one or more of their accounts.

VARIATION IN COMPENSATION. A conflict of interest may arise where the financial or other benefits available to the portfolio manager differ among the accounts that they manage. If the structure of the Adviser’s management fee or the portfolio manager’s compensation differs among accounts (such as where certain accounts pay higher management fees or performance-based management fees), the portfolio managers may be motivated to favor certain accounts over others. The portfolio managers also may be motivated to favor accounts in which they have an investment interest, or in which the Adviser, or its affiliates have investment interests. In Mr. Gabelli’s case, the Adviser’s compensation and expenses for the Fund are marginally greater as a percentage of assets than for certain other accounts and are less than for certain other accounts managed by Mr. Gabelli, while his personal compensation structure varies with near-term performance to a greater degree in certain performance fee based accounts than with on-performance based accounts. In addition, he has investment interests in several of the funds managed by the Adviser and its affiliates.

The Adviser and the Funds have adopted compliance policies and procedures that are designed to address the various conflicts of interest that may arise for the Adviser and their staff members. However, there is no guarantee that such policies and procedures will be able to detect and prevent every situation in which an actual or potential conflict may arise.

COMPENSATION STRUCTURE FOR MARIO J. GABELLI

Mr. Gabelli receives incentive-based variable compensation based on a percentage of net revenues received by the Adviser for managing the Trust. Net revenues are determined by deducting from gross investment management fees the firm’s expenses (other than Mr. Gabelli’s compensation) allocable to this Trust. Four closed-end registered investment companies managed by Mr. Gabelli have arrangements whereby the Adviser will only receive its investment advisory fee attributable to the liquidation value of outstanding preferred stock (and Mr. Gabelli would only receive his percentage of such advisory fee) if certain performance levels are met. Additionally, he receives similar incentive based variable compensation for managing other accounts within the firm and its affiliates. This method of compensation is based on the premise that superior long-term performance in managing a portfolio should be rewarded with higher compensation as a result of growth of assets through appreciation and net investment activity. The level of

compensation is not determined with specific reference to the performance of any account against any specific benchmark. One of the other closed-end registered investment companies managed by Mr. Gabelli has a performance (fulcrum) fee arrangement for which his compensation is adjusted up or down based on the performance of the investment company relative to an index. Mr. Gabelli manages other accounts with performance fees. Compensation for managing these accounts has two components. One component is based on a percentage of net revenues to the investment adviser for managing the account. The second component is based on absolute performance of the account, with respect to which a percentage of such performance fee is paid to Mr. Gabelli. As an executive officer of the Adviser’s parent company, GBL, Mr. Gabelli also receives ten percent of the net operating profits of the parent company. He receives no base salary, no annual bonus, and no stock options.

COMPENSATION STRUCTURE FOR PORTFOLIO MANAGERS OF THE ADVISER OTHER THAN MARIO GABELLI

The compensation of the Portfolio Managers for the Fund is structure to enable the Adviser to attract and retain highly qualified professionals in a competitive environment. The Portfolio Managers receive a compensation package that includes a minimum draw or base salary, equity-based incentive compensation via awards of restricted stock, and incentive-based variable compensation based on a percentage of net revenue received by the Adviser for managing a Fund to the extent that the amount exceeds a minimum level of compensation. Net revenues are determined by deducting from gross investment management fees certain of the firm’s expenses (other than the respective Portfolio Manager’s compensation) allocable to the respective Fund (the incentive-based variable compensation for managing other accounts is also based on a percentage of net revenues to the investment adviser for managing the account). This method of compensation is based on the premise that superior long-term performance in managing a portfolio should be rewarded with higher compensation as a result of growth of assets through appreciation and net investment activity. The level of equity-based incentive and incentive-based variable compensation is based on an evaluation by the Adviser’s parent, GBL, of quantitative and qualitative performance evaluation criteria. This evaluation takes into account, in a broad sense, the performance of the accounts managed by the Portfolio Manager, but the level of compensation is not determined with specific reference to the performance of any account against any specific benchmark. Generally, greater consideration is given to the performance of larger accounts and to longer term performance over smaller accounts and short-term performance.

OWNERSHIP OF SHARES IN THE FUND

Mario J. Gabelli, Kevin V. Dreyer, Jeffrey J. Jonas, and Sara Wojda each owned over $1,000,000, $50,001-$100,000, $100,001-$500,000, and $0, respectively, of shares of the Trust as of December 31, 2023.

(b)

Not applicable.

Item 9.

Purchases of Equity Securities by Closed-End Management Investment Company and Affiliated Purchasers.

REGISTRANT PURCHASES OF EQUITY SECURITIES

Period

(a) Total Number of
Shares (or Units)
Purchased

(b) Average Price
Paid per Share
(or Unit)

(d) Maximum Number
(or Approximate Dollar Value)
of Shares (or Units)
that May Yet Be Purchased
Under the Plans or Programs

Month #1
07/01/2023 through 07/31/2023

Common – 44,539

Preferred Series G – N/A

Preferred Series E – N/A

Common – $9.88

Preferred Series G – N/A

Preferred Series E – N/A

Common – 44,539

Preferred Series G – N/A

Preferred Series E – N/A

Common – 16,679,968 - 44,539 = 16,635,429

Preferred Series G – 2,395,500

Preferred Series E – 4,000,000

Month #2
08/01/2023 through 08/31/2023

Common – 100,139

Preferred Series G – N/A

Preferred Series E – N/A

Common – $9.68

Preferred Series G – N/A

Preferred Series E – N/A

Common – 100,139

Preferred Series G – N/A

Preferred Series E – N/A

Common – 16,635,429 - 100,139 = 16,535,290

Preferred Series G – 2,395,500

Preferred Series E – 4,000,000

Month #3
09/01/2023 through 09/30/2023

Common – 185,354

Preferred Series G – N/A

Preferred Series E – N/A

Common – $9.10

Preferred Series G – N/A

Preferred Series E – N/A

Common – 185,354

Preferred Series G – N/A

Preferred Series E – N/A

Common – 16,535,290 - 185,354 = 16,349,936

Preferred Series G – 2,395,500

Preferred Series E – 4,000,000

Month #4
10/01/2023 through 10/31/2023

Common – 129,470

Preferred Series G – N/A

Preferred Series E – N/A

Common – $8.26

Preferred Series G – N/A

Preferred Series E – N/A

Common – 129,470

Preferred Series G – N/A

Preferred Series E – N/A

Common – 16,349,936 - 129,470 = 16,220,466

Preferred Series G – 2,395,500

Preferred Series E – 4,000,000

Month #5
11/01/2023 through 11/30/2023

Common – 85,572

Preferred Series G – N/A

Preferred Series E – N/A

Common – $8.55

Preferred Series G – N/A

Preferred Series E – N/A

Common – 85,572

Preferred Series G – N/A

Preferred Series E – N/A

Common – 16,220,466 - 85,572 = 16,134,894

Preferred Series G – 2,395,500

Preferred Series E – 4,000,000

Month #6
12/01/2023 through 12/31/2023

Common – 178,616

Preferred Series G – N/A

Preferred Series E – N/A

Common – $9.08

Preferred Series G – N/A

Preferred Series E – N/A

Common – 178,616

Preferred Series G – N/A

Preferred Series E – N/A

Common – 16,134,894 - 178,616 = 15,956,278

Preferred Series G – 1,297,000

Preferred Series E – 4,000,000

Total

Common – 723,690

Preferred Series G – N/A

Preferred Series E – N/A

Common – $9.06

Preferred Series G – N/A

Preferred Series E – N/A

Common – 723,690

Preferred Series G – N/A

Preferred Series E – N/A

N/A

Footnote columns (c) and (d) of the table, by disclosing the following information in the aggregate for all plans or programs publicly announced:

The date each plan or program was announced – The notice of the potential repurchase of common and preferred shares occurs semiannually in the Fund’s shareholder reports in accordance with Section 23(c) of the Investment Company Act of 1940, as amended.

The dollar amount (or share or unit amount) approved – Any or all common shares outstanding may be repurchased when the Fund’s common shares are trading at a discount of 10% or more from the net asset value of the shares. Any or all preferred shares outstanding may be repurchased at a discount to the respective liquidation value of $20.00.

The expiration date (if any) of each plan or program – The Fund’s repurchase plans are ongoing.

Each plan or program that has expired during the period covered by the table – The Fund’s repurchase plans are ongoing.

Each plan or program the registrant has determined to terminate prior to expiration, or under which the registrant does not intend to make further purchases. – The Fund’s repurchase plans are ongoing.

Item 10.

Submission of Matters to a Vote of Security Holders.

There have been no material changes to the procedures by which the shareholders may recommend nominees to the registrant’s Board of Trustees, where those changes were implemented after the registrant last provided disclosure in response to the requirements of Item 407(c)(2)(iv) of Regulation S-K (17 CFR 229.407) (as required by Item 22(b)(15) of Schedule 14A (17 CFR 240.14a-101)), or this Item.

Item 11.

Controls and Procedures.

(a)

The registrant’s principal executive and principal financial officers, or persons performing similar functions, have concluded that the registrant’s disclosure controls and procedures (as defined in Rule 30a-3(c) under the Investment Company Act of 1940, as amended (the “1940 Act”) (17 CFR 270.30a-3(c))) are effective, as of a date within 90 days of the filing date of the report that includes the disclosure required by this paragraph, based on their evaluation of these controls and procedures required by Rule 30a-3(b) under the 1940 Act (17 CFR 270.30a-3(b)) and Rules 13a-15(b) or 15d-15(b) under the Securities Exchange Act of 1934, as amended (17 CFR 240.13a-15(b) or 240.15d-15(b)).

(b)

There were no changes in the registrant’s internal control over financial reporting (as defined in Rule 30a-3(d) under the 1940 Act (17 CFR 270.30a-3(d))) that occurred during the period covered by this report that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting.

Item 12.

Disclosure of Securities Lending Activities for Closed-End Management Investment Companies.

(a)

If the registrant is a closed-end management investment company, provide the following dollar amounts of income and fees/compensation related to the securities lending activities of the registrant during its most recent fiscal year:

(1)

Gross income from securities lending activities; $0

(2)

All fees and/or compensation for each of the following securities lending activities and related services: any share of revenue generated by the securities lending program paid to the securities lending agent(s) (“revenue split”); fees paid for cash collateral management services (including fees deducted from a pooled cash collateral reinvestment vehicle) that are not included in the revenue split; administrative fees that are not included in the revenue split; fees for indemnification that are not included in the revenue split; rebates paid to borrowers; and any other fees relating to the securities lending program that are not included in the revenue split, including a description of those other fees; $0

(3)

The aggregate fees/compensation disclosed pursuant to paragraph (2); $0 and

(4)

Net income from securities lending activities (i.e., the dollar amount in paragraph (1) minus the dollar amount in paragraph (3)). $0

(b)

If the registrant is a closed-end management investment company, describe the services provided to the registrant by the securities lending agent in the registrant’s most recent fiscal year. N/A

Item 13.

Exhibits.

(a)(1)

Code of ethics, or any amendment thereto, that is the subject of disclosure required by Item 2 is attached hereto.

(a)(2)

Certifications pursuant to Rule 30a-2(a) under the 1940 Act and Section 302 of the Sarbanes-Oxley Act of 2002 are attached hereto.

(a)(2)(1)

Not applicable.

(a)(2)(2)

Not applicable.

(b)

Certifications pursuant to Rule 30a-2(b) under the 1940 Act and Section 906 of the Sarbanes-Oxley Act of 2002 are attached hereto.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

(Registrant)	The Gabelli Healthcare & Wellness^Rx Trust

By (Signature and Title)*	/s/ John C. Ball
	John C. Ball, Principal Executive Officer

Date	March 8, 2024

Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

By (Signature and Title)*	/s/ John C. Ball
	John C. Ball, Principal Executive Officer

Date	March 8, 2024

By (Signature and Title)*	/s/ John C. Ball
	John C. Ball, Principal Financial Officer

Date	March 8, 2024

Print the name and title of each signing officer under his or her signature.

EX-99.CODE ETH 2 grx_ex99codeeth.htm EXHIBIT 99.CODE ETH

EX-99.CODE ETH

SECTION S

Gabelli Funds, LLC

GAMCO Asset Management Inc.

G.research, LLC.

G.distributors, LLC

Gabelli & Partners, LLC

Gabelli & Company Investment Advisers, Inc.

The Code of Ethics applies to each Registered Investment Company or Private Fund Client or series thereof (each of which is considered to be a Company for this purpose) for which any of the Companies listed above presently or hereafter provides investment advisory or principal underwriting services, other than a money market fund or a fund that does not invest in Securities.

Introduction

This Code of Ethics establishes rules of conduct for persons who are associated with the companies named above or with the registered investment companies for which such companies provide investment advisory or principal underwriter services. The Code governs their personal investment and other investment-related activities.

The basic rule is very simple: we all have a fiduciary duty to put the client’s interests first. In particular, you are reminded that investment opportunities must be offered first to clients before the firms or staff may act on them. This is one of the important objectives that the procedures set forth in this Code are intended to accomplish. The rest of the rules elaborate this principle. Some of the rules are imposed specifically by law. For example, the laws that govern investment advisers specifically prohibit fraudulent activity, making statements that are not true or that are misleading or omit something that is significant in the context and engaging in manipulative practices. These are general words, of course, and over the years the courts, the regulators and investment advisers have interpreted these words and established codes of conduct for their employees and others who have access to their investment decisions and trading activities. Indeed, the rules obligate investment advisers to adopt written rules that are reasonably designed to prevent the illegal activities described above and must follow procedures that will enable them to prevent such activities.

The purpose of this Code is to reinforce and enhance the long-standing commitment of the firms to the highest standards of ethical business conduct. Our business depends on our reputation for integrity and principled business conduct, and this reputation, in turn, depends on the day-to-day actions of every staff member. Accordingly, we must avoid conflicts of interest, which may occur when your private interests interfere in any way, or even appear to interfere, with the interests of the firms or its clients. A conflict situation can arise when you take actions or have interests that make it difficult for you to perform your work objectively and effectively. Your obligation to conduct the firms’ business in an ethical manner includes the ethical handling of actual or apparent conflicts of interest between personal and business relationships, including full disclosure of such conflicts. Each staff member is responsible for conducting himself/herself in a lawful, honest and ethical manner at all times, and in accordance with all laws, rules and regulations applicable to our business, including this Code and all other internal policies and procedures adopted by the firms.

Revised: August 3, 2023

S-1

INTERNAL USE ONLY

This Code is intended to assist the companies in fulfilling their obligations under the law. The first part lays out who the Code applies to, the second part deals with personal investment activities, the third part deals with other sensitive business practices, and subsequent parts deal with reporting and administrative procedures.

The Code is very important to the Companies and their staff members. Violations can not only cause the Companies embarrassment, loss of business, legal restrictions, fines, and other punishments, but for staff members, can lead to demotion, suspension, firing, ejection from the securities business, and very large fines.

Applicability

The Code applies to each of the following:

The Companies named or described at the top of page one of the Code and all entities that are under common management with these Companies or otherwise agree to be subject to the Code (“Affiliates”). A listing of the Affiliates, which is periodically updated, is attached as Exhibit A.

Any officer, director or employee of any Company, Affiliate or Fund Client (as defined below) whose job regularly involves him/her in the investment process. This includes the formulation and making of investment recommendations and decisions, the purchase and sale of securities for Clients and the utilization of information about investment recommendations, decisions and trades. Due to the manner in which the Companies and the Affiliates conduct their business, every employee should assume that he or she is subject to the Code unless the Compliance Officer specifies otherwise.¹

With respect to all of the Companies, Affiliates and Fund Clients, any natural person who Controls any of the Companies, Affiliates or Fund Clients and who obtains information regarding the Companies’ or the Affiliates’ investment recommendations or decisions. However, a person whose Control arises only as a result of his or her official position with such entity is excluded. Disinterested directors of Fund Clients and Independent Directors, for example, are excluded from coverage under this item.

Consultants, interns and part-time employees may be subject to the restrictions and reporting requirements of personal investment activities promulgated under the Code.

Revised: August 3, 2023

S-2

INTERNAL USE ONLY

As an exception, the Code does not apply to any director, officer or employee of any Fund Client with respect to which the Companies’ services do not involve the formulation or making of investment recommendations or decisions or the execution of portfolio transactions if that person is also a director, officer or employee of any entity that does perform such services. These individuals are covered by codes of ethics adopted by such entities.

Definitions

Access Persons. The (i) Companies, (ii) the persons described in items (A)2 and (A)3 above and (iii) such person’s Immediate Family, other than those excluded by item (A)4 above.

Access Person Account. Other than Client Accounts, includes all advisory, brokerage, trust or other accounts over which one or more Access Persons has (i) a substantial proportionate economic interest or (ii) Control. Control is defined as having investment and/or trade discretion over the account.

A substantial proportionate economic interest will generally be 25% of the equity in the account in the case of any single Access Person or 25% of the equity in the account in the case of all Access Persons in the aggregate. Interests in Private Fund Clients and similar indirect means of ownership of underlying securities shall also be treated as Access Person Accounts for purposes of this Code.²

As an exception, accounts in which one or more Access Persons and/or their immediate family have a substantial proportionate interest which are managed by an investment adviser who has no affiliation with the Companies and with respect to which no Access Person has, in the judgment of the Compliance Officer after reviewing the terms and circumstances, any direct or indirect influence or control over the investment or portfolio execution process are not Access Person Accounts.

Affiliated Mutual Funds and SICAV Funds (“Affiliated Mutual and SICAV Funds”) shall not be treated as Access Person Accounts for purposes of this Code. Because there are investment limitations imposed by the Investment Company Act and applicable European Law over the investment activity of Affiliated Mutual and SICAV Funds, the firms take the position that the indirect benefit potentially gained by an Access Person through the trading activity of these Clients to the potential detriment of other Clients of the firms is sufficiently mitigated. In addition, the firms have determined that the risk to other investors in Affiliated Mutual and SICAV Funds caused by subjecting these Clients to the trading restrictions imposed by this Code outweigh the risks to other Clients of the firms that the firms will seek to benefit the Access Person to the detriment of the firms’ other Clients. In addition, subject to the review of the Chief Compliance Officer, market making accounts controlled by G.research, LLC and error accounts of Access Persons shall not be deemed Access Person Accounts for purposes of this Code.

Revised: August 3, 2023

S-3

INTERNAL USE ONLY

As a further exception, subject to the provisions of Article II(I)7, bona fide market making accounts of G.research, LLC are not Access Person Accounts.

As a further exception, subject to the provisions of Article II(I)7, bona fide error accounts of the Companies and the Affiliates are not Access Person Accounts.

Affiliated Mutual Funds. Registered open-end investment companies or series thereof advised or sub-advised by any of the Companies or their Affiliates.

Associate Portfolio Managers. Access Persons who are engaged in securities research and analysis for designated Clients or are responsible for investment recommendations for designated Clients but who are not principally responsible for investment decisions with respect to any Client Accounts.

Clients. Persons that have investment advisory accounts maintained with any of the Companies or Affiliates by any person, other than Access Person Accounts. However, Fund Clients covered by item (A)(4) above are considered Client Accounts only with respect to employees specifically identified by the Compliance Officer as having regular information regarding investment recommendations or decisions or portfolio transactions for such Fund Clients.

Client Accounts. Shall mean accounts of Clients (i) that are Controlled by an Access Person and (ii) in which no Access Person has a substantial proportionate economic interest; provided that, the Client pays a management, advisory or any other similar arms-length fee to the Access Person and the beneficiary of the Client Account is not an Immediate Family member of an Access Person.

Companies. The companies named or described at the top of page one of the Code.

Compliance Officer. The persons designated as the compliance officers of the Companies.

Covered Persons. The Companies, the Access Persons and the persons described in items A(3) and (A)4 above.

10.

Fund Clients. Clients that are Affiliated Mutual Funds, Private Fund Clients or a series thereof.

Revised: August 3, 2023

S-4

INTERNAL USE ONLY

11.

Immediate Family. An Access Person’s spouse and Minor Descendants; provided that, with respect to accounts for the benefit of Minor Descendants who are not also Minor Children, an Access Person Controls such account.

12.

Independent Directors. A director of any of the Companies or Affiliates, other than an investment advisor to a Fund Client, who would not be an “interested person” of any of such entities under Section 2(a)(19) of the Investment Company Act of 1940 but for the fact that he or she serves as such a director and may own beneficially securities of any such entity constituting less than 5% of the voting securities thereof and may be an associated person of or own securities in a broker-dealer or parent company thereof and who does not have any involvement in the day-to-day activities of any of the Companies or Fund Clients.

13.

Minor Children. A child, whether natural or via adoption, of an Access Person, under the age of twenty-one years.

14.

Minor Descendants. Direct descendants of an Access Person, whether natural or via adoption, under the age of twenty-one years.

15.

Portfolio Managers. Access Persons who are principally responsible for investment decisions with respect to any Client Accounts.

16.

Private Fund Client. Any Client the securities of which were offered or sold pursuant to Section 3(c)(1) or the 3(c)(7) of the Investment Company Act of 1940, as amended.

17.

Security. Any financial instrument treated as a security for investment purposes and any related instrument such as a futures, forward or swap contract entered into with respect to one or more securities, a basket of or an index of securities or components of securities. However, the term security does not include securities issued by the Government of the United States, bankers’ acceptances, bank certificates of deposit, commercial paper and high quality short-term debt instruments, including repurchase agreements, or shares of registered open-end investment companies. Shares of affiliated registered open-end investment companies are not securities but are subject to special rules under this Code.

II.

Restrictions on Personal Investing Activities

Basic Restriction on Investing Activities

If a purchase or sale order is pending or under active consideration for any Client Account by any Company or Affiliate, neither the same Security nor any related Security (such as an option, warrant, right, futures contract or convertible security) may be bought or sold for any Access Person Account.

Revised: August 3, 2023

S-5

INTERNAL USE ONLY

Initial Public Offerings

No Security or related Security may be acquired in an initial public offering for any Access Person Account.

Blackout Period

No Security may be bought or sold for the account of any Portfolio Manager or Associate Portfolio Manager, including any of the firms’ proprietary accounts managed by a Portfolio Manager or Associate Portfolio Manager, during the period commencing seven (7) calendar days prior to and ending seven (7) calendar days after the purchase or sale (or entry of an order for the purchase or sale) of that Security for any Client Account with respect to which such person has been designated a Portfolio Manager or Associate Portfolio Manager, unless the Client Account receives at least as good a price as the account of the Portfolio Manager or Associate Portfolio Manager by the transaction for the account of the Portfolio Manager or Associate Portfolio Manager.

In the event that a Security is bought or sold for the account of any Portfolio Manager or Associate Portfolio Manager within the Blackout Period at a price that is more advantageous than the price of the same Security bought or sold for any Client Account with respect to which such person has been designated a Portfolio Manager or Associate Portfolio Manager, then the price difference advantage of the Portfolio Manager or Associate Portfolio Manager account over the Client Account will be disgorged, in which case no violation will be deemed to have occurred; except where such price difference advantage is of a de minimis amount, in which case no disgorgement will be required. For purposes of the Blackout Period, a de minimis amount is defined as a price difference advantage in an amount of $250 or less per security.

Short-term Trading and Affiliated Mutual Funds

No Security or related Security may, within a 30 calendar day holding period may be bought and sold or sold and bought at a profit for any Access Person Account if the Security or related Security was held at any time during that period in any Client Account, unless (i) the Client Account liquidates its position and (ii) no Access Person Account has a greater profit (on a proportionate per share basis) for dealing in the applicable Security than any such Client Account, in each case within such 30 day period.

No Affiliated Mutual Fund, except the Gabelli U.S. Treasury Money Market Fund and the Gabelli ABC Fund, may be bought and sold within a 30 calendar day holding period (measured on a last-in first-out basis) for a single Access Person Account. The Gabelli U.S. Treasury Money Market Fund shall be exempt from the 30 calendar day holding period. The ABC Fund shall have a 7 calendar day holding period (measured on a last-in first-out basis).

Revised: August 3, 2023

S-6

INTERNAL USE ONLY

Shares of Affiliated Mutual Funds purchased via automated investments or by reinvestment of dividends or capital gain distributions will not be subject to the holding period. Shares of Affiliated Mutual Funds held in 401(k) accounts administered by Charles Schwab will not be subject to the holding period where the shares were purchased under the following circumstances:

■

Shares purchased by reinvestment of dividends or capital gain distributions;

■

Shares purchased in rollover transactions;

■

Shares purchased for automatic contribution election; and

■

Shares purchased for automated account rebalance.

Exchange Traded Funds (ETFs):

Generally, broad-based index ETFs are required to be pre-cleared as described in paragraph (I) and are subject to the Blackout Period of paragraph (C), but are not subject to the Short-term Trading restrictions of paragraph (D) as it pertains to the 30-day holding period in the first paragraph.

The Gabelli Exchange Traded Funds are required to be pre-cleared as described in paragraph (I) and are subject to the Blackout Period of paragraph (C) and the Short-term Trading restrictions of paragraph (D) as it pertains to the 30-day holding period in the first paragraph.

Derivative Securities

Securities that derive their value, at least in part, from an underlying asset (such as options, warrants, rights, swaps and futures contracts) may be bought and sold or sold and bought at a profit unless the underlying asset is subject to the restrictions set forth in paragraphs (A), (C), (D) and (I) or the exemptions set forth in paragraph (H).

However, rights that were received pro rata with other security holders are exempt from the 30 calendar day holding period set forth in paragraph (D).

Spinoffs

Securities that are derived by the creation of an independent company through the sale or distribution of new shares of an existing company or division of a parent company is subject to the restrictions set forth in paragraphs (A), (C), (D) and (I), but exempt from the 30 calendar day hold requirement set forth in paragraph (D) or the exemptions set forth in paragraph (H).

Revised: August 3, 2023

S-7

INTERNAL USE ONLY

Exempt Transactions

Participation on an ongoing basis in an issuer’s dividend reinvestment or stock purchase plan, participation in any transaction over which no Access Person had any direct or indirect influence or control and involuntary transactions (such as mergers, inheritances, gifts, etc.) are exempt from the restrictions set forth in paragraphs (A), (C) and (D) above with case by case pre-clearance under paragraph (I) below.

Permitted Exceptions

Purchases and sales of the following Securities for Access Person Accounts are exempt from the restrictions set forth in paragraphs (A), (C) and the first sentence of paragraph (D) above if such purchases and sales comply with the pre-clearance requirements of paragraph (I) below:

Publicly traded non-convertible fixed income Securities rated at least “A”;

Publicly traded equity Securities having a market capitalization in excess of $1.0 billion;³

Publicly traded equity Securities having a market capitalization in excess of $500 million if the transaction in question and the aggregate amount of such Securities and any related Securities purchased and sold for the Access Person Account in question during the preceding 30 calendar days does not exceed 100 shares;

Municipal Securities; and

Securities transactions that the Compliance Officer concludes are being effected for federal, state or local income tax purposes.

The exercise of rights that were received pro rata with other security holders is exempt.

Securities issued by the United States Government, banker’s acceptances, bank certificates of deposit and commercial paper.

Market capitalization includes all classes of public shares outstanding that are convertible to common shares.

Revised: August 3, 2023

S-8

INTERNAL USE ONLY

Pre-Clearance of Personal Securities Transactions

No Security may be bought or sold for an Access Person Account unless: (i) the Access Person obtains prior approval from the Compliance Officer or, in the absence of the Compliance Officer, from the General Counsel or a designee; or via an automated Compliance pre-clearance system (ii) the approved transaction is completed on the same day approval is received; and (iii) the Compliance Officer or the General Counsel or designee does not rescind such approval prior to execution of the transaction (See paragraph K below for details of the Pre-Clearance Process.)

Private Placements

The Compliance Officer will not approve purchases or sales of Securities that are not publicly traded, unless the Access Person provides full details of the proposed transaction (including written certification that the investment opportunity did not arise by virtue of such person’s activities on behalf of any Client) and that the Companies would have no foreseeable interest in investing in such Security or any related Security for the account of any Client.

Pre-Clearance Process

No Securities may be purchased or sold for any Access Person Account other than through the trading desk of G.research, LLC, unless express permission is granted by the Compliance Officer. Such permission may be granted only on the condition that the third party broker supply the Compliance Officer, on a timely basis, duplicate copies of confirmations of all personal Securities transactions for such Access Person in the accounts maintained with such third party broker and copies of periodic statements for all such accounts.

No Securities may be purchased or sold for any Access Person Account unless the particular transaction has been approved in writing by the Compliance Officer or, in his or her absence, the General Counsel of GAMCO Investors, Inc., Associated Capital Group, Inc. or their designees; or via an automated Compliance pre-clearance system. The Compliance Officer or a designee shall review reports from the trading desk (or, if applicable, confirmations from brokers) to assure that all transactions effected for Access Person Accounts are effected in compliance with this Code. A Trading Approval Form, attached as Exhibit B, must be completed and submitted to the Compliance Officer or a designee for approval prior to entry of an order.

Revised: August 3, 2023

S-9

INTERNAL USE ONLY

After reviewing the proposed trade, the level of potential investment interest on behalf of Clients in the Security in question and the Companies’ restricted lists, the Compliance Officer shall approve (or disapprove) a trading order on behalf of an Access Person as expeditiously as possible. The Compliance Officer will generally approve transactions described in paragraph (G) above unless the Security in question or a related security is on the Restricted List or the Compliance Officer believes for any other reason that the Access Person Account should not trade in such Security at such time.

Once an Access Person’s Trading Approval Form is approved, the form must be forwarded to the trading desk (or, if a third party broker is permitted, to the Compliance Officer) for execution on the same day. If the Access Person’s trading order request is not approved, or is not executed on the same day it is approved, the clearance lapses although such trading order request may be resubmitted at a later date.

In the absence of the Compliance Officer, an Access Person may submit his or her Trading Approval Form to the General Counsel of GAMCO Investors, Inc., Associated Capital Group, Inc. or a designee; or via an automated Compliance pre-clearance system. Trading approval for the Compliance Officer must be obtained from the General Counsel, and trading approval for the General Counsel must be obtained from the Compliance Officer or a designee. In no case will the Trading Desk accept an order for an Access Person Account unless it is accompanied by a signed Trading Approval Form; or a Trading Approval Form generated by an automated Compliance pre-clearance system that approves the trade.

The Compliance Officer shall review all Trading Approval Forms, all initial, quarterly and annual disclosure certifications and the trading activities on behalf of all Client Accounts with a view to ensuring that all Covered Persons are complying with the spirit as well as the detailed requirements of this Code. The Compliance Officer will review all transactions in the market making accounts of G.research, LLC. and the error accounts of the Companies and the Affiliates in order to ensure that such transactions are bona fide market making or error transactions or are conducted in accordance with the requirements of this Article II.

III.

Other Investment-Related Restrictions

Gifts

No Access Person shall accept any gift or other item of more than $100 in value from any person or entity that does business with or on behalf of any Client.

Revised: August 3, 2023

S-10

INTERNAL USE ONLY

Service As a Director

No Access Person shall commence service on the Board of Directors of a publicly traded company or any company in which any Client Account has an interest without prior authorization from the Compliance Committee based upon a determination that the Board service would not be inconsistent with the interests of the Clients. The Compliance Committee shall include the senior Compliance Officer and the General Counsel of GAMCO Investors, Inc. and Associated Capital Group, Inc., and at least two of the senior executives from among the Companies.

IV.

Reports and Additional Compliance Procedures

Every Covered Person must submit a quarterly report (a form of which is appended as Exhibit C) containing the information set forth in paragraph (B) below with respect to transactions in any Security or Affiliated Mutual Fund in which such Covered Person has or by reason of such transaction acquires, any direct or indirect beneficial ownership (as defined in Exhibit D) in the Security, or Affiliated Mutual Fund and with respect to any account established by the Covered Person in which any Securities or Affiliated Mutual Funds were held for the direct or indirect benefit of the Covered Person; provided, however, that:

a Covered Person who is required to make reports only because he or she is a director of one of the Fund Clients and who is a “disinterested” director thereof or who is an Independent Director need not make a report with respect to any transactions other than those where he or she knew or should have known in the course of his or her duties as a director that any Fund Client has made or makes a purchase or sale of the same or a related Security, or the investment adviser of any such Fund Client has considered causing any Fund Client to purchase or sell the same or a related Security, within 15 days before or after the purchase or sale of such Security or related Security by such director.

a Covered Person need not make a report with respect to any transaction effected for, and Securities and Affiliated Mutual Funds held in, any account over which such person does not have any direct or indirect influence or control; and

A Covered Person need not make a report with respect to any transaction in securities issued by the United States Government, banker’s acceptances, bank certificates of deposit and commercial paper.

Revised: August 3, 2023

S-11

INTERNAL USE ONLY

a Covered Person will be deemed to have complied with the requirements of this Article IV insofar as the Compliance Officer receives in a timely fashion duplicate monthly or quarterly brokerage statements or transaction confirmations on which all transactions required to be reported hereunder are described.

A Covered Person must submit the report required by this Article to the Compliance Officer no later than 30 days after the end of the calendar quarter in which the transaction or account to which the report relates was effected or established, and the report must contain the date that the report is submitted.

This report must contain the following information with respect to transactions:

The date of the transaction, the title and number of shares and the principal amount of each Security and Affiliated Mutual Fund involved;

The nature of the transaction (i.e., purchase, sale or any other type of acquisition or disposition);

The price at which the transaction was effected; and

The name of the broker, dealer or bank with or through whom the transaction was effected.

This report must contain the following information with respect to accounts established:

The name of the broker, dealer or bank with whom the account was established; and

The date the account was established.

Any report submitted to comply with the requirements of this Article IV may contain a statement that the report shall not be construed as an admission by the person making such report that he or she has any direct or indirect beneficial ownership in the Security or Affiliated Mutual Fund to which the report relates. A person need not make any report under this Article IV with respect to transactions effected for, and Securities, and Affiliated Mutual Funds held in, any account over which the person has no direct or indirect influence or control.

Revised: August 3, 2023

S-12

INTERNAL USE ONLY

No later than 10 days after beginning employment with any of the Companies or Affiliates or otherwise becoming a Covered Person, each Covered Person (except for a “disinterested” director of the Fund Client or an Independent Director who is required to submit reports under this Article IV solely by reason of being such a director) must submit a report, which must be current as of a date no more than 45 days prior to the date of beginning employment, containing the following information:

The title, number of shares and principal amount of each Security and Affiliated Mutual Fund in which the Covered Person had any direct or indirect beneficial ownership when the person became a Covered Person;

The name of any broker, dealer or bank with whom the Covered Person maintained an account in which any Securities and Affiliated Mutual Fund were held for the direct or indirect benefit of the Covered Person as of the date the person became a Covered Person; and

The date that the report is submitted.

The form of such report is attached as Exhibit E.

Annually each Covered Person must certify that he or she has read and understood the Code and recognizes that he or she is subject to such Code. In addition, annually each Covered Person must certify that he or she has disclosed or reported all personal Securities and Affiliated Mutual Fund transactions required to be disclosed or reported under the Code. Furthermore, each Covered Person (except for a “disinterested” director of the Fund Client or an Independent Director who is required to submit reports under this Article IV solely by reason of being such a director) annually must submit a report containing the following information (which information must be current as of a date no more than 45 days before the report is submitted):

The title, number of shares and principal amount of each Security and Affiliated Mutual Fund in which the Covered Person had any direct or indirect beneficial ownership held in an account not previously disclosed other than a G.research, affiliated funds or a firm-sponsored retirement plan account;

The name of any broker, dealer or bank with whom the Covered Person maintains an account in which any Securities and Affiliated Mutual Funds are held for the direct or indirect benefit of the Covered Person in an account other than a G.research, affiliated funds or a firm-sponsored retirement plan account; and

3. The date that the report is submitted.

The form of such certification and report is attached as Exhibit F.

Revised: August 3, 2023

S-13

INTERNAL USE ONLY

At least annually (or quarterly in the case of Items 4 and 5 below), each of the Companies that has a Fund Client or that provides principal underwriting services for a Fund Client shall, together with each Fund Client, furnish a written report to the Board of Directors of the Fund Client that:

Describes any issues arising under the Code since the last report.

Certifies that the Companies have developed procedures concerning Covered Persons’ personal trading activities and reporting requirements relevant to such Fund Clients that are reasonably necessary to prevent violations of the Code;

Recommends changes, if any, to the Fund Clients’ or the Companies’ Codes of Ethics or procedures;

Provides a summary of any material or substantive violations of this Code by Covered Persons with respect to such Fund Clients which occurred during the past quarter and the nature of any remedial action taken; and

Describes any material or significant exceptions to any provisions of this Code of Ethics as determined under Article VI below.

The Compliance Officer shall notify each employee of any of the Companies or Affiliates as to whether such person is considered to be an Access Person or Covered Person and shall notify each other person that is considered to be an Access Person or Covered Person.

Sanctions

The Compliance Officer or his or her designee will review all Trading Approval Forms, all initial, quarterly and annual disclosure certifications and the trading activities on behalf of all Client Accounts with a view to ensuring that all Covered Persons are complying with the spirit as well as the detailed requirements of the Code.

All violations of the Code must be reported to the Chief Compliance Officer for the appropriate registered investment adviser. In addition, if a staff member becomes aware of or suspects a violation of the Code by any other staff member, the violation or suspected violation must be promptly reported to the Chief Compliance Officer or the General Counsel. Staff members may make such reports anonymously, and will not be retaliated against by any of the firms for reporting conduct that may constitute a violation of the Code.

Revised: August 3, 2023

S-14

INTERNAL USE ONLY

Upon discovering that a Covered Person has not complied with the requirements of this Code, the Chief Compliance Officer or the General Counsel will advise the Board of Directors of the relevant Company or of the relevant Fund Client. whichever is most appropriate under the circumstances, which may impose on that person whatever sanctions the Board deems appropriate, including, among other things, disgorgement of profit, censure, suspension or termination of employment. Material violations of requirements of this Code by employees of Covered Persons and any sanctions imposed in connection therewith shall be reported not less frequently than quarterly to the Board of Directors of any relevant Company or Fund Client, as applicable.

The General Counsel will ensure that the Fund Clients and each Gabelli entity that has a Fund Client, furnish a written report to the Board of Directors of each Fund Client, annually or quarterly as required by the Code, containing the information set forth in Section IV(F) of the Code.

VI.

Exceptions

The Compliance Committee of the Companies reserves the right to decide, on a case-by-case basis, exceptions to any provisions under this Code. Any exceptions made hereunder will be maintained in writing by the Compliance Committee and presented to the Board of Directors of any relevant Fund Client at its next scheduled meeting.

VII.

Preservation of Documents

This Code, a copy of each report by a Covered Person, any written report made hereunder by the Companies or the Compliance Officer, lists of all persons required to make reports, a list of any exceptions, and the reasons therefore, with respect to Article II.B, and any records under Article II.G with respect to purchases pursuant to Article II.H above, shall be preserved with the records of the relevant Company and any relevant Fund Client for the period required by Rule 17j-1.

In accordance with the Investment Advisers Act, the following documents also will be preserved:

Records of all violations of the Code and any action taken as a result of such violation;

Records of all written acknowledgements of receipt of the Code for all Access Persons for a five-year period;

C. A list of all staff members who are or have been Access Persons during the past five years; and

Records of any decision and supporting reasons for approving the acquisition of securities by Access Persons in limited offerings.

Revised: August 3, 2023

S-15

INTERNAL USE ONLY

VIII.

Other Laws, Rules and Statements of Policy

Nothing contained in this Code shall be interpreted as relieving any Covered Person from acting in accordance with the provision of any applicable law, rule or regulation or any other statement of policy or procedure governing the conduct of such person adopted by the Companies, the Affiliates or the Fund Clients.

IX.

Further Information

If any person has any question with regard to the applicability of the provisions of this Code generally or with regard to any Securities transaction or transactions, he or she should consult the Compliance Officer.

Revised: August 3, 2023

S-16

INTERNAL USE ONLY

EXHIBIT A

LIST OF AFFILIATES OF THE COMPANIES

Associated Capital Group, Inc.

Gabelli & Partners GmbH

Gabelli & Partners Italia LLC

Gabelli & Partners Italia L.P.

Gabelli & Partners Italia Management LLC

Gabelli & Partners Italia S.R.L.

Gabelli Arbitrage Holdings LLC

Gabelli Associates Fund

Gabelli Associates Fund II, LP

Gabelli Associates Limited

Gabelli Associates Limited II E

Gabelli Entertainment and Telecommunication Acquisition Corp.

Gabelli Fixed Income LLC

Gabelli Fund, LDC

Gabelli Global Partners, Ltd.

Gabelli Global Partners Master Fund, Ltd.

Gabelli Intermediate Credit Fund, LP

Gabelli Intermediate Credit Fund, Ltd.

Gabelli International Limited

Gabelli Investment Partners International LLC

Gabelli Japan K.K.

Gabelli Multimedia Partners, LP

Gabelli Performance Partnership LP

Gabelli Securities International Limited (U.K.)

Gabelli Securities International, Ltd. (Bermuda)

Gabelli Trading Holdings LLC

GAMA Capital Opportunities Ltd.

GAMA Capital Opportunities Master Ltd.

GAMA Capital Partners LP

GAMA Funds Holdings GmbH

GAMA Funds LLC

GAMA Select Energy Plus Master Fund, Ltd.

GAMCO Acquisitions LLC

GAMCO Asset Management (UK) Ltd.

GAMCO International Partners LLC

GAMCO Investors, Inc.

GAMCO Medical Opportunities, LP

Gemini Capital Management LLC

Gemini Capital Management Partners, LP

Gemini Global Partners, LP

Greenwich Acquisition LLC

Greenwich PMV Acquisition Corp.

Institutional Services Holdings, LLC

Morgan Group Holding Co.

MJG Associates, Inc.

MJG IV Ltd.

PMV Consumer Acquisition Corp.

PMV Consumer Acquisition Holding Company LLC

Revised: August 3, 2023

S-17

INTERNAL USE ONLY

EXHIBIT B

PRE-CLEARANCE TRADING APPROVAL FORM

I, ______________________________________ (name), am an Access Person or authorized officer thereof and seek pre-clearance to engage in the transaction described below for the benefit of myself or another Access Person:

Acquisition or Disposition (circle one)

Name of Account:

Account Number:

Date of Request:

Security:

Amount or # of Shares:

Broker:

If the transaction involves a Security that is not publicly traded, a description of proposed transaction, source of investment opportunity and any potential conflicts of interest:

I hereby certify that, to the best of my knowledge, the transaction described herein is not prohibited by the Code of Ethics and that the opportunity to engage in the transaction did not arise by virtue of my activities on behalf of any Client.

Signature:			Print Name:

Approved or Disapproved (Circle One)

Date of Approval:

Signature:			Print Name:

If approval is granted, please forward this form to the trading desk (or if a third party broker is permitted, to the Compliance Officer) for immediate execution.

Revised: August 3, 2023

S-18

INTERNAL USE ONLY

EXHIBIT C

QUARTERLY TRANSACTION REPORT

Report submitted by:
	Print Name

This transaction report (the “Report”) is submitted pursuant to Section IV (B) of the Code of Ethics of the Companies and supplies information with respect to transactions in any Security or Affiliated Mutual Fund in which you, or an Access Person, may be deemed to have, or by reason of such transaction acquire, any direct or indirect beneficial ownership interest, and with respect to accounts established by you, or an Access Person, in which any Securities or Affiliated Mutual Funds were held for your direct or indirect benefit, or for the benefit of an Access Person, for the period specified below.¹ If you were not employed by or affiliated with us during this entire period, amend the dates specified below to cover your period of employment or affiliation.

Unless the context otherwise requires, all terms used in the Report shall have the same meaning as set forth in the Code of Ethics.

If you have no reportable transactions or new accounts, sign and return this page only. If you have reportable transactions or new accounts, complete, sign and return page two only and include any attachments.

Every employee is considered an Access Person and is therefore subject to the Firms’ Code of Ethics. Access Person Accounts, which exclude Client Accounts, include all advisory, brokerage, trust or other accounts or forms of direct beneficial ownership in which one or more Access Persons and/or one or more members of an Access Person’s immediate family have a substantial proportionate economic interest or control. “Immediate family” is defined as your spouse and minor descendants. With respect to accounts for the benefit of minor descendants who are not also minor children, any account that you control. Minor children is any child, whether natural or via adoption, of an Access Person, under the age of twenty-one years. A substantial proportionate economic interest will generally be 25% of the equity in the account in the case of any single Access Person or 25% of the equity in the account in the case of all Access Persons in the aggregate. Interests in investment partnerships and similar indirect means of ownership of underlying securities shall also be treated as Access Person Accounts for purposes of this Code.

I HAD NO REPORTABLE SECURITIES OR AFFILIATED MUTUAL FUND TRANSACTIONS OR ACCOUNTS ESTABLISHED DURING THE PREVIOUS CALENDAR QUARTER. I CERTIFY THAT I AM FULLY FAMILIAR WITH THE CODE OF ETHICS AND THAT, TO THE BEST OF MY KNOWLEDGE, THE INFORMATION FURNISHED IN THIS REPORT IS TRUE AND CORRECT.

Signature Date

Position

Revised: August 3, 2023

S-19

INTERNAL USE ONLY

Page 2

QUARTERLY TRANSACTION REPORT

Report submitted by:
	Print Name

The following tables supply the information required by Section IV (B) of the Code of Ethics for the period specified below. All transactions including transactions in Affiliated Mutual Funds and any new accounts established during the previous calendar quarter must be listed below.² Transactions reported on brokerage statements or duplicate confirmations actually received by the Compliance Officer do not have to be listed although it is your responsibility to make sure that such statements or confirmations are complete and have been received in a timely fashion. If you had transactions of the kind described above, you may simply state, “See statements.”

Acknowledgement of the firms’ Privacy Policy and consent for the firms to receive trading information via electronic feed, duplicate statements and/or trade confirmations will be deemed to have been given for all approved accounts.

TRANSACTIONS

Securities
(Name and Symbol)

Date of
Transaction

Whether Purchase,
Sale, Short
Sale or Other
Type of
Disposition or

Acquisition

Quantity of
Securities

Price per Share
or Other Unit

Name of Broker/
Dealer with
or through
Whom the
Transaction was
Effected

Nature of
Ownership of
Securities

NEW ACCOUNTS ESTABLISHED
Name of Broker, Dealer or Bank	Account Number	Date Account Established

Outside accounts must be pre-cleared prior to being opened (See, Section T of the Compliance Manual).

Revised: August 3, 2023

S-20

INTERNAL USE ONLY

Page 3

Managed Accounts:

When the personal account of an access person is managed by a third party, or in the case of a trust where an access person is the grantor or beneficiary that provides a trustee with management authority over the trust, the access person should not, in any way, directly or indirectly have influence or control over the personal account/trust.

Please certify to one of the following:

☐

I do NOT have any accounts managed by a third party or trustee.³

☐

I do have account(s) managed by a third party or trustee and I do NOT have trade or investment discretion over the account(s). I did not direct, suggest or consult a third party or trustee to make any purchases or sales of securities in the account(s) or trust during the previous calendar quarter.³

☐

 I do have account(s) managed by a third party or trustee and I have investment and/or trade discretion over at least one of the accounts or trusts and did direct, suggest or consult the manager to make purchases or sales of securities in the account(s) or trust(s) during the previous calendar quarter.³

A hedge fund would be considered an account managed by a third party if it is managed as a separate account, but would not apply if you are one of other limited partners. An investment in a mutual fund managed by a third party would not apply because it is not solely for your benefit.

If you have an account or trust that was not previously disclosed, please list the details in the “New Accounts Established” section above and contact the Legal/Compliance department immediately.

I CERTIFY THAT I AM FULLY FAMILIAR WITH THE CODE OF ETHICS AND THAT, TO THE BEST OF MY KNOWLEDGE, THE INFORMATION IN THIS REPORT IS TRUE AND CORRECT FOR THE PREVIOUS CALENDAR QUARTER.

Signature			Date

Position

Revised: August 3, 2023

S-21

INTERNAL USE ONLY

EXHIBIT D

BENEFICIAL OWNERSHIP

For purposes of the attached Code of Ethics, “beneficial ownership” shall be interpreted in the same manner as it would be in determining whether a person is subject to the provisions of Section 16 of the Securities Exchange Act of 1934 and the rules and regulations thereunder, except the determination of direct or indirect beneficial ownership shall apply to all securities that a Covered Person has or acquires. The term “beneficial ownership” of securities would include not only ownership of securities held be a Covered Person for his or her own benefit, whether in bearer form or registered in his or her name or otherwise, but also ownership of securities held for his or her benefit by others (regardless of whether or how they are registered) such as custodians, brokers, executors, administrators, or trustees (including trusts in which he or she has only a remainder interest), and securities held for his or her account by pledges, securities owned by a partnership in which he or she is a member if he or she may exercise a controlling influence over the purchase, sale of voting of such securities, and securities owned by any corporation or similar entry in which he or she owns securities if the shareholder is a control-ling shareholder of the entity and has or shares investment control over the entity’s portfolio.

Ordinarily, this term would not include securities held by executors or administrators in estates in which a Covered Person is a legatee or beneficiary unless there is a specified legacy to such person of such securities or such person is the sole legatee or beneficiary and there are other assets in the estate sufficient to pay debts ranking ahead of such legacy, or the securities are held in the estate more than a year after the decedent’s death.

Securities held in the name of another should be considered as beneficially owned by a Covered Person where such person enjoys “financial benefits substantially equivalent to ownership.” The Securities and Exchange Commission has said that, although the final determination of beneficial ownership is a question to be determined in the light of the facts of the particular case, generally a person is regarded as the beneficial owner of securities held in the name of his or her spouse and their minor children. Absent special circumstances such relationship ordinarily results in such person obtaining financial benefits substantially equivalent to ownership, e.g., application of the income derived from such securities to maintain a common home, or to meet expenses that such person otherwise would meet from other sources, or the ability to exercises a controlling influence over the purchase, sale or voting of such securities.

A Covered Person also may be regarded as the beneficial owner of securities held in the name of another person, if by reason of any contract, understanding, relationship, agreement, or other agreement, he or she obtains therefrom financial benefits substantially equivalent to those of ownership.

A Covered Person also is regarded as the beneficial owner of securities held in the name of a spouse, minor children or other person, even though he or she does not obtain therefrom the aforementioned benefits of ownership, if he or she can vest or re-vest title in himself/herself at once or at some future time.

Revised: August 3, 2023

S-22

INTERNAL USE ONLY

EXHIBIT E

INITIAL HOLDINGS REPORT

Report submitted by:
	Print Name

This initial holdings report (the “Report”) is submitted pursuant to Section IV (D) of the Code of Ethics of the Companies and supplies information with respect to any Security and Affiliated Mutual Fund in which you, or an Access Person, may be deemed to have, or by reason of such transaction acquire, any direct or indirect beneficial ownership interest, and with respect to accounts established by you, or an Access Person, in which any Securities or Affiliated Mutual Funds were held for your direct or indirect benefit, or the benefit of an Access Person, as of a date not more than 45 days ago.¹

Unless the context otherwise requires, all terms used in the Report shall have the same meaning as set forth in the Code of Ethics.

If you have no reportable Securities, Affiliated Mutual Funds, or accounts, sign and return this page only. If you have reportable Securities, Affiliated Mutual Funds, or accounts, complete, sign and return Page 2 and any attachments.

I HAVE NO REPORTABLE SECURITIES OR AFFILIATED MUTUAL FUND ACCOUNTS AS OF ___________________. I CERTIFY THAT I AM FULLY FAMILIAR WITH THE CODE OF ETHICS AND THAT, TO THE BEST OF MY KNOWLEDGE, THE INFORMATION FURNISHED IN THIS REPORT IS TRUE AND CORRECT.

Signature			Date

Position

Revised: August 3, 2023

S-23

INTERNAL USE ONLY

Page 2

Initial holdings REPORT

Report submitted by:
	Print Name

The following tables supply the information required by Section IV (D) of the Code of Ethics as of the date you became subject to the Code. Include all holdings of Affiliated Mutual Funds and attach your most recent statement(s).

SECURITIES HOLDINGS
Securities (Name and Symbol)	Quantity of Securities	Name of Broker/Dealer Where Securities Are Held	Nature of Ownership of Securities

Accounts
Name of Broker, Dealer or Bank		Account Number

 Outside accounts must be pre-cleared prior to being opened (See, Section T of the Compliance Manual).

Revised: August 3, 2023

S-24

INTERNAL USE ONLY

Page 3

Managed Accounts:

Please certify to one of the following:

☐

I do NOT have any accounts managed by a third party or trustee.³

☐

A hedge fund would be considered an account managed by a third party if it is managed as a separate account, but would not be a separate account if you are a limited partner. An investment in a mutual fund managed by a third party would not be a separate account because it is not solely for your benefit.

If you have an account or trust that was not previously disclosed, please list the details in the “New Accounts Established” section above and contact the Legal/Compliance department immediately.

I CERTIFY THAT I AM FULLY FAMILIAR WITH THE CODE OF ETHICS AND THAT, TO THE BEST OF MY KNOWLEDGE, THE INFORMATION IN THIS REPORT IS TRUE AND CORRECT AS OF __________________________________.

Signature			Date

Position

Revised: August 3, 2023

S-25

INTERNAL USE ONLY

EXHIBIT F

ANNUAL CERTIFICATION OF CODE OF ETHICS

I (a Covered Person) hereby certify that I have read and understand the Code of Ethics, and recognize that I am subject to and I am in Compliance with its provisions. In addition, I hereby certify that I have disclosed or reported all personal transactions in Securities and Affiliated Mutual Funds required to be disclosed or reported under the Code of Ethics. In addition, I have read and understand the firms’ Compliance Policies & Procedures Manual, Supervisory Policies & Procedures Manual, Code of Business Conduct, IT Staff Awareness and Whistleblower Policy posted on the firms’ Intranet website, and recognize that I am subject to and I am in compliance with its provisions;

Within the last ten years there have been no complaints or disciplinary actions filed against me by any regulated securities or commodities exchange, any self-regulatory securities or commodities organization, any attorney general, or any governmental office or agency regulating insurance, securities, commodities or financial transactions in the United States, in any state of the United States, or in any other country;

I have not within the last ten years been convicted of or acknowledged commission of any felony or misdemeanor arising out of my conduct as an employee, salesperson, officer, director, insurance agent, broker, dealer, underwriter, investment manager or investment advisor; and

I have not been denied permission or otherwise enjoined by order, judgment or decree of any court of competent jurisdiction, regulated securities or commodities exchange, self-regulatory securities or commodities organization or other federal or state regulatory authority from acting as an investment advisor, securities or commodities broker or dealer, commodity pool operator or trading advisor or as an affiliated person or employee of any investment company, bank, insurance company or commodity broker, dealer, pool operator or trading advisor, or from engaging in or continuing any conduct or practice in connection with any such activity or the purchase or sale of any security.

Unless I am exempt from filing an Annual Holdings Report (as a “disinterested” director of a Fund Client or an Independent Director of an Affiliate), I have attached a completed Annual Outside Accounts/Holdings Report which is accurate as of a date no more than 45 days ago.

Print Name:

Signature:

Date:

Revised: August 3, 2023

S-26

INTERNAL USE ONLY

Annual Outside Accounts/Holdings Report

Name:	(Last name, First)	Job Title/Department:

☐

Neither I nor anyone in my immediate family has Reportable Securities Accounts.¹

☐

I have Reportable Securities Account(s)¹for my immediate family or myself outside the firm that was/were previously disclosed and approved by the Legal/Compliance department. The account(s) is/are listed below:

☐

In 20xx, the following Reportable Securities Account(s)¹ listed below was/were opened for my immediate family or myself and not previously disclosed to and approved by the Legal/Compliance Department:

Reportable Securities Accounts include:

●

Advisory, brokerage, trust, mutual fund, or other accounts that you currently have open or are intending to open outside the firms, where you or your immediate family have a substantial proportionate economic interest or control.

○

“Immediate family” is defined as your spouse and minor descendants. With respect to accounts for the benefit of minor descendants who are not also minor children, any account that you control.

“Minor children” is any child, whether natural or via adoption, of an Access Person, under the age of twenty-one years. Every employee is considered an Access Person and is therefore subject to the Code of Ethics.

“Control” is defined as having investment and/or trade discretion over the account.

○

A “substantial proportionate economic interest” will generally be 25% of the equity in the account in the case of any single Access Person or 25% of the equity in the account in the case of all Access Persons in the aggregate. Interests in private fund clients and similar indirect means of ownership of underlying securities shall also be treated as Access Person Accounts.

Excluded from the definition of mutual fund accounts are non-brokerage accounts that can only hold a single family of mutual funds (i.e., direct investment mutual fund accounts).

●

Any outside account of an Access Person that is managed by a third party, or in the case of a trust where an access person is the grantor or beneficiary that provides a trustee with management authority over the trust, the access person should not, in any way, directly or indirectly have influence or control over the personal account/trust. [Note: a hedge fund would be considered an account managed by a third party if it is managed as a separate account, but would not be a separate account if you are a limited partner. An investment in a mutual fund managed by a third party would not be a separate account because it is not solely for your benefit].

Failure to disclose an account is a violation of the firms’ Code of Ethics. Along with this signed form, please enclose a copy of your most recent statement for each new Reportable Securities Account(s) listed below:

*Print Your Name:*

*Signature:*

*Date:*

Revised: August 3, 2023

S-27

INTERNAL USE ONLY

1. Account Title:
Account Number:
Firm Name:
Firm Address:
		For Internal Use Only↓
		Receiving Statements & Confirms?

2. Account Title:
Account Number:
Firm Name:
Firm Address:
		For Internal Use Only↓
		Receiving Statements & Confirms?

3. Account Title:
Account Number:
Firm Name:
Firm Address:
		For Internal Use Only↓
		Receiving Statements & Confirms?

4. Account Title:
Account Number:
Firm Name:
Firm Address:
		For Internal Use Only↓
		Receiving Statements & Confirms?

For additional accounts, please make a copy of this page.

Page 2 of 2

Revised: August 3, 2023

S-28

INTERNAL USE ONLY

EX-99.CERT 3 grx_ex99-cert.htm EXHIBIT 99.CERT

Exhibit 99.CERT

Certification Pursuant to Rule 30a-2(a) under the 1940 Act and Section 302 of the Sarbanes-Oxley Act

I, John C. Ball, certify that:

I have reviewed this report on Form N-CSR of The Gabelli Healthcare & Wellness^Rx Trust;

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations, changes in net assets, and cash flows (if the financial statements are required to include a statement of cash flows) of the registrant as of, and for, the periods presented in this report;

The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Rule 30a-3(c) under the Investment Company Act of 1940) and internal control over financial reporting (as defined in Rule 30a-3(d) under the Investment Company Act of 1940) for the registrant and have:

(a)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b)

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c)

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of a date within 90 days prior to the filing date of this report based on such evaluation; and

(d)

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the period covered by this report that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

The registrant’s other certifying officer(s) and I have disclosed to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a)

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize, and report financial information; and

(b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date:	March 8, 2024		/s/ John C. Ball
			John C. Ball, Principal Executive Officer

Certification Pursuant to Rule 30a-2(a) under the 1940 Act and Section 302 of the Sarbanes-Oxley Act

I, John C. Ball, certify that:

I have reviewed this report on Form N-CSR of The Gabelli Healthcare & Wellness^Rx Trust;

(a)

(b)

(c)

(d)

(a)

(b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date:	March 8, 2024		/s/ John C. Ball
			John C. Ball, Principal Financial Officer

EX-99.906 CERT 4 grx_ex99-906cert.htm EXHIBIT 99.906 CERT

Exhibit 99.906 CERT

Certification Pursuant to Rule 30a-2(b) under the 1940 Act and Section 906 of the Sarbanes-Oxley Act

I, John C. Ball, Principal Executive Officer of The Gabelli Healthcare & Wellness^Rx Trust (the “Registrant”), certify that:

The Form N-CSR of the Registrant (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Registrant.

Date:	March 8, 2024		/s/ John C. Ball
			John C. Ball, Principal Executive Officer

I, John C. Ball, Principal Financial Officer of The Gabelli Healthcare & Wellness^Rx Trust (the “Registrant”), certify that:

The Form N-CSR of the Registrant (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Registrant.

Date:	March 8, 2024		/s/ John C. Ball
			John C. Ball, Principal Financial Officer

GRAPHIC 5 grx_001.jpg GRAPHIC begin 644 grx_001.jpg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end GRAPHIC 6 grx_002.jpg GRAPHIC begin 644 grx_002.jpg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end GRAPHIC 7 grx_003.jpg GRAPHIC begin 644 grx_003.jpg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end GRAPHIC 8 grx_004.jpg GRAPHIC begin 644 grx_004.jpg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

7U M5F9VAI:FML;6YO8W1U=G=X>7I[?'U^?W$0 " @$"! 0#! 4&!P<&!34! (1 M R$Q$@1!46%Q(A,%,H&1%*&Q0B/!4M'P,R1BX7*"DD-3%6-S-/$E!A:BLH,' M)C7"TD235*,79$55-G1EXO*SA,/3=>/S1I2DA;25Q-3D]*6UQ=7E]59F=H:6 MIK;&UN;V)S='5V=WAY>GM\?_V@ , P$ A$#$0 _ .A(]Q^)_*I )XU/Q/Y4 MX"*% )P$X"D DI8!.&J0"D&DF!J3P.Z2F&U+:H79F%1(OR*JR-""\;O\QNYZ MHN^M7U:;8*W=1J:XZ>YM@ _KO=5L9_;22Z.U,6J55E-[/4HLKN9^_4]M@_SJ MW.3D)*0EJ&YJ.0AN"2&N]J"]JLO""]J2FJ\(3@K#VH+QJDI__]#IXU/Q*7[SER.9USJ?6*B[$L^R81,>C7+;'CW-_3Y9V;JW?3?71^B_P ' M^L?SBQ.M]9SNLO%N2\55![A3C"=E;)]N^/YZ[_2+09DNIP*V5NOMRK !0QPD MQ$;ZJ6;W-8DIQLI^9186ML5VW8MPR<-UF'<.'U$L M_P"I_P"H!H[)H(8^/WWX[OT+W?U+*5+J73J=Q:VL$1K MIV7.GILV;JY+)((F"#_WY)3Z;T_JG3NJ4NNP+QM4[WLW?F/_ M )NS_!HS@O,.D]1=T?K&/EU$0UQKR&;MK;*7?3J$E/\ _]'JXU/Q*D E M&I^)4P$5* 6/]<0/^;.:XMW^F:7P=>+JFN='\EKEM +(^N+'.^J_4-@DL;6\ M^36VU.>[^RQ)3Q6']4NNYYKMII:,>PDAS[&@- )9#V_2_-_,:O1NA= P>D5 ML NRW >KE/'N)\&3]!G[JS_J@2_H6([N6'XGW.U70,=M,$P/%)3.S5I\NZS, MKZ,'NM+>TG4B%E9+_5LV,UCDI(<;-I#VE\<@AG_ %2R_M?U9P7G1U+#C/\ MC0?2'^=7Z:\NN;M>0>R]'_Q?M=_S:#B(:[*NVGQ_F]W_ )%!1=UX07!6'A!< M$4-=X0'!6'H+@DI__]+KXU/Q*D E&I^)3@(J7 5?JM8LZ1GU.X?BW@R8'\V_ MNK(4;ZO6HLIW%AL:6[P&DB=/HV!];O[;4E/.=#OS:?J_TFO%:P&['!?8\D!K M6DGG^5N2R_K'>Y];*NH8[O5.VIN/3;:YY;NW>FXL].YC=C_4LJ?L6KT_IE Z M6WIMK=[*&>B >[1Q/]E:#:6M:UNQH#1#)EQ:/"IOYB2FO@7ORL'U7"+ "/HE MH)&DAKUQ6'1E]7ZC64U,_>/I_I;'?R&+O(T>UO9NGR7)](L MMH^L-N-JU]SAY GZ4.=^]M24T\_HW4&^JW[#BMJK@!X=87V"!OF[V,=7;[MS%SU MA+@7'E=C_BVP-UF?U-[/YMK,6AY_>?\ I\G;_P!;;CM_ZX@E[1P07H[T%Z*$ M#T%X1W!">$D/_]/LNY^)4@FC4_$IT5+A2"8)PDAK6'T[RW@. (_(B6Y;:*V[ M1-MA#&#DR3"AF@@,L'YI()^*KWW-H8;GN#6M:?/D7![2'[6/8-I&NQSV;K/ZVW8LGJ%&2;WVX_3M@(AKKW[#[6_Z-LV>[\SV M))=C%SLK+P&/R"UUK6@/+?&/I:KDOK%8YUQYB(=^5=#T"O)+'')=6?2'%9); MKR/4='J;?Y+=BP?K#96-A= P*<76M M]++WV007V7-;==:YKOWG';_48O)7N+:W.[@$KV/IF.W$Z5@XK22VC&I8"8!, M,;SM_E(**5R Y'<@N14A 0=/@LSJ/6Z? ML[G%P)G: #J2/I0U)+"_-IZ?ZON :P!H@Z21HN1ZI_32&CP"2FHX!P+3J':'X+TWZL_6;#ZMC48=MQ M_:M5(%S+ &FTUB'WX[A[;?8WU;F?SK%YWB]/RLKW5,]G[YX@( LLQLEE^):6 MVT.#Z;F\AS=6V-02^R.0G*MT7K./UOIST[GXJ03=S\4Z*ET\)-:YQAH)/@.5B=7^N/ M1>EN?2'G.RV$M=CXQ!#7#MD9)_0U?U&>O=_P22'< )( U)X 69U'ZP=/PKQA M5V-R.IV6,IJPZSN<++"&U_:7MEF-6W=NLW_IO^"7"]5^M_6^IL=2^QN%BN!# M\?%ENYI_-NR'%V3;_5:^FM_^A1OJ1THYO7L1T;*<-XR+(@>YH=917_:>WU;$ MDO3]?Z/4W,N:&_H[#ZM)XT?[G;7?R7^UB59N4<1V14VP-+WM:]C[ P$,DVV 26CAH/T7VN_,;_ -6K?2/JI?D7^MU :#7: M=&_VOY*].Q>AX6)4VFBL-K!+O%SG'Z5ECS_.V/\ WW_]0L/ZT]6IZ#2UU6U^ M=>",6LB6@-_G,JUDC]7H^CZ?^%O_ .N)*>1^MF15B?Y(Q0&N: YSWN)]WYSGN*85R$E,>G] M0S^DY'VGI]OI6O&VP. W=]'\]G^#LK77].^O?3\DBOJ=?[/M M,Q<"7XQ_MZWT?]<;97_PRXIPW6./:=H^#?:H$0@I]8)#F->TAU=@W5O:0YKF MGZ+V/;[7M_JH+N5YMTWJW4NDN)P+S76XAUF.X;Z7D?OTN^C_ %ZO3L76=*^M MV!F@59VW RM![C^@>3I^BN=_-?\ %Y/_ &[8BJG_UNU[GXE9'7_K1@]#VU/8 M[*S7@.;BL<&PPSMMON+7^DQVWV>RRY_^C]/WJ[U;J#>F=-RNH.:'G'82QAT# MK'$5TL_M6O9_87E;G777/R,FPW9%SB^VUW+GGZ3RBIO]5^L?6^L!S,F_T<5X M@X>/-=1$S^E]SK[^=M]G_ 5/ M]1B_5YW4\WZQ8;NG?HKJW>K MFVC_ $_OH_1?S(>L9MN58^QXK)>]UDCW!NT;/2W>W]%4W9Z-/[G_ %Q>@_57 MI&-TKHU/I@G)S6LNR;7 >H^Q[=^UW\FAIV5L_,24Z6=GXN!A79V4_9C4-+[' M1)C]T-^DZQ_T6-7CO5>IY75NH7=1R]+;B-MX''P*:Q[ M*6RX@'D#O\@FMW;="01SM,&/SH*$&-&K0->2._\ :_.14C:TAK0>0!/Q3.:B M[4Q""4#FJ!';[U8+5 L24__7N_XP,@-Z?BX@=#K[W6EOBRII9+O^NY-:XP+H M?K[9NZQ16#/I8S=/ OLML_ZEK%SP_P!J*D;SJ?N4*X#B\Z-8)U\>R=Q\?FM/ MZM=,/4^N86 1-9?Z^3I,5U_I'AW]?:VI)3Z1]3NBMZ3T:HNUSS=_.6.=L?]I=_UK_3I*:6;B-JQ75.:!:\%S:8]Y< YM;;OSJ:W[_H M?SM_L_XY=K];NN_L3IP9C.'VNT&C%D-):[:/4RBUWYF+5M_,V>M?36N4P6UO MZSBNODF?3K'T1_Q MEG\[=_VW_@DE.<&@"!^.I)\2F,!247N:QI>XPUO)Y\M/[22D5M@K )&YQ,,9 MWO (8X@Q74S]W^2LRRF^ /1M\?YM__ )%%2$ . M>!VY/P&J]#_Q9=+C$RNLV#WYC_0HTC]%4?TCV_\ &W_^>EY^S%S+/9738;+G M-IKECOI/(;^[^\YJ].YH,SMVVY'L^BYK/4MW?Z9!3 MS_UAZ@.I=4L]$S1@CT*SV+G$MRK:_P"2^UE=.[\]E?L_166^O4IKW$O>=M33 M%CCY@_HVQ[GVO;]"IO\ Y[3X6&YFTVU/APBNH!S7$$?HWN=M_15?^"6?X/\ MTR'DVVMK=[%QY:'-+,AY/ MN>WK_ .DO^W4:ZG(>[T159MYM(8_Z)XK;[?IV M_P#GI2]"_P#T-GE['?\ D4E(2$T(QHO_ -#9_F._\BAOJO\ ]#;_ -MN_P#( MI*1DH9G)E4WI.5&-Z M:V,Y9"(_/B \>#IX;7!M971A('AM;&YS.G@](F%D;V)E.FYS.FUE=&$O(B!X M.GAM<'1K/2)!9&]B92!835 @0V]R92 U+C,M8S Q,2 V-BXQ-#4V-C$L(#(P M,3(O,#(O,#8M,30Z-38Z,C<@(" @(" @("(^(#QR9&8Z4D1&('AM;&YS.G)D M9CTB:'1T<#HO+W=W=RYW,RYO&UL;G,Z<&AO=&]S:&]P M/2)H='1P.B\O;G,N861O8F4N8V]M+W!H;W1O7!E+U)E&UP+F1I9#I!.#,V-40X.3!",C V.#$Q M.#(R04(W031%0T$X,#0U,R(^(#QP:&]T;W-H;W Z1&]C=6UE;G1!;F-E&UP+FEI9#I!.#,V-40X.3!",C V.#$Q.#(R04(W031% M0T$X,#0U,R(@&UP34TZ2&ES=&]R>3X@/"]R M9&8Z1&5S8W)I<'1I;VX^(#PO'0 0V]P>7)I M9VAT("AC*2 Q.3DX($AE=VQE='0M4&%C:V%R9"!#;VUP86YY !D97-C M !)S4D="($E%0S8Q.38V+3(N,0 $G-21T(@245#-C$Y M-C8M,BXQ M !865H@ \U$ 0 $6S%A96B M 6%E:( &^B X]0 Y!865H@ 8ID +>% 8 MVEA96B DH #X0 +;/9&5S8P 6245#(&AT=' Z+R]W M=W &, : !M '( =P!\ ($ A@"+ ) E0": M )\ I "I *X L@"W +P P0#& ,L T #5 -L X #E .L \ #V /L! 0$' 0T! M$P$9 1\!)0$K 3(!. $^ 44!3 %2 5D!8 %G 6X!=0%\ 8,!BP&2 9H!H0&I M ;$!N0'! $!Z0'R ?H" P(, A0"'0(F B\". )! DL"5 )= F<" M<0)Z H0"C@*8 J("K *V L$"RP+5 N "ZP+U P #"P,6 R$#+0,X T,#3P-: M V8#<@-^ XH#E@.B ZX#N@/' ],#X /L _D$!@03!" $+00[!$@$501C!'$$ M?@2,!)H$J 2V!,0$TP3A!/ $_@4-!1P%*P4Z!4D%6 5G!7<%A@66!:8%M07% M!=4%Y07V!@8&%@8G!C<&2 99!FH&>P:,!IT&KP; !M$&XP;U!P<'&09!ZP'OP?2!^4'^ @+"!$,@A&"%H(;@B"")8(J@B^"-((YPC[ M"1 ))0DZ"4$9 EY"8\)I FZ"<\)Y0G["A$*)PH]"E0*:@J!"I@*K@K%"MP* M\PL+"R(+.0M1"VD+@ N8"[ +R OA"_D,$@PJ#$,,7 QU#(X,IPS #-D,\PT- M#28-0 U:#70-C@VI#<,-W@WX#A,.+@Y)#F0.?PZ;#K8.T@[N#PD/)0]!#UX/ M>@^6#[,/SP_L$ D0)A!#$&$0?A";$+D0UQ#U$1,1,1%/$6T1C!&J$)%ZX7TA?W M&!L80!AE&(H8KQC5&/H9(!E%&6L9D1FW&=T:!!HJ&E$:=QJ>&L4:[!L4&SL; M8QN*&[(;VAP"'"H<4AQ['*,0!YJ'I0>OA[I M'Q,?/A]I'Y0?OQ_J(!4@02!L()@@Q"#P(1PA2"%U(:$ASB'[(B--@U M$S5--8Y",$)R0K5"]T,Z0WU#P$0#1$=$BD3.11)%546: M1=Y&(D9G1JM&\$25^!8+UA]6,M9 M&EEI6;A:!UI66J9:]5M%6Y5;Y5PU7(9O5\/7V%?LV % M8%=@JF#\84]AHF'U8DEBG&+P8T-CEV/K9$!DE&3I93UEDF7G9CUFDF;H9SUG MDV?I:#]HEFCL:4-IFFGQ:DAJGVKW:T]KIVO_;%=LKVT(;6!MN6X2;FMNQ&\> M;WAOT7 K<(9PX'$Z<95Q\')+%V/G:;=OAW M5G>S>!%X;GC,>2IYB7GG>D9ZI7L$>V-[PGPA?(%\X7U!?:%^ 7YB?L)_(W^$ M?^6 1X"H@0J!:X'-@C""DH+T@U>#NH0=A("$XX5'A:N&#H9RAM>'.X>?B 2( M:8C.B3.)F8G^BF2*RHLPBY:+_(QCC,J-,8V8C?^.9H[.CS:/GI &D&Z0UI$_ MD:B2$9)ZDN.339.VE""4BI3TE5^5R98TEI^7"I=UE^"83)BXF229D)G\FFB: MU9M"FZ^<')R)G/>=9)W2GD">KI\=GXN?^J!IH-BA1Z&VHB:BEJ,&HW:CYJ16 MI,>E.*6IIAJFBZ;]IVZGX*A2J,2I-ZFIJARJCZL"JW6KZ:QK_UP'# [,%GP>/"7\+;PUC# MU,11Q,[%2\7(QD;&P\=!Q[_(/%$XIZ#+HO.E&Z=#J6^KEZW#K^^R&[1'MG.XH[K3O0._,\%CPY?%R\?_R MC/,9\Z?T-/3"]5#UWO9M]OOWBO@9^*CY./G'^E?ZY_MW_ ?\F/TI_;K^2_[< M_VW____N "%!9&]B90!D $# ! # @,& _]L A & M! 0$!00&!04&"08%!@D+" 8&" L,"@H+"@H,$ P,# P,#! ,# P,# P,# P, M# P,# P,# P,# P,# P,# P, 0<'!PT,#1@0$!@4#@X.%!0.#@X.%!$,# P, M#!$1# P,# P,$0P,# P,# P,# P,# P,# P,# P,# P,# P,# S_P@ 1" &$ M 38# 1$ A$! Q$!_\0 P @$% 0 @,! 0%!@<( 0$! M 0 0(0 $#! $" P8& P # 0 $ @,1! 4&(1(' M$#$30% B,Q07(&!!(Q8(,' 5,B0G0A$ 0," P0%" 4(" 4$ P 1$" P A M,1($05%A!1!Q(C(3@9&Q0E)B=5Q:[FFWV65UR5A MU*Y[^9<@LS&F/,+6"-=-5BU76UPS>8NRY' "S&&#K'$F".?QJRZW+8+)WFYZZ@4J$4L6)$BA0)N$0&$&2$ M2$>0FO0=SOD7 9="PC!&#IQ1JIS:,"NO2XQ1.[W/84 5218L0*$B@3<(H((( M((DD\TKUZS?8>) &"C2:UD8:^:Y&&5ABC!323M=SVY!%TD4*%"10L W"*""" M"))).#+T*RT&F"+PZ/"#S\7=9@PBXN2V6X3"+KDMFMP>@[GIB+I(H4*$@"0# M<(@,(((D(HXLNZV618FMQE*Z*9./,R]#LZ":>8 S1;'(9=9E4M'H.YZBBZ2* M$BA0 H6;A%!!$A$A$G'C?:479E(6/%'#JW0WV,95J.-#.-S6#A*F>O+C+BZ2 M)%"A8L6+-PB @B0@B23&EC6R0@D86H!Q&KLZ_$&,K531SF&=6I;&U'K"Y 6* MI(H6*%BQ1N,0&222$$408LR0T:"6AQI59='LNY M$ 6*I(H6+%B@#<(H(DD(DH(H6:]5Y"J869ABQ-8,>;0;@:":!&F30#3V;

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

EXCEL 17 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 18 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 19 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 21 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.0.1 html 124 50 1 false 49 0 false 4 false false R1.htm 995470 - Disclosure - N-2 Sheet http://xbrl.sec.gov/cef/role/N2 N-2 Cover 1 false false All Reports Book All Reports grx-20231231.xsd grx-20231231_def.xml grx-20231231_lab.xml grx-20231231_pre.xml grx_ncsr.htm grx_001.jpg grx_002.jpg grx_003.jpg grx_004.jpg grx_005.jpg grx_back.jpg http://fasb.org/us-gaap/2023 http://xbrl.sec.gov/cef/2023 http://xbrl.sec.gov/dei/2023 true false JSON 23 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "grx_ncsr.htm": { "nsprefix": "grx", "nsuri": "http://gabelli.com/20231231", "dts": { "schema": { "local": [ "grx-20231231.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/2006/xbrldi-2006.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/cef/2023/cef-2023.xsd", "https://xbrl.sec.gov/cef/2023/cef-2023_pre.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023_lab.xsd" ] }, "definitionLink": { "local": [ "grx-20231231_def.xml" ] }, "labelLink": { "local": [ "grx-20231231_lab.xml" ] }, "presentationLink": { "local": [ "grx-20231231_pre.xml" ] }, "inline": { "local": [ "grx_ncsr.htm" ] } }, "keyStandard": 50, "keyCustom": 0, "axisStandard": 1, "axisCustom": 0, "memberStandard": 1, "memberCustom": 48, "hidden": { "total": 87, "http://xbrl.sec.gov/cef/2023": 68, "http://fasb.org/us-gaap/2023": 17, "http://xbrl.sec.gov/dei/2023": 2 }, "contextCount": 124, "entityCount": 1, "segmentCount": 49, "elementCount": 247, "unitCount": 4, "baseTaxonomies": { "http://xbrl.sec.gov/cef/2023": 273, "http://fasb.org/us-gaap/2023": 36, "http://xbrl.sec.gov/dei/2023": 5 }, "report": { "R1": { "role": "http://xbrl.sec.gov/cef/role/N2", "longName": "995470 - Disclosure - N-2", "shortName": "N-2", "isDefault": "true", "groupType": "disclosure", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "grx_ncsr.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-12-31", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "grx_ncsr.htm", "first": true, "unique": true } } }, "tag": { "cef_AcquiredFundFeesAndExpensesNoteTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "AcquiredFundFeesAndExpensesNoteTextBlock", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Acquired Fund Fees and Expenses, Note [Text Block]" } } }, "auth_ref": [ "r121" ] }, "cef_AcquiredFundFeesAndExpensesPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "AcquiredFundFeesAndExpensesPercent", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Acquired Fund Fees and Expenses [Percent]" } } }, "auth_ref": [ "r122" ] }, "cef_AcquiredFundFeesEstimatedNoteTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "AcquiredFundFeesEstimatedNoteTextBlock", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Acquired Fund Fees Estimated, Note [Text Block]" } } }, "auth_ref": [ "r123" ] }, "cef_AcquiredFundIncentiveAllocationNoteTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "AcquiredFundIncentiveAllocationNoteTextBlock", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Acquired Fund Incentive Allocation, Note [Text Block]" } } }, "auth_ref": [ "r124" ] }, "cef_AcquiredFundTotalAnnualExpensesNoteTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "AcquiredFundTotalAnnualExpensesNoteTextBlock", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Acquired Fund Total Annual Expenses, Note [Text Block]" } } }, "auth_ref": [ "r125" ] }, "dei_AdditionalSecurities462b": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AdditionalSecurities462b", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Additional Securities. 462(b)" } } }, "auth_ref": [ "r169" ] }, "dei_AdditionalSecurities462bFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AdditionalSecurities462bFileNumber", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Additional Securities, 462(b), File Number" } } }, "auth_ref": [ "r169" ] }, "dei_AdditionalSecuritiesEffective413b": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AdditionalSecuritiesEffective413b", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Additional Securities Effective, 413(b)" } } }, "auth_ref": [ "r168" ] }, "dei_AddressTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AddressTypeDomain", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Address Type [Domain]", "documentation": "An entity may have several addresses for different purposes and this domain represents all such types." } } }, "auth_ref": [] }, "cef_AllRisksMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "AllRisksMember", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "All Risks:" } } }, "auth_ref": [] }, "dei_AmendmentDescription": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentDescription", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Amendment Description", "documentation": "Description of changes contained within amended document." } } }, "auth_ref": [] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "cef_AnnualCoverageReturnRatePercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "AnnualCoverageReturnRatePercent", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Annual Coverage Return Rate [Percent]" } } }, "auth_ref": [ "r151" ] }, "cef_AnnualDividendPayment": { "xbrltype": "perShareItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "AnnualDividendPayment", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Annual Dividend Payment" } } }, "auth_ref": [ "r150" ] }, "cef_AnnualDividendPaymentCurrent": { "xbrltype": "perShareItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "AnnualDividendPaymentCurrent", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Annual Dividend Payment, Current" } } }, "auth_ref": [ "r150" ] }, "cef_AnnualDividendPaymentInitial": { "xbrltype": "perShareItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "AnnualDividendPaymentInitial", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Annual Dividend Payment, Initial" } } }, "auth_ref": [ "r150" ] }, "cef_AnnualExpensesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "AnnualExpensesTableTextBlock", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Annual Expenses [Table Text Block]" } } }, "auth_ref": [ "r129" ] }, "cef_AnnualInterestRateCurrentPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "AnnualInterestRateCurrentPercent", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Annual Interest Rate, Current [Percent]" } } }, "auth_ref": [ "r150" ] }, "cef_AnnualInterestRateInitialPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "AnnualInterestRateInitialPercent", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Annual Interest Rate, Initial [Percent]" } } }, "auth_ref": [ "r150" ] }, "cef_AnnualInterestRatePercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "AnnualInterestRatePercent", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Annual Interest Rate [Percent]" } } }, "auth_ref": [ "r150" ] }, "grx_AntiTakeoverProvisionsOfTheFundsGoverningDocumentsMember": { "xbrltype": "domainItemType", "nsuri": "http://gabelli.com/20231231", "localname": "AntiTakeoverProvisionsOfTheFundsGoverningDocumentsMember", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Anti Takeover Provisions Of The Funds Governing Documents [Member]" } } }, "auth_ref": [] }, "dei_ApproximateDateOfCommencementOfProposedSaleToThePublic": { "xbrltype": "dateOrAsapItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "ApproximateDateOfCommencementOfProposedSaleToThePublic", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Approximate Date of Commencement of Proposed Sale to Public", "documentation": "The approximate date of a commencement of a proposed sale of securities to the public. This element is disclosed in S-1, S-3, S-4, S-11, F-1, F-3 and F-10 filings." } } }, "auth_ref": [] }, "cef_BasisOfTransactionFeesNoteTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "BasisOfTransactionFeesNoteTextBlock", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Basis of Transaction Fees, Note [Text Block]" } } }, "auth_ref": [ "r127" ] }, "cef_BdcFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "BdcFileNumber", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "BDC File Number" } } }, "auth_ref": [] }, "dei_BusinessContactMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "BusinessContactMember", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Business Contact [Member]", "documentation": "Business contact for the entity" } } }, "auth_ref": [ "r91", "r92" ] }, "cef_BusinessDevelopmentCompanyFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "BusinessDevelopmentCompanyFlag", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Business Development Company [Flag]" } } }, "auth_ref": [ "r94" ] }, "cef_CapitalStockLongTermDebtAndOtherSecuritiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "CapitalStockLongTermDebtAndOtherSecuritiesAbstract", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Capital Stock, Long-Term Debt, and Other Securities [Abstract]" } } }, "auth_ref": [ "r95" ] }, "cef_CapitalStockTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "CapitalStockTableTextBlock", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Capital Stock [Table Text Block]" } } }, "auth_ref": [ "r96" ] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "us-gaap_ClassOfStockDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ClassOfStockDomain", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock." } } }, "auth_ref": [ "r12", "r13", "r14", "r15", "r16", "r18", "r19", "r20", "r21", "r22", "r23", "r24", "r25", "r26", "r27", "r28", "r29", "r30", "r47", "r48", "r49", "r50", "r51", "r52", "r54", "r55", "r56", "r57", "r58", "r59", "r60", "r61", "r62", "r63", "r64", "r65", "r66", "r67", "r68", "r69", "r70", "r73", "r74", "r75", "r76", "r77", "r78", "r79", "r177", "r178", "r180" ] }, "grx_CommonShareDistributionPolicyRiskMember": { "xbrltype": "domainItemType", "nsuri": "http://gabelli.com/20231231", "localname": "CommonShareDistributionPolicyRiskMember", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Common Share Distribution Policy Risk [Member]" } } }, "auth_ref": [] }, "grx_CommonSharesMember": { "xbrltype": "domainItemType", "nsuri": "http://gabelli.com/20231231", "localname": "CommonSharesMember", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Common Shares [Member]" } } }, "auth_ref": [] }, "grx_CommonStocksMember": { "xbrltype": "domainItemType", "nsuri": "http://gabelli.com/20231231", "localname": "CommonStocksMember", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Common Stocks [Member]" } } }, "auth_ref": [] }, "dei_ContactPersonnelName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "ContactPersonnelName", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Contact Personnel Name", "documentation": "Name of contact personnel" } } }, "auth_ref": [] }, "grx_CoronavirusCOVID19AndGlobalHealthEventRiskMember": { "xbrltype": "domainItemType", "nsuri": "http://gabelli.com/20231231", "localname": "CoronavirusCOVID19AndGlobalHealthEventRiskMember", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Coronavirus C O V I D 19 And Global Health Event Risk [Member]" } } }, "auth_ref": [] }, "grx_CounterpartyRiskMember": { "xbrltype": "domainItemType", "nsuri": "http://gabelli.com/20231231", "localname": "CounterpartyRiskMember", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Counterparty Risk [Member]" } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "grx_CumulativePreferredStocksMember": { "xbrltype": "domainItemType", "nsuri": "http://gabelli.com/20231231", "localname": "CumulativePreferredStocksMember", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Cumulative Preferred Stocks [Member]" } } }, "auth_ref": [] }, "grx_CyberSecurityRiskMember": { "xbrltype": "domainItemType", "nsuri": "http://gabelli.com/20231231", "localname": "CyberSecurityRiskMember", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Cyber Security Risk [Member]" } } }, "auth_ref": [] }, "us-gaap_DebtInstrumentAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentAxis", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Debt Instrument [Axis]", "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities." } } }, "auth_ref": [ "r3", "r7", "r8", "r10", "r11", "r17", "r31", "r32", "r33", "r34", "r35", "r36", "r37", "r38", "r39", "r40", "r41", "r42", "r43", "r44", "r45", "r46", "r53", "r80", "r81", "r82", "r83", "r84", "r179" ] }, "us-gaap_DebtInstrumentNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentNameDomain", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities." } } }, "auth_ref": [ "r4", "r17", "r31", "r32", "r33", "r34", "r35", "r36", "r37", "r38", "r39", "r40", "r41", "r42", "r43", "r44", "r45", "r46", "r53", "r80", "r81", "r82", "r83", "r84", "r179" ] }, "grx_DeflationRiskMember": { "xbrltype": "domainItemType", "nsuri": "http://gabelli.com/20231231", "localname": "DeflationRiskMember", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Deflation Risk [Member]" } } }, "auth_ref": [] }, "dei_DelayedOrContinuousOffering": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DelayedOrContinuousOffering", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Delayed or Continuous Offering" } } }, "auth_ref": [ "r93", "r94", "r164" ] }, "grx_DependenceOnKeyPersonnelMember": { "xbrltype": "domainItemType", "nsuri": "http://gabelli.com/20231231", "localname": "DependenceOnKeyPersonnelMember", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Dependence On Key Personnel [Member]" } } }, "auth_ref": [] }, "cef_DistributionServicingFeesPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "DistributionServicingFeesPercent", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Distribution/Servicing Fees [Percent]" } } }, "auth_ref": [ "r133" ] }, "cef_DistributionsMayReducePrincipalTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "DistributionsMayReducePrincipalTextBlock", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Distributions May Reduce Principal [Text Block]" } } }, "auth_ref": [ "r103" ] }, "cef_DividendAndInterestExpensesOnShortSalesPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "DividendAndInterestExpensesOnShortSalesPercent", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Dividend and Interest Expenses on Short Sales [Percent]" } } }, "auth_ref": [ "r133" ] }, "cef_DividendExpenseOnPreferredSharesPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "DividendExpenseOnPreferredSharesPercent", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Dividend Expenses on Preferred Shares [Percent]" } } }, "auth_ref": [ "r133" ] }, "dei_DividendOrInterestReinvestmentPlanOnly": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DividendOrInterestReinvestmentPlanOnly", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Dividend or Interest Reinvestment Plan Only" } } }, "auth_ref": [ "r93", "r94", "r164" ] }, "cef_DividendReinvestmentAndCashPurchaseFees": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "DividendReinvestmentAndCashPurchaseFees", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Dividend Reinvestment and Cash Purchase Fees" } } }, "auth_ref": [ "r119" ] }, "grx_DividendsOnPreferredSharesNotIncludedMember": { "xbrltype": "domainItemType", "nsuri": "http://gabelli.com/20231231", "localname": "DividendsOnPreferredSharesNotIncludedMember", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Dividends On Preferred Shares Not Included [Member]" } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentRegistrationStatement": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentRegistrationStatement", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Document Registration Statement", "documentation": "Boolean flag that is true only for a form used as a registration statement." } } }, "auth_ref": [ "r89" ] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "grx_DoddFrankActRiskMember": { "xbrltype": "domainItemType", "nsuri": "http://gabelli.com/20231231", "localname": "DoddFrankActRiskMember", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Dodd Frank Act Risk [Member]" } } }, "auth_ref": [] }, "grx_EconomicEventsAndMarketRiskMember": { "xbrltype": "domainItemType", "nsuri": "http://gabelli.com/20231231", "localname": "EconomicEventsAndMarketRiskMember", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Economic Events And Market Risk [Member]" } } }, "auth_ref": [] }, "dei_EffectiveAfter60Days486a": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EffectiveAfter60Days486a", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Effective after 60 Days, 486(a)" } } }, "auth_ref": [ "r173" ] }, "dei_EffectiveOnDate486a": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EffectiveOnDate486a", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Effective on Date, 486(a)" } } }, "auth_ref": [ "r173" ] }, "dei_EffectiveOnDate486b": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EffectiveOnDate486b", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Effective on Date, 486(b)" } } }, "auth_ref": [ "r174" ] }, "dei_EffectiveOnSetDate486a": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EffectiveOnSetDate486a", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Effective on Set Date, 486(a)" } } }, "auth_ref": [ "r173" ] }, "dei_EffectiveOnSetDate486b": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EffectiveOnSetDate486b", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Effective on Set Date, 486(b)" } } }, "auth_ref": [ "r174" ] }, "dei_EffectiveUponFiling462e": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EffectiveUponFiling462e", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Effective Upon Filing, 462(e)" } } }, "auth_ref": [ "r172" ] }, "dei_EffectiveUponFiling486b": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EffectiveUponFiling486b", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Effective upon Filing, 486(b)" } } }, "auth_ref": [ "r174" ] }, "dei_EffectiveWhenDeclaredSection8c": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EffectiveWhenDeclaredSection8c", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Effective when Declared, Section 8(c)" } } }, "auth_ref": [ "r176" ] }, "cef_EffectsOfLeveragePurposeTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "EffectsOfLeveragePurposeTextBlock", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Effects of Leverage, Purpose [Text Block]" } } }, "auth_ref": [ "r152" ] }, "cef_EffectsOfLeverageTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "EffectsOfLeverageTableTextBlock", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Effects of Leverage [Table Text Block]" } } }, "auth_ref": [ "r152" ] }, "cef_EffectsOfLeverageTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "EffectsOfLeverageTextBlock", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Effects of Leverage [Text Block]" } } }, "auth_ref": [ "r149" ] }, "grx_EmergingMarketsMember": { "xbrltype": "domainItemType", "nsuri": "http://gabelli.com/20231231", "localname": "EmergingMarketsMember", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Emerging Markets [Member]" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine2", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine3": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine3", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Three", "documentation": "Address Line 3 such as an Office Park" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityAddressesAddressTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressesAddressTypeAxis", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Entity Addresses, Address Type [Axis]", "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table." } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r90" ] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r90" ] }, "dei_EntityExTransitionPeriod": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityExTransitionPeriod", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Entity Ex Transition Period", "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards." } } }, "auth_ref": [ "r175" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Securities Act File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityInvCompanyType": { "xbrltype": "invCompanyType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityInvCompanyType", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Entity Inv Company Type", "documentation": "One of: N-1A (Mutual Fund), N-1 (Open-End Separate Account with No Variable Annuities), N-2 (Closed-End Investment Company), N-3 (Separate Account Registered as Open-End Management Investment Company), N-4 (Variable Annuity UIT Separate Account), N-5 (Small Business Investment Company), N-6 (Variable Life UIT Separate Account), S-1 or S-3 (Face Amount Certificate Company), S-6 (UIT, Non-Insurance Product)." } } }, "auth_ref": [ "r166" ] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r90" ] }, "dei_EntityWellKnownSeasonedIssuer": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityWellKnownSeasonedIssuer", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Entity Well-known Seasoned Issuer", "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A." } } }, "auth_ref": [ "r167" ] }, "grx_EquityRiskMember": { "xbrltype": "domainItemType", "nsuri": "http://gabelli.com/20231231", "localname": "EquityRiskMember", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Equity Risk [Member]" } } }, "auth_ref": [] }, "dei_ExhibitsOnly462d": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "ExhibitsOnly462d", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Exhibits Only, 462(d)" } } }, "auth_ref": [ "r171" ] }, "dei_ExhibitsOnly462dFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "ExhibitsOnly462dFileNumber", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Exhibits Only, 462(d), File Number" } } }, "auth_ref": [ "r171" ] }, "cef_ExpenseExampleTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "ExpenseExampleTableTextBlock", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Expense Example [Table Text Block]" } } }, "auth_ref": [ "r119" ] }, "cef_ExpenseExampleYear01": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "ExpenseExampleYear01", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Expense Example, Year 01" } } }, "auth_ref": [ "r126" ] }, "cef_ExpenseExampleYears1to10": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "ExpenseExampleYears1to10", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Expense Example, Years 1 to 10" } } }, "auth_ref": [ "r126" ] }, "cef_ExpenseExampleYears1to3": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "ExpenseExampleYears1to3", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Expense Example, Years 1 to 3" } } }, "auth_ref": [ "r126" ] }, "cef_ExpenseExampleYears1to5": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "ExpenseExampleYears1to5", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Expense Example, Years 1 to 5" } } }, "auth_ref": [ "r126" ] }, "cef_FeeTableAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "FeeTableAbstract", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Fee Table [Abstract]" } } }, "auth_ref": [ "r119" ] }, "cef_FinancialHighlightsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "FinancialHighlightsAbstract", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Financial Highlights [Abstract]" } } }, "auth_ref": [ "r134" ] }, "us-gaap_FixedIncomeSecuritiesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FixedIncomeSecuritiesMember", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Fixed Income Securities [Member]", "documentation": "Investment that provides a return in the form of fixed periodic payments and eventual return of principal at maturity." } } }, "auth_ref": [ "r85", "r86", "r87", "r182" ] }, "grx_ForeignSecuritiesMember": { "xbrltype": "domainItemType", "nsuri": "http://gabelli.com/20231231", "localname": "ForeignSecuritiesMember", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Foreign Securities [Member]" } } }, "auth_ref": [] }, "grx_ForwardCurrencyExchangeContractsMember": { "xbrltype": "domainItemType", "nsuri": "http://gabelli.com/20231231", "localname": "ForwardCurrencyExchangeContractsMember", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Forward Currency Exchange Contracts [Member]" } } }, "auth_ref": [] }, "grx_FuturesTransactionsMember": { "xbrltype": "domainItemType", "nsuri": "http://gabelli.com/20231231", "localname": "FuturesTransactionsMember", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Futures Transactions [Member]" } } }, "auth_ref": [] }, "cef_GeneralDescriptionOfRegistrantAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "GeneralDescriptionOfRegistrantAbstract", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "General Description of Registrant [Abstract]" } } }, "auth_ref": [ "r146" ] }, "cef_HighestPriceOrBid": { "xbrltype": "perShareItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "HighestPriceOrBid", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Highest Price or Bid" } } }, "auth_ref": [ "r153" ] }, "cef_HighestPriceOrBidNav": { "xbrltype": "perShareItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "HighestPriceOrBidNav", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Highest Price or Bid, NAV" } } }, "auth_ref": [ "r157" ] }, "cef_HighestPriceOrBidPremiumDiscountToNavPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "HighestPriceOrBidPremiumDiscountToNavPercent", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Highest Price or Bid, Premium (Discount) to NAV [Percent]" } } }, "auth_ref": [ "r158" ] }, "cef_IncentiveAllocationMaximumPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "IncentiveAllocationMaximumPercent", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Incentive Allocation Maximum [Percent]" } } }, "auth_ref": [ "r124" ] }, "cef_IncentiveAllocationMinimumPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "IncentiveAllocationMinimumPercent", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Incentive Allocation Minimum [Percent]" } } }, "auth_ref": [ "r124" ] }, "cef_IncentiveAllocationPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "IncentiveAllocationPercent", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Incentive Allocation [Percent]" } } }, "auth_ref": [ "r124" ] }, "cef_IncentiveFeesPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "IncentiveFeesPercent", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Incentive Fees [Percent]" } } }, "auth_ref": [ "r133" ] }, "grx_IndustryConcentrationRisksMember": { "xbrltype": "domainItemType", "nsuri": "http://gabelli.com/20231231", "localname": "IndustryConcentrationRisksMember", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Industry Concentration Risks [Member]" } } }, "auth_ref": [] }, "grx_InflationRiskMember": { "xbrltype": "domainItemType", "nsuri": "http://gabelli.com/20231231", "localname": "InflationRiskMember", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Inflation Risk [Member]" } } }, "auth_ref": [] }, "cef_InterestExpensesOnBorrowingsPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "InterestExpensesOnBorrowingsPercent", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Interest Expenses on Borrowings [Percent]" } } }, "auth_ref": [ "r132" ] }, "us-gaap_InterestRateRiskMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InterestRateRiskMember", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Interest Rate Risk [Member]", "documentation": "The risk associated with changes in interest rates that effect the value of an interest-bearing asset or liability, and a servicing asset or liability." } } }, "auth_ref": [] }, "grx_InterestRateTransactionsMember": { "xbrltype": "domainItemType", "nsuri": "http://gabelli.com/20231231", "localname": "InterestRateTransactionsMember", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Interest Rate Transactions [Member]" } } }, "auth_ref": [] }, "cef_IntervalFundFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "IntervalFundFlag", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Interval Fund [Flag]" } } }, "auth_ref": [ "r94" ] }, "dei_InvestmentCompanyActFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "InvestmentCompanyActFileNumber", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Investment Company Act File Number" } } }, "auth_ref": [ "r94", "r161", "r162", "r163" ] }, "dei_InvestmentCompanyActRegistration": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "InvestmentCompanyActRegistration", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Investment Company Act Registration" } } }, "auth_ref": [ "r165" ] }, "dei_InvestmentCompanyRegistrationAmendment": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "InvestmentCompanyRegistrationAmendment", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Investment Company Registration Amendment" } } }, "auth_ref": [ "r165" ] }, "dei_InvestmentCompanyRegistrationAmendmentNumber": { "xbrltype": "sequenceNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "InvestmentCompanyRegistrationAmendmentNumber", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Investment Company Registration Amendment Number" } } }, "auth_ref": [ "r165" ] }, "cef_InvestmentObjectivesAndPracticesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "InvestmentObjectivesAndPracticesTextBlock", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Investment Objectives and Practices [Text Block]" } } }, "auth_ref": [ "r147" ] }, "grx_InvestmentRestrictionsMember": { "xbrltype": "domainItemType", "nsuri": "http://gabelli.com/20231231", "localname": "InvestmentRestrictionsMember", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Investment Restrictions [Member]" } } }, "auth_ref": [] }, "cef_LatestNav": { "xbrltype": "perShareItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "LatestNav", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Latest NAV (Deprecated 2023-01-31)" } } }, "auth_ref": [ "r159" ] }, "cef_LatestPremiumDiscountToNavPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "LatestPremiumDiscountToNavPercent", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Latest Premium (Discount) to NAV [Percent]" } } }, "auth_ref": [ "r159" ] }, "cef_LatestSharePrice": { "xbrltype": "perShareItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "LatestSharePrice", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Latest Share Price (Deprecated 2023-01-31)" } } }, "auth_ref": [ "r159" ] }, "grx_LegislationRiskMember": { "xbrltype": "domainItemType", "nsuri": "http://gabelli.com/20231231", "localname": "LegislationRiskMember", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Legislation Risk [Member]" } } }, "auth_ref": [] }, "grx_LeverageRiskMember": { "xbrltype": "domainItemType", "nsuri": "http://gabelli.com/20231231", "localname": "LeverageRiskMember", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Leverage Risk [Member]" } } }, "auth_ref": [] }, "cef_LoanServicingFeesPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "LoanServicingFeesPercent", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Loan Servicing Fees [Percent]" } } }, "auth_ref": [ "r133" ] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "cef_LongTermDebtDividendsAndCovenantsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "LongTermDebtDividendsAndCovenantsTextBlock", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Long Term Debt, Dividends and Covenants [Text Block]" } } }, "auth_ref": [ "r110" ] }, "cef_LongTermDebtIssuanceAndSubstitutionTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "LongTermDebtIssuanceAndSubstitutionTextBlock", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Long Term Debt, Issuance and Substitution [Text Block]" } } }, "auth_ref": [ "r111" ] }, "cef_LongTermDebtPrincipal": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "LongTermDebtPrincipal", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Long Term Debt, Principal" } } }, "auth_ref": [ "r108" ] }, "cef_LongTermDebtRightsLimitedByOtherSecuritiesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "LongTermDebtRightsLimitedByOtherSecuritiesTextBlock", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Long Term Debt, Rights Limited by Other Securities [Text Block]" } } }, "auth_ref": [ "r112" ] }, "cef_LongTermDebtStructuringTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "LongTermDebtStructuringTextBlock", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Long Term Debt, Structuring [Text Block]" } } }, "auth_ref": [ "r109" ] }, "cef_LongTermDebtTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "LongTermDebtTableTextBlock", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Long Term Debt [Table Text Block]" } } }, "auth_ref": [ "r108" ] }, "cef_LongTermDebtTitleTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "LongTermDebtTitleTextBlock", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Long Term Debt, Title [Text Block]" } } }, "auth_ref": [ "r108" ] }, "grx_LongTermObjectiveMember": { "xbrltype": "domainItemType", "nsuri": "http://gabelli.com/20231231", "localname": "LongTermObjectiveMember", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Long Term Objective [Member]" } } }, "auth_ref": [] }, "grx_LowerGradeSecuritiesMember": { "xbrltype": "domainItemType", "nsuri": "http://gabelli.com/20231231", "localname": "LowerGradeSecuritiesMember", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Lower Grade Securities [Member]" } } }, "auth_ref": [] }, "cef_LowestPriceOrBid": { "xbrltype": "perShareItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "LowestPriceOrBid", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Lowest Price or Bid" } } }, "auth_ref": [ "r153" ] }, "cef_LowestPriceOrBidNav": { "xbrltype": "perShareItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "LowestPriceOrBidNav", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Lowest Price or Bid, NAV" } } }, "auth_ref": [ "r157" ] }, "cef_LowestPriceOrBidPremiumDiscountToNavPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "LowestPriceOrBidPremiumDiscountToNavPercent", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Lowest Price or Bid, Premium (Discount) to NAV [Percent]" } } }, "auth_ref": [ "r158" ] }, "cef_ManagementFeeNotBasedOnNetAssetsNoteTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "ManagementFeeNotBasedOnNetAssetsNoteTextBlock", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Management Fee not based on Net Assets, Note [Text Block]" } } }, "auth_ref": [ "r131" ] }, "cef_ManagementFeesPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "ManagementFeesPercent", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Management Fees [Percent]" } } }, "auth_ref": [ "r130" ] }, "grx_ManagementRiskMember": { "xbrltype": "domainItemType", "nsuri": "http://gabelli.com/20231231", "localname": "ManagementRiskMember", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Management Risk [Member]" } } }, "auth_ref": [] }, "grx_MarketDisruptionAndGeopoliticalRiskMember": { "xbrltype": "domainItemType", "nsuri": "http://gabelli.com/20231231", "localname": "MarketDisruptionAndGeopoliticalRiskMember", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Market Disruption And Geopolitical Risk [Member]" } } }, "auth_ref": [] }, "grx_MarketValueAndNetAssetValueMember": { "xbrltype": "domainItemType", "nsuri": "http://gabelli.com/20231231", "localname": "MarketValueAndNetAssetValueMember", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Market Value And Net Asset Value [Member]" } } }, "auth_ref": [] }, "grx_MisconductOfEmployeesAndOfServiceProvidersRiskMember": { "xbrltype": "domainItemType", "nsuri": "http://gabelli.com/20231231", "localname": "MisconductOfEmployeesAndOfServiceProvidersRiskMember", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Misconduct Of Employees And Of Service Providers Risk [Member]" } } }, "auth_ref": [] }, "us-gaap_NetAssetValuePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetAssetValuePerShare", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "NAV Per Share", "documentation": "Net asset value per share or per unit of investments in certain entities that calculate net asset value per share. Includes, but is not limited to, by unit, membership interest, or other ownership interest. Investment includes, but is not limited to, investment in certain hedge funds, venture capital funds, private equity funds, real estate partnerships or funds. Excludes fair value disclosure." } } }, "auth_ref": [ "r0", "r1", "r2", "r61", "r68", "r69", "r71", "r72", "r75", "r88" ] }, "cef_NetExpenseOverAssetsPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "NetExpenseOverAssetsPercent", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Net Expense over Assets [Percent]" } } }, "auth_ref": [ "r133" ] }, "cef_NewCefOrBdcRegistrantFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "NewCefOrBdcRegistrantFlag", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "New CEF or BDC Registrant [Flag]" } } }, "auth_ref": [ "r94" ] }, "dei_NewEffectiveDateForPreviousFiling": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "NewEffectiveDateForPreviousFiling", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "New Effective Date for Previous Filing" } } }, "auth_ref": [ "r94", "r161", "r162", "r163" ] }, "cef_NoPublicTradingTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "NoPublicTradingTextBlock", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "No Public Trading [Text Block]" } } }, "auth_ref": [ "r156" ] }, "dei_NoSubstantiveChanges462c": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "NoSubstantiveChanges462c", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "No Substantive Changes, 462(c)" } } }, "auth_ref": [ "r170" ] }, "dei_NoSubstantiveChanges462cFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "NoSubstantiveChanges462cFileNumber", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "No Substantive Changes, 462(c), File Number" } } }, "auth_ref": [ "r170" ] }, "cef_NoTradingHistoryTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "NoTradingHistoryTextBlock", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "No Trading History [Text Block]" } } }, "auth_ref": [ "r160" ] }, "cef_OtherAnnualExpense1Percent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "OtherAnnualExpense1Percent", "calculation": { "http://xbrl.sec.gov/cef/role/Item3Ae": { "parentTag": "cef_OtherAnnualExpensesPercent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Other Annual Expense 1 [Percent]" } } }, "auth_ref": [ "r133" ] }, "cef_OtherAnnualExpense2Percent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "OtherAnnualExpense2Percent", "calculation": { "http://xbrl.sec.gov/cef/role/Item3Ae": { "parentTag": "cef_OtherAnnualExpensesPercent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Other Annual Expense 2 [Percent]" } } }, "auth_ref": [ "r133" ] }, "cef_OtherAnnualExpense3Percent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "OtherAnnualExpense3Percent", "calculation": { "http://xbrl.sec.gov/cef/role/Item3Ae": { "parentTag": "cef_OtherAnnualExpensesPercent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Other Annual Expense 3 [Percent]" } } }, "auth_ref": [ "r133" ] }, "cef_OtherAnnualExpensesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "OtherAnnualExpensesAbstract", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Other Annual Expenses [Abstract]" } } }, "auth_ref": [ "r133" ] }, "cef_OtherAnnualExpensesPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "OtherAnnualExpensesPercent", "calculation": { "http://xbrl.sec.gov/cef/role/Item3Ae": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Other Annual Expenses [Percent]" } } }, "auth_ref": [ "r133" ] }, "cef_OtherExpensesNoteTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "OtherExpensesNoteTextBlock", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Other Expenses, Note [Text Block]" } } }, "auth_ref": [ "r129" ] }, "cef_OtherFeederFundExpensesPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "OtherFeederFundExpensesPercent", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Other Feeder Fund Expenses [Percent]" } } }, "auth_ref": [ "r133" ] }, "cef_OtherMasterFundExpensesPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "OtherMasterFundExpensesPercent", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Other Master Fund Expenses [Percent]" } } }, "auth_ref": [ "r133" ] }, "cef_OtherSecuritiesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "OtherSecuritiesTableTextBlock", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Other Securities [Table Text Block]" } } }, "auth_ref": [ "r113" ] }, "cef_OtherSecurityDescriptionTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "OtherSecurityDescriptionTextBlock", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Other Security, Description [Text Block]" } } }, "auth_ref": [ "r113" ] }, "cef_OtherSecurityTitleTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "OtherSecurityTitleTextBlock", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Other Security, Title [Text Block]" } } }, "auth_ref": [ "r113" ] }, "cef_OtherTransactionExpense1Percent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "OtherTransactionExpense1Percent", "calculation": { "http://xbrl.sec.gov/cef/role/Item3Te": { "parentTag": "cef_OtherTransactionExpensesPercent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Other Transaction Expense 1 [Percent]" } } }, "auth_ref": [ "r128" ] }, "cef_OtherTransactionExpense2Percent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "OtherTransactionExpense2Percent", "calculation": { "http://xbrl.sec.gov/cef/role/Item3Te": { "parentTag": "cef_OtherTransactionExpensesPercent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Other Transaction Expense 2 [Percent]" } } }, "auth_ref": [ "r128" ] }, "cef_OtherTransactionExpense3Percent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "OtherTransactionExpense3Percent", "calculation": { "http://xbrl.sec.gov/cef/role/Item3Te": { "parentTag": "cef_OtherTransactionExpensesPercent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Other Transaction Expense 3 [Percent]" } } }, "auth_ref": [ "r128" ] }, "cef_OtherTransactionExpensesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "OtherTransactionExpensesAbstract", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Other Transaction Expenses [Abstract]" } } }, "auth_ref": [ "r128" ] }, "cef_OtherTransactionExpensesPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "OtherTransactionExpensesPercent", "calculation": { "http://xbrl.sec.gov/cef/role/Item3Te": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Other Transaction Expenses [Percent]" } } }, "auth_ref": [ "r128" ] }, "cef_OtherTransactionFeesBasisMaximum": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "OtherTransactionFeesBasisMaximum", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Other Transaction Fees Basis, Maximum" } } }, "auth_ref": [ "r128" ] }, "cef_OtherTransactionFeesBasisMaximumPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "OtherTransactionFeesBasisMaximumPercent", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Other Transaction Fees Basis, Maximum [Percent]" } } }, "auth_ref": [ "r128" ] }, "cef_OtherTransactionFeesBasisNoteTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "OtherTransactionFeesBasisNoteTextBlock", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Other Transaction Fees Basis, Note [Text Block]" } } }, "auth_ref": [ "r128" ] }, "cef_OtherTransactionFeesNoteTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "OtherTransactionFeesNoteTextBlock", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Other Transaction Fees, Note [Text Block]" } } }, "auth_ref": [ "r128" ] }, "cef_OutstandingSecuritiesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "OutstandingSecuritiesTableTextBlock", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Outstanding Securities [Table Text Block]" } } }, "auth_ref": [ "r114" ] }, "cef_OutstandingSecurityAuthorizedShares": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "OutstandingSecurityAuthorizedShares", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Outstanding Security, Authorized [Shares]" } } }, "auth_ref": [ "r116" ] }, "cef_OutstandingSecurityHeldShares": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "OutstandingSecurityHeldShares", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Outstanding Security, Held [Shares]" } } }, "auth_ref": [ "r117" ] }, "cef_OutstandingSecurityNotHeldShares": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "OutstandingSecurityNotHeldShares", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Outstanding Security, Not Held [Shares]" } } }, "auth_ref": [ "r118" ] }, "cef_OutstandingSecurityTitleTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "OutstandingSecurityTitleTextBlock", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Outstanding Security, Title [Text Block]" } } }, "auth_ref": [ "r115" ] }, "grx_PortfolioTurnoverMember": { "xbrltype": "domainItemType", "nsuri": "http://gabelli.com/20231231", "localname": "PortfolioTurnoverMember", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Portfolio Turnover [Member]" } } }, "auth_ref": [] }, "dei_PostEffectiveAmendment": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PostEffectiveAmendment", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Post-Effective Amendment" } } }, "auth_ref": [ "r89" ] }, "dei_PostEffectiveAmendmentNumber": { "xbrltype": "sequenceNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PostEffectiveAmendmentNumber", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Post-Effective Amendment Number", "documentation": "Amendment number to registration statement under the Securities Act of 1933 after the registration becomes effective." } } }, "auth_ref": [ "r89" ] }, "grx_PotentialDilutionInRightsOfferingsMember": { "xbrltype": "domainItemType", "nsuri": "http://gabelli.com/20231231", "localname": "PotentialDilutionInRightsOfferingsMember", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Potential Dilution In Rights Offerings [Member]" } } }, "auth_ref": [] }, "dei_PreEffectiveAmendment": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreEffectiveAmendment", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Pre-Effective Amendment" } } }, "auth_ref": [ "r89" ] }, "dei_PreEffectiveAmendmentNumber": { "xbrltype": "sequenceNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreEffectiveAmendmentNumber", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Pre-Effective Amendment Number", "documentation": "Amendment number to registration statement under the Securities Act of 1933 before the registration becomes effective." } } }, "auth_ref": [ "r89" ] }, "us-gaap_PreferredStockLiquidationPreference": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockLiquidationPreference", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Preferred Stock Liquidating Preference", "documentation": "The per share liquidation preference (or restrictions) of nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) that has a preference in involuntary liquidation considerably in excess of the par or stated value of the shares. The liquidation preference is the difference between the preference in liquidation and the par or stated values of the share." } } }, "auth_ref": [ "r5", "r6", "r9", "r178", "r181" ] }, "cef_PreferredStockRestrictionsArrearageTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "PreferredStockRestrictionsArrearageTextBlock", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Preferred Stock Restrictions, Arrearage [Text Block]" } } }, "auth_ref": [ "r104" ] }, "cef_PreferredStockRestrictionsOtherTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "PreferredStockRestrictionsOtherTextBlock", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Preferred Stock Restrictions, Other [Text Block]" } } }, "auth_ref": [ "r105" ] }, "cef_PrimaryShelfFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "PrimaryShelfFlag", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Primary Shelf [Flag]" } } }, "auth_ref": [ "r94" ] }, "cef_PrimaryShelfQualifiedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "PrimaryShelfQualifiedFlag", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Primary Shelf Qualified [Flag]" } } }, "auth_ref": [ "r94" ] }, "cef_ProspectusLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "ProspectusLineItems", "lang": { "en-us": { "role": { "label": "Prospectus [Line Items]" } } }, "auth_ref": [ "r94" ] }, "cef_ProspectusTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "ProspectusTable", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Prospectus:" } } }, "auth_ref": [ "r94" ] }, "cef_PurposeOfFeeTableNoteTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "PurposeOfFeeTableNoteTextBlock", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Purpose of Fee Table , Note [Text Block]" } } }, "auth_ref": [ "r120" ] }, "cef_RegisteredClosedEndFundFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "RegisteredClosedEndFundFlag", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Registered Closed-End Fund [Flag]" } } }, "auth_ref": [ "r94" ] }, "grx_RegulationAndGovernmentInterventionRiskMember": { "xbrltype": "domainItemType", "nsuri": "http://gabelli.com/20231231", "localname": "RegulationAndGovernmentInterventionRiskMember", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Regulation And Government Intervention Risk [Member]" } } }, "auth_ref": [] }, "grx_RelianceOnServiceProvidersRiskMember": { "xbrltype": "domainItemType", "nsuri": "http://gabelli.com/20231231", "localname": "RelianceOnServiceProvidersRiskMember", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Reliance On Service Providers Risk [Member]" } } }, "auth_ref": [] }, "cef_ReturnAtMinusFivePercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "ReturnAtMinusFivePercent", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Return at Minus Five [Percent]" } } }, "auth_ref": [ "r152" ] }, "cef_ReturnAtMinusTenPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "ReturnAtMinusTenPercent", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Return at Minus Ten [Percent]" } } }, "auth_ref": [ "r152" ] }, "cef_ReturnAtPlusFivePercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "ReturnAtPlusFivePercent", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Return at Plus Five [Percent]" } } }, "auth_ref": [ "r152" ] }, "cef_ReturnAtPlusTenPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "ReturnAtPlusTenPercent", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Return at Plus Ten [Percent]" } } }, "auth_ref": [ "r152" ] }, "cef_ReturnAtZeroPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "ReturnAtZeroPercent", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Return at Zero [Percent]" } } }, "auth_ref": [ "r152" ] }, "cef_RightsLimitedByOtherSecuritiesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "RightsLimitedByOtherSecuritiesTextBlock", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Rights Limited by Other Securities [Text Block]" } } }, "auth_ref": [ "r107" ] }, "cef_RightsSubjectToOtherThanMajorityVoteTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "RightsSubjectToOtherThanMajorityVoteTextBlock", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Rights Subject to Other than Majority Vote [Text Block]" } } }, "auth_ref": [ "r106" ] }, "cef_RiskAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "RiskAxis", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Risk [Axis]" } } }, "auth_ref": [] }, "cef_RiskFactorsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "RiskFactorsTableTextBlock", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Risk Factors [Table Text Block]" } } }, "auth_ref": [ "r148" ] }, "cef_RiskTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "RiskTextBlock", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Risk [Text Block]" } } }, "auth_ref": [] }, "cef_SalesLoadPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "SalesLoadPercent", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Sales Load [Percent]" } } }, "auth_ref": [ "r119" ] }, "cef_SecurityDividendsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "SecurityDividendsTextBlock", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Security Dividends [Text Block]" } } }, "auth_ref": [ "r97" ] }, "cef_SecurityLiabilitiesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "SecurityLiabilitiesTextBlock", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Security Liabilities [Text Block]" } } }, "auth_ref": [ "r100" ] }, "cef_SecurityLiquidationRightsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "SecurityLiquidationRightsTextBlock", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Security Liquidation Rights [Text Block]" } } }, "auth_ref": [ "r99" ] }, "cef_SecurityObligationsOfOwnershipTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "SecurityObligationsOfOwnershipTextBlock", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Security Obligations of Ownership [Text Block]" } } }, "auth_ref": [ "r102" ] }, "cef_SecurityPreemptiveAndOtherRightsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "SecurityPreemptiveAndOtherRightsTextBlock", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Security Preemptive and Other Rights [Text Block]" } } }, "auth_ref": [ "r101" ] }, "cef_SecurityTitleTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "SecurityTitleTextBlock", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Security Title [Text Block]" } } }, "auth_ref": [ "r96" ] }, "cef_SecurityVotingRightsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "SecurityVotingRightsTextBlock", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Security Voting Rights [Text Block]" } } }, "auth_ref": [ "r98" ] }, "cef_SeniorSecuritiesAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "SeniorSecuritiesAmount", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Senior Securities Amount (Deprecated 2023-01-31)" } } }, "auth_ref": [ "r139" ] }, "cef_SeniorSecuritiesAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "SeniorSecuritiesAmt", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Senior Securities Amount" } } }, "auth_ref": [ "r139" ] }, "cef_SeniorSecuritiesAverageMarketValuePerUnit": { "xbrltype": "perShareItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "SeniorSecuritiesAverageMarketValuePerUnit", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Senior Securities Average Market Value per Unit" } } }, "auth_ref": [ "r142" ] }, "cef_SeniorSecuritiesAveragingMethodNoteTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "SeniorSecuritiesAveragingMethodNoteTextBlock", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Senior Securities Averaging Method, Note [Text Block]" } } }, "auth_ref": [ "r144" ] }, "cef_SeniorSecuritiesCoveragePerUnit": { "xbrltype": "perShareItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "SeniorSecuritiesCoveragePerUnit", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Senior Securities Coverage per Unit (Deprecated 2023-01-31)" } } }, "auth_ref": [ "r140" ] }, "cef_SeniorSecuritiesCvgPerUnit": { "xbrltype": "perShareItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "SeniorSecuritiesCvgPerUnit", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Senior Securities Coverage per Unit" } } }, "auth_ref": [ "r140" ] }, "cef_SeniorSecuritiesHeadingsNoteTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "SeniorSecuritiesHeadingsNoteTextBlock", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Senior Securities Headings, Note [Text Block]" } } }, "auth_ref": [ "r145" ] }, "cef_SeniorSecuritiesHighlightsAnnualizedNoteTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "SeniorSecuritiesHighlightsAnnualizedNoteTextBlock", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Senior Securities Highlights Annualized, Note [Text Block]" } } }, "auth_ref": [ "r136", "r143" ] }, "cef_SeniorSecuritiesHighlightsAuditedNoteTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "SeniorSecuritiesHighlightsAuditedNoteTextBlock", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Senior Securities Highlights Audited, Note [Text Block]" } } }, "auth_ref": [ "r137", "r143" ] }, "cef_SeniorSecuritiesInvoluntaryLiquidatingPreferencePerUnit": { "xbrltype": "perShareItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "SeniorSecuritiesInvoluntaryLiquidatingPreferencePerUnit", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Senior Securities Involuntary Liquidating Preference per Unit (Deprecated 2023-01-31)" } } }, "auth_ref": [ "r141" ] }, "cef_SeniorSecuritiesNoteTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "SeniorSecuritiesNoteTextBlock", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Senior Securities, Note [Text Block]" } } }, "auth_ref": [ "r135", "r143" ] }, "cef_SeniorSecuritiesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "SeniorSecuritiesTableTextBlock", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Senior Securities [Table Text Block]" } } }, "auth_ref": [ "r138" ] }, "grx_SeriesACumulativePreferredStockMember": { "xbrltype": "domainItemType", "nsuri": "http://gabelli.com/20231231", "localname": "SeriesACumulativePreferredStockMember", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Series A Cumulative Preferred Stock [Member]" } } }, "auth_ref": [] }, "grx_SeriesBCumulativePreferredStockMember": { "xbrltype": "domainItemType", "nsuri": "http://gabelli.com/20231231", "localname": "SeriesBCumulativePreferredStockMember", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Series B Cumulative Preferred Stock [Member]" } } }, "auth_ref": [] }, "grx_SeriesCCumulativePreferredStockMember": { "xbrltype": "domainItemType", "nsuri": "http://gabelli.com/20231231", "localname": "SeriesCCumulativePreferredStockMember", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Series C Cumulative Preferred Stock [Member]" } } }, "auth_ref": [] }, "grx_SeriesECumulativePreferredStockMember": { "xbrltype": "domainItemType", "nsuri": "http://gabelli.com/20231231", "localname": "SeriesECumulativePreferredStockMember", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Series E Cumulative Preferred Stock [Member]" } } }, "auth_ref": [] }, "grx_SeriesGCumulativePreferredStockMember": { "xbrltype": "domainItemType", "nsuri": "http://gabelli.com/20231231", "localname": "SeriesGCumulativePreferredStockMember", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Series G Cumulative Preferred Stock [Member]" } } }, "auth_ref": [] }, "us-gaap_SharePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharePrice", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Share Price", "documentation": "Price of a single share of a number of saleable stocks of a company." } } }, "auth_ref": [] }, "cef_SharePriceTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "SharePriceTableTextBlock", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Share Price [Table Text Block]" } } }, "auth_ref": [ "r154" ] }, "cef_SharePricesNotActualTransactionsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "SharePricesNotActualTransactionsTextBlock", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Share Prices Not Actual Transactions [Text Block]" } } }, "auth_ref": [ "r155" ] }, "cef_ShareholderTransactionExpensesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "ShareholderTransactionExpensesTableTextBlock", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Shareholder Transaction Expenses [Table Text Block]" } } }, "auth_ref": [ "r119" ] }, "grx_SmallerCompaniesMember": { "xbrltype": "domainItemType", "nsuri": "http://gabelli.com/20231231", "localname": "SmallerCompaniesMember", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Smaller Companies [Member]" } } }, "auth_ref": [] }, "grx_SpecialRisksForHoldersOfSubscriptionRightsMember": { "xbrltype": "domainItemType", "nsuri": "http://gabelli.com/20231231", "localname": "SpecialRisksForHoldersOfSubscriptionRightsMember", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Special Risks For Holders Of Subscription Rights [Member]" } } }, "auth_ref": [] }, "grx_SpecialRisksOfDerivativeTransactionsMember": { "xbrltype": "domainItemType", "nsuri": "http://gabelli.com/20231231", "localname": "SpecialRisksOfDerivativeTransactionsMember", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Special Risks Of Derivative Transactions [Member]" } } }, "auth_ref": [] }, "grx_SpecialRisksRelatedToFundInvestmentsInPreferredSecuritiesMember": { "xbrltype": "domainItemType", "nsuri": "http://gabelli.com/20231231", "localname": "SpecialRisksRelatedToFundInvestmentsInPreferredSecuritiesMember", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Special Risks Related To Fund Investments In Preferred Securities [Member]" } } }, "auth_ref": [] }, "us-gaap_StatementClassOfStockAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementClassOfStockAxis", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Class of Stock [Axis]", "documentation": "Information by the different classes of stock of the entity." } } }, "auth_ref": [ "r12", "r13", "r14", "r15", "r16", "r18", "r19", "r20", "r21", "r22", "r23", "r24", "r25", "r26", "r27", "r28", "r29", "r30", "r47", "r48", "r49", "r50", "r51", "r52", "r54", "r55", "r56", "r57", "r58", "r59", "r60", "r61", "r62", "r63", "r64", "r65", "r66", "r67", "r68", "r69", "r70", "r73", "r74", "r75", "r76", "r77", "r78", "r79", "r177", "r178", "r180" ] }, "grx_StatusAsARegulatedInvestmentCompanyMember": { "xbrltype": "domainItemType", "nsuri": "http://gabelli.com/20231231", "localname": "StatusAsARegulatedInvestmentCompanyMember", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Status As A Regulated Investment Company [Member]" } } }, "auth_ref": [] }, "grx_SwapAgreementsMember": { "xbrltype": "domainItemType", "nsuri": "http://gabelli.com/20231231", "localname": "SwapAgreementsMember", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Swap Agreements [Member]" } } }, "auth_ref": [] }, "grx_TaxStatusMember": { "xbrltype": "domainItemType", "nsuri": "http://gabelli.com/20231231", "localname": "TaxStatusMember", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Tax Status [Member]" } } }, "auth_ref": [] }, "grx_TemporaryInvestmentsMember": { "xbrltype": "domainItemType", "nsuri": "http://gabelli.com/20231231", "localname": "TemporaryInvestmentsMember", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Temporary Investments [Member]" } } }, "auth_ref": [] }, "cef_TotalAnnualExpensesPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "TotalAnnualExpensesPercent", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Total Annual Expenses [Percent]" } } }, "auth_ref": [ "r132" ] }, "cef_UnderwritersCompensationPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "UnderwritersCompensationPercent", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Underwriters Compensation [Percent]" } } }, "auth_ref": [ "r128" ] }, "grx_ValueInvestingRiskMember": { "xbrltype": "domainItemType", "nsuri": "http://gabelli.com/20231231", "localname": "ValueInvestingRiskMember", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Value Investing Risk [Member]" } } }, "auth_ref": [] }, "cef_WaiversAndReimbursementsOfFeesPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "WaiversAndReimbursementsOfFeesPercent", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Waivers and Reimbursements of Fees [Percent]" } } }, "auth_ref": [ "r133" ] }, "cef_WarrantsOrRightsCalledAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "WarrantsOrRightsCalledAmount", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Warrants or Rights, Called Amount" } } }, "auth_ref": [ "r113" ] }, "cef_WarrantsOrRightsCalledPeriodDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "WarrantsOrRightsCalledPeriodDate", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Warrants or Rights, Called Period [Date]" } } }, "auth_ref": [ "r113" ] }, "cef_WarrantsOrRightsCalledTitleTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "WarrantsOrRightsCalledTitleTextBlock", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Warrants or Rights, Called Title" } } }, "auth_ref": [ "r113" ] }, "cef_WarrantsOrRightsExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://xbrl.sec.gov/cef/2023", "localname": "WarrantsOrRightsExercisePrice", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "lang": { "en-us": { "role": { "label": "Warrants or Rights, Exercise Price" } } }, "auth_ref": [ "r113" ] } } } }, "std_ref": { "r0": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "54B", "SubTopic": "10", "Topic": "820", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482134/820-10-35-54B" }, "r1": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "59", "SubTopic": "10", "Topic": "820", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482134/820-10-35-59" }, "r2": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6A", "SubTopic": "10", "Topic": "820", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-6A" }, "r3": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(22))", "SubTopic": "10", "Topic": "210", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r4": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.22)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r5": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-3" }, "r6": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-4" }, "r7": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r8": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r9": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(28))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r10": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(13))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r11": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(16))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r12": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(a)", "Publisher": "SEC" }, "r13": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(27)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r14": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(28))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r15": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(29))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r16": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r17": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-04(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-3" }, "r18": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-2" }, "r19": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-3" }, "r20": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B" }, "r21": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r22": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482987/272-10-50-1" }, "r23": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482987/272-10-50-3" }, "r24": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r25": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r26": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r27": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r28": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r29": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r30": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r31": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r32": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r33": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r34": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r35": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r36": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r37": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D" }, "r38": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D" }, "r39": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D" }, "r40": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E" }, "r41": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E" }, "r42": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E" }, "r43": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F" }, "r44": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F" }, "r45": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F" }, "r46": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F" }, "r47": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r48": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r49": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r50": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14" }, "r51": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2" }, "r52": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28" }, "r53": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "835", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482900/835-30-50-1" }, "r54": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r55": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(2)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r56": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(2)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r57": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r58": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4" }, "r59": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-2" }, "r60": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "27", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-27" }, "r61": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r62": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r63": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r64": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r65": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r66": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r67": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r68": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r69": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-4" }, "r70": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(16)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r71": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r72": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.6-05(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2" }, "r73": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483580/946-220-50-3" }, "r74": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r75": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-1" }, "r76": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2" }, "r77": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2" }, "r78": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2" }, "r79": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2" }, "r80": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r81": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69B" }, "r82": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69C", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69C" }, "r83": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69E", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69E" }, "r84": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69F", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69F" }, "r85": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480482/715-20-55-17" }, "r86": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r87": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r88": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-12" }, "r89": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12" }, "r90": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r91": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Number": "249", "Section": "220", "Subsection": "f" }, "r92": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Number": "249", "Section": "240", "Subsection": "f" }, "r93": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form F-3" }, "r94": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-2" }, "r95": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-2", "Section": "Item 10" }, "r96": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-2", "Section": "Item 10", "Subsection": "1", "Paragraph": "a" }, "r97": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-2", "Section": "Item 10", "Subsection": "1", "Paragraph": "a", "Subparagraph": "1" }, "r98": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-2", "Section": "Item 10", "Subsection": "1", "Paragraph": "a", "Subparagraph": "2" }, "r99": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-2", "Section": "Item 10", "Subsection": "1", "Paragraph": "a", "Subparagraph": "3" }, "r100": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-2", "Section": "Item 10", "Subsection": "1", "Paragraph": "a", "Subparagraph": "4" }, "r101": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-2", "Section": "Item 10", "Subsection": "1", "Paragraph": "a", "Subparagraph": "5" }, "r102": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-2", "Section": "Item 10", "Subsection": "1", "Paragraph": "a", "Subparagraph": "6" }, "r103": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-2", "Section": "Item 10", "Subsection": "1", "Paragraph": "a", "Subparagraph": "Instruction 2" }, "r104": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-2", "Section": "Item 10", "Subsection": "1", "Paragraph": "b", "Subparagraph": "1" }, "r105": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-2", "Section": "Item 10", "Subsection": "1", "Paragraph": "b", "Subparagraph": "2" }, "r106": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-2", "Section": "Item 10", "Subsection": "1", "Paragraph": "c" }, "r107": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-2", "Section": "Item 10", "Subsection": "1", "Paragraph": "d" }, "r108": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-2", "Section": "Item 10", "Subsection": "2" }, "r109": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-2", "Section": "Item 10", "Subsection": "2", "Paragraph": "a" }, "r110": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-2", "Section": "Item 10", "Subsection": "2", "Paragraph": "b" }, "r111": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-2", "Section": "Item 10", "Subsection": "2", "Paragraph": "c" }, "r112": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-2", "Section": "Item 10", "Subsection": "2", "Paragraph": "e" }, "r113": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-2", "Section": "Item 10", "Subsection": "3" }, "r114": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-2", "Section": "Item 10", "Subsection": "5" }, "r115": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-2", "Section": "Item 10", "Subsection": "5", "Paragraph": "1" }, "r116": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-2", "Section": "Item 10", "Subsection": "5", "Paragraph": "2" }, "r117": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-2", "Section": "Item 10", "Subsection": "5", "Paragraph": "3" }, "r118": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-2", "Section": "Item 10", "Subsection": "5", "Paragraph": "4" }, "r119": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-2", "Section": "Item 3", "Subsection": "1" }, "r120": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-2", "Section": "Item 3", "Subsection": "1", "Paragraph": "Instruction 1" }, "r121": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-2", "Section": "Item 3", "Subsection": "1", "Paragraph": "Instruction 10", "Subparagraph": "a" }, "r122": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-2", "Section": "Item 3", "Subsection": "1", "Paragraph": "Instruction 10", "Subparagraph": "a, g, h" }, "r123": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-2", "Section": "Item 3", "Subsection": "1", "Paragraph": "Instruction 10", "Subparagraph": "f" }, "r124": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-2", "Section": "Item 3", "Subsection": "1", "Paragraph": "Instruction 10", "Subparagraph": "g" }, "r125": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-2", "Section": "Item 3", "Subsection": "1", "Paragraph": "Instruction 10", "Subparagraph": "i" }, "r126": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-2", "Section": "Item 3", "Subsection": "1", "Paragraph": "Instruction 11" }, "r127": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-2", "Section": "Item 3", "Subsection": "1", "Paragraph": "Instruction 4" }, "r128": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-2", "Section": "Item 3", "Subsection": "1", "Paragraph": "Instruction 5" }, "r129": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-2", "Section": "Item 3", "Subsection": "1", "Paragraph": "Instruction 6" }, "r130": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-2", "Section": "Item 3", "Subsection": "1", "Paragraph": "Instruction 7", "Subparagraph": "a" }, "r131": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-2", "Section": "Item 3", "Subsection": "1", "Paragraph": "Instruction 7", "Subparagraph": "b" }, "r132": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-2", "Section": "Item 3", "Subsection": "1", "Paragraph": "Instruction 8" }, "r133": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-2", "Section": "Item 3", "Subsection": "1", "Paragraph": "Instruction 9" }, "r134": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-2", "Section": "Item 4" }, "r135": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-2", "Section": "Item 4", "Subsection": "1", "Paragraph": "Instruction 2" }, "r136": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-2", "Section": "Item 4", "Subsection": "1", "Paragraph": "Instruction 3" }, "r137": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-2", "Section": "Item 4", "Subsection": "1", "Paragraph": "Instruction 8" }, "r138": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-2", "Section": "Item 4", "Subsection": "3" }, "r139": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-2", "Section": "Item 4", "Subsection": "3", "Paragraph": "2" }, "r140": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-2", "Section": "Item 4", "Subsection": "3", "Paragraph": "3", "Subparagraph": "Instruction 2" }, "r141": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-2", "Section": "Item 4", "Subsection": "3", "Paragraph": "4", "Subparagraph": "Instruction 3" }, "r142": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-2", "Section": "Item 4", "Subsection": "3", "Paragraph": "5" }, "r143": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-2", "Section": "Item 4", "Subsection": "3", "Paragraph": "Instruction 1" }, "r144": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-2", "Section": "Item 4", "Subsection": "3", "Paragraph": "Instruction 4" }, "r145": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-2", "Section": "Item 4", "Subsection": "3", "Paragraph": "Instruction 5" }, "r146": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-2", "Section": "Item 8" }, "r147": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-2", "Section": "Item 8", "Subsection": "2", "Paragraph": "b, d" }, "r148": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-2", "Section": "Item 8", "Subsection": "3", "Paragraph": "a" }, "r149": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-2", "Section": "Item 8", "Subsection": "3", "Paragraph": "b" }, "r150": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-2", "Section": "Item 8", "Subsection": "3", "Paragraph": "b", "Subparagraph": "1" }, "r151": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-2", "Section": "Item 8", "Subsection": "3", "Paragraph": "b", "Subparagraph": "2" }, "r152": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-2", "Section": "Item 8", "Subsection": "3", "Paragraph": "b", "Subparagraph": "3" }, "r153": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-2", "Section": "Item 8", "Subsection": "5", "Paragraph": "b" }, "r154": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-2", "Section": "Item 8", "Subsection": "5", "Paragraph": "b", "Subparagraph": "4" }, "r155": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-2", "Section": "Item 8", "Subsection": "5", "Paragraph": "b", "Subparagraph": "Instruction 2" }, "r156": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-2", "Section": "Item 8", "Subsection": "5", "Paragraph": "b", "Subparagraph": "Instruction 3" }, "r157": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-2", "Section": "Item 8", "Subsection": "5", "Paragraph": "b", "Subparagraph": "Instruction 4" }, "r158": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-2", "Section": "Item 8", "Subsection": "5", "Paragraph": "b", "Subparagraph": "Instructions 4, 5" }, "r159": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-2", "Section": "Item 8", "Subsection": "5", "Paragraph": "c" }, "r160": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-2", "Section": "Item 8", "Subsection": "5", "Paragraph": "e" }, "r161": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-3" }, "r162": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-4" }, "r163": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-6" }, "r164": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form S-3" }, "r165": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Investment Company Act", "Number": "270" }, "r166": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "313" }, "r167": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "405" }, "r168": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "413", "Subsection": "b" }, "r169": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "462", "Subsection": "b" }, "r170": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "462", "Subsection": "c" }, "r171": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "462", "Subsection": "d" }, "r172": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "462", "Subsection": "e" }, "r173": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "486", "Subsection": "a" }, "r174": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "486", "Subsection": "b" }, "r175": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "7A", "Section": "B", "Subsection": "2" }, "r176": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Section": "8", "Subsection": "c" }, "r177": { "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-3" }, "r178": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r179": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(f))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r180": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "55", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-55" }, "r181": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r182": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" } } } ZIP 24 0001829126-24-001462-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001829126-24-001462-xbrl.zip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�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ⅅ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b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
~~~~~~7QCP[:+?Y-WK%97[^V ML'N#F%\J<:LX;SI2_EV<+Y#A?2.]S&5$VC\\^0=:V@L/P9H~~~~~~
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
DT'^K8G>"XP]NMB_,-2N*1JM-LBLJ_D8P.-N,>[2,0DU',B/H MF_^%?PF2["24UGW09RS\:S,"H> N4 2SU+A-JV]A*0[H5)4R")#81 &]:DDC M6K$60KX*)E2"2H7#4/'[QM#E6((+F(_\N M@^XR7IE,5D;0S!679#\6""X#4#8#9H&B(F:,/1XR]H M"@*$>J(!+ 6[ZJMQ,+)H O!AYE^ZW2DJZ!+34CWHV%3_3MD]\;T%6@CA/'@J M/,?> 3HUZ%WS$N(1J3Q5]#!RC&F&2]<^)Z3=Z%9(3$M%I*-USL4[;T_7!8[LL.\ F#VH+F0KY&F70 MUL7'0%K *F'Z@W7/#[=4N5D#ZV\B$P-%(#1+BE!R'9,"A!X$ M28H7LQ0X>]5>-M-*P;'-2!I(?*;A]=+ <,E+& IO[R1S:K^;7-NBP?_0<.,- ME>@ P5&04K&&!S RI_A:.-NFK^35U ).6?>@4,8:AU9QOD5QJ.N4:"'++V23:=I@FPTI\T?Z83.)3QZ'B3XF:0ZL18U-UG1@B++ ^PQP S3<"!"L>L<[YH+V4>R5WWC7C^5-? V9..;?=CS MO+'EQ>>U#YPR/FHCSU^@8!Z>4.0%8\NA,C81]VM&ML==*.ZR;A!)30/\GI)C MKU /MJLJI@H:F!HB27B5@"B8VBB+S8$87Y2^E+Z=TZ9QDA?8B>,@48[X1SP< M<,JNF$,2DR6!I@!NM5YA1QB5@7 #H/W4N8ZP8$=8YBV& QH(K,6=#F0(=1N@ MS?$.I14CL\E/E)T$,XN\T1W4#5ZTUS"'S,CM>CBT[/E#V+:^%W5M;VQJ5!NO MKLR]@GO*N LB#/[S(X@]!^M1KF_"(G?HR>ZV[BT#_!^YU^WBLZEU")/!$#K M[@%#G5\2^Z0US3E")A%U2I@O;J3^'*CG#UGOQLZMYW"3^<)55U,I9]'?16%& MQP8<$E$6UH-T%9FA^,1K%\3YC?K7&XSNJSG).AR>FG5PF$^(,@Y,>Q1#A%2; M\+]2.$5* (INHQ_X/6% U85'-<1(G&*;!;EU2B-Q&Q$8 EH 0236EMI,BG+] MYP"&QY0Z]"*&Y(^NM*)KQ$HWB3M!%(T9.R5F([L5!A[D^HFY?0D5,T+7ITZ@ M1K>X4E_I;$R\:RNB*6,G$MU5/^?7S%>K+IDU6DRE^9&W=^,YV@OYS^69UJ[/ M,ZVW)@>[FR?9YM;[I9_]YYEG6KT[D''[XL/Z29ZKDF9;[Y\'WW8/%HQ^+3WMQGD2>29W" M]L7GWK>WAWM1\&S33(NMR=>%^=6/ZR>;EU]^)3WYN&FF3=L@D=@N9'S 9(8[ MM,?4N4*]J9,E0VZI8-DD[6)L/%DT>Y2E"!9MD+[6U7/F=1RY05.0L"?#-!B$ MQ4#I[)#->EUY;M7F6:]',%!&E+G8Q0UB-AE#W/&O0%>,9?V&9A^39+)C FY;A]ZMRA4X1.W EL2K+$-4WH!0UIRY]26HJBWTS 5'S@V!M@DT: M]&STRZLR(T?D2HD0$6@VV#+^%\G$OI5"A>6!]&DV XQ4>+NR@'*]P(A?7$96C/0(9GR@6:" MKV4SU@[9FQQ"Z+ZL&]-/P4I@(]B3*A=%@]LKP]1)##_2G1>Q%>8#2 MF07C>55)H,1B=5KE=8 1(^Z>)SRV\J&BC69!'LJ&!4>,. XB(?G04@GH_I>4 MHPF:Z@B*Q'OQ\3I$XK65&5CDS%=V5;S$LYET=6K+BDYA4LOA?"+5/#W\X,44 M@+">VU<&9(/[R1MX^"OH8 O;>N7;Y+MP"'K0=!:4 W>$A>EC:WOIC/I:R7W% MB(-TDZR7O<1PU^)=C)^/S1&R1LY:#S\B&GJ$DEUS'=G&$@T;VEV\!LRWAWA>D@/<\_IK;[+L_7#KN[I!4Q?80P)*R,]TMD;5K]) M04XK:&]S4>LJ+RL[F/4Q[(]F@O71:5M&*7I[TV#/7/OH^N,AD\ATUO6FXZ(F M3!Q#! #" M7+PJ1M6!Z)?\'LA)9-36N.[[$$.H9*GIJW^6#$0S)36'[!4=+M9@"9-$?,F^+7L,S6CFFL%$LPX2(!)H7( M E+4QB$8,(#=,W[[+]\[/GW;RYM$S6]NMR?C#^6#U7?+U]&?XM!?G262V M=EJ3M4'[A_=QNU=\7WJVJ2VEC"XVBI,B//[Q]MO"S*2V$I?M.XQUA(\HGC%U M +9(4_Q6I<3M*WM*@07@##L0CE(60">/*)[ _I-N>\"V".4-"K*-Y/7*-P#4 M#3(Y$UH*79H@#Q +%7"G;F.:#9*+0-)$%L:E-B7&Y-;P@E@9G%E&"&*BDJUY MIB':U$$JZQ4E]!P.;Q9/GDFI6:G)32U(\/#0G^&VIJ$N63(*S'_^H2H#GB.PHSAE!Q6E%Z%,Z"7 MU*&0T#\&-.NAO5;(E_UG4[2!C;FCB'8;'4X77UF%!4.LF3J^ )W-I<0!)%Q- M1:MQ,6@S6*'L, ^PKR7'TW-&;LXUCH4LD)L>>\1]0G%'Z9],*$^[=S*@67$8 MIEH,_M6-H%<@@N=1IUH]+LIC,NQ2/))3Z_+K44],'8MT< 0<@4'//X,&CGD> MT<5Z9?(?BC\)-5W*++2#?!0$M7%HF9T#:,:ISC6VQCKZHX,1]N%-^ 1:^QA< MVHV8,E,L< 7^00><$(XR@/Y,?.+8PH%H*H* K5Z1('$5+A92"Q@M#O*JWE Z0E9Y)N .IY5C#.@/ M ?G#QF.)4@D07@7PEY)%*!ZE3XTM/(UF*KH64E/SF'K0R31%7DX]WLO0G/CF MG0>V+5^4I1500LPE#9(^$^G3W6LMFU>+/Q8^9E8_+?Q%G=,@S7S4C5QT@NIB M8/END>DNLOIB/SS=-@X*ZAB*L=:C*E@STJI0RZ1\E+P!4VFLD5:L2XU&HAF3 MF1H'O20/N4T9Z3$EGD&JKQC^T9BF?H*W/]I8RO(8%+@6J)C).B\R]ZNY4B%?9IY2;D(/.VF?-,N[*&+.0=2ZP.JQ&32L0^B< M]G^LZG'HYSSD^DLC%WP\A,2-K\>:YW-E<^:L"J?3C/,V"\)Q5'*T)=U22Q8H M97L85HC ;\0L2!9$8[/*E6=%L.R<<-5F%7MYH'H8 UF14A'-:T,1GLC+/<=, M*C/QPU1H=2WK3N3%*"&J&?-LIU#HYZ#M)755N_H\I@%!@2S[3R-!G/UHH_[N MD#UK$MBUD1(PL8(@MQ]J03#^N1*DC>L3-1NMR=GR9.M#M/!^E(3/,U&S?L=$ MS4)KLM@]6#YYVSV=?S];B9KUUN1R(]S<^=O;WNO\2J[D+HD:)7,?_<6\NS6^ MW'C_TLO:79REUN0B7&YW-D[V7)M\73HSQ??+:)&E#D M@\VLN^IO?CC\E4/UR#5(=DR\QH"@5M4YT!_DIM7T<)@FRK-!^E[J@TF7^02,9\*"W/C^,JEPSIJ#'2-[6@LQEM3 MZ,*-8!X,=\)$9L+-^5_XUUZ1XQ)O:]\2ENK0&%K\ 29>T_QC7A18]"O YD?/ MT=5 KQ"*(Q\' *M\7CXJ7OAK9A5 LU/MPD C*$UQ$2!%W8H;NPZ+J]1+B3,] ME-JZH-(O:5 (V8'H!X];/*E;3!5X&^]WI@;B?O\S%9[ \IP8N@6M8V&@4.8R!F*E"HY(]E*/HA0 @9,&3 "O)$B6'<"<-LW*()'^ MQ<78"P064770U%S0>39 7*=Q*EC/V@V&I%=(T+9F23&T W$[B-\EP*TVGATE MFRQ>!LPJ$0\W@;C<]\Y45\T4_WD2Z M. ++D[05,&2/X:[2TY"DKZ^T M#P3E <@.:X#C>\V07S/:\QA:1)JFZ2&M-2LO.4H>!U GAZ8) M1NY!/@%.GB0^TT7)EO".FST],2D\%E0ES.7!7'AI*)QX,)RFC =V25-#FHT6 MH1C *OA>B(W$JVA,CK2GC6EUL!4=8Q(I2CU9]:\Z2E_"%=8*+&49]-K/P-5HD 84_"[O1UWP M6X>[K\K>< TT&1P#Q%M;RU3SIIO70E\A"R;H-M?X4JYPME#]%/-SE7'Y%A-M MXI;-2L@_L=-T[M],/VNAK42U7%'^G4XQ #XE^+,7X<%F":)7FFX)/#+:3%W6 MHFS*-&P7N6$4]7+K#) ,6SW3\:4#J<(R:M ! 9<60V\/,>P072$*>1UBNED& M@==\W*2"FG4I$7>M?-3I!R&#!D1Z]N6&&O9 MYF>\&D9%YI9+)%F>O38!O$KJ5- \4JX!;^QB@WBVP8=)R I=4F*U0XFAS+9 M2;_:ID8FLFD=RD0CY$O)9V<@EOZ5V?^II)CK<::-VT]@M>A.96V/$7!/7L;( M$S031?4UY$)S306;/-274R,21>DBS= M%?V_->Y8Q?3#@''UW>S/<:H;ONA=)-3HD HGF@:AA*D\6T&.P3-WHO=^H2F) M.=C.K&:UCS'$MUUEB0B"S,22,?3NZR2)$*29BCKKJ1B! !IXG6GAL9"8<>)2 MZD&T>4"^;3@ HRCHF+0#JFT+UM!QW+W2.-L!#,L:+14ED+%#V$M.6LFR.] N MS6VM]5 $]@UO]RP(^&E]P +J\#J1%PZD D])=(;ZNL=WY&X&"]"$VWNKV[:3B#RZDG)K:TO QGR.AT(1^B1E)>,Y[=3673 MPD2I#,F%Q(B6X)IKR4NI1Q598"V-B.(KNK^E[D=^#?*?)I[_AD _4U@6G9(@ M^>[KDJZIO+.I5![2LMIIW)$W+)T+9,!3^RT?D=IR@V5^)1TL*6M&:3$8GT8D M$VF>BW^^[P-U\RS4TOR-LE#C3RN;9W^?[Q\N/\\DU,8=DU [KMG73C::=9'CT'M=B: M](OMK8NC^;5.TGW:B_,D!,@\BN-3!>55NHK*XP3R S_V&L6DV@=I*[I0KZFL[78?^JBV'4K6, MVHLSYI7X2:>,\C*$TW.-;ZY=])MK*9A(>1=#M:6AZ'$WF;[@OXU7"Z\ICM%C MEH^&&T?E(F9TWC,G9JU61OE'8=;_K9)$DX@/M7TH.J[E(= FYAA>T?%IJ]>* M<8A*A#E>%V)''+'!PO,D_'R]QVP[#%AB9YY]?1,="U1=00"1<*6B7%&<3JFSX#'_+_QK7WRG8SAR5^>53\&;!#4(2>53 M6[PJI/FU+ID5O]# ?]"^> >$G=AN!7QB=C(7&D"X%=0CJ4=)D&/TJ& *#%, MZ%/J!^W<]AA-A-@BWT)/+0^PV8O.V@00(]K M41,%B\NCLX*5>"718/M*EI.46Z01TAOSV>)^!8 M[%S5Q)!EY2'ULNBDA[56\/)24M>=+ R88RSM<>,\"(8BA#I*S.^6F,^GS:^F M4X45L<00$HT;UY3Q_.J_D /5*MGLB04@9]6CF9CT)E%<)K-YF2IG G0L8!^P M04=N-]QP(H:UWT-XB/M%)%:ZX6&QB+-,B;65&\)N3(3[118?+DG09#R80; J M:2766]U@O%(0ZV]U=,-F<-#*3FGM*!EE9C.P/HO8W; 7GN[NH@T(9BE4&\% M)M)Y^10IGX&;P*(2RVL5^W4*G78>74N2-]7;XPZNX)(GHJWT^.SK&@ M<1$>1%J;ZE35<<*#;!0.+2#KB?(43$?WMEE$W]H^2*I4[E@RL:U&@VF8Z3PM MY/VFO4XS"8 @8/*6V1[!^8 ];.U[WJK!RO@D(F,3, M\Q25">S*N>Y9.'%EV?=J:O=J$KNBW,&U2Y"H"@WDK#9/7'DDU9I5/,@(C_&;*W&UR3:4?4%D?W<09I,]5FOK:C5/'P(XQT@Z3BG%*8IK-H6_4E)[A>S7B#K[#'A-NR7X M]7:GMIY0@UH;=.TX]/Y<89'*UA&T*,.4L/IO=:^H.1E>:@QJ<_+2SD7R**;% M+;)("]=GD?9:D_T?1UN;P^UX-XN>91II:?Z.::2EUF3Q4_:VOS_8V5OKS%0: M:;G">11UIO33:C=OPAZOU<&RT\VSS20FM2_.RNIIVEI8VULYG)(YTR M^)1-V9N87ZY_R>2X)8O,6%Y,ZRM%TB7O#,XRPV01RU;;I*BF;*$$X!7$\#1L M,'<@9T(Y%X!:KGQ( PQKT/.AD$O7-]BX3NF:4VD#4K\>2$G$[>)QXF#T8N00 M6]&G)N4VQ5Z"6*Q:SLPT]M$[=JT]=I,-X\# D]HQKJ^80IW_:/NF8YW7A4S< M^CHK&"+&,RY#+862B;E;?/\8*&+^H/)LB?*-"<"MXH4VXS9-89"[#C7\WC7. MK0F>U^$LI\&-IT7W*#9QQ9?*P0GE.TKJKQP!KH'&AKFS:M@7(2'77VD\K-,R MBX+9#-I/7*';SF467,?_A7^=0):Q)@N%MCPQ7%$?7(Q5(J 3BCJ:TI7<#[H> M(A;=H*8F(%:[=IJ]M)[WG%;$,"/4/R;/S\DI>0D:#4TX_G"N.10%5TC3 M<;IYISFAH4RI"V*A8K4)!9M$8<+CR"278#$#]+X0N([^7?< 26G=,':6!D 1:>EL?]_((&J\"K]-7J\1) MNV/][4WXNP/:=D+B2M;QFDEUOLV(E2$\;>("Z.RRE1&S9H(Q(0A.L/E HVA M+Q]I.I4NQ$64/NR0LD>$ @?@K]@9NZ;6<*.5E!.<6Y$ F:C,*IR)6D"[>LDB MI84P+52+PJ]+.UL'FN$$^+AQD:!1BI6"62TXI?HT4CLD!1U,3-6QMJHG8R7O M %@5TDKE%ZL;PBID6<$%O/5O-+>/@-)M_EVMJ@/HR#8;]_UIS4UN7[SN)&5F-FD+D(L(L20CLMOD.-3M27ND8C;NLL"]^17),J6C$* M>C"=W+MD PGU0!'SWXT7S"7(VA@ML>O2I:^41IK"2=+V-U&]VSELH-^ _8L3 M.N"1-\(6CZJ>/B&78NJ:H>U063+V<=2(!2 7IF1@9>2*@JM> M>@=^!E8AA_9^-'P+C=JT^F7^4T1Z2XLWZGATEJZ<'J0_^ZM!\#R33PMW3#[M MM2;GJ\-/H_Z[XZ6-Y9E*/BVU)I_\K^_[/_/$/WJHDHL>+&=NI>@<,4ZA=&N93"L_ -BQ%XB1@ M/0N>PO_"OW0# 9O%I+8NY:U$M9M5NO\::+A%AI+38RA\X$+-KD,_USW&#[-. MD658 ";'%]N-N-Y"97 USRKGQT2L=14;N<8P-HA("-A2YB<"!B.])%M. MD_,K-@QF<--]*E$G#CW9)L-U=M5&V6QIH+7S/FC&(BMU,#?996C24L6&\P,\ M+MKK,!V8O<(:(1NX<$REG0$.7QV9U76(,AP-P> MO^K&AWE=O<$,Z.K3$C#79F I:SJB$M:M$)E-IPX9+HE].S!482Q#N+4:AQ9* M XUHLCC I2B!<8R[Y")CKZXB@GO-J1\A#5/#N-B11U5KU29#"L0>1T81K2$;W6VL$M=(-2E8Z@V;$:> MBQO5\T23$E\F_PB51.LDP\JS4 MG!]2*-],H>E2VYG+%@WJ,&:L%0;>J92Y0N5(B;RDG7-W<_ELASH/Q4$WS/\T M!>FZUVD85T8M;;1DMRB/V'08@X.X#]Z(&:\!?W%1?$*26-]_<=9"VH!-,:/? M1[K86Y14'['>S(38F$ HI=YS=>9GRJE=&P:B63+@ C%WDU175W:$ ].F)-JA M/V,>.63CJA2\:= &,OD2Q*Y41.TJ$L_0RB@P0I0(K+EH554><:Q= L4MU0'3".W(JC M9J60Z69[I_N[HDY-O6&HLRHFXOG*I:QU1'+;>)(O8.G-1F\P1OJ M#O8_UL9H:>GZ[,LN,@\=KOV8')Q>KC_/[,OB';,OT#GDY_#L5XQ_QY?OU=O;(R9>%UF3P\/3DRV)KTME<6/^X ML3LYWEMZVHOS))(O2I(_#M^-5[K+Y_U=_]DF7Y3<^._W)Z-W9^'?P_;,)%^@ M1TZ2CJ"]A0X=:]Y<;8K78L@U)ZQ\;QK)FTV>K=O65OF+)%A5PE7I9I'RYXI# M2=7J3Q;QU\Z]>%M'[UK@\9J$^:3..VM8*@WSB@=QMUHA+<>@-5!9OJ*^(S0 M(=-26AC@&RF(@L#J>.IGH6K%DSW0BU'9!QO)*S:HQ<]NJ,IAH> GE@B]&&6F M8^.J:!-X#H@0=:!-/]+MHF%WXJD,MXR5U6^GF#_ 8.GEWIA_MD+!IDC!TQ7T ML$PQ!ZAJZ!K,4*ZLV?$ZG;3P(LZX27Y'#XD:Q;BT<$<2*2HM@TQ9WCMUZI7! MC"U?PX[FJTG\+)*ZN#[YYQ"?E%^T X\=XMMR@]%*VTF#&0BR..H:L^/VK@25 M-7>ZTYH8=&+W=^H!TLVNQC,LE$[ X-44KDFUC@-IP#.>>A)>WSC#,TT4"*^G M$80=Q/SG#&3-DZ9[+[NG"D'TZR/+^QS]'L76FTTD,6\PT.6IF+ M0]A28)3""IU/IZ#-.<"2 HA2:0:JL1FG92DDV8UC1*K*A8]M3=C.DVSP SN:T%:\AS^3N MG9 ^F;;EMQ\[MWRZ_;"WU0 015/D9NSR5#O@R>:H8$?J)7LF$AFG$F(MU73@ MX1;J+3F$I,8 N21N#:Q!<5Z1 M'@OVE*FK,G+6S?)6O3:DJ$W4PC%7[.'9@S( G%E8^/^%?V$^;1\J+)52 MVE'^TEC-8D=,QA/7>]31)5 #.8-2KV(D,&:"_D+-?6Y\5X?\4%!%1 MKN)X=:?C5/[H\_C%Y)5/L"*C?#YBN9GFB%FC,'8$)((JJUXP1B\K-N,:6 MPMMG+DHL<6TZ)I',]1]+52U?GZI:!IC]AZ/-'\L_1G\_SV9'2TMW;W;T;N/O MT^W\?/?\4S13J:K-UN3T8#'\]B4Z7OORV(5"T&EI=V-4?.U_VS]^*12JE'"M M#P_W_.Y@,5WZE9UY+KDJ=0I'G?G%\^&G=EB$SS97I9;AZP^_<[0S^'(2G,], MKDHSM;!7$UBM[CF2$0ON,C/MSY4E!D!$S: #O.$74&-/$::L& RLIN*#(.V! M/=A)TF&"?D$:)&G/B\.);@")E#L0!J=2%FR82ADC#R'U37P/8(VZ;'=8'-)H M/>%@')<+F_X&O00ZI>CB>P)!EWH&2X2('$ Q')KD2G*G8'R[CN)QS_.ADL+ M]6*:MJ%,.'-=)T_M>JJ9%WDC3"6, HUX3^+(,>3JS!N3AD#TD5YV888A +<$ ME&31ZE!Q3OC1"HM:EAD%C+HCPFF\7EK?65A%Y;(%B2$N. R_EG>V(==1PR%+P#BE-6 (766.$4X#5,S%AJD]3FHX@M&X!BK88.BJ,0W M>()J3H, M;M]D;#*>D)I-)8).<\.O9I5EU]]4MU0P )L!6IZI484I!2_PK=61UVT?%_K" M14BEOAA**C/D8'W$#.A=(Q:8+?"3(0AZ3TTF@&A7)D9*H'-MTX)SUF%$A5(H MV:)2;%D3?$^3+9M8][VWI0"SFR3"8F X2VMEO\&4IL596%[>M'?)L!E9=S/T M%UI\VOI3(6CR!!1$\ )L'2TA_FD92W["AAV1G/9DO*JG4A'!] MJ<6SJ0X!?<]ZEM-ES9VS#RFL$%"%4ZN_^.66 5Z_+<9Q,T4?N! ) )CD)J6G M.?;\+.@;$RVJ=%JS/,QI%';&O-*4PF:?!^W -UIK C"*YXR[=62:64*#677 M==!QUY(QX,+SK).&ZHT-J%\+8[L=H1=CU2*::(UQ4C2X#9RI)$,SYM>G*%89 MI0!CQK\A.XG(.8%VB%@8%198MW#363?A>O?-LG7_6>I^"KDPK1L4&C/RJ"B1 MK>)8!(=IB"/QOF!,( \"EAU\KX02@P\*3)7S*1RIRPN)7OCY6_@UW/JBM97 M[S%\;H_M4-B\$P!7*B4!9'?J%B/ZV ROI,4_Y8_'N+OJ&%DR8J$\Y>,[UISL M/T.[-[D$RPOYI;*0]\.?12='M MO90K5C+YN7FIR>>'WLJ*:!W\Y_??4X.=\?IRK-- >VU)G]_&G0R3S/.44U\,X2RFYXD)WH(EB^XDL+^K?((2", M421F6'?BN\;@>L5_SI,>1;T\*EJ/>X ,CY2]^=I8H=H%MRVRS\2'R?.8;L*\J.F5;9%($&WV=QY0][^'I M@OWNE1>GG1U MP)6A7\J+52("@'7C51%L3NM@,/I&K('E\^IA?S9>+;ZVT>=65P*;-XZ1C E& MBZSVILPG5W46*K55]6QHPM)39D4+3<,0"\:)Q?@!AUCJ!XWO D S(AP!^JX# M-=5!&FH]:WGQ1T++6<\1O@L0"1XF8--0E M Z:TAD,V"(+%, 6,=I%".N5PAUK)Y=<-=?.D%#%RU]!%AP\A-IHS,!*Y,CL8 M20=Z;3ZR>L(FW(!I>'P^/;RA.>=PQL60NXJ\4;Y@ZE][N+G":"QT#95H+Z>M M!KJ$(3=*'EF4,H0ZLT,(4H&L&)Z?3(GJPX_F*4+,\T59+6"H9G3 M+&^@NRC#I1,#FFSF%?R>GK(ZCP63IE'* %C4F7@(@W0X$7>BK]5&K[S&PT>G MOA07O87PZ/2(JUJ]_UP1MH6C60J&OKZ%',AZE67!RPP''VL/ MN5A?_TDAV=77%-*07GKN+4.WB=PUO*#0'ZGKI0+4UTL%3:@88Q";AP;IM3D# M.U_0)%U,JKR^)3-$-1#XS:$-".D#R;2S1Q)7)*KC L9@1TW="T!9\! MK3X"]%O>0>'V%%%&G6BBW'1E0%V?1O?9J)H8FNI!H[8&F%Z-CCI;.1?.<-E[ M;)F/N.WT;)@)\A?@=46?%TZ!W+NDDG@XCVK." 6(.R!H1 8(VO9+C/'NDYQ^ M$_C8SXX_!ES9FK>JZJ9-$0-3?= -,VAZB.B1!F6@=X(.9 12.G1+"TUE.BXN MX1S5#XNTUHL+?^!O%I;_:$I1.+:.F87SKK3]EEAM-3BNBK&*$!>3CRYI=]OG MM74!^M'&DALH$Q,R-]2D3IUZO>/P"X21@BXNDY!!B"1.XD^%^D38L8,RZPOK MKR_.BWL_QR#^RNW"N[_XR%\W-S[/U E MZ7F $_OT8NXS,--?#Z!?%3.W!'JFHN%7!\#O-8UJ%#=&\=1^'P?=__M]3YD# M<*>^F5]0_YLG^//"XANHR0G4?3Q4K\_30FGT6.F;__N]$W3_"\X:YZ-/P68X M50_; B+TW_%"""\OWBPLS2\M_>Y<$?-;+76;=]^\F?KUUN3#VZVU+XOAT8>S MY;M>(:Q9JWJU3AVC:![OGWQH[&UNGQX>GS0V/^TT3HYVM_:ZB(;XB+;DU7(]198W7%E>WK9DVE][%P>?NP]GN#+L!K.N @Y,B/2KHUE="9E M%B89=7T21=)C;-55Z"?*E"6<&-"!VG43RP:_3-I+#Z/""=4"#3':VW;$A>UK MS!%!L"]W^F"\DJ"BTS8=LR\U-B-$+&Z:)7W1*/JM^%%5C\4)1$QX,G4FYQ1YL8B=Q52#BC7\4_QK1?5F001PV97$&K3T2\4^P @@,6'%LW?-(CM#D( MZYKI1B1IRD4VT@ND)T$9]# HCSTK/*N6IXJ!5ZL7 0L)(_\D M-3AMAR2K:+:T@_<8A+O4OL' >NI4Y7UN/Z^%Q@\&24]-HP\7!B^4D_BR6,.[ MB=+-V+!$O\7T@^ >"9KJ$:%_YMEY"D^9:[R31@TR(Y*BS"ZCX3@E5L@()81.XN$P\_=WSD^]2X@E%[]@FJ\LE,[WVJW.=VD$KK#%]UU>GEJK!AZ1 S;+>^YX^_D,PW T/G.?: M!D*_C:V+AMH1KG01Y=($M&V@4!_@&S&T?)=J4)A238[$137 6P(/^W(11LK& M_4 YM5$)&19X9K^P]':Y@X5)J#@Y7"]>@L)EU#%'\WURIZTNU3BI0:6YR=E) M/@G2.?W?/SO'!;/_5N/"SVRCA?)B52J1@]V?FYQ!?!H]HE- M@4.O]FN__^?Q1A$%W9Q_ T5[\)9Y^$S=L-1&;ZRN;:B=SOU['F&-*JN.ZO>_ MT.:H0WG6-99R %/B+%[1F^F5!?-TTZFV1V>EIM/R$S3&0:G/[#5SQA!&EN ^ M36H[.$HT'XH%.2UQ$"W/^@&GG13"^::48TDXXZKLQ/54J50%9)-VGT(@.?L5'( M-/72O)&.LNE4#(@3TP48>"S_31=.(KSZS<.?REM4$JY=7TDXWYJ<[QY/%OM; MW_>_=YYG)>'J'2L)%Y6'-3D[/MC+WW]^/UN5A%! ^K98^CM//ZUZ:X]<2;C9 MFJP>G7W=73_8W_SZ*SV:9@?5<*N.=(NCA;<'P]/V:.W.F>-9 4+<0R7A5FNR M?7IPOKNX^//'YO.M)%2*/-^=;)UY\P?C].D5$M+_S%5L%BV7U/^&XPY@*Y.= M3TD&N_3&Z7UC_)GI-H/CU1#OGNT3+1CSX]KJ/LW[$J1/.13Y$>=*V-N'*VE<9">A=*BA-7!L M]+M9"6):>08/\.?*AT0/L\E=?M\$",.-E2[AJ'HYLC8G92>0OS#?@9)4BN:U MH;,"<9HB*'U:L^9,5VFA4PLA-F8> 0+ 8! 6 ZQ-,RR&E)Y$^J*#$(,-6=U0 MZ@HAF%11O\D0(YIGGO8!4J&>Z'6@QA#3_'":]3N\\H1I&1%7E 7 ;)>3<$! M,XP[)I]*G^%>SADR)<'$I85WE6@&& A#]0 APPNQ(X4]9W1N9#Y-R#@G(VPF MA%T->$*F>07$4U%373$;JP6%7BC/K'[(7)3#-(G5+SK8NKGAS,HC"]C!#X8!.I^&JCBXA%773,4BF+94XOV 7[ :#5)F&F#K-84! M0C-6QU[I0ZMW[(1^8B^L'V2T'(8%#_N+6]^U"@1MQ],;0; ;]Y.6@;-[) X1J63:I"=\.>\B M. HNR%^XB]=+=_'"K>[B\A!:DX_=I9_#P;>5CYMWII6Y_=5+PT",WHS>K#)"0H01Z$L6HX+^A(:!4*@.]Y,: M>1/K)N%:S71!*JQU$;.!H6X+I@0&FZ13N?16"7V,Z+:3X$!A5!:%ONMF%&F M:E>@P?7]KK#@$/D^Z!B[GRHG+ WURYR%-8?!.Q4WPT"(/ZC27R)I.7>I0OQKN5%ATH!PV#*9,9:I/ *2O6[ MP0N NQ_[L7&_8"9."B!XW"&.>%7Z/^FFH)?7\,H-P7GDHXB5I9,HH M\-1-HCU'*2RW;RIS9,L4<*G+KU1K:?4.:@.IGEO56MOC6EM; MHM/P;N0>M B%HC&-1?DAQ2"H@Z9.25)<%3KBCRA%H5Y)GJ8,QE#]NJ]O>_$YH>S!D'$+R<6=+9'%5>-* MZ$ FT/($5P%=O"(+:@,.-7(E[4AQU.(RQMASC^)/R,]IUL?"V!OF1.;T=%K) M0;A"PF=CN7>XKA]@#@,$#G5UNJ5*]W&5B@57%3/&,.[2F88G(GEH-"8^6ITF M$6_5-Q(CFU2BD"QB(VBPH+%2J! ;2I$1N>;;L.$%LSE8=,DP1%-5Y03A@=) M::H.:W(NS9*$JJ"7S!NHF2@XS>J#*6 [^#L##,TS JA[5DE) */YG$[0OZ4 M8_:[?,((\O,+$?NE7ZO#KAU':Q*>G@T^K<:?-Y8>L5I3QM+@P"BZ'"P#<,O9 M+@AUTJQ)NH!;=N:RR#H):2E9@: KNM58\,L!GU>C@AELLG),1U#V>6"*Y@_ MI\3DR]S)G$O$8ZQ];"^;2KS=?K-$(T[$O)Q%C(20+"%%NR9-LEN MHEI#6=YL!'PPB=*:8 A:, ZIDAK/FG3,!E_$[BE"PBV\4B3C L^S6P.S*" J M$$6Y$1=PR=E:V6&>-_WGK ]:]$86#XPW951ZF4LI0+>IPY\-R#,('! *>B" MJ>5RC/$>X%L1*P[%LN1Z5M" MXD9#:1=J-%3@V4T]TML%\P@1@Q'UTBA,EVLKO3E6RF6@GA3$%V&:"".2TI+J M]?![HV\1T.E12U[U!U>O<'-S?ER3.P)W@4.=8@7H0& $ +)9":*+E5W8-' 5 M>_!-QRY5H\D#>:\$"#KEAS9ODLY5,@.L6?Q[9!'@[ZE0OM12(F'\I M+,,FR9G%U;,YH)P(!3C4'6/,3HO<;;4F1Q>'&QM9L.NO/U#D[A9)HXT;-0Y\ M?[D8K?Q<63OZO/$\DT;K=TP:;;0FEQL_E[9_C'IOX]E*&BVV)BN?O963S;<_ MY[?NB]'ZIDDC]?*H]['X&GS/#KYX3SLO\NA)HY769.WK(,B'X=*2U+%^'GHK&\\V:;37FHPG[>WAX4%\%F\\T(F^O] +WDO:M?PE M\/O":HF,>7GO5M&7:4-I34[/DZW/X?'ZIX.%QPO 4.&9\;IG" VO@S#(0 D& M78EDJ=JYW8DB:/S1E3R;XI,I8PV6RB>D-:5'(%LC54=84I:[_7+(WP572:A+ M2[%?=D&TVZ.CON+4,@!Q2D39(9!F2MD:4EL]#.OM!MF(WG\045*/ETRY@2'5 M^*E M&#GWFY$O($I<>B;Q@/RQ.MUAAQ9>^0I)W(,N2MZ%(5$C D6)G-':V3XCTWVB MI^R'V3#23YJ^+/9RL'O-)5W@MU^P\]\8)/#E8F#C(&6F.V'6"8<1\O!X?I_\ M%X2.RZP?2F@P.?QX/^\>7P?@1>P/P8!IZ-+-VS91B_3R= MTGU"B4&7]-B&T8(ZB8-1/1NTUM.59]N7A3 0N. "+!(V!Z=*_5,"W?FU3_B3$6::472;2S$24C-10;@5.U FXR0XM(G:+R M'*:M]DZ3Y&;],@A*AE6VK+P?0%=9,T#S]"NZ3SY)M5=D;WJ>-VSM 2/^/F*J M[Z,P::V'JN[6O&RL?'M'8QA$U:$BS5Z*T9S<\ M<+ 1TPN+T-ZKK:+)*RU4LA=NTQ<&P2F#>%R^0.PEN"_E2\>@ND&_F*:"=''A M.'19;3N1G@-LOL-Q>H"*N3_L/LPN X" MCF/?^3#>Y97B;W/%E =[HV$**0*E_Y #VGIGAL/ TG'*WTS[' S(9B:I*8G1 MEZ3XANJ_3I];>A"7I.,D ]"S. 1#^]$/(2,'.PZXW&14^CZ/@6FECZF7NQI* M#SPCC]Z(:HH_050TU' U!L2*TGG8.Q.+?U)I*XZ#"+I=2--Q@4^*V2"90Y>0 MK%*;9KA>&+'IS!$7O$H?Z=\&)O M%[E%$-JEP H.P\+]ZM%H/AW3(QI[XE*7TBXQV;S!O@M(.Q/WZ!\U1PJSGD-* MKFMZ=9R<[I)"X] GG+8"Q3<(_"'OMS*,W@KSPJO+]S<1-UGKFS^1?VE:& L M'.^\[BH<"PP&O%A46IX%&Q'P$"EH(@.)QLS9+;>5D(M++S&+&,V*NS4MKQC: M3P$)49,4,<)V!]PKS'JDUBN])/'=X$+3N@XY2IQ(@V?3-D$0_IK]W'<7"-D( MG+)?S4?XP@?^HC=F6F]L W5-;ND-_D6]WK )]6]D/M==_P8HAR:#*)4P%B,& MK/PP(J3\6-_Z_W%;TCM 8FQG!):Q%.V80_J4V,&7YV]48[Z6;$X^;42]2[_W M/.%"&W>$"ZVU)E^^QUL'Y_,G1R>]F8(+K;8F_=6PO;/[.4F_/12X8-K+E]2Z MG?:65K_LC!?ZJT\;$?/H<*'-UN3\TAM_>__I[&SEB6.IG@I+%E*Z:*>;?0X^'RY^[#X4W?]#LH.[*9^QU4 5Z8[-K0T0%(?^*2^RN4;) MCC EKWA7>U6X/);K0"BGQZQ_9.,C,?UQBGED)ADCY,IOS% M#G^QPQ_2#C^"L/&%K=^66^/,\9%X"W8Q1C.935NW.1NX@#IP;*Q2W6N MPDQHC).A(+"&^$[+ME9NGG2 9_@V MXQ>J,INP0+@L30I\#(JZ/ !*:#-F#%1/EB'*QE)B%2^%IR8,Y,;Q*#=5? D" MO"B?&5<^QS8EK%$_SJ_K%1"?$HWZN9&C;U'GT0LR!H,DG2#PF0T/\QY0?IEK ML2"Y]2A07C (YSPEQ3!RRE_ M\%.^4Z2F;/0CI17'I22_!66!^YGH:; J/3CG>G+/A]?0B=4'W*-(/5SHNA2< M,Y=CA"U3Y7*8D9$A?VJ\;5/G1J5V$'[1S*R$)7V*2CH"- 3!<&%;& MQ@N1"+]NFH%AYGF@7)'"="NEN".7=',Y;_5]GL'&(?;< !A8[6@:*-$_35-; M#*\9!2"X &CFUDJ)7]!S9\SF$,L2KRQ\(=!653>6T)KY"X3NY'6 M]ACAHLDEX.X!1["B%&+8+3]-/TA]?N&/IGZ>W&;ZCRM_S#7>*?,3Z50E$XV M<)=O;,K%I18)Q(#J=!W3US:L6;I2V71MBR.H-+>,7>EZ C3^5@ /:(.+C,06P8_VZM'Q6"Q(+:0_U!W"_F^U^0X>$RR " M(R! RT^NA E)(![!N]ER"U#!9G7K5X RQ/[_*IP+YIKV M) EX8Z08D;50#5$'44!? =KRU/R1F\L[X!.8-[ZWLIIZ,SQDFK8.LMY/5#T6 MN0H3#,G&6W+1#="XXK[MV$D^TT0#(DGZ 4B\@57F6"=.U%%14$+M@IHPRV\G M=XM4.5SRLG+W =?H$)-?B =QRPXW>W7= V6KDS2"OUB!3] <4#\D$ZQ>J_YLSI/]64M9E^!EBI!;0+D1MA)9>' M4/@N0L-\1O<^N8"03(A=TMF_@J'(F@C.#@J>VL#K#UM7$#GD%36 3M/G+)-# M*FX1(RC.2&T*)XEN@*,UJY)][ >#(5Q6YQGPA@2]L65"UAF+^AE9T0$".S@A MU0OA)>;RXHW-N#=VH+F#+.R%U'[>N.I XB>,)TZ@BA>_I4X1OD!Y!H$F'Y/G M6P?_2(A7\#,+"W\")AAYM@)BX]GG!UFU&T+$]CAQD5O *Q:NAUL=.:#+:.=RY7LR_;H[69@EY<7'WNC[\+)R=JA]\3[BS\ZO&*C-1FN=7\L+::#C;,[=T)\1O"*O=8D M.#]?'0R_?3U=BIXMOF*W-1F-LW9O=.:M+_T*9NEQV%@.P']\"ZF,>R@375PK M]Z];NE6-_/3!M":;/R]VE_RDB#8>L2,X#JB!(YJ]&M&W4M33Y.@! EB,0 MT3"0,@I\,)%P.2-L_ZZW' N^FU-"+WB^ A 89FZ&)A UB#=A)S(TMC1I8KCW MD)>?VME#"]X+3XVUR#27+T:ZG.BHW6R0.6@QL&D:R37K3A!3>JN!4H7-N%E' M9Z%#9"+-?.;JQ)/(;-4IR"0P3K3!!5)^Z)H?-1/*T='K3"4BKXJ+&;1YK>&0 M]U*+N;@T)1.S;MI=((%]5=EX^8,P43Q$O^Q2&X5RJ)8.D%N76DMI[>543SQ% M89A"*>&M#IW6]?9!-<)9YL5B= ?\Z+"F6+U,]6.GW'36"\36:0ZBQ M9^"@'4RYB&!A78X[#0*0*X-RZ]+::=^BG,-L758R*9B@7:?O7A&$TI,\WA7) M3DXR:E@'[3AB)92X!6[^ 4T;;PJ0M-TD-8DG:>SJ";A+S"FM MB)0GQ;UD0@JU2RE]FM M(G>G !9Z(@ K=A(3?@ 5"3=5,^<>[UGB*C2*M*R]*FVH)T&:2*J)UL1N]FP; MNM086C-(:$J!$DL S9"MK^GI>AP^O9"(,U#=P!6H<;X9])D=9$Y,&:_/Q3^G MT/SP7ZN$D+ESVWHKF3\A VG/M+2P 7>VU=:.A6$N%9'U)0-^E)Y[J2DSD/DQ<1_"#R+=DLI>P;<"MD]G[1WW5JA*9PH_Y+ M$S2KKDQ'&.:PG6*M46>(5'= M$'$[$9)HREM;#AX>YNX2S!K=3SMY%6\HHA,D8FS(4[<:S12K6BDY7+K$%R) MW*:QCV%E,[IZP\B-&PX "4O+ 3'+'@"/+?"8#5SM>%E?^2K)B!H@(\22UOIG M$:;DVC4M#!P1\)0@D!:]#T XF^BBQ#WE'B*6U03T.!@!$#(P"F'I8&OA9Q.# M;$H$&QL;450(X#'T 'Z%UR,-S%5C8(M;*MEVIA(K\TG%F07"LIV$520Q,P0!5CDE0U@7(EX$ZM0X;$:)%=-^UFSB1Y M2G!KIU5AJ4FRARA=+TTPMAL.2+GK_$R*7:1)MQUYF:ZP-+]GM]N7V)RNJG < MU'(ZT4+.EP+-DBBU6CZ7OZQKO=RJ*">1"W(4L+N,9XJR1>5G.=G:6BY.BKI[ M2)0)0.Q0&7 >A+JS/I:347"E6T @]DDRE4N#!NI#";&W[+"[ R2?&$4\-=WL M[PY(65HH-PA:OEW3AAL/KC4Y[ZR]_;[T;33YZQ],4U8VS8@YP1 MR(I3ZDGZ .T(4LAZ9KDU,VYK8_]*>@_+D0TNU;&A>U*Z'%AJ1_KZHCGB75)N M!+2*O-TZ3HFT:J5SA:&Q;.0-W1ZY4(0I[>MUG- 9('=^<,*UW%:(6J?*1TT! M4 E@/<(+"-O$&KIFKXW9'?@0X!(,IH-J'"BJW[VNQH++;:3PJEP30S2:EEUN M!Y:EB;*>OU,6:F4K*3NJE!\G,7B?&2F3TNS:7)6XT]?]7V6&*@?T5N MU] TE2Y_@![B_-O&T9L&/J6WTY_1G7FAYG^I*9FAFA*WP?)U]5UL^\9D[8U%#CU L\G*\7H[7PQVO< "ANT ."H>@VD$^ M"@*KF9%UL]'U.[3C7_V?O2YO39KJTO\^OH%)S5R5O$3^L-IY[)E5X MC1-O,5Z2?*$$$B ;)"()V_#KWSY++Q(";QA#S$S-W(X-4JO5??HLU[DN:*@W MT\\&S1%UVT,N<+4W5GOC[]D;AW:\%99!8"A[M= M'^T'I^MV[6N_^WYY4LKUT5&_7?U]Y=:Z&XVE@>&>)!$ B )ZV1<>=BC7(BJHR2LR>$%XU\VN8R$Q<,^!D;AACQO4Z6[M@26N&CD2[,F\ M!:;JO 0$M@$^Z$&>!T!3/ R";&'3+W<_(*H0NU"?A4W&4EXZ>&7-\6,SU4[VM"D 1I:^S:5(-D ME"-JG3"Q,Z'%^!$E1(-E4#S@,I5 WXX_"":MD(_N[2>":O<4) ,>2B7!E;H+ MB:%&49>X>(FSA-E>FHX]D!RMM!UCV.LI$XA$++7 S5Z!)G8D_-M Y1%LX);3A'+-RR&Z-O"$1&;C,O\N'<+D%I .+_[:*%!4 PBPD 9A/Q MZ .\J;HR W\U#,L-.\1NB3I CL%#8-H\M]@U( =5Q/Z MBW^ =00XMV,2'"6URQ6'@G&7I'&+P:?$V(QV["2#9RAWG7XF8R)B;TQNK<^\ M*6*K0EPKOE+B9XTX$,2VD83^ZD21)-\6AE,!]E&HN)7Y IA2U#A2 *_=&P"C MN8M$U7!SH)J1!-?CQ@1XHQDU+HXMYQ9Z@>4@Q+M.L&FKC%3:I4 "VHITJW!M M=UL>5MM^K^H>VY)SMD[P%Q<1RWAFA8ZF=PD-,HQ&X%LH^"0B>MECPF8G M;2CB V"T\4&**1GB/ C..]IGVL+:PT6"O+Q9/" KHS@Z<8RU)@,L16;T&\4 V2D M6"ILENK&E,U5@\Q#=-DQ.R"?-+;')'>U\OV6X)B%2I51'%-+"7H89N4#F @BQZ$;Y2NMSB?D, MX''SFZ4<2%*D][MI#P0XSAT7_PC !=-:(ZA64Q-Y'K0JL0\LB5@\J$V)W^/' MR#^"1@[Y'G"2%;4,'M2?K>@SD:^-$W28K]E$K(M34>TG>&1ZV(NQAY6$':BA MM0QO\7_=&&I?G Q38@SA]F8Q'/+PP+/4/9'SRF0C$LCI>$GG1!2N>"?8#S9 MA4T!147MF+HI^.34H%5SW\>"-X/HCWSKAA37R65#\TFA_' MBWQ>::B%Y&!1GH.5+&4>($I^B04$%G[]'I@41F+BXO.$1U_2A5FJB&YV4DAU#7,$LN!'Q<(0^B4I@!\:+6JI1%5L M/S$\APO!?T4T[J(@E3;)*8^M2*":5LB F+L /&"/)R2;N;.H&(F;(-T]@,20 MENK@F11'G\N!*BIE4;!MI]]4[C9;W=;47N5?8IMI_'MI;]+RDB\S\2:A4Y"? M\@UI7DH/EY>VZJ.MV^WU8>WF\/=F^WV6EXK/+"_MUD>-X5EX=+O=+!TUEZV\ M='?^LWQ4V#[V!_,N+^W51Y5?UR=[I7RIO[XJ+XWQJ6\<'6W\MKL[]N E!#SO MI;RT41^=55J#R][]]M%9_CW7ES:#=O77G_U1?ZNP-/4E<#C&,W$#SV(7!_UX M(YA38"8S62?])IGAL1WTGE1N^C'^J6>K\L-8!DW)B6D/1%U*C!;'N!39H9H6 M\^+NS\?WQ8Q7\6(4@6$R6DI49U((*5[2]);2,CJ4HJ8 MG((R!IS6=FNI])-25>M8LDO98;9%:,"-":R:NMO@)S+:U<)DFQ3T!2=?:^!Z M1@8GC3 TDMG]M/2WZH>**UB-Y #"#$5[EAVQB]. M=&ET[..XGY&/K468);KPJ10?>PZ4Z-M[A>"&7XY%T MR 4=[30Z,7!R54&B79)3N*)# B=VW$A*"RV,3KE16/ M]&DFRX,T]36*G.1C26NOW]J$#QBATS8PXGG#R756884[(E:)9!S\V4&Z!=0/ M(@8?^4R8&,M29S@\"\F5H2]*A%3#],<:RH<*'!;TH'-(JSQE/@Z\KB1=;,5+ M*<5<[A]Y7=)-;_I4NN7+?LIP12MQU_CM4 )CVGT*#]X'(Q-QKGH73):RX$HP M'N%^-F")&&1EX*:U?:30E:NT$$P:S?PA7[[HM1Z<#5,,[C \11+3[(&6"U)C$2THB:6]83"L_7$PK MU4>VN_'GM'!_51SFWV;_6ISI9GP<#&M M7!]]^]:(*@?>>:%\_6Z+:6)';_^N?-O=J1;OMEY+U'KVSH[D[;9"F0Q!=U:E M3HSS6M$#_,M2ON 9=$#@$ZG&E0S OYP]"APBWA ^L9(P!+E9'9XI1F9R%1.8 MW'C2'6F@B/$4@C;NBH@%1>(9)GJF@S2G[E_6);[]A#GLSTAJ*IJ( M?16N:0/O0) )Q']""@8A2X9W D_/>$'-8;,;)Y@UX@UN8P"!8IRZ?F<80FX1 M9)?Q$O@I$P(FBSKF[["VP)^' $0LDF(Y8T-JD$LQF N"[.)2),(NDA,$?1P$ M'>.P^9#AO>9RNH!4Z^Y]TV'?>BQF3^*'341P,E.0%+J&29RT=L?R#.E!-;O; M\>P#AAW]OO#FH5ICW@'35D"W1=PHGAZ8Z\F_=X%5 M04QNEJ4,I RO%?I0EX>&&_B^2LK#9@U]%#6S:3(F/;VT)N9LRA SAIS.?+RT MSCYQ1*6@UIR3A+_!>P: JE@%T/ZCJJ0RFM "R8&NU0'$[;0'?$>(K0D274X&)JU7&)XA:%U/QFF)^W)MGS8YL)R@E0E,V^# MDDU@WSA./ZFUL@R;;BQ7%OBW8D9"Q@SSKF(*0">1DO5J'GUQ9["C>E)XW/ K._ )LS1(0O$PJFH1$W3,SC M)UC52GG9%V_J'VF4/2>2D31<0\H8TV6L)BPF3.VD&:A/<5@OSBPSMT.YBANA M&),+)2LEJ&146(SM;]H*-@6D"*F?F\S"1[@GS\K#5EBER99@ YP:.IIC!CWF MZ4"\S7KOTWTH<-4><*'B@ L\#MJ4_R-C+$Z2 ?5+QI*C2>O,X S4VGG9D(P4 MIKHU>))TF#V4HYZ2SB6O#)0WM2M*/J2P'6*! CR,_+R8HO?8EHPG8E&IQX?' MPB.2?$]+-J\^UOUW[AT%COC-O=TY&9]=+RS^WN]4F[M M1M9B3\Y"I"/%A'4*5MGI%(N_G<*[34=6ZB/G>-,K58]NFV'EE7;T["3.&!0S M$T6S4F4]H6BV^21%LXECJ8_.CD]+^[7!T9'W[!ZDIPN8I0&&EE&LK$>@+^TM M&QWT9A/%]I7XTXJ$=GE(:,<;Z\<;;%3S45PQC2A/ MJ,\!,HZ:K9G@RRN*\]7>6.J]H9@+D&G(!"FA/'H,BFZ3R#!R 1 PE#NM5KM@ MM0O^MET@BU^PS(4'R=Q]ANPT-PAR$E_V'.IBUVI3K#;%W[$I,.Y67$J0@N:3 M@!HQ95-*P'VJK>Z@*=LZ5YM@M0F6>A,\K&P9;Q=-G!(Q_ @;I)(7MZ0(Q&2>6YB#[,L,$*G2@5U49_MFYTW*ADLB= M[CXI=YHVC/JH>GWDURSW6_G;_+*F,)*,'LJ2)$QQU :<0C;#JV9VU4M+),\( MIKCK,&A*L5/@-"#0AR-B[#!""(CMM"Q@S?:)"T/W-DI.;PWZX0,C?E\-)N'V M?TF[@X05\4N&YC4)X$'#EGPO\D'7,E>,0Y[4Y!DF)D;S;2IZ&MSF 5P%-WT< M5N!C9RKTB/(L@.+ZT]36->&,I*"1X&D)!HN&?>JSCV$" D"1W0"> -EK?.1, M5GR[CC!,'G>=TQ097U[+;#&SB?C+D-JN[WR>Q/C1WC _J'D[L/,=&!#X?GB? M$#KT$<";17;FL=GE#JXF=S!KPFZ)*P66FRYYW&N9,[/QE'K!U1= =3$8 %N) M1N%D$-C45F T-?E-;!R5I!0/ TW@>1-#)VH&_"73;1+5!;PV0,J)_>>@E5<# M6,L<('6)9LF$I6X0MRHZ N.J)L!;(T,!X^:VQ$-ZD4$Y(9\5X=7 T\F\]9R\ MVO%M^_-> +BE*P 6U:( =M*9@_3-\&JAD1R.! O1MP("HW1X@*%7#X7P\P9 M5]/,OY]B\/WL-)S+9$R/:F,&@ OWUXVO'&(,%8NMZXXDQ$N2RXK=XX@=:.LF M[QAV; UI5,9I1J0-# <- , 3!I?QF;,'5LVPIDD]!-M,-27I%Q3CR_,/Z6(I M<4@7GE;@?-3 ZJ-N\Z9X=?;[^M!^-O#@&=5.28PC&;KD\#15SI*KSI ]@QU)_B0%.@[08,I,%V1.AI387#0'J? MW@K[7HJZ+8K=2?H8:G7B2_"[&5>[#GBN!Q$5*7W%+0%K4I]TC!#W6EV26-:4 M0/VNY7FRD0'QXL.LZDGG9C#D-(-><#D,D^S)9/;@NFW2"8X $94R/1K+ WPPF<5 E5 M&XYF>;JI5:G%1&N:[I+;Z.EQ\(#5,PC-^+['['U&TQ@L"<,T$#(6?0+DKL+5 MT"$%#W&[\8B"CW./?$/QZ2ZB:&GH*N0&111M\*BKP92*$6:-":+,;K/7T9IX M DQVXV&8['I]=/JCU[OZM5/^=G#]/F&RZ\^$R6Z(N=NZO;BX+WX]_;Y<7?N% M^BC,-[;O=PJ'-X67-,X_$R9[_=T=1)6MTMV=N]A(T+G#9+>%M_I]_R#WX_CP MZJ"UV).S$##94GU4/*CN7E_D_?O-FW<+DRW71S\W?][M6]'W\N%+-M5\8+(' M3.-[)GRBF6!ER^O)4/)I6-GI ZJ/?O5KS?U^^:?;?C8EPM-#2#FH#(QJZ6&S M1N;%2A Y4_8%XIYXWH228!R1C7^#'3[X 5JB,QVWW0%& .(M%,8*-1_=6Z83 M592L83PNC3NF,D2--:>'V7AXJM3%QFB:\$^+G,W9-IX#]L'SM]Q&+K'EJD_: M M&2R4.H>A6==BO)$'+S&5K'F"_ ?M?4B\"(T%"S2EM!.)[\KDH)J5T1.#X M05N$U",R -@X[H )21"0TSU)Z4PK[ZE[,^$7 P MUUI/["-F S:,1GU*9JDLLZXB=ICGW&E]W2&T8P->#M+-7HRN@4F\LV0B#1D[ MI]?OD*BUQ][&1^JN3O"S:\X,MHW;>^?;GYBZ>XP>\]%7J>UN?R(#8CR%YCE% MTP!.#\D%!YB^D_5EKAC2P[@BVHHS.8$1$[] OG+ZD8^*@<=\59[LXU"5S"S< MZ$9$/U)3FS*DJN1I4;TY7!,O?&!S'='0-[X#^<4V\MR+=S6(@&.&\ORR@,FK MD,7"M7^7.HD %X:A4\E8_/19)ECAULAMOP3[BM+B9F&5Y!3I&9DO %<#"4[# M$E :V5)4@#.Z_&>5RI6\[F*F3.5)7=E/]Z8!AG0OUX/$6/#"C?PVX@04A^PV M+$+@E8>_:ZI?=>HEA,5QR'CFQ[Z8,03 Y4/18I-\!I(2:@(+LR_A4:0$SOQO MJ8+@AJNOJL.)FZ)[$-@DTA,+6C3E<5Q9-?8T:XF'T\*GL./-Z0"5YGNQN(G6 M6$X!;F#Z/1()64VJ74NZM=KNGIQI1?> \12K36CE#S,9W7*68T?HG%)WF#7< ML?@1D1WS9P>>%$#GM8K-!,G?PBLT?I=F6&+U ;P+VIE/I"B04=8O\2X!C@E# M4;Q/N/YQ$%,%ZC^"@0U(N;-E\&RQTFJ2!]XX,"Q]_XX%CF$D=EZM8P5)Y(Z! M1ODH-XZE)0O$AD*@#9X8R%W^*1/77&5%%$2<1K"6I9NN@3"& 5O+5*&RU7>G>WK6IQJ>J3^?JH[_7\B["R>_K!\<]JZL@_5W6Y_(NT\7U9QB8?B_H%VA^@$4S+G&DB,F5IUQJ,*":H#D;B<]J*S6N:- MW'(9;1M!ISIL6 _2X%KC[*K$!,"K IG11?Z,0U2YXAI/&,$DKG M/A@/[82'!]YIX(AW(>:^IMRM9V>XU_/Y1(9[YVF-2B\;L=B6W\\+/W?O-_+# M9V_+9S0UL;0<84=YW+"BV%#'N)74X#-Z],N2.,=P$7<-/W$Z:?@$,DY&(/;5 M!)CT^"IJ6/%$K7I;EZBW56Q_U%Z$)6UU"1\.V_DT995S,P&%UQY=PBNSLC(K MKVQ6CGWO\_:@ARG"6R>S(S>6-C,UV"II)RIG"+W/3?7];*;G6!XE;]EGUEO5 M]G%#64W^/*DU>\++Q=]#8Q\FT"UH+:UBTXK!^Z5[6$P3EV"5C(]F@A]P!SX& M%XW)&(FA.;3;L7<6&G)CW=&8"!_TR;2)ZUG0@1A*^980:@@=OVMC-;?6H7X* M3UX; I '!S;,=(#6S&RVM1V*D8CTDONII]ADGT$O\HK9<2>)>HYES<6*]-W9 M5HYWUL@,O@OSD^0KG#Z:1[P,>&=))4E\H[K/VQ;!(%:?8L"H'L@.B0D! [FR MQ"M+_!=8XMH 7CNC8A_P\CBMP)_GZK@/&Q'Y=#D[THAB]5 L\;-5TK5\KB%J MN ^D)R1Y .H!:Q8$88/!;+/[!+>BLBL7YT@QCC5S8 R8,T]#6DI2 A-QB456 MK!VR" @^@+)0<2WAU89?;?AEW_"'DK?N$2%=PTF@]5#(CD$/M'.TEH[I[,CD M)@@-@H< RN1X7%^LU=;,GEG]I=7V6FVOOV)[$5[\TL>TX!D6"?16VY^I>MR\2&M7T#VR1.>:"CU.?7MM/^,%VT 30* ME4E:F:2_P"2I*HYC.SW2O4R:I0,--+RU I2FC76Q9..9A=2@&O:Y^)7C])*\ MG^C/$QA2FQ54[\WL4?T1[Y(E3I5DL3(]G6+AO?AQV,1$8HVT)7V8E6&$-7!# MB(\"())#",B^QN3^,EWK#A"1YC7CJ1J$6H*,H7L+>0I7F%99;J;L!N>+)B96 M5K9D94O^ EMR*O94Y/&2ZMMFUPI"V/:K+B@B[)8.!E+TI*R/R":EIA1_(VZK0OY"==):?;YTFAZTFX*-E#W1LBN0QE\L(9YU_,?-08 M4U0.)?(=S%_#""/AX?@#])%L/Q/ZGV)$F&8J-"&M:28Q">PZI#H49$2H,0@J M86<'VTM&0VO *L11\I6-)$-OM#J2:DXY\_O^G4<.B5FP 0Y=69D"XJJA!ID18IV' MQH P'VC6L%.Y-N$BZ5\WG\Q,Q5!R5(P,/+*>>"A@:PM\KGVA,>:V,QX V"Y^ M1U/(BOH_FV[N>O.7'=V\#G3P":CUS8=1ZQOU4?&P[1?M07FTN?$^4>N59Z+6 MQ=MNYO:')_N'7\^_+A>K5KD^^E9ICYJ7/^Z/MIKS1ZVWKW[O7/[<9XLZ M_J6H]:WZZ-+Z%C5[5SN_1\\F\'E'J/5*?;1Q^5! ML%EM_MX9E)8&M8X%%.1/MUT@5,>R9?RX/V!5%2N4JMFD(6&4%$\AXP.N,?S99S],7XVN%983)LU6%_1$7@&]BRRZ\,'RA2;%0JA\B07Z@5CQW#XLW!"P(L>+@ MPC8C'%F>,%(01+^(0V@ MPS! (SW],&A))?DXI6;$$B8KU1WR)VV-&22*C93&<&S)=V*"(9'3['BN<+\) M3,/,=59W&))Q[EDWU&:@OF&+@#U4N&AIIDFTFFP,$U<+.Z.:C)0)"ADA(P5" MJ#<]1,@R6?F%WG2GMF4+!0\@UO)R.!1Q5].WXK1=Y.^R@OA"$[B?>=V=X*A[-]SRG^_Q= MD2\G=L7>TQC=I@Y(A"T#]^ZHO+E>&LU1ZT,/"C+Z8E@9-:XEV25'P1K=X<@2 M#F[FVUI&!NCHZIMH=3B+ M.!GW@:89\+S4Q$OCHVH0(W8\0.N[JONIU'?3[$ M70$70O8V)[A%WRX-EY+2.,=*!=R3DS(TI".#FHE/J4U]AY1!9:D-5HL(\8>3 MA:"IB'-]9B90YT!_ M6?7L?22$H>S2[NV+?>A"LDNW_$2NVZ<-L3ZZZ'>WN\7>C7?_&ODJ(+Q5(U+4 M8CBTS_E-Q:T(YQV-DO-T&1SG,CG?51&R#B),'U/K"I-$PP*SVBX4/>$H!EH> M/2% K(0:9^;$9-3$T+Z]$W]ON4$8Z9X.L1]WQ++ <+B0RV]*]37))V8IGB(Q MLP[HR>"5R#40G[6@!1&]<8*!L,7D+Y$(S3 IHX3%;O4WTIH!!X;&8\6_+6X) M"84P1%#^$<#XL.U11>:8C).T??(6P%_ 2DW0!2.^SB1+C4'H0K)6$VCI+X(% MLAU631,W&4+$WL'B/IP7HX5DMJI=>-X!-HG^CW@RA7Q M.Q;(L&=)?,^R2?#%5J,2'MD@LJ$9,POF%T J4C*G14:3U9D"X1:*)692!2N) M>@R2Q M-L(21M3V?5N2+M'1D4U\20U#D9#C-101E"E>!,AF$;L-(6WF,CLZ M\ PK61MP%P&4J%YC_%J<[T'$$QMW))^CE]\=,K.KB!,Q34Y'4QY)42['J%CUB.%-$*0IT(N05BQ41_5TP2_$ MQ2R>&8/Y"EDKTC^'6D #4QS*X"Y5AVD/^C2HVIHNNP1=NSX"-^T'1IXZG4;# M"LT;T\LN \_:.1'464V6='1#TRAFC4=S^BYN67I@@F'B!?FJ0OE%E"M=@EN::PQ4.^.U/C>?B6Q#"Z M0_*AA!D!Z*X4G85_0G+$97,4.M(@T"@Y4#0M0MPFQYQ.IC,GK.%Q]3+[=JQJ MY=RC5)\V;HX'X<%5\["Z^3[KTYO/KT_7CH+^MV:S_+N\7/7I8GWTY^SNZG94 MW.X[C3G7IZOUT>_2^<;P1[5[<6$O=@EV[O7I3;$A?U9N#V]+.QO;J_KTP_5I ML9HJM]4[.RHT?];>K^K33GUT%MP,-\L'S7[ME:!1K^!H$)PU*YTWBA6@,( G MO)&<((J &!U*PAF,G;S3KWOKRBL#/3*B[XV&?3>2K?J+G.HX0L]GQPTY-H L M@N.##BG"KU^6XR@77J3&_.BQB9/@V'9_]$IA>6>.$C\TOHP>(*4WC"$N4U[C MO).@(]*ZPZTN4 9*G>*S@8A6+'S6BYM !)>.F4# 0).\;NB:%_N(]UEK$!"( M7'F]((>KF:G%)83+$V+7GYI0))G682S3-_$5)L5FNMPBSJ@'0B['Q4&IJ%;\ M$:BWX4<9C4$DJZ1Y5(21E4"-L:!<1-Y]Z\XSB?/E'*)6A\-8>@IE0-Z$2(&B FY/11T^_:,G5T!YV0_M@%18@5#3"0"5K$AL!]SL,& MV+)('#OA)\I^2Q #AEY.T $&='%X837):^OLD93#-=:(Y=F*$D9R6DT):ZBT M15\34PKCR@Q+("H[4<%Q2*Q]WA[XV<2A;I MTS$.]MH^PI-4[*M::V46]5/6B)-A17(:DNGY6RB*,\#N"L?B8KQ,+@$'I]K2 M=W[0M;,0&P]$K/L?QQ.+Q9>"R^+;5ABA0AVDC'P1>$<97C"3,Q16@$4%X^K( M1]A5LM9D#['E)1!_Q4Z9)@3U8B91WD),._T6-FH;.?2STBB(B>FBX@Y8&Y:^ MQA2-M$D3!F4@B2".@EM@QTV &UA.O4PZF0,=>!)4#@H+,*O&%ZGHY&+MH^]' MG+JDW[3$FW1(7CIP])>TCL/N(!#NA-@O%QYZN+RE=R]4DIPQ$KMF8NY(7!5M M GXK:XPY 8L39DQV$.BGZ5.)&:5.+(^ZD>3GH7#4T>8^07N0C5$@Z.QG7,HP M7N3F;,JM#V^)5KDJE4,B#.E3F#,_E'8"[XMC@^4#YF"V2X#I3%JNZ!>4JFRR:@WZ3QWL(1.'Z*4I M#84QV2E+%-66M*U(>05&)5+ZFQ8EFC 1CG3\,(L63NYGG-S&P&X[$0W(:;E- MU\@_H^1\EEG"C'R:\0;3WSEKPYCI+)G]5,:?E1#2C+_9/1;/M")Z5"LRC'W3 M<."%!0ACFC22GR?^*%+]!@NQ5I<@J;K3+S5[&\O9ILS 6D9'JEB541D+\UV:I):L; M$ET>_M @*$&3^:+D6/ >H&-#5!4AV"'46L0_6$UP)94")J]&^8Z(P/;9$-8/@2QBW3MK,-,7=H4X%#)PPTQXWK +2V$'WJH$\ MH\;91 !7X7ZH%[@M;)*EUE#,,*%UA!8GZ>.(X(YS6+:N*[NNPF'BMT8:F JBA7)R>5#: RB8A@85;:W+K: MHDE5SRX6$Y&IVL*9#(:I!E1VZAL[ I>TSD*LD671=R=B0O&IIF/87X\?F!P- M\^T2( 7K*#<.#UH,YA'$AW#[]Q)TZB-@ICCVT$7ZB(P.:2VG# 1N+QP M):(YOS#$BJ#K,%"U9;$PL9.9[4K\BQJUK18N4;SHY4N31\>_.BMM:.7);@AU'H>//K7-NFDVKC%$1M/ U"%5)_B#[1=5NJC3>_\L'=S M%NS==]ZZ[;*.MO"X_= L!KFA02=5:QFZ!F3YRS\&"5F MJB%X.JK5WI#\ZUIFCWTX2&P.0O9B"0DN_#.BUAK/49I3E/*B,)/<-=C5HTA& MBDV6 F:^+FYHM 7E86[GU?A'2(PQVE;%XO!W-Y*U9$-87=@E##92897ZR2"R MQN0#\TUV1;24-NTPLBX@4B&RD'='AA%1VPV ).%*I^PSC-ONO1QC%650PQ2R\L63CE(9, M!&FD( 1<]V.V))BILVD>BQ"5S6HJ>^2>BXY MT3%,)L(G?DW&F]@>'5)KB>8$B'&SQDM@EII)1;'^>#/(-XU%U=P%'Z21I#YK;DSLW3'M8 M6;G!1>HY;3]R98N_.OT @3[M[%.6.CYCRU!/O>JX78)<$ML(+Q*W&@S!S$6X_4CBFD ^@2G)SZ8 M50W4(0NP^PV0UH;T"G-[@G,2^'?B=8O+A6X8"9>#:0C/'#C:R3(UA]..79D> MC9^NV42AP3N&7K1!#:0)XAQ=B*6!%/6LBLC=8W$L/:Q"ZDZN3"3E&4/ MQO '-Y.5;99A:L=1(9;IO%@-X:8_B/]/!\S0":>8%?J!WW*[*F$>7]9Q^@92 M19)*3>!O9#KB_ZCDWG'B#,C:T8 CSZA]2ER+T<[$+1 RHXUO7[MGB2_$"[%F M==]L!QH?RX-MK2D#DWTQ:&'TP<'B2$JO2G[,J)48\'1N50UN4;(]";SSL0VA"KC,!F0P_UL!HJ1.5MQ2UQ"H%X=)8\)!R*88C(*4,WLW: MD75F=,%X%F'B84E\-]I#:PPE30Y<4-510Z,T&K/TQBCU6%2#+$S= \6W9_$M_\SBVWI]='$< MM<[/?P3-FKM4Q;>-^B@:_AGLYB]/?_2?#>9_9O5MLSZZ]6KYLWYI8[_37>P" MTYM4WVJ]XFC]YFJKLMASLQ#%MYWZZ/?/X\[OFX/<]:CU;HMOI?IHO7N_^7W[ MH/UCM[TTQ3?78_PDA2M&V*9/;(D0)'E7@AZI "AV?@.)%Y!&2@8AR7@:!V02 M=LDUX\"I85^6>NH-."1\%M/95"B"]],%QI X\YZZ$CAUD47(1O@:G@@@>6 M+3&UB"8.L:[4L+P;N%=S*/.'_'F$2:I<"&/.+7#G?4_?!]\)]@N1 M55XT^ M BA+ E.LB"9\F2!&GJ^)8$+9FA6GLQE7/PHG0JWU[RF"X"%D7X*#T^AR8WVG*^7,LY_SY<3EGV/H2F1Y/,V>>F&>F M^5_('/+L\DUGJG8,7;>JJ^$ IN\6FV2\%^6>*H67]08_:7SUD7WY]8?U\_+[ M[]H<&4[U&*DQ6/>&F,-9]2PS?X?"!(&GC,WP.;?"USZ+3= M4%XT,&^A;!8C5;!Z06=J\EZA_![8=,P/=2=>EO$/WL@$:@:!DF/+V,QBTQ65CK MXQO'4"-W. HC(!'#Z.*2= )4"?J?2B:4MF>9I[P^LW MM+E=0XJ H[&D_!60.0(QH6-_=F*X%250G!0[5IEFZ*E)70 @_REV>T! .2YA M 6S <6Z(QA#>+[(-\!M^S)M-/M$R['U5H4RI.>K3 ZR ZOZ*&VU4(--F6VD\ MR*5+J":VEU@PQ+?5-+VV*578\,;$1$![;=8:+$!.1A MH;R!D(RH0P6V1+X@-%IT;4V[8<5L::Z":]<=R 6N9JCE^E;#+LB\I/CDY MS\;G H/2-&<4&1W40()'Y+Q=HHG='B!G+9P:!A!,1:$\HJS&4=&<,9($DR5& MT8^Y= V59F[49.2B?# )>Z<_8D>Q,%JRT9 9:R0+"]+?ZA.0A09F;L&>4!8L M/EP6S(M@;G08V=??![5>XWV6!0O/+ MNUD?[N^?K@V#K=G"U;%7!_M[IZ?ZF M=Q+TYJV$N%T?>9>'![UJM._MOZ0D^3=6!;?JH^/=/_G?T?=N>V_%-/EP65!, MV.:?W^L[W^Z__SEIOMNRX([8T=T?V_TM;[=]=?WT=?.@Q1VWM]/V_BP%;F;B M99>36D];3U2U2?&R2]^"D]')EK]S.E$^IFH,(/:D#*K[-9K)@K4.!@X22(E6SW%PS>FFA.& M 41G:'":RDHB$HC0+U6)#SMNR O-IDI>6<\H;"]R%'W(=?*7;>_UI&C5TZ"W MXX.HCX+]SOG%;>>WW2W.;W?+@2S3YE:9**96$O'3 &-"65;T[%!J@TA\Z@!B M*PF1P,*JD?WI#P*@; DA/H/MD28SNR:Y.^6,2?Y.!F:(#:DNTW,LCRT.*LDU MAD:UP6JWH0H>21(?HC;S7#^(8UE9D8#"38@G'5ON:Q5#]KN#,'%1\5A^5UP6 MN :I^FIQ*AV>1W8[C&_=I,YJ QH 4P6U(A^S?&C#,#X7UTMM*R]2E*X?4\V_ M>CK(+O?[@7^/C%CB118*_Z2.+W'3+O9%NT[XN(=!TXDM%&)K\VQ#0C!9^HZG M"70!.SF%:YG3U%OH*^/1$<]//WPS5$0S[VAJJKW:=IK3;E5O1ZX"6[&MB7D8 M(.D7G&*81H%)! MD0+DA]F,3?9#L$>*$'1,?%LC1A1:"D(BL^M CA, ')@U=[@Y ).$"BF!Z\]$ M3N@&(7JDGEC2L29@,PW9 QH#([N5,K4+^-IE8Q0V*FG!VJES3AE7TSUB35"E M,8 \S(R,7W9N!=V7+T/8ILQD2X\)-\IM)').Z:Y,8?^$ZJ.[>4DEBKJ^GE>90 MX1VOL>W;KU"&H:9W"JC_[T/N0P;$O\*^U10C5?_N@^_-_W[JC8T@_E^^S^X7/S3!TBG_6\4//'R'S@+%]E/'M<45Y'&0A-<^&*M10%:E_^@K5N8*([^=VULBQN*G,-D MC@'V09IG'RM]RC4CC*WX)L1* 800[(9,FE[N4X9J25;.S+8]EH,&/X/,?&C(13$SE6E "1>\YUN' M$SZVJPDKT_6IY!J%"E#]T<4JZZ>)]L /L'N6*$60I"0^)3FS8=&XTDZ/ M!O,.0/ !LK,QG*GG.%'".-&3,8]P^J!P&M$MH-S$ '(PT*E 4^L1&FIL M;KQ3$M?B,PO&N?KH=.]\9W!TWOO6LA>O8CRQNE2HCZ+J]_5^>["?+\VY7+Q1 M'S5^Y_.W%V>_3W^_I%;]-Y:+=^JC7_?Y8O^NVO[Z:U4N?KA*-BLVW?&A=@!RV6'PT M?&9_T:A]G1WD- 1!Q%+.5,Y(('=3"PGQPZ:4MZ0 U#5#I?E&.T1O:0J$(8XEK+B MKNS!>3 W#F%YB_MX.3R-K'M5;U[+:%).[IM3-7"(!IT>WG7,O$6Q-FT/-36A M; P;U&..6+UVU8N0S1,X#A06XK#^I8\9+P'(%JO)?'*Q]A#ZE".;4L!6 76H M&:[#56.O=U5E6%49EJO*4.,"Z9GDG#7\@CWW7BS\,W K$L6(D,*:I4X2_Z_[ MY:"KZ 2$/_\%0!B FF$SYH.+AHP79#=D9XPP'-0Z*5.=1#8\-$4(-99DRB0F MVA:?(=)0C*O02;_^%=M%RLP'COVYB!=JO9/,<^RY^\Y$Z2&)0G\Z#I@ MRW%$SYYU>CJ8+YA[U=TC#@J7I.6(3.5V<#C:GC*I'F6(N8T.W MH]6*^ RSN>@C;R CM&SL?<$KYZO2V/ -QGD-Y:M;R^S0L/$"-& *,/'DO!,? M!U.@D)Z67/&N9]X3O@+P$OSJD/8)KCKQ#GVQ4=I*N,(6K]]?$^1 $B6(',(F0!,F1G4KL&NR^PZ*0:AHD1K()%0Z5E[0 MR@OZ:[R@8Q\);1EXP2V>;&%1]Q(6IQN"@)'A#P!=E$??C)-7X1Y6?S443(?C MFQ4,!"/X&!,&(J/,:$_@/S?0BD82"&@[S-5%:%!I2)K# M1?)OS<'36^WPU0Y_TQV.R_YMPIPGE+?+CZ))CKZNM[9^_2FUJ\7W6=XN/;.\ MG:^/;@J-_K>JM>5=.HM7WI[.YUTZN'1')^U6H7PS?YKDG5[Q,'?\N[LU'QW. M\;)U9KQL_5^O5[;>K8\N3JJ'%\?E0?7J+9Y8UZ(SR5KT?\VM%KTA%MWZ_=7I M\>G1KPWWW=:B*_71_F'A5]'=<*Y:S^ZU>SU&X\=$I=M4Y6"LL=,?!"*^"\GS M=;\8OQ@O39HD)-3JB:PB$OZ:#L[3ON9X-85[9-+E_,:E?F%*E:Z8W&4H_J]2FQ(&*G@YY"[I1CJ#&F M"G15+2[1Z4A^-^25C9!.1U@MW:#3MEPO9" E!RL6X% M\6T'JCLH_!6%B2(= M)E@S;7%M#XO!V>1ZPZ')FU@A4MI)V3SS4@QTI=R;@K@B3"&^2/O H@3F&RR M&ZO)T4).664S7<>I=WC:.A;NDR-[3L$-SNQ1>(>O2_K'D)IS;<5Q!F!@BD==VXN-+^!I4AF8_[#GY<@8NP!3BN+ M^ASLXQNUG1#R[O^"$I>#A,IN:E(>4Z6:LAM2_).OC*L42 =T31F3V["#[6S* M]J8R-'Z\YWIN;]"328%8U99N2\G62?>.PY!YBFC<7+H%:(]%RLQ3IB[M!JH; M,39W*;!K#:?O@5YB**X;MJAIEJ)\@$9WF516+ 3 VYB9&S[" J?KW ('8*(N M+_6,Z(NP![!')B9$*N\9)=(]$T=J[%&X(B+3[S3S.,]15BJ4"M^.=/MHXDGH M-X3V2UNVF8-T+1ID%.L;2K4F1.4[EL?:UO@Z$P_(PYLZ87(2VL)@.:1L$.L9 MC+4TN*&"8W *'V<,#(?7YCP8C,PGR36)B3#Q$VN9JX3M'8?KF[Y$J@FVY)," MX$)= !][J+>#@O[@Y/(.$-ZKV!R1VY9JK-1$BA48*%>P?"CD\J9L>2($Y4'( MU"' FO!%6B#310@K<0D",6E@O5XA\OU((G@8R5JF*J^K'L2R[0!Z^K&5Q#Q: MM+@Q'S+J8>(W$F\*D4P$@ZK&ULF0W[G-9"(PWJNLYI334!63J,JC;VQH M>4E@6 C\*3;8(AHT%>P28[(-MGP]''&>"SM/IO2!-W1'*5T1-#J4M]4+&9MO M$>^";R5 4M' [*2?;))5L49\S./+8)*34"D2(=9T@^:@!Z(;S57E9)577>Z\ MJDJFQA.LIO?(I13NQHQ5)R2@CT/#A>TD7;47+GA[H7;:9]E.R-ZNL:YIH;X0 MU*T W<9UG@OJ3@_JX7G#L:=%:@ST'E&U1[$#QYX;W 8^TK4R5#9MT\@X1&(_ M'@7/CC/R,%9[#N7&)U1!2J(]NCL[\V_SOX<_;N>A2SJ7@ M,NUY!Z?E0>N\>7CQPLE^267%[/+[KU>MK*S71^?-MOWS)MSJG]^\V\K*7GUT M^?.TN?['[GX/7TO\=14CK6*D5V7R4<[XODZ="0^($LV9JM3" F]V'&I,@CJ< MH]X3BQ*R@AQ$O5GBE=*LV#S'I(=&X*4RERI%J<6!I#J8GHAGIV%EP,!N^Z3< M93(%^?24/& U9#4Z-!?Q]-3'_"=LCD%@@*L0 ]#,_ 2*7P5!X>W[ ML? )6A= H$UE'XF]V>_>&A1,W$4<2C"V?\WJ9%U0Y+,E%9QEJ&KC#^H">-%8 M>K.5*:T5"_]DJ22 L /FDZ.$I@1=Q'1]4@ZAC_!,0/ MHO@TY==R^<=-5(P%"M-!=/Z8\Y4R3^IT5Z02G&,B72]VX8QD]>LJ-,YT$WI)V=@@92>XEI^ZA6I20GR* M#[RX./,DP#V]2CWS5D/,#Z4#WL=2UX51U@//6 M37,6Y(BQZHN_SO^;SXG-Q#^7Q8_PS_(_>#_Q)[FZ< +B'>+Z^>63P[QUAGU8 MP&CL,BVW/5 Y6DYIFZ5A8>;0K[U5CS'U^K G A>R8F@9$DV2YE]CK,<)S$XH M,3:XX&B9:3$O+""'*:SH\/8?0X0^A= NS0!^?KX%M,:8-2,$A:7Q:_*H)Y// M8W%[F@.'3#=ZR])-3!(:9;&2-#0/7EK6*Z7/K6%2DQ>.ERSFDO*F>R>] MN:2W]]3[373H$AFG<>_ND8FLI/M!"5]Q8ZMYTPZ$2V##S?U .&CMQL="KI0M M%"O90KG\*=TW?.1M8[[,Y]Q:GEPQGKK/X(:!@\:_YDDDQ-*5$SS#1PY'ON)_9OI$:^";_Z2$(C,=^<=\;@GG^],_J[6\6LMC:[F\A-.]6LJKI3P^\F4T MRJN%O%K(8R-?1I.\6LBKA3PV\J7TD\=6LDHUO')(?M5Q(V>.!$7)7#Z7K]?AISS0/]0GR*O2FZY%?O,FE/*J7W\>_;X\/E[?J>6? M@\]Z8,YF;+@^LL#M7D $IZ8F;?H4?7B2".[X!'W($&P.%&ZC__$&/=N/ &C0 ML[H?,OQ#^'\?#H[WQ.P)6R)&\QF0?>+IQ4\?,@//I5L#3,;76KF%4BZ_^>%+ MOK16SDL57_E4LS++F8N5N9B%N:@FS,5O)_!G:"F:WXNA>WEIM?J;?X6E M,*9GD8U$7C@5:^7*RDBLC,1K&(G3[LQ=BC]5KW^TWG>^%1N+;R@>MA.)&7HC M6S'-1!0^?"FM53;_"A.QLA!O;2%**19BMBF*&[OC>A>-WN'67V,@WCQ!,W)Z%AI>27SPA7T!ASN@S#E61GR0:/!!M= MWW)C(,W,1T1R$SA=7)-X;J"%!4#F7>"*B)R@YWH:VQE9]X00'D/49CYJ@OU) MV-I/+ K1MX8$ZY6 9Q)ZL)U&)-O&#/TK^F,2O_@)L9$#;^Q>;ZCAN_%PRWV^ M/BKD;WYTMZZO#BN=]]ESO_[,GONM^JA?;CN_W?/\CZ]+U7)?J(_"HK7G-W[G M^KW7XEF=(E1K6Z/:;1 -J[L;?TW+_72.XV-K=/*G?W6])%Y#@6V^7H M^N#VY-OO7XW[TKOMQ!?+O_;[OK;_[<=/*[> ',<3UICL1IG>=:).7__. UX] M0X-0G-BUW>U,(":*VR,(1D]-)4SSIKX/6E8^DK+>P,F/.K9 "J0Z.WD\U$T$ MLHC7_C#FH:QE]K ]Q )=TBRV(."=DD2\T'?P3Z(?FS^IAL3NA:NH>7$B2&Q1 M\U*),2LN*K_5 @H@\="Z(T)L6:/Q]:Z$+FR()K(/4Q_ WXJF=")/S8H=5'U;M\J?3KIA:&[>=:M(EJX6GN(--!R)YP.3Y8 M+C3"C!HB'62+0Z0\P;ZFB!LIF^1X;8M;_BREC:Q$%6-:RG<=9#Q&+M9[$=Z[ MU#_O0N-I [9['^>)+]*S0#8NDH$:"#@S)2>)"WK&;81%!^5JX<%W(632O&I= M'3@9_88FG]U0C<6>/!@\+2Q)I93]./,[-> M[,;$?6=\!EA;N_Z=8B+4?^)S3]S*)9.**H)K1/?-C;G9%]\DI?--JT>FW%]^ M8VQ-Q&<*F\"-68(7T^LY-I GZ"GC:UGM=N @5:_F8G0#.0[7L/]\=<69"S00 M+@AH18ID4(Y('513AT7,D/+]39H?/9B[CA-Q;S')-GC8=:O_!5\40.T[Z)FPXQ-2H=HZZPHTGELF= M- 7QN9 BJG?0 3]F%6BA$.,&7D#OU\2:D==1.W2A9!HF&4O4CQ/3BC; 0O-#6W;M=Y M#:F-V?D[G#^&V3/U#TC^ 'R0Y[L[Y5S"W=E[DKOSR)'51^ZNOU]M[A_ZWUOS M\W8>I1RQ+,Z.7/P=T)ZW_3YVDY.[/C0)SH5A(KZ#F-ZPS/YN^58@=IW8+)S! MC>>7.40;VZ__G5O+EPU3"C_]&8C#P@DF,;_.7\Y%J;A@[S\2D82A)%G"L\J. M/2Z3#S]=V@7=+/-*YOPK!EI-EL&,PT0U\Q*]EV0&G?B@=52N.)PZIL*SC&N9 M]PM#/]1>"3-#R,5D4"3:C.^EO&=<&]E@AC#MOW$S,PE@Q>=:1; R5Z'9/C ) M$XK7@$D ?-WB[ 7"*DI(P+=:+I3!\#5EB )B1RP1L"VT[XKY; 8,9^P=VLGR M":WD]1S.N;G(LPF^&O&I7$$75.XLH$5Q>KCEQJ;;<(Q@<^)]>7- !28V@N0K M'M]M8ID(Q^[;P'/HR0KB1 UA(0O$K^LN-)$HF>6K6Z!O(#,1;C"2Q.KWIA5 M>>.45$'3H;,2'@[64N1&@VC:5%"5RY7#=:S$=L&TCZ+$:%@A:0CAIK$"#]D! M8QPNZI^F$P*L/&.7I@%81,^3-@[)L\[4(O#HZE&3KXK$JUT?[!\/UG8O6^>G6^U7QS-5'E?[A=G!8JX4; MC5?:>[,+2 ^=MAMV<:F\+/SV4S7>$*.-!W/(B8Y\/B)X=>#3"@Y\UIM4C*1&5[= M6L:<,52[:@^,JU,0BQ^_PQP1^^(ZAHA"I]O*X #QFZ3VX@A#IMRRJGTK0HQ M)BS[P)3,(Z+P+%1*(\Y=I@TAF<>T;,9P\.GXB5U(^<-'="DQ /?.@S]Z5#$- M+/*D.?Z>=FET,DD];5RC,Z&TTD#Z;2S+4M$P44[5I;SG.Y@/>EGC.^+5TEYG M3M>%F3SQQ.!NW:9S&OB0+0C"EQF=2O%%);['#$N<[>7^:&/DY?U^>7XV2 X- MHA4>7$:-;IFLD@JH$5N \(!!GT,P$;NCH\($C"$_9U\]I]@@_!FE=-<:>%@D MB4D!$MK1T7_,*-T\2$2U \HFC6U$OZ\P F !6JXGQ@(U56-D:YD]R^T. DR\ M@1%(#I/DIH( *1Z)!KS1!;U'&<]K.Y=>SP=:)@1=+,Y+O M';-A0+@IA@M3Q&9.)@)Y:/2JD?F!P<56,0 M @U^"CGM:\_3(A09K% Y"S"I*0EI\WE ^+T&ST!BSC CQ@ED19$(*L-_ MXP,2MAM5<7TM'1$.P\CIA5G*@?MB="1;Z3G1G1_<8 G:=N":28S?Y%D=$+>W M_,.40^M?--7RG\AB'JH)"%"Q#\FG.>/?[PQ# &N $F!@*74(XR+BO? 3T6C# M01\"AD>,>BU#*YUG+F-A50?IT]5BP-09".W&32<+GH]/!.IO*&?:)0& \:'$ M:MM**H->-(/N7"]]V>D#G[")_S+@43KH8IAXKUB5',Y5$1>$,!IU%DB(!U6U M?4+^P6+A3]+KTE=&GZ';Q&!G_!4?5R__S=RZ/I]X&-GT^UWQ\F";0:7;:@X- MJORN=2>NSL&(#]ST)-;9%U%=%["IL(/Z@TBM$ZMGM1WXI=MK#,3\4M"ASGVQ MF!TOI+.XZ8>1N#BW@E@ZU828*7)2\3,)F7NQWP>)SX/>#IRZ*4;")/*F(Y @ M.EC9'P30:D/*E/*"V713HS1;>+F0-DY(FULA=5-"4(R]8DYE')B25BH0ER%% M [X)X$L!RXK05E9P4R>M7;':_*'CA%7//FG--H[<+"=89!R2&:<6O#)725>8*8)P<9#*G' MHCV2KMO#J _EU^!!P6%I@C^&!X4&QL?\&'%EO!M7.O%X$*-J C!#_'K@":,& MAU=KT$WY;.8CFL@L(3; 3*)?9LGS%GX_\ "]Y_&MR;3;/!S=@,@+84J?UJ:? M__FUN&N?!L]VV:=GTI]0;MU\5#]AJ=FLWMU9P^KE.^TGK#RSW%JNCWY5SO:O M[[]>M8PVL64HM^[51S\&OW+#WLVV:]ES+K?NUD?>MYT_^]O[O?:-]1[*K>*) M2P/?_AG=W?OYMU M7HARJ[".)^7KFM6]LFKWS7=;;BW51XU2I]>\.]S<..@L M34,A^"?6#1RL*6X*=" $=.IZ2N0>#&#;1_#^(7D8+,,)P0Z?O(C,DRY#FOC; MF!>3S2BB@"PF52&%C5Z%14$6Y! XU #$EG!S1@XZ!>PSBN$CWD[$I*RBB>7! M1*CFQ/S,]$C?A01*'X%VV!H'M -A$^.I6";'"&UDM$8SH=T/$6%S%ISR#X'K M#T(CV!?1?,]X]DVYJ4E<*53#%B)R)9+>X&H8Y$3$HY'419 M9JF^*5:%F2*!;T+:73[\4P<'M7"<#_+\6;T@%,+ M26KL&37X)0EPSY./4FT'CLZ9[3C-KA6H"AIZ65CRZTFI/1LSN@KU8+#$()88 M@/5*2U*+XX5D.B*?:%X:0T@W9LTK$R0<@"<0N(K_9E5HV]/;;ZZ.OU7F?OYB2P+YSY M[7X:'Q6WU1#-@X0'N62['%'Z* 4/0N]9[0_87(/J 1["^ "DUEL.T!YT)6E# M9-VK]+FL_LL),A+939H@<@=M
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�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grx_ncsr_htm.xml IDEA: XBRL DOCUMENT 0001391437 2023-01-01 2023-12-31 0001391437 grx:CommonStocksMember 2023-12-31 2023-12-31 0001391437 grx:CommonSharesMember 2023-12-31 0001391437 grx:SeriesACumulativePreferredStockMember 2023-12-31 0001391437 grx:SeriesACumulativePreferredStockMember 2022-12-31 0001391437 grx:SeriesACumulativePreferredStockMember 2021-12-31 0001391437 grx:SeriesACumulativePreferredStockMember 2020-12-31 0001391437 grx:SeriesACumulativePreferredStockMember 2019-12-31 0001391437 grx:SeriesACumulativePreferredStockMember 2023-01-01 2023-12-31 0001391437 grx:SeriesACumulativePreferredStockMember 2022-01-01 2022-12-31 0001391437 grx:SeriesACumulativePreferredStockMember 2021-01-01 2021-12-31 0001391437 grx:SeriesACumulativePreferredStockMember 2020-01-01 2020-12-31 0001391437 grx:SeriesACumulativePreferredStockMember 2019-01-01 2019-12-31 0001391437 grx:SeriesBCumulativePreferredStockMember 2023-12-31 0001391437 grx:SeriesBCumulativePreferredStockMember 2022-12-31 0001391437 grx:SeriesBCumulativePreferredStockMember 2021-12-31 0001391437 grx:SeriesBCumulativePreferredStockMember 2020-12-31 0001391437 grx:SeriesBCumulativePreferredStockMember 2019-12-31 0001391437 grx:SeriesBCumulativePreferredStockMember 2023-01-01 2023-12-31 0001391437 grx:SeriesBCumulativePreferredStockMember 2022-01-01 2022-12-31 0001391437 grx:SeriesBCumulativePreferredStockMember 2021-01-01 2021-12-31 0001391437 grx:SeriesBCumulativePreferredStockMember 2020-01-01 2020-12-31 0001391437 grx:SeriesBCumulativePreferredStockMember 2019-01-01 2019-12-31 0001391437 grx:SeriesCCumulativePreferredStockMember 2023-12-31 0001391437 grx:SeriesCCumulativePreferredStockMember 2022-12-31 0001391437 grx:SeriesCCumulativePreferredStockMember 2021-12-31 0001391437 grx:SeriesCCumulativePreferredStockMember 2020-12-31 0001391437 grx:SeriesCCumulativePreferredStockMember 2019-12-31 0001391437 grx:SeriesCCumulativePreferredStockMember 2023-01-01 2023-12-31 0001391437 grx:SeriesCCumulativePreferredStockMember 2022-01-01 2022-12-31 0001391437 grx:SeriesCCumulativePreferredStockMember 2021-01-01 2021-12-31 0001391437 grx:SeriesCCumulativePreferredStockMember 2020-01-01 2020-12-31 0001391437 grx:SeriesCCumulativePreferredStockMember 2019-01-01 2019-12-31 0001391437 grx:SeriesECumulativePreferredStockMember 2023-12-31 0001391437 grx:SeriesECumulativePreferredStockMember 2022-12-31 0001391437 grx:SeriesECumulativePreferredStockMember 2021-12-31 0001391437 grx:SeriesECumulativePreferredStockMember 2020-12-31 0001391437 grx:SeriesECumulativePreferredStockMember 2019-12-31 0001391437 grx:SeriesECumulativePreferredStockMember 2023-01-01 2023-12-31 0001391437 grx:SeriesECumulativePreferredStockMember 2022-01-01 2022-12-31 0001391437 grx:SeriesECumulativePreferredStockMember 2021-01-01 2021-12-31 0001391437 grx:SeriesECumulativePreferredStockMember 2020-01-01 2020-12-31 0001391437 grx:SeriesECumulativePreferredStockMember 2019-01-01 2019-12-31 0001391437 grx:SeriesGCumulativePreferredStockMember 2023-12-31 0001391437 grx:SeriesGCumulativePreferredStockMember 2022-12-31 0001391437 grx:SeriesGCumulativePreferredStockMember 2021-12-31 0001391437 grx:SeriesGCumulativePreferredStockMember 2020-12-31 0001391437 grx:SeriesGCumulativePreferredStockMember 2019-12-31 0001391437 grx:SeriesGCumulativePreferredStockMember 2023-01-01 2023-12-31 0001391437 grx:SeriesGCumulativePreferredStockMember 2022-01-01 2022-12-31 0001391437 grx:SeriesGCumulativePreferredStockMember 2021-01-01 2021-12-31 0001391437 grx:SeriesGCumulativePreferredStockMember 2020-01-01 2020-12-31 0001391437 grx:SeriesGCumulativePreferredStockMember 2019-01-01 2019-12-31 0001391437 grx:CumulativePreferredStocksMember 2023-01-01 2023-12-31 0001391437 grx:IndustryConcentrationRisksMember 2023-01-01 2023-12-31 0001391437 grx:LongTermObjectiveMember 2023-01-01 2023-12-31 0001391437 grx:TaxStatusMember 2023-01-01 2023-12-31 0001391437 grx:MarketValueAndNetAssetValueMember 2023-01-01 2023-12-31 0001391437 grx:EquityRiskMember 2023-01-01 2023-12-31 0001391437 grx:ForeignSecuritiesMember 2023-01-01 2023-12-31 0001391437 grx:EmergingMarketsMember 2023-01-01 2023-12-31 0001391437 grx:ValueInvestingRiskMember 2023-01-01 2023-12-31 0001391437 grx:SmallerCompaniesMember 2023-01-01 2023-12-31 0001391437 us-gaap:FixedIncomeSecuritiesMember 2023-01-01 2023-12-31 0001391437 grx:LowerGradeSecuritiesMember 2023-01-01 2023-12-31 0001391437 grx:SpecialRisksOfDerivativeTransactionsMember 2023-01-01 2023-12-31 0001391437 grx:FuturesTransactionsMember 2023-01-01 2023-12-31 0001391437 grx:SwapAgreementsMember 2023-01-01 2023-12-31 0001391437 grx:ForwardCurrencyExchangeContractsMember 2023-01-01 2023-12-31 0001391437 grx:InterestRateTransactionsMember 2023-01-01 2023-12-31 0001391437 grx:CounterpartyRiskMember 2023-01-01 2023-12-31 0001391437 grx:DoddFrankActRiskMember 2023-01-01 2023-12-31 0001391437 grx:SpecialRisksRelatedToFundInvestmentsInPreferredSecuritiesMember 2023-01-01 2023-12-31 0001391437 grx:SpecialRisksForHoldersOfSubscriptionRightsMember 2023-01-01 2023-12-31 0001391437 grx:ManagementRiskMember 2023-01-01 2023-12-31 0001391437 grx:PortfolioTurnoverMember 2023-01-01 2023-12-31 0001391437 grx:DependenceOnKeyPersonnelMember 2023-01-01 2023-12-31 0001391437 grx:CoronavirusCOVID19AndGlobalHealthEventRiskMember 2023-01-01 2023-12-31 0001391437 grx:MarketDisruptionAndGeopoliticalRiskMember 2023-01-01 2023-12-31 0001391437 grx:EconomicEventsAndMarketRiskMember 2023-01-01 2023-12-31 0001391437 grx:RegulationAndGovernmentInterventionRiskMember 2023-01-01 2023-12-31 0001391437 grx:InflationRiskMember 2023-01-01 2023-12-31 0001391437 grx:DeflationRiskMember 2023-01-01 2023-12-31 0001391437 grx:LeverageRiskMember 2023-01-01 2023-12-31 0001391437 grx:CommonStocksMember 2023-01-01 2023-12-31 0001391437 grx:PotentialDilutionInRightsOfferingsMember 2023-01-01 2023-12-31 0001391437 grx:CommonShareDistributionPolicyRiskMember 2023-01-01 2023-12-31 0001391437 grx:LegislationRiskMember 2023-01-01 2023-12-31 0001391437 grx:RelianceOnServiceProvidersRiskMember 2023-01-01 2023-12-31 0001391437 grx:CyberSecurityRiskMember 2023-01-01 2023-12-31 0001391437 grx:MisconductOfEmployeesAndOfServiceProvidersRiskMember 2023-01-01 2023-12-31 0001391437 grx:AntiTakeoverProvisionsOfTheFundsGoverningDocumentsMember 2023-01-01 2023-12-31 0001391437 grx:StatusAsARegulatedInvestmentCompanyMember 2023-01-01 2023-12-31 0001391437 grx:TemporaryInvestmentsMember 2023-01-01 2023-12-31 0001391437 grx:InvestmentRestrictionsMember 2023-01-01 2023-12-31 0001391437 grx:DividendsOnPreferredSharesNotIncludedMember 2023-01-01 2023-12-31 0001391437 grx:SeriesACumulativePreferredStockMember 2018-12-31 0001391437 grx:SeriesACumulativePreferredStockMember 2018-01-01 2018-12-31 0001391437 grx:SeriesACumulativePreferredStockMember 2017-01-01 2017-12-31 0001391437 grx:SeriesACumulativePreferredStockMember 2016-01-01 2016-12-31 0001391437 grx:SeriesACumulativePreferredStockMember 2015-01-01 2015-12-31 0001391437 grx:SeriesACumulativePreferredStockMember 2014-01-01 2014-12-31 0001391437 grx:SeriesACumulativePreferredStockMember 2017-12-31 0001391437 grx:SeriesACumulativePreferredStockMember 2016-12-31 0001391437 grx:SeriesACumulativePreferredStockMember 2015-12-31 0001391437 grx:SeriesACumulativePreferredStockMember 2014-12-31 0001391437 grx:SeriesBCumulativePreferredStockMember 2018-12-31 0001391437 grx:SeriesBCumulativePreferredStockMember 2017-12-31 0001391437 grx:SeriesBCumulativePreferredStockMember 2016-12-31 0001391437 grx:SeriesBCumulativePreferredStockMember 2015-12-31 0001391437 grx:SeriesBCumulativePreferredStockMember 2014-12-31 0001391437 grx:SeriesBCumulativePreferredStockMember 2018-01-01 2018-12-31 0001391437 grx:SeriesBCumulativePreferredStockMember 2017-01-01 2017-12-31 0001391437 grx:SeriesBCumulativePreferredStockMember 2016-01-01 2016-12-31 0001391437 grx:SeriesBCumulativePreferredStockMember 2015-01-01 2015-12-31 0001391437 grx:SeriesBCumulativePreferredStockMember 2014-01-01 2014-12-31 0001391437 grx:CommonStocksMember 2022-01-01 2022-03-31 0001391437 grx:CommonStocksMember 2022-04-01 2022-06-30 0001391437 grx:CommonStocksMember 2022-07-01 2022-09-30 0001391437 grx:CommonStocksMember 2022-10-01 2022-12-31 0001391437 grx:CommonStocksMember 2023-01-01 2023-03-31 0001391437 grx:CommonStocksMember 2023-04-01 2023-06-30 0001391437 grx:CommonStocksMember 2023-07-01 2023-09-30 0001391437 grx:CommonStocksMember 2023-10-01 2023-12-31 iso4217:USD shares iso4217:USD shares pure false 0001391437 N-CSR The Gabelli Healthcare & WellnessRx Trust 2023-12-31 15956278 11.58 30000000 1200000 25.00 25.86 114.03 37036000 1481000 25.00 26.03 114.03 40000000 40000000 2000000 2000000 20.00 20.00 20.00 20.00 85.99 141.08 40000000 40000000 40000000 4000000 4000000 4000000 10.00 10.00 10.00 10.00 10.00 10.00 44.66 61.16 42.99 13320000 1332000 10.00 10.00 44.66 6. Capital. The Fund is authorized to issue an unlimited number of shares of beneficial interest (par value $0.001). The Board has authorized the repurchase of its shares on the open market when the shares are trading on the NYSE at a discount of 10% or more (or such other percentage as the Board may determine from time to time) from the NAV of the shares. During the years ended December 31, 2023 and December 31, 2022, the Fund repurchased and retired 1,081,299 and 143,380 common shares in the open market at investments of $10,118,752 and $1,596,912, respectively, at average discounts of approximately 18.00% and 13.02% from its NAV. Transactions in shares of beneficial interest were as follows: <table cellpadding="0" cellspacing="0" style="font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"> <tr style="font-family: Arial, Helvetica, Sans-Serif; vertical-align: bottom"> <td style="font-family: Arial, Helvetica, Sans-Serif; text-indent: -0.125in; padding-left: 0.125in; padding-bottom: 1pt; text-align: left"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; font-weight: bold"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; font-weight: bold; text-align: center">Year Ended December 31, 2023</td> <td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">Year Ended December 31, 2022</td> <td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="font-family: Arial, Helvetica, Sans-Serif; vertical-align: bottom"> <td style="font-family: Arial, Helvetica, Sans-Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; font-weight: bold; text-align: center">Shares</td> <td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; font-weight: bold"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; font-weight: bold; text-align: center">Amount</td> <td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; font-weight: bold"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; font-weight: bold; text-align: center">Shares</td> <td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; font-weight: bold"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; font-weight: bold; text-align: center">Amount</td> <td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="font-family: Arial, Helvetica, Sans-Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Arial, Helvetica, Sans-Serif; text-indent: -0.125in; padding-left: 0.125in; width: 52%; text-align: left">Net decrease from repurchase of common shares</td> <td style="font-family: Arial, Helvetica, Sans-Serif; width: 1%"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif; width: 9%; text-align: right">(1,081,299</td> <td style="font-family: Arial, Helvetica, Sans-Serif; width: 1%; text-align: left">)</td> <td style="font-family: Arial, Helvetica, Sans-Serif; width: 1%"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif; width: 1%; text-align: left">$</td> <td style="font-family: Arial, Helvetica, Sans-Serif; width: 9%; text-align: right">(10,118,752</td> <td style="font-family: Arial, Helvetica, Sans-Serif; width: 1%; text-align: left">)</td> <td style="font-family: Arial, Helvetica, Sans-Serif; width: 1%"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif; width: 9%; text-align: right">(143,380</td> <td style="font-family: Arial, Helvetica, Sans-Serif; width: 1%; text-align: left">)</td> <td style="font-family: Arial, Helvetica, Sans-Serif; width: 1%"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif; width: 1%; text-align: left">$</td> <td style="font-family: Arial, Helvetica, Sans-Serif; width: 9%; text-align: right">(1,596,912</td> <td style="font-family: Arial, Helvetica, Sans-Serif; width: 1%; text-align: left">)</td></tr> </table> <p id="xdx_845_ecef--PreferredStockRestrictionsOtherTextBlock_hcef--RiskAxis__custom--CumulativePreferredStocksMember_zLyVozDoiQLl" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The Fund’s Declaration of Trust, as amended, authorizes the issuance of an unlimited number of shares of $0.001 par value Preferred Shares. The Preferred Shares are senior to the common shares and result in the financial leveraging of the common shares. Such leveraging tends to magnify both the risks and opportunities to common shareholders. Dividends on Preferred Shares are cumulative. The Fund is required by the 1940 Act and by the Statement of Preferences to meet certain asset coverage tests with respect to the Preferred Shares. If the Fund fails to meet these requirements and does not correct such failure, the Fund may be required to redeem, in part or in full, the Preferred Shares at their liquidation preference plus an amount equal to the accumulated and unpaid dividends whether or not declared on such shares in order to meet these requirements. Additionally, failure to meet the foregoing asset coverage requirements could restrict the Fund’s ability to pay dividends to common shareholders and could lead to sales of portfolio securities at inopportune times. The income received on the Fund’s assets may vary in a manner unrelated to the fixed rates, which could have either a beneficial or detrimental impact on net investment income and gains available to common shareholders. As of December 31, 2023 the Fund had an effective shelf registration authorizing the issuance of $200 million in common or preferred shares. On December 18, 2020, the Fund issued 2,000,000 shares of Series C 4.00% Cumulative Preferred Shares receiving $39,841,048 after the deduction of offering expenses of $158,952. The Series C Preferred had a liquidation value of $20 per share, an annual dividend rate of 4.00%, and was subject to mandatory redemption by the Fund on December 18, 2024. On December 26, 2022, 2,000,000 Shares of the Series C were put back to the Fund at their liquidation preference of $20 per share plus accrued and unpaid dividends. On October 15, 2021, the Fund issued 4,000,000 shares of Series E 4.00% Cumulative Preferred Shares receiving $39,875,000 after the deduction of actual offering expenses of $100,000. The Series E Preferred has a liquidation value of $10 per share and an annual dividend rate of 4.00%. The Series E Preferred Shares are callable at the Fund’s option at any time commencing on December 26, 2024 and thereafter. The Series E Preferred Shares are puttable on June 26, 2024. The Series E Preferred is subject to mandatory redemption by the Fund on December 26, 2025. At December 31, 2023, 4,000,000 shares of Series E Preferred were outstanding and accrued dividends amounted to $22,222. On January 18, 2023, and February 1, 2023, the Fund issued 2,100,000 shares and 295,500 shares, respectively, of Series G 5.20% Cumulative Preferred Shares receiving $23,755,000 after the deduction of actual offering expenses of $200,000. The Series G Preferred has a liquidation value of $10 per share and an annual dividend rate of 5.20%. The Series G Preferred Shares are puttable on June 26, 2024 and December 26, 2024. On December 26, 2023, 1,098,500 shares were put back to the Fund at their liquidation preference plus accumulated and unpaid dividends, leaving 1,297,000 shares. The Fund issued 35,000 shares on December 26, 2023, receiving $345,000 after the deduction of estimated offering expenses. The Series G Preferred is subject to mandatory redemption by the Fund on June 26, 2025. At December 31, 2023, 1,332,000 shares of Series G Preferred were outstanding and accrued dividends amounted to $9,620. <table cellpadding="0" cellspacing="0" style="font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"> <tr style="font-family: Arial, Helvetica, Sans-Serif; vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">Series</td> <td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">Issue Date</td> <td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">Authorized</td> <td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; font-weight: bold; text-align: center">Number of Shares Outstanding at 12/31/2023</td> <td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; font-weight: bold"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">Net Proceeds</td> <td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">2023 Dividend Rate Range</td> <td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">Dividend Rate at 12/31/2023</td> <td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">Accrued Dividends at 12/31/2023</td> <td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"> </td></tr> <tr style="font-family: Arial, Helvetica, Sans-Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_983_ecef--OutstandingSecurityTitleTextBlock_c20230101__20231231__cef--RiskAxis__custom--SeriesECumulativePreferredStockMember_zZtx3Z3UNKRk" style="font-family: Arial, Helvetica, Sans-Serif; text-indent: -0.125in; padding-left: 0.125in; width: 16%; text-align: left">E 4.000%</td> <td style="font-family: Arial, Helvetica, Sans-Serif; width: 1%"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif; width: 12%; text-align: center">October 15, 2021</td> <td style="font-family: Arial, Helvetica, Sans-Serif; width: 1%"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif; width: 1%"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"> </td> <td id="xdx_981_ecef--OutstandingSecurityAuthorizedShares_c20230101__20231231__cef--RiskAxis__custom--SeriesECumulativePreferredStockMember_zU90BuBHgy8l" style="font-family: Arial, Helvetica, Sans-Serif; width: 9%; text-align: right">4,000,000</td> <td style="font-family: Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif; width: 1%"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"> </td> <td id="xdx_982_ecef--OutstandingSecurityHeldShares_c20230101__20231231__cef--RiskAxis__custom--SeriesECumulativePreferredStockMember_z1W8osvYZa64" style="font-family: Arial, Helvetica, Sans-Serif; width: 9%; text-align: right">4,000,000</td> <td style="font-family: Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif; width: 1%"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif; width: 1%; text-align: left">$</td> <td style="font-family: Arial, Helvetica, Sans-Serif; width: 9%; text-align: right">39,875,000</td> <td style="font-family: Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif; width: 1%"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif; width: 9%; text-align: center">Fixed Rate</td> <td style="font-family: Arial, Helvetica, Sans-Serif; width: 1%"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif; width: 9%; text-align: right">4.000</td> <td style="font-family: Arial, Helvetica, Sans-Serif; width: 1%; text-align: left">%</td> <td style="font-family: Arial, Helvetica, Sans-Serif; width: 1%"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif; width: 1%; text-align: left">$</td> <td style="font-family: Arial, Helvetica, Sans-Serif; width: 9%; text-align: right">22,222</td> <td style="font-family: Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"> </td></tr> <tr style="font-family: Arial, Helvetica, Sans-Serif; vertical-align: bottom; background-color: White"> <td id="xdx_983_ecef--OutstandingSecurityTitleTextBlock_c20230101__20231231__cef--RiskAxis__custom--SeriesGCumulativePreferredStockMember_zL5E8O1nWzB9" style="font-family: Arial, Helvetica, Sans-Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left">G 5.200%</td> <td style="font-family: Arial, Helvetica, Sans-Serif"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: center">Various</td> <td style="font-family: Arial, Helvetica, Sans-Serif"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"> </td> <td id="xdx_982_ecef--OutstandingSecurityAuthorizedShares_c20230101__20231231__cef--RiskAxis__custom--SeriesGCumulativePreferredStockMember_zyq0J5kLkRN7" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">2,395,500</td> <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"> </td> <td id="xdx_981_ecef--OutstandingSecurityHeldShares_c20230101__20231231__cef--RiskAxis__custom--SeriesGCumulativePreferredStockMember_zreTAEmQHpb9" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">1,332,000</td> <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td> <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">23,755,000</td> <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: center">Fixed Rate</td> <td style="font-family: Arial, Helvetica, Sans-Serif"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">5.200</td> <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">%</td> <td style="font-family: Arial, Helvetica, Sans-Serif"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td> <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">9,620</td> <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"> </td></tr> </table> The holders of Preferred Shares generally are entitled to one vote per share held on each matter submitted to a vote of shareholders of the Fund and will vote together with holders of common stock as a single class. The holders of Preferred Shares voting together as a single class also have the right currently to elect two Trustees and under certain circumstances are entitled to elect a majority of the Board. In addition, the affirmative vote of a majority of the votes entitled to be cast by holders of all outstanding shares of the Preferred Shares, voting as a single class, will be required to approve any plan of reorganization adversely affecting the Preferred Shares, and the approval of two-thirds of each class, voting separately, of the Fund’s outstanding voting stock must approve the conversion of the Fund from a closed-end to an open-end investment company. The approval of a majority (as defined in the 1940 Act) of the outstanding Preferred Shares and a majority (as defined in the 1940 Act) of the Fund’s outstanding voting securities are required to approve certain other actions, including changes in the Fund’s investment objectives or fundamental investment policies. <p id="xdx_845_ecef--PreferredStockRestrictionsOtherTextBlock_hcef--RiskAxis__custom--CumulativePreferredStocksMember_zLyVozDoiQLl" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify">The Fund’s Declaration of Trust, as amended, authorizes the issuance of an unlimited number of shares of $0.001 par value Preferred Shares. The Preferred Shares are senior to the common shares and result in the financial leveraging of the common shares. Such leveraging tends to magnify both the risks and opportunities to common shareholders. Dividends on Preferred Shares are cumulative. The Fund is required by the 1940 Act and by the Statement of Preferences to meet certain asset coverage tests with respect to the Preferred Shares. If the Fund fails to meet these requirements and does not correct such failure, the Fund may be required to redeem, in part or in full, the Preferred Shares at their liquidation preference plus an amount equal to the accumulated and unpaid dividends whether or not declared on such shares in order to meet these requirements. Additionally, failure to meet the foregoing asset coverage requirements could restrict the Fund’s ability to pay dividends to common shareholders and could lead to sales of portfolio securities at inopportune times. The income received on the Fund’s assets may vary in a manner unrelated to the fixed rates, which could have either a beneficial or detrimental impact on net investment income and gains available to common shareholders. As of December 31, 2023 the Fund had an effective shelf registration authorizing the issuance of $200 million in common or preferred shares. On December 18, 2020, the Fund issued 2,000,000 shares of Series C 4.00% Cumulative Preferred Shares receiving $39,841,048 after the deduction of offering expenses of $158,952. The Series C Preferred had a liquidation value of $20 per share, an annual dividend rate of 4.00%, and was subject to mandatory redemption by the Fund on December 18, 2024. On December 26, 2022, 2,000,000 Shares of the Series C were put back to the Fund at their liquidation preference of $20 per share plus accrued and unpaid dividends. On October 15, 2021, the Fund issued 4,000,000 shares of Series E 4.00% Cumulative Preferred Shares receiving $39,875,000 after the deduction of actual offering expenses of $100,000. The Series E Preferred has a liquidation value of $10 per share and an annual dividend rate of 4.00%. The Series E Preferred Shares are callable at the Fund’s option at any time commencing on December 26, 2024 and thereafter. The Series E Preferred Shares are puttable on June 26, 2024. The Series E Preferred is subject to mandatory redemption by the Fund on December 26, 2025. At December 31, 2023, 4,000,000 shares of Series E Preferred were outstanding and accrued dividends amounted to $22,222. On January 18, 2023, and February 1, 2023, the Fund issued 2,100,000 shares and 295,500 shares, respectively, of Series G 5.20% Cumulative Preferred Shares receiving $23,755,000 after the deduction of actual offering expenses of $200,000. The Series G Preferred has a liquidation value of $10 per share and an annual dividend rate of 5.20%. The Series G Preferred Shares are puttable on June 26, 2024 and December 26, 2024. On December 26, 2023, 1,098,500 shares were put back to the Fund at their liquidation preference plus accumulated and unpaid dividends, leaving 1,297,000 shares. The Fund issued 35,000 shares on December 26, 2023, receiving $345,000 after the deduction of estimated offering expenses. The Series G Preferred is subject to mandatory redemption by the Fund on June 26, 2025. At December 31, 2023, 1,332,000 shares of Series G Preferred were outstanding and accrued dividends amounted to $9,620. <table cellpadding="0" cellspacing="0" style="font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"> <tr style="font-family: Arial, Helvetica, Sans-Serif; vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: left">Series</td> <td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">Issue Date</td> <td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">Authorized</td> <td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; font-weight: bold; text-align: center">Number of Shares Outstanding at 12/31/2023</td> <td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; font-weight: bold"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">Net Proceeds</td> <td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">2023 Dividend Rate Range</td> <td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">Dividend Rate at 12/31/2023</td> <td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">Accrued Dividends at 12/31/2023</td> <td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"> </td></tr> <tr style="font-family: Arial, Helvetica, Sans-Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_983_ecef--OutstandingSecurityTitleTextBlock_c20230101__20231231__cef--RiskAxis__custom--SeriesECumulativePreferredStockMember_zZtx3Z3UNKRk" style="font-family: Arial, Helvetica, Sans-Serif; text-indent: -0.125in; padding-left: 0.125in; width: 16%; text-align: left">E 4.000%</td> <td style="font-family: Arial, Helvetica, Sans-Serif; width: 1%"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif; width: 12%; text-align: center">October 15, 2021</td> <td style="font-family: Arial, Helvetica, Sans-Serif; width: 1%"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif; width: 1%"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"> </td> <td id="xdx_981_ecef--OutstandingSecurityAuthorizedShares_c20230101__20231231__cef--RiskAxis__custom--SeriesECumulativePreferredStockMember_zU90BuBHgy8l" style="font-family: Arial, Helvetica, Sans-Serif; width: 9%; text-align: right">4,000,000</td> <td style="font-family: Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif; width: 1%"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"> </td> <td id="xdx_982_ecef--OutstandingSecurityHeldShares_c20230101__20231231__cef--RiskAxis__custom--SeriesECumulativePreferredStockMember_z1W8osvYZa64" style="font-family: Arial, Helvetica, Sans-Serif; width: 9%; text-align: right">4,000,000</td> <td style="font-family: Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif; width: 1%"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif; width: 1%; text-align: left">$</td> <td style="font-family: Arial, Helvetica, Sans-Serif; width: 9%; text-align: right">39,875,000</td> <td style="font-family: Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif; width: 1%"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif; width: 9%; text-align: center">Fixed Rate</td> <td style="font-family: Arial, Helvetica, Sans-Serif; width: 1%"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif; width: 9%; text-align: right">4.000</td> <td style="font-family: Arial, Helvetica, Sans-Serif; width: 1%; text-align: left">%</td> <td style="font-family: Arial, Helvetica, Sans-Serif; width: 1%"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif; width: 1%; text-align: left">$</td> <td style="font-family: Arial, Helvetica, Sans-Serif; width: 9%; text-align: right">22,222</td> <td style="font-family: Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"> </td></tr> <tr style="font-family: Arial, Helvetica, Sans-Serif; vertical-align: bottom; background-color: White"> <td id="xdx_983_ecef--OutstandingSecurityTitleTextBlock_c20230101__20231231__cef--RiskAxis__custom--SeriesGCumulativePreferredStockMember_zL5E8O1nWzB9" style="font-family: Arial, Helvetica, Sans-Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left">G 5.200%</td> <td style="font-family: Arial, Helvetica, Sans-Serif"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: center">Various</td> <td style="font-family: Arial, Helvetica, Sans-Serif"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"> </td> <td id="xdx_982_ecef--OutstandingSecurityAuthorizedShares_c20230101__20231231__cef--RiskAxis__custom--SeriesGCumulativePreferredStockMember_zyq0J5kLkRN7" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">2,395,500</td> <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"> </td> <td id="xdx_981_ecef--OutstandingSecurityHeldShares_c20230101__20231231__cef--RiskAxis__custom--SeriesGCumulativePreferredStockMember_zreTAEmQHpb9" style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">1,332,000</td> <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td> <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">23,755,000</td> <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: center">Fixed Rate</td> <td style="font-family: Arial, Helvetica, Sans-Serif"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">5.200</td> <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">%</td> <td style="font-family: Arial, Helvetica, Sans-Serif"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">$</td> <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">9,620</td> <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"> </td></tr> </table> E 4.000% 4000000 4000000 G 5.200% 2395500 1332000 The holders of Preferred Shares generally are entitled to one vote per share held on each matter submitted to a vote of shareholders of the Fund and will vote together with holders of common stock as a single class. The holders of Preferred Shares voting together as a single class also have the right currently to elect two Trustees and under certain circumstances are entitled to elect a majority of the Board. In addition, the affirmative vote of a majority of the votes entitled to be cast by holders of all outstanding shares of the Preferred Shares, voting as a single class, will be required to approve any plan of reorganization adversely affecting the Preferred Shares, and the approval of two-thirds of each class, voting separately, of the Fund’s outstanding voting stock must approve the conversion of the Fund from a closed-end to an open-end investment company. The approval of a majority (as defined in the 1940 Act) of the outstanding Preferred Shares and a majority (as defined in the 1940 Act) of the Fund’s outstanding voting securities are required to approve certain other actions, including changes in the Fund’s investment objectives or fundamental investment policies. Investment Objective The Fund’s investment objective is long term growth of capital. Under normal market conditions, the Fund will invest at least 80% of its net assets (plus borrowings made for investment purposes) in equity securities (such as common stock and preferred stock) and income producing securities (such as fixed income debt securities and securities convertible into common stock) of domestic and foreign companies in the healthcare and wellness industries. Companies in the healthcare and wellness industries are defined as those companies which are primarily engaged in providing products, services and/or equipment related to healthcare, medical, or lifestyle needs (i.e., nutrition, weight management, and food and beverage companies primarily engaged in healthcare and wellness). “Primarily engaged,” as defined in this registration statement, means a company that derives at least 50% of its revenues or earnings from, or devotes at least 50% of its assets to, the indicated business. The above 80% policy includes investments in derivatives that have similar economic characteristics to the securities included in the 80% policy. The Fund values derivatives at market value for purposes of the 80% policy. Specific sector investments for the Fund will include, but are not limited to, dental, orthopedics, cardiology, hearing aid, life science, in-vitro diagnostics, medical supplies and products, aesthetics and plastic surgery, veterinary, pharmacy benefits management, healthcare distribution, healthcare imaging, pharmaceuticals, biotechnology, healthcare plans, healthcare services, and healthcare equipment, as well as food, beverages, nutrition and weight management. The Fund will focus on companies that are growing globally due to favorable demographic trends and may invest without limitation in securities of foreign issuers, including issuers in emerging markets. The Fund’s investment objective is “fundamental” and therefore may not be changed without the approval of the holders of a majority of the Fund’s outstanding voting securities, as defined in the Investment Company Act of 1940, as amended (the “1940 Act”). Except as expressly stated herein, none of the Fund’s policies are fundamental and may be modified by the Board without shareholder approval. The Fund will invest primarily in equity securities of companies in the healthcare and wellness industries. However, the Fund may also invest in debt securities of any quality, any maturity and any duration of such companies when it appears that the Fund will be better able to achieve its investment objective through investments in such securities or when the Fund is temporarily in a defensive position. The remaining 20% of the Fund’s assets may be invested in other securities, including stocks, debt obligations (such as U.S. Treasury securities) and money market instruments, as well as certain derivative instruments. Moreover, should extraordinary conditions affecting such sectors or securities markets as a whole warrant, the Fund may temporarily be primarily invested in money market instruments. These factors may change rapidly. The Fund emphasizes quality in selecting healthcare and wellness investments, and looks for companies that have sound financial structures and identifiable growth prospects. Believing that demographic trends will affect global market opportunities, the Fund intends to position itself to take advantage of these trends. The Fund may invest up to 10% of its total assets in fixed-income securities rated below investment grade by recognized statistical rating agencies or unrated securities of comparable quality. These securities, which may be preferred stock or debt, are predominantly speculative and involve major risk exposure to adverse conditions. Debt securities that are not rated or that are rated lower than “BBB” by Standard & Poor’s Ratings Services, a Division of The McGraw-Hill Companies, Inc., or lower than “Baa” by Moody’s Investors Services, Inc. are referred to in the financial press as “junk bonds.” The Fund may invest without limitation in securities of foreign issuers, which generally are denominated in foreign currencies, and may include issuers in emerging markets. Foreign investments may involve certain risk and opportunity considerations not typically associated with investing in domestic issuers and could cause the Fund to be affected favorably or unfavorably by changes in currency exchange rates and revaluations of currencies. The average duration and average maturity of the Fund’s investments in debt securities will vary from time to time depending on the views of Gabelli Funds, LLC (the “Investment Adviser”). Duration is a mathematical calculation of the average life of a bond that serves as a measure of its price risk. Each year of duration represents an expected 1% change in the value of a debt security for every 1% immediate change in interest rates. See “Risk Factors and Special Considerations — Fixed Income Securities — Duration and Maturity Risk.” No assurance can be given that the Fund’s investment objective will be achieved. Investment Methodology of the Fund In selecting securities for the Fund, the Investment Adviser normally will consider the following factors, among others: <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Arial, Helvetica, Sans-Serif"> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 0.25in; text-align: right; vertical-align: top"></td> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top">●</td> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; text-align: justify; text-indent: 0in">the Investment Adviser’s own evaluations of the private market value (as defined below), cash flow, earnings per share and other fundamental aspects of the underlying assets and business of the company;</td> </tr> </table> <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Arial, Helvetica, Sans-Serif"> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 0.25in; text-align: right; vertical-align: top"></td> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top">●</td> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; text-align: justify; text-indent: 0in">the potential for capital appreciation of the securities;</td> </tr> </table> <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Arial, Helvetica, Sans-Serif"> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 0.25in; text-align: right; vertical-align: top"></td> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top">●</td> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; text-align: justify; text-indent: 0in">the interest or dividend income generated by the securities;</td> </tr> </table> <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Arial, Helvetica, Sans-Serif"> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 0.25in; text-align: right; vertical-align: top"></td> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top">●</td> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; text-align: justify; text-indent: 0in">the prices of the securities relative to other comparable securities;</td> </tr> </table> <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Arial, Helvetica, Sans-Serif"> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 0.25in; text-align: right; vertical-align: top"></td> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top">●</td> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; text-align: justify; text-indent: 0in">whether the securities are entitled to the benefits of call protection or other protective covenants;</td> </tr> </table> <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Arial, Helvetica, Sans-Serif"> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 0.25in; text-align: right; vertical-align: top"></td> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top">●</td> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; text-align: justify; text-indent: 0in">the existence of any anti-dilution protections or guarantees of the security; and</td> </tr> </table> <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Arial, Helvetica, Sans-Serif"> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 0.25in; text-align: right; vertical-align: top"></td> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top">●</td> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; text-align: justify; text-indent: 0in">the diversification of the portfolio of the Fund as to issuers.</td> </tr> </table> The Investment Adviser’s investment philosophy with respect to equity securities is to identify assets that are selling in the public market at a discount to their private market value. The Investment Adviser defines private market value as the value informed purchasers are willing to pay to acquire assets with similar characteristics. The Investment Adviser also normally evaluates an issuer’s free cash flow and long-term earnings trends. Finally, the Investment Adviser looks for a catalyst, something indigenous to the company, its industry or country, that will surface additional value. The Fund’s investment objective of long term growth of capital is a fundamental policy of the Fund. The Fund’s policy of concentration in companies in the healthcare and wellness industries is also a fundamental policy of the Fund. Under the 1940 Act, a fundamental policy may not be changed without the vote of a majority, as defined in the 1940 Act, of the outstanding voting securities of the Fund (voting together as a single class). Certain Investment Practices Special Situations. Although the Fund typically invests in the securities of companies on the basis of fundamental value, the Fund from time to time may, as a non-principal investment strategy, invest in companies that are determined by the Investment Adviser to possess “special situation” characteristics. In general, a special situation company is a company whose securities are expected to increase in value solely by reason of a development particularly or uniquely applicable to the company. Developments that may create special situations include, among others, a liquidation, reorganization, recapitalization or merger, material litigation, technological breakthrough or new management or management policies. The principal risk associated with investments in special situation companies is that the anticipated development thought to create the special situation may not occur and the investment therefore may not appreciate in value or may decline in value. Temporary Investments. Subject to the Fund’s investment restrictions, when a temporary defensive period is believed by the Investment Adviser to be warranted (“temporary defensive periods”), the Fund may, without limitation, hold cash or invest its assets in securities of United States government sponsored instrumentalities, including U.S. Treasury securities, in repurchase agreements in respect of those instruments, and in certain high-grade commercial paper instruments. During temporary defensive periods, the Fund may also invest in money market mutual funds that invest primarily in securities of United States government sponsored instrumentalities and repurchase agreements in respect of those instruments. Obligations of certain agencies and instrumentalities of the United States government, such as the Government National Mortgage Association, are supported by the “full faith and credit” of the United States government; others, such as those of the Export-Import Bank of the United States, are supported by the right of the issuer to borrow from the United States Treasury; others, such as those of the Federal National Mortgage Association, are supported by the discretionary authority of the United States government to purchase the agency’s obligations; and still others, such as those of the Student Loan Marketing Association, are supported only by the credit of the instrumentality. No assurance can be given that the United States government would provide financial support to United States government sponsored instrumentalities if it is not obligated to do so by law. During temporary defensive periods, the Fund may not achieve its investment objective. Options. On behalf of the Fund, the Investment Adviser may, subject to the guidelines of the Board and Securities and Exchange Commission (“SEC”) or staff guidance and any other applicable regulatory authority, purchase or sell (i.e., write) options on securities, securities indices and foreign currencies which are listed on a national securities exchange or in the U.S. over-the-counter (“OTC”) markets as a means of achieving additional return or of hedging the value of the Fund’s portfolio. The Fund may write covered call options on common stocks that it owns or has an immediate right to acquire through conversion or exchange of other securities in an amount not to exceed 25% of its total assets or invest up to 10% of its total assets in the purchase of put options on common stocks that the Fund owns or may acquire through the conversion or exchange of other securities that it owns. A call option is a contract that gives the holder of the option the right to buy from the writer (seller) of the call option, in return for a premium paid, the security underlying the option at a specified exercise price at any time during the term of the option. The writer of the call option has the obligation, upon exercise of the option, to deliver the underlying security upon payment of the exercise price during the option period. A put option is a contract that gives the holder of the option the right to sell to the writer (seller), in return for the premium, the underlying security at a specified price during the term of the option. The writer of the put, who receives the premium, has the obligation to buy the underlying security upon exercise, at the exercise price during the option period. If the Fund has written an option, it may terminate its obligation by effecting a closing purchase transaction. This is accomplished by purchasing an option of the same series as the option previously written. There can be no assurance that a closing purchase transaction can be effected when the Fund so desires. An exchange-traded option may be closed out only on an exchange which provides a secondary market for an option of the same series. Although the Fund will generally purchase or write only those options for which there appears to be an active secondary market, there is no assurance that a liquid secondary market on an exchange will exist for any particular option. A call option is “covered” if the Fund owns the underlying instrument covered by the call or has an absolute and immediate right to acquire that instrument without additional cash consideration upon conversion or exchange of another instrument held in its portfolio (or for additional cash consideration held in a segregated account by its custodian). A call option is also covered if the Fund holds a call on the same instrument as the call written where the exercise price of the call held is (i) equal to or less than the exercise price of the call written or (ii) greater than the exercise price of the call written if the difference is maintained by the Fund in cash, U.S. government obligations or other high-grade short term obligations in a segregated account with its custodian. A put option is “covered” if the Fund maintains cash or other high-grade short term obligations with a value equal to the exercise price in a segregated account with its custodian, or else holds a put on the same instrument as the put written where the exercise price of the put held is equal to or greater than the exercise price of the put written. If the Fund has written an option, it may terminate its obligation by effecting a closing purchase transaction. This is accomplished by purchasing an option of the same series as the option previously written. However, once the Fund has been assigned an exercise notice, it will be unable to effect a closing purchase transaction. Similarly, if the Fund is the holder of an option, it may liquidate its position by effecting a closing sale transaction. This is accomplished by selling an option with the same terms as the option previously purchased. There can be no assurance that either a closing purchase or sale transaction can be effected when the Fund so desires. The Fund will realize a profit from a closing transaction if the price of the transaction is less than the premium it received from writing the option or is more than the premium it paid to purchase the option; the Fund will realize a loss from a closing transaction if the price of the transaction is more than the premium it received from writing the option or is less than the premium it paid to purchase the option. Since call option prices generally reflect increases in the price of the underlying security, any loss resulting from the repurchase of a call option may also be wholly or partially offset by unrealized appreciation of the underlying security. Other principal factors affecting the market value of a put or a call option include supply and demand, interest rates, the current market price and price volatility of the underlying security and the time remaining until the expiration date. Gains and losses on investments in options depend, in part, on the ability of the Investment Adviser to predict correctly the effect of these factors. The use of options cannot serve as a complete hedge since the price movement of securities underlying the options will not necessarily follow the price movements of the portfolio securities subject to the hedge. An option position may be closed out only on an exchange that provides a secondary market for an option with the same terms or in a private transaction. Although the Fund will generally purchase or write only those options for which there appears to be an active secondary market, there is no assurance that a liquid secondary market on an exchange will exist for any particular option. In such event, it might not be possible to effect closing transactions in particular options, so that the Fund would have to exercise its options in order to realize any profit and would incur brokerage commissions upon the exercise of call options and upon the subsequent disposition of underlying securities for the exercise of put options. If the Fund, as a covered call option writer, is unable to effect a closing purchase transaction in a secondary market, it will not be able to sell the underlying security until the option expires or it delivers the underlying security upon exercise or otherwise covers the position. In addition to options on securities, the Fund may also purchase and sell call and put options on securities indices. A stock index reflects in a single number the market value of many different stocks. Relative values are assigned to the stocks included in an index and the index fluctuates with changes in the market values of the stocks. The options give the holder the right to receive a cash settlement during the term of the option based on the difference between the exercise price and the value of the index. By writing a put or call option on a securities index, the Fund is obligated, in return for the premium received, to make delivery of this amount. The Fund may offset its position in the stock index options prior to expiration by entering into a closing transaction on an exchange or it may let the option expire unexercised. The Fund may also buy or sell put and call options on foreign currencies. A put option on a foreign currency gives the purchaser of the option the right to sell a foreign currency at the exercise price until the option expires. A call option on a foreign currency gives the purchaser of the option the right to purchase the currency at the exercise price until the option expires. Currency options traded on U.S. or other exchanges may be subject to position limits which may limit the ability of the Fund to reduce foreign currency risk using such options. OTC options differ from exchange-traded options in that they are two-party contracts with price and other terms negotiated between buyer and seller and generally do not have as much market liquidity as exchange-traded options. OTC options are considered illiquid securities. Use of options on securities indices entails the risk that trading in the options may be interrupted if trading in certain securities included in the index is interrupted. The Fund will not purchase these options unless the Investment Adviser is satisfied with the development, depth and liquidity of the market and the Investment Adviser believes the options can be closed out. Price movements in the portfolio of the Fund may not correlate precisely with the movements in the level of an index and, therefore, the use of options on indices cannot serve as a complete hedge and will depend, in part, on the ability of the Investment Adviser to predict correctly movements in the direction of the stock market generally or of a particular industry. Because options on securities indices require settlement in cash, the Fund may be forced to liquidate portfolio securities to meet settlement obligations. Although the Investment Adviser will attempt to take appropriate measures to minimize the risks relating to the Fund’s writing of put and call options, there can be no assurance that the Fund will succeed in any option writing program it undertakes. Futures Contracts and Options on Futures. A “sale” of a futures contract (or a “short” futures position) means the assumption of a contractual obligation to deliver the assets underlying the contract at a specified price at a specified future time. A “purchase” of a futures contract (or a “long” futures position) means the assumption of a contractual obligation to acquire the assets underlying the contract at a specified price at a specified future time. Certain futures contracts, including stock and bond index futures, are settled on a net cash payment basis rather than by the sale and delivery of the assets underlying the futures contracts. No consideration will be paid or received by the Fund upon the purchase or sale of a futures contract. Initially, the Fund will be required to deposit with the broker an amount of cash or cash equivalents equal to approximately 1% to 10% of the contract amount (this amount is subject to change by the exchange or board of trade on which the contract is traded and brokers or members of such board of trade may charge a higher amount). This amount is known as “initial margin” and is in the nature of a performance bond or good faith deposit on the contract. Subsequent payments, known as “variation margin,” to and from the broker will be made daily as the price of the index or security underlying the futures contract fluctuates. At any time prior to the expiration of a futures contract, the Fund may close the position by taking an opposite position, which will operate to terminate its existing position in the contract. An option on a futures contract gives the purchaser the right, in return for the premium paid, to assume a position in a futures contract at a specified exercise price at any time prior to the expiration of the option. Upon exercise of an option, the delivery of the futures position by the writer of the option to the holder of the option will be accompanied by delivery of the accumulated balance in the writer’s futures margin account attributable to that contract, which represents the amount by which the market price of the futures contract exceeds, in the case of a call option, or is less than, in the case of a put option, the exercise price of the option on the futures contract. The potential loss related to the purchase of an option on a futures contract is limited to the premium paid for the option (plus transaction costs). Because the value of the option purchased is fixed at the point of sale, there are no daily cash payments by the purchaser to reflect changes in the value of the underlying contract; however, the value of the option does change daily and that change would be reflected in the net assets of the Fund. Futures and options on futures entail certain risks, including but not limited to the following: no assurance that futures contracts or options on futures can be offset at favorable prices, possible reduction of the yield of the Fund due to the use of hedging, possible reduction in value of both the securities hedged and the hedging instrument, possible lack of liquidity due to daily limits on price fluctuations, imperfect correlation between the contracts and the securities being hedged and losses from investing in futures transactions that are potentially unlimited. The Investment Adviser has claimed an exclusion, granted to operators of registered investment companies like the Fund, from registration as a commodity pool operator (“CPO”) with respect to the Fund under the Commodity Exchange Act (the “CEA”), and, therefore, is not subject to registration or regulation with respect to the Fund under the CEA. As a result, the Fund is limited in its ability to use commodity futures (which include futures on broad-based securities indices and interest rate futures) or options on commodity futures, engage in certain swaps transactions or make certain other investments (whether directly or indirectly through investments in other investment vehicles) for purposes other than “bona fide hedging,” as defined in the rules of the Commodity Futures Trading Commission. With respect to transactions other than for bona fide hedging purposes, either: (1) the aggregate initial margin and premiums required to establish the Fund’s positions in such investments may not exceed 5% of the liquidation value of its portfolio (after accounting for unrealized profits and unrealized losses on any such investments); or (2) the aggregate net notional value of such instruments, determined at the time the most recent position was established, may not exceed 100% of the liquidation value of its portfolio (after accounting for unrealized profits and unrealized losses on any such positions). In addition to meeting one of the foregoing trading limitations, the Fund may not market itself as a commodity pool or otherwise as a vehicle for trading in the futures, options or swaps markets. If the Investment Adviser were required to register as a CPO with respect to the Fund, compliance with additional registration and regulatory requirements would increase Fund expenses. Other potentially adverse regulatory initiatives could also develop. Interest Rate Futures Contracts and Options Thereon. The Fund may purchase or sell interest rate futures contracts to take advantage of, or to protect against, fluctuations in interest rates affecting the value of debt securities which the Fund holds or intends to acquire. For example, if interest rates are expected to increase, the Fund might sell futures contracts on debt securities, the values of which historically have a high degree of positive correlation to the values of the Fund’s portfolio securities. Such a sale would have an effect similar to selling an equivalent value of the Fund’s portfolio securities. If interest rates increase, the value of the Fund’s portfolio securities will decline, but the value of the futures contracts to the Fund will increase at approximately an equivalent rate, thereby keeping the net asset value (“NAV”) of the Fund from declining as much as it otherwise would have. The Fund could accomplish similar results by selling debt securities with longer maturities and investing in debt securities with shorter maturities when interest rates are expected to increase. However, since the futures market may be more liquid than the cash market, the use of futures contracts as a risk management technique allows the Fund to maintain a defensive position without having to sell its portfolio securities. Similarly, the Fund may purchase interest rate futures contracts when it is expected that interest rates may decline. The purchase of futures contracts for this purpose constitutes a hedge against increases in the price of debt securities (caused by declining interest rates) which the Fund intends to acquire. Since fluctuations in the value of appropriately selected futures contracts should approximate that of the debt securities that will be purchased, the Fund can take advantage of the anticipated rise in the cost of the debt securities without actually buying them. Subsequently, the Fund can make its intended purchase of the debt securities in the cash market and concurrently liquidate its futures position. The purchase of a call option on a futures contract is similar in some respects to the purchase of a call option on an individual security. Depending on the pricing of the option compared to either the price of the futures contract upon which it is based or the price of the underlying debt securities, it may or may not be less risky than ownership of the futures contract or underlying debt securities. As with the purchase of futures contracts, when the Fund is not fully invested it may purchase a call option on a futures contract to hedge against a market advance due to declining interest rates. The purchase of a put option on a futures contract is similar to the purchase of protective put options on portfolio securities. The Fund will purchase a put option on a futures contract to hedge the Fund’s portfolio against the risk of rising interest rates and a consequent reduction in the value of portfolio securities. The writing of a call option on a futures contract constitutes a partial hedge against declining prices of the securities that are deliverable upon exercise of the futures contract. If the futures price at expiration of the option is below the exercise price, the Fund will retain the full amount of the option premium, which provides a partial hedge against any decline that may have occurred in the Fund’s portfolio holdings. The writing of a put option on a futures contract constitutes a partial hedge against increasing prices of the securities that are deliverable upon exercise of the futures contract. If the futures price at expiration of the option is higher than the exercise price, the Fund will retain the full amount of the option premium, which provides a partial hedge against any increase in the price of debt securities that the Fund intends to purchase. If a put or call option the Fund has written is exercised, the Fund will incur a loss which will be reduced by the amount of the premium it received. Depending on the degree of correlation between changes in the value of its portfolio securities and changes in the value of its futures positions, losses of the Fund from options on futures it has written may to some extent be reduced or increased by changes in the value of its portfolio securities. Swaps. The Fund may enter into total rate of return, credit default, interest rate or other types of swaps and related derivatives for various purposes, including to gain economic exposure to an asset or group of assets that may be difficult or impractical to acquire or for hedging and risk management. These transactions generally provide for the transfer from one counterparty to another of certain risks inherent in the ownership of a financial asset such as a common stock or debt instrument. Such risks include, among other things, the risk of default and insolvency of the obligor of such asset, the risk that the credit of the obligor or the underlying collateral will decline or the risk that the underlying collateral will decline. The transfer of risk pursuant to a derivative of this type may be complete or partial, and may be for the life of the related asset or for a shorter period. These derivatives may be used as a risk management tool for a pool of financial assets, providing the Fund with the opportunity to gain or reduce exposure to one or more reference securities or other financial assets (each, a“Reference Asset”) without actually owning or selling such assets in order, for example, to increase or reduce a concentration risk or to diversify a portfolio. Conversely, these derivatives may be used by the Fund to reduce exposure to an owned asset without selling it. Because the Fund would not own the Reference Assets, the Fund may not have any voting rights with respect to the Reference Assets, and in such cases will not be able to vote on matters related to the obligors or issuers of the Reference Assets, including whether to exercise certain remedies. Total rate of return swaps and similar derivatives are subject to many risks, including the possibility that the market will move in a manner or direction that would have resulted in gain for the Fund had the swap or other derivative not been utilized (in which case it would have been better had the Fund not engaged in the transactions), nearly unlimited exposure to changes in the value of the Reference Assets, total loss to the Fund of the entire notional amount of the swap, the risk of imperfect correlation between the risk sought to be hedged and the derivative transactions utilized, the possible inability of the counterparty to fulfill its obligations under the swap and potential illiquidity of the instrument utilized, which may make it difficult for the Fund to close out or unwind one or more transactions. Total rate of return swaps and related derivatives are a relatively recent development in the financial markets. Consequently, there are certain legal, tax and market uncertainties that present risks in entering into such an arrangement. There is currently little or no case law or litigation characterizing total rate of return swaps or related derivatives, interpreting their provisions, or characterizing their tax treatment. In addition, additional regulations and laws may apply to these types of derivatives that have not previously been applied. There can be no assurance that future decisions constructing similar provisions to those in any swap agreement or other related documents or additional regulations and laws will not have an adverse effect on the Fund that utilizes these instruments. The Fund will monitor these risks and seek to utilize these instruments in a manner that does not lead to undue risk regarding the tax or other structural elements of the Fund. The Fund will not invest in these types of instruments if the Reference Assets are commodities except for bona fide hedging or risk management purposes. Currency Futures and Options Thereon. Generally, foreign currency futures contracts and options thereon are similar to the interest rate futures contracts and options thereon discussed previously. By entering into currency futures and options thereon, the Fund will seek to establish the rate at which it will be entitled to exchange U.S. dollars for another currency at a future time. By selling currency futures, the Fund will seek to establish the number of dollars it will receive at delivery for a certain amount of a foreign currency. In this way, whenever the Fund anticipates a decline in the value of a foreign currency against the U.S. dollar, the Fund can attempt to “lock in” the U.S. dollar value of some or all of the securities held in its portfolio that are denominated in that currency. By purchasing currency futures, the Fund can establish the number of dollars it will be required to pay for a specified amount of a foreign currency in a future month. Thus, if the Fund intends to buy securities in the future and expects the U.S. dollar to decline against the relevant foreign currency during the period before the purchase is effected, the Fund can attempt to “lock in” the price in U.S. dollars of the securities it intends to acquire. The purchase of options on currency futures will allow the Fund, for the price of the premium and related transaction costs it must pay for the option, to decide whether or not to buy (in the case of a call option) or to sell (in the case of a put option) a futures contract at a specified price at any time during the period before the option expires. If the Investment Adviser, in purchasing an option, has been correct in its judgment concerning the direction in which the price of a foreign currency would move as against the U.S. dollar, the Fund may exercise the option and thereby take a futures position to hedge against the risk it had correctly anticipated or close out the option position at a gain that will offset, to some extent, currency exchange losses otherwise suffered by the Fund. If exchange rates move in a way the Fund did not anticipate, however, the Fund will have incurred the expense of the option without obtaining the expected benefit; any such movement in exchange rates may also thereby reduce, rather than enhance, the Fund’s profits on its underlying securities transactions. Securities Index Futures Contracts and Options Thereon. Purchases or sales of securities index futures contracts are used for hedging purposes to attempt to protect the Fund’s current or intended investments from broad fluctuations in stock or bond prices. For example, the Fund may sell securities index futures contracts in anticipation of or during a market decline to attempt to offset the decrease in market value of its securities portfolio that might otherwise result. If such decline occurs, the loss in value of portfolio securities may be offset, in whole or part, by gains on the futures position. When the Fund is not fully invested in the securities market and anticipates a significant market advance, it may purchase securities index futures contracts in order to gain rapid market exposure that may, in part or entirely, offset increases in the cost of securities that it intends to purchase. As such purchases are made, the corresponding positions in securities index futures contracts will be closed out. The Fund may write put and call options on securities index futures contracts for hedging purposes. Forward Currency Exchange Contracts. The Fund may engage in currency transactions other than on futures exchanges to protect against future changes in the level of future currency exchange rates. The Fund will conduct such currency exchange transactions either on a spot, i.e., cash, basis at the rate then prevailing in the currency exchange market or on a forward basis, by entering into forward contracts to purchase or sell currency. A forward contract on foreign currency involves an obligation to purchase or sell a specific currency at a future date, which may be any fixed number of days agreed upon by the parties from the date of the contract, at a price set on the date of the contract. Dealing in forward currency exchange by the Fund will be limited to hedging involving either specific transactions or portfolio positions. Transaction hedging is the purchase or sale of forward currency with respect to specific receivables or payables of the Fund generally arising in connection with the purchase or sale of its portfolio securities and accruals of interest receivable and fund expenses. Position hedging is the forward sale of currency with respect to portfolio security positions denominated or quoted in that currency or in a currency bearing a high degree of positive correlation to the value of that currency. The Fund may not position hedge with respect to a particular currency for an amount greater than the aggregate market value (determined at the time of making any sale of forward currency) of the securities held in its portfolio denominated or quoted in, or currently convertible into, such currency. At or before the maturity of a forward sale contract, the Fund may either sell a portfolio security and make delivery of the currency, or retain the security and offset its contractual obligations to deliver the currency by purchasing a second contract pursuant to which the Fund will obtain, on the same maturity date, the same amount of the currency which it is obligated to deliver. If the Fund retains the portfolio security and engages in an offsetting transaction, the Fund, at the time of execution of the offsetting transaction, will incur a gain or a loss to the extent that movement has occurred in forward contract prices. Should forward prices decline during the period between entering into a forward contract by the Fund for the sale of a currency and the date it enters into an offsetting contract for the purchase of the currency, the Fund will realize a gain to the extent the price of the currency it has agreed to purchase is less than the price of the currency it has agreed to sell. Should forward prices increase, the Fund will suffer a loss to the extent the price of the currency it has agreed to purchase exceeds the price of the currency it has agreed to sell. Closing out forward purchase contracts involves similar offsetting transactions. The cost to the Fund of engaging in currency transactions varies with factors such as the currency involved, the length of the contract period and the market conditions then prevailing. Because forward transactions in currency exchange are usually conducted on a principal basis, no fees or commissions are involved. The use of foreign currency contracts does not eliminate fluctuations in the underlying prices of the securities, but it does establish a rate of exchange that can be achieved in the future. In addition, although forward currency contracts limit the risk of loss due to a decline in the value of the hedged currency, they also limit any potential gain that might result if the value of the currency increases. If a decline in any currency is generally anticipated by the Investment Adviser, the Fund may not be able to contract to sell the currency at a price above the level to which the currency is anticipated to decline. When Issued, Delayed Delivery Securities and Forward Commitments. The Fund may enter into forward commitments for the purchase or sale of securities, including on a “when issued” or “delayed delivery” basis, in excess of customary settlement periods for the type of security involved. In some cases, a forward commitment may be conditioned upon the occurrence of a subsequent event, such as approval and consummation of a merger, corporate reorganization or debt restructuring, i.e., a when, as and if issued security. When such transactions are negotiated, the price is fixed at the time of the commitment, with payment and delivery taking place in the future, generally a month or more after the date of the commitment. While it will only enter into a forward commitment with the intention of actually acquiring the security, the Fund may sell the security before the settlement date if it is deemed advisable. Securities purchased under a forward commitment are subject to market fluctuation, and no interest (or dividends) accrues to the Fund prior to the settlement date. Restricted and Illiquid Securities. The Fund may invest without limit in illiquid securities. Illiquid securities include securities the disposition of which is subject to substantial legal or contractual restrictions. The sale of illiquid securities often requires more time and results in higher brokerage charges or dealer discounts and other selling expenses than does the sale of securities eligible for trading on national securities exchanges or in the OTC markets. Restricted securities may sell at a price lower than similar securities that are not subject to restrictions on resale. Unseasoned issuers are companies (including predecessors) that have operated less than three years. The continued liquidity of such securities may not be as well assured as that of publicly traded securities, and accordingly the Board will monitor their liquidity. The Board will review pertinent factors such as trading activity, reliability of price information and trading patterns of comparable securities in determining whether to treat any such security as liquid. To the extent the Board treats such securities as liquid, temporary impairments to trading patterns of such securities may adversely affect the liquidity of the Fund. The Board has adopted guidelines and delegated to the Investment Adviser, subject to the supervision of the Board, the function of determining and monitoring the liquidity of particular Rule 144A securities under the Securities Act of 1933 Act, as amended (the “Securities Act”). Leverage. As provided in the 1940 Act, and subject to compliance with the Fund’s investment limitations, the Fund may issue senior securities representing (i) shares, such as preferred shares, so long as immediately following such issuance of stock, its total assets exceed 200% of the amount of such shares and (ii) indebtedness, such as notes, so long as immediately following such issuance of indebtedness, its total assets exceed 300% of the amount of such indebtedness. The use of leverage magnifies the impact of changes in NAV. For example, a fund that uses 33% leverage will show a 1.5% increase or decline in NAV for each 1% increase or decline in the value of its total assets. In addition, if the cost of leverage exceeds the return on the securities acquired with the proceeds of leverage, the use of leverage will diminish, rather than enhance, the return to the Fund. The use of leverage generally increases the volatility of returns to the Fund. Additionally, the Fund may enter into derivative transactions that have economic leverage embedded in them. Derivative transactions that the Fund may enter into and the risks associated with them are described herein. The Fund cannot assure you that investments in derivative transactions that have economic leverage embedded in them will result in a higher return on its common shares. Under Rule 18f-4 under the 1940 Act, among other things, the Fund must either use derivatives in a limited manner or comply with an outer limit on fund leverage risk based on value-at-risk. See “Risk Factors and Special Considerations—Special Risks of Derivative Transactions—Derivatives Transactions Subject to Rule 18f-4 Under the 1940 Act.” Investment Restrictions. The Fund has adopted certain investment restrictions as fundamental policies of the Fund. Under the 1940 Act, a fundamental policy may not be changed without the vote of a majority, as defined in the 1940 Act, of the outstanding voting securities of the Fund (voting together as a single class). The Fund’s fundamental investment restrictions prohibit the Fund from: (1) concentrating its investments (i.e., investing more than 25% of the Fund’s total assets) in securities of issuers in any industry other than the healthcare and wellness industries; (2) purchasing or selling commodities or commodity contracts, except that the Fund may purchase or sell futures contracts and related options thereon if certain conditions are met, and purchasing or selling sell real estate, provided that the Fund may invest in securities secured by real estate or interests therein or issued by companies which invest in real estate or interests therein; (3) making loans of money, except by the purchase of a portion of private or publicly distributed debt obligations or the entering into of repurchase agreements, and the Fund reserves the authority to make loans of its portfolio securities to financial intermediaries in an aggregate amount not exceeding 20% of its total assets; (4) borrowing money, except to the extent permitted by applicable law (i.e., the Fund generally may borrow money in amounts of up to one-third of the Fund’s total assets for any purpose, subject to the requirement that the Fund have asset coverage of at least 300% of the amount of its borrowings at the time the borrowing is incurred, and may borrow up to 5% of the Fund’s total assets for temporary purposes (for up to 60 days) without maintaining such 300% asset coverage); (5) issuing senior securities, except to the extent permitted by applicable law (i.e., the Fund may issue senior securities (which may be stock, such as preferred shares, and/or securities representing debt, such as notes), subject to the requirement that the Fund maintain asset coverage as required by the 1940 Act); and (6) underwriting securities of other issuers except insofar as the Fund may be deemed an underwriter under the Securities Act of 1933, as amended, in selling portfolio securities. See also “Leverage Risk — Portfolio Guidelines of Rating Agencies for Preferred Shares and/or Credit Facility.” Portfolio Turnover. The Fund will buy and sell securities to accomplish its investment objective. The investment policies of the Fund may lead to frequent changes in investments, particularly in periods of rapidly fluctuating interest or currency exchange rates. The portfolio turnover may be higher than that of other investment companies. Portfolio turnover generally involves some expense to the Fund, including brokerage commissions or dealer mark-ups and other transaction costs on the sale of securities and reinvestment in other securities. The portfolio turnover rate is computed by dividing the lesser of the amount of the securities purchased or securities sold by the average monthly value of securities owned during the year (excluding securities whose maturities at acquisition were one year or less). High portfolio turnover may also result in the realization of substantial net short term capital gains and any distributions resulting from such gains will be taxable at ordinary income rates for United States federal income tax purposes. The Fund’s portfolio turnover rates for the fiscal years ended December 31, 2023 and 2022 were 21% and 14%, respectively. Borrowing. The Fund may borrow money in accordance with its investment restrictions, including as a temporary measure for extraordinary or emergency purposes. RISK FACTORS AND SPECIAL CONSIDERATIONS Investors should consider the following risk factors and special considerations associated with investing in the Fund: <p id="xdx_84C_ecef--RiskTextBlock_hcef--RiskAxis__custom--IndustryConcentrationRisksMember_zuJDqaMcxOMg" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">Industry Concentration Risks The Fund is concentrated in the healthcare and wellness industries. Under normal market conditions, the Fund will invest at least 80% of its net assets (plus borrowings made for investment purposes) in equity securities (such as common stock and preferred stock) and income producing securities (such as fixed income debt securities and securities convertible into common stock) of domestic and foreign companies in the healthcare and wellness industries. As a result of investing a significant portion of its assets in companies in the healthcare and wellness industries, the value of the Fund’s shares will be more susceptible to factors affecting those particular types of companies, which may include, among others, governmental regulation, changes in government subsidy and reimbursement levels, the governmental approval process, rapid obsolescence of products and services and patent expirations. The Investment Adviser believes that certain healthcare and wellness related companies could experience growth as a result of demographic changes and the Fund intends to focus on companies that will benefit from these demographic trends. However, certain of these companies may be less able to anticipate demographic trends and investments in these companies would not be likely to perform as well as investments in those that do. Long Term Objective The Fund seeks long term growth of capital. The Fund is not meant to provide a vehicle for those who wish to exploit short term swings in the stock market. An investment in shares of the Fund should not be considered a complete investment program. Each shareholder should take into account the shareholder’s investment objectives when considering an investment in the Fund. Tax Status To qualify as a “regulated investment company,” or “RIC,” for purposes of the Internal Revenue Code of 1986, as amended (the “Code”), the Fund has in the past conducted and intends to conduct its operations in a manner that will relieve it of any liability for federal income tax to the extent its earnings are distributed to shareholders. To so qualify as a “regulated investment company,” among other requirements, the Fund will limit its investments so that, at the close of each quarter of the taxable year: <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Arial, Helvetica, Sans-Serif"> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 0.25in; text-align: right; vertical-align: top"></td> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top">●</td> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; text-align: justify; text-indent: 0in">not more than 25% of the market value of its total assets will be invested in the securities (other than United States government securities or the securities of other RICs) of a single issuer, any two or more issuers in which the Fund owns 20% or more of the voting securities and which are determined to be engaged in the same, similar or related trades or businesses or in the securities of one or more qualified publicly traded partnerships (as defined in the Code); and</td> </tr> </table> <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Arial, Helvetica, Sans-Serif"> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 0.25in; text-align: right; vertical-align: top"></td> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top">●</td> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; text-align: justify; text-indent: 0in">at least 50% of the market value of the Fund’s assets will be represented by cash, securities of other RICs, United States government securities and other securities, with such other securities limited in re-</td> </tr> </table> spect of any one issuer to an amount not greater than 5% of the value of the Fund’s total assets and not more than 10% of the outstanding voting securities of such issuer. <p id="xdx_847_ecef--RiskTextBlock_hcef--RiskAxis__custom--MarketValueAndNetAssetValueMember_zC9cpunyccqh" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">Market Value and Net Asset Value The Fund is a diversified, closed-end management investment company. Shares of closed-end funds are bought and sold in the securities markets and may trade at either a premium to or discount from NAV. Listed shares of closed-end investment companies often trade at discounts from NAV. This characteristic of shares of a closed-end fund is a risk separate and distinct from the risk that its NAV may decrease. The Fund cannot predict whether its listed shares will trade at, below or above NAV. The risk of holding shares of a closed-end fund that might trade at a discount is more pronounced for shareholders who wish to sell their shares in a relatively short period of time after acquiring them because, for those investors, realization of a gain or loss on their investments is likely to be more dependent upon the existence of a premium or discount than upon portfolio performance. The Fund’s shares are not subject to redemption. Shareholders desiring liquidity may, subject to applicable securities laws, trade their Fund shares on the New York Stock Exchange (“NYSE”) or other markets on which such shares may trade at the then-current market value, which may differ from the then current NAV. Shareholders will incur brokerage or other transaction costs to sell shares. Equity Risk Investing in the Fund involves equity risk, which is the risk that the securities held by the Fund will fall in market value due to adverse market and economic conditions, perceptions regarding the industries in which the issuers of securities held by the Fund participate and the particular circumstances and performance of particular companies whose securities the Fund holds. An investment in the Fund represents an indirect economic stake in the securities owned by the Fund, which are for the most part traded on securities exchanges or in the OTC markets. The market value of these securities, like other market investments, may move up or down, sometimes rapidly and unpredictably. The NAV of the Fund may at any point in time be worth less than the amount at the time the shareholder invested in the Fund, even after taking into account any reinvestment of distributions. Foreign Securities There is no limitation on the amount of foreign securities, including emerging market securities, in which the Fund may invest. Investments in the securities of foreign issuers involve certain considerations and risks not ordinarily associated with investments in securities of domestic issuers and such securities may be more volatile than those of issuers in the United States. Foreign companies are not generally subject to uniform accounting, auditing and financial standards and requirements comparable to those applicable to United States companies. Foreign securities exchanges, brokers and listed companies may be subject to less government supervision and regulation than exists in the United States. Dividend and interest income may be subject to withholding and other foreign taxes, which may adversely affect the net return on such investments. There may be difficulty in obtaining or enforcing a court judgment abroad. In addition, it may be difficult to effect repatriation of capital invested in certain countries. Also, with respect to certain countries, there are risks of expropriation, confiscatory taxation, political or social instability or diplomatic developments that could affect assets of the Fund held in foreign countries. Dividend income that the Fund receives from foreign securities may not be eligible for the special tax treatment applicable to qualified dividend income. Moreover, certain equity investments in foreign issuers classified as passive foreign investment companies may be subject to additional taxation risk. There may be less publicly available information about a foreign company than a United States company. Foreign securities markets may have substantially less volume than United States securities markets and some foreign company securities are less liquid than securities of otherwise comparable United States companies. A portfolio of foreign securities may also be adversely affected by fluctuations in the rates of exchange between the currencies of different nations and by exchange control regulations. Foreign markets also have different clearance and settlement procedures that could cause the Fund to encounter difficulties in purchasing and selling securities on such markets and may result in the Fund missing attractive investment opportunities or experiencing loss. In addition, a portfolio that includes foreign securities can expect to have a higher expense ratio because of the increased transaction costs on non-United States securities markets and the increased costs of maintaining the custody of foreign securities. The Fund also may purchase sponsored American Depositary Receipts (“ADRs”) or United States dollar denominated securities of foreign issuers, including emerging market issuers. ADRs are receipts issued by United States banks or trust companies in respect of securities of foreign issuers held on deposit for use in the United States securities markets. While ADRs may not necessarily be denominated in the same currency as the securities into which they may be converted, many of the risks associated with foreign securities may also apply to ADRs. In addition, the underlying issuers of certain depositary receipts, particularly unsponsored or unregistered depositary receipts, are under no obligation to distribute shareholder communications to the holders of such receipts, or to pass through to them any voting rights with respect to the deposited securities. Emerging Markets The Fund may invest in securities of issuers whose primary operations or principal trading market is in an “emerging market.” An “emerging market” country is any country that is considered to be an emerging or developing country by the International Bank for Reconstruction and Development (the “World Bank”). Investing in securities of companies in emerging markets may entail special risks relating to potential political and economic instability and the risks of expropriation, nationalization, confiscation or the imposition of restrictions on foreign investment, the lack of hedging instruments and restrictions on repatriation of capital invested. Emerging securities markets are substantially smaller, less developed, less liquid and more volatile than the major securities markets. The limited size of emerging securities markets and limited trading value compared to the volume of trading in U.S. securities could cause prices to be erratic for reasons apart from factors that affect the quality of the securities. For example, limited market size may cause prices to be unduly influenced by traders who control large positions. Adverse publicity and investors’ perceptions, whether or not based on fundamental analysis, may decrease the value and liquidity of portfolio securities, especially in these markets. Other risks include high concentration of market capitalization and trading volume in a small number of issuers representing a limited number of industries, as well as a high concentration of investors and financial intermediaries; overdependence on exports, including gold and natural resources exports, making these economies vulnerable to changes in commodity prices; overburdened infrastructure and obsolete or unseasoned financial systems; environmental problems; potential for sanctions; less developed legal systems, and deficiencies in regulatory oversight, market infrastructure, shareholder protections; differences in regulatory, accounting, auditing and financial reporting and recordkeeping standards; and less reliable securities custodial services and settlement practices. Value Investing Risk The Fund focuses its investments on the securities of companies that the Investment Adviser believes to be undervalued or inexpensive relative to other investments. These types of securities may present risks in addition to the general risks associated with investing in common and preferred stocks. These securities generally are selected on the basis of an issuer’s fundamentals relative to current market price. Such securities are subject to the risk of mis-estimation of certain fundamental factors. In addition, during certain time periods market dynamics may strongly favor “growth” stocks of issuers that do not display strong fundamentals relative to market price based upon positive price momentum and other factors. Disciplined adherence to a “value” investment mandate during such periods can result in significant underperformance relative to overall market indices and other managed investment vehicles that pursue growth style investments and/or flexible equity style mandates. Smaller Companies The Fund may invest in smaller companies that may benefit from the development of new products and services. These smaller companies may present greater opportunities for capital appreciation, and may also involve greater investment risk than larger, more established companies. For example, smaller companies may have more limited product lines, market, or financial resources, and their securities may trade less frequently and in lower volume than the securities of larger, more established companies. As a result, the prices of the securities of such smaller companies may fluctuate to a greater degree than the prices of securities of other issuers. Fixed Income Securities Fixed income securities in which the Fund may invest are generally subject to the following risks: <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Arial, Helvetica, Sans-Serif"> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 0.25in; text-align: right; vertical-align: top"></td> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 0.25in; text-align: left; vertical-align: top">●</td> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; text-align: justify">Interest Rate Risk. The market value of bonds and other fixed-income or dividend paying securities changes in response to interest rate changes and other factors. Interest rate risk is the risk that prices of bonds and other income or dividend paying securities will increase as interest rates fall and decrease as interest rates rise. The Fund may be subject to a greater risk of rising interest rates due to the recent period of historically low interest rates. The Federal Reserve began raising the federal funds rate in March 2022 as part of its efforts to address rising inflation. There is a risk that interest rates will continue to rise, which will likely drive down prices of bonds and other fixed-income securities. The magnitude of these price reductions in the market price of bonds and other fixed-income securities is generally greater for those securities with longer maturities. Fluctuations in the market price of the Fund’s investments will not affect interest income derived from instruments already owned by the Fund, but will be reflected in the Fund’s NAV. The Fund may lose money if short-term or long-term interest rates rise sharply in a manner not anticipated by the Investment Adviser. </td> </tr> </table> <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Arial, Helvetica, Sans-Serif"> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 0.25in; text-align: right; vertical-align: top"></td> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top">●</td> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; text-align: justify; text-indent: 0in">Issuer Risk. Issuer risk is the risk that the value of an income or dividend paying security may decline for a number of reasons which directly relate to the issuer, such as management performance, financial leverage, reduced demand for the issuer’s goods and services, historical and prospective earnings of the issuer, and the value of the assets of the issuer.</td> </tr> </table> <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Arial, Helvetica, Sans-Serif"> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 0.25in; text-align: right; vertical-align: top"></td> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top">●</td> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; text-align: justify; text-indent: 0in">Credit Risk. Credit risk is the risk that one or more income or dividend paying securities in the Fund’s portfolio will decline in price or fail to pay interest/distributions or principal when due because the issuer</td> </tr> </table> of the security experiences a decline in its financial status. Credit risk is increased when a portfolio security is downgraded or the perceived creditworthiness of the issuer deteriorates. <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Arial, Helvetica, Sans-Serif"> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 0.25in; text-align: right; vertical-align: top"></td> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top">●</td> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; text-align: justify; text-indent: 0in">Prepayment Risk. Prepayment risk is the risk that during periods of declining interest rates, borrowers may exercise their option to prepay principal earlier than scheduled. For income or dividend paying securities, such payments often occur during periods of declining interest rates, forcing the Fund to reinvest in lower yielding securities, resulting in a possible decline in the Fund’s income and distributions to shareholders.</td> </tr> </table> <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Arial, Helvetica, Sans-Serif"> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 0.25in; text-align: right; vertical-align: top"></td> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top">●</td> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; text-align: justify; text-indent: 0in">Reinvestment Risk. Reinvestment risk is the risk that income from the Fund’s portfolio will decline if the Fund invests the proceeds from matured, traded or called fixed income securities at market interest rates that are below the Fund portfolio’s current earnings rate.</td> </tr> </table> <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Arial, Helvetica, Sans-Serif"> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 0.25in; text-align: right; vertical-align: top"></td> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top">●</td> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; text-align: justify; text-indent: 0in">Duration and Maturity Risk. The Fund may incur costs in seeking to adjust the portfolio average duration or maturity. In comparison to maturity (which is the date on which the issuer of a debt instrument is obligated to repay the principal amount), duration is a measure of the price volatility of a debt instrument as a result in changes in market rates of interest, based on the weighted average timing of the instrument’s expected principal and interest payments. Specifically, duration measures the anticipated percentage change in NAV that is expected for every percentage point change in interest rates. The two have an inverse relationship. For example, a duration of five years means that a 1% decrease in interest rates will increase the NAV of the portfolio by approximately 5%; if interest rates increase by 1%, the NAV will decrease by 5%. However, in a managed portfolio of fixed income securities having differing interest or dividend rates or payment schedules, maturities, redemption provisions, call or prepayment provisions and credit qualities, actual price changes in response to changes in interest rates may differ significantly from a duration-based estimate at any given time. Actual price movements experienced by a portfolio of fixed income securities will be affected by how interest rates move (i.e., changes in the relationship of long term interest rates to short term interest rates), the magnitude of any move in interest rates, actual and anticipated prepayments of principal through call or redemption features, the extension of maturities through restructuring, the sale of securities for portfolio management purposes, the reinvestment of proceeds from prepayments on and from sales of securities, and credit quality-related considerations whether associated with financing costs to lower credit quality borrowers or otherwise, as well as other factors. Accordingly, while duration maybe a useful tool to estimate potential price movements in relation to changes in interest rates, investors are cautioned that duration alone will not predict actual changes in the net asset or market value of the Fund’s shares and that actual price movements in the Fund’s portfolio may differ significantly from duration-based estimates. Duration differs from maturity in that it takes into account a security’s yield, coupon payments and its principal payments in addition to the amount of time until the security matures. As the value of a security changes over time, so will its duration. There can be no assurance that the Investment Adviser’s assessment of current and projected market conditions will be correct or that any strategy to adjust duration or maturity will be successful at any given time.</td> </tr> </table> <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Arial, Helvetica, Sans-Serif"> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 0.25in; text-align: right; vertical-align: top"></td> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top">●</td> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; text-align: justify; text-indent: 0in">Liquidity Risk. Certain fixed income securities in which the Fund invests may be or become illiquid. See “Certain Investment Practices – Restricted and Illiquid Securities.”</td> </tr> </table> Lower Grade Securities Generally, lower grade securities and unrated securities of comparable quality offer a higher current yield than is offered by higher rated securities, but also (i) will likely have some quality and protective characteristics that, in the judgment of the rating organizations, are outweighed by large uncertainties or major risk exposures to adverse conditions and (ii) are predominantly speculative with respect to the issuer’s capacity to pay interest and repay principal in accordance with the terms of the obligation. The market values of certain of these securities also tend to be more sensitive to individual corporate developments and changes in economic conditions than higher quality securities. In addition, such securities generally present a higher degree of credit risk. The risk of loss due to default by these issuers is significantly greater because such lower grade securities and unrated securities of comparable quality generally are unsecured and frequently are subordinated to the prior payment of senior indebtedness. In light of these risks, the Investment Adviser, in evaluating the creditworthiness of an issue, whether rated or unrated, will take various factors into consideration, which may include, as applicable, the issuer’s operating history, financial resources and its sensitivity to economic conditions and trends, the market support for the facility financed by the issue, the perceived ability and integrity of the issuer’s management, and regulatory matters. In addition, the market value of lower securities is more volatile than that of higher quality securities, and the markets in which such lower grade or unrated securities are traded are more limited than those in which higher rated securities are traded. The existence of limited markets may make it more difficult for the Fund to obtain accurate market quotations for purposes of valuing its portfolio and calculating its NAV. Moreover, the lack of a liquid trading market may restrict the availability of securities for the Fund to purchase and may also have the effect of limiting the ability of the Fund to sell securities at their fair value in response to changes in the economy or the financial markets. Lower grade securities also present risks based on payment expectations. If an issuer calls the obligation for redemption (often a feature of fixed income securities), the Fund may have to replace the security with a lower yielding security, resulting in a decreased return for investors. Also, as the principal value of nonconvertible bonds and preferred stocks moves inversely with movements in interest rates, in the event of rising interest rates the value of the securities held by the Fund may decline proportionately more than a portfolio consisting of higher rated securities. Investments in zero coupon bonds may be more speculative and subject to greater fluctuations in value due to changes in interest rates than bonds that pay regular income streams. See “—Fixed Income Securities—Interest Rate Risk” above. As part of its investment in lower grade securities, the Fund may invest in securities of issuers in default. The Fund will make an investment in securities of issuers in default only when the Investment Adviser believes that such issuers will honor their obligations or emerge from bankruptcy protection under a plan pursuant to which the securities received by the Fund in exchange for its defaulted securities will have a value in excess of the Fund’s investment. By investing in securities of issuers in default, the Fund bears the risk that these issuers will not continue to honor their obligations or emerge from bankruptcy protection or that the value of the securities will not otherwise appreciate. In addition to using recognized rating agencies and other sources, the Investment Adviser also performs its own analysis of issues in seeking investments that it believes to be underrated (and thus higher yielding) in light of the financial condition of the issuer. Its analysis of securities of issuers may include, among other things, current and anticipated cash flow and borrowing requirements, value of assets in relation to historical cost, strength of management, responsiveness to business conditions, credit standing, and current anticipated results of operations. In selecting investments for the Fund, the Investment Adviser may also consider general business conditions, anticipated changes in interest rates, and the outlook for specific industries. Subsequent to its purchase by the Fund, an issuer of securities may cease to be rated or its rating may be reduced. In addition, it is possible that statistical rating agencies may change their ratings of a particular issuer to reflect subsequent events. Moreover, such ratings do not assess the risk of a decline in market value. None of these events will require the sale of the securities by the Fund, although the Investment Adviser will consider these events in determining whether the Fund should continue to hold the securities. The market for lower grade and comparable unrated securities has experienced several periods of significantly adverse price and liquidity, particularly at or around times of economic recessions. Past market recessions have adversely affected the value of such securities as well as the ability of certain issuers of such securities to repay principal and pay interest thereon or to refinance such securities. The market for those securities may react in a similar fashion in the future. <p id="xdx_844_ecef--RiskTextBlock_hcef--RiskAxis__custom--SpecialRisksOfDerivativeTransactionsMember_zkc7GY3WwzUj" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">Special Risks of Derivative Transactions The Fund may participate in derivative transactions. Such transactions entail certain execution, market, liquidity, hedging and tax risks. Participation in the options, futures or swaps markets and in currency exchange transactions involves investment risks and transaction costs to which the Fund would not be subject absent the use of these strategies. If the Investment Adviser’s prediction of movements in the direction of the securities, foreign currency and interest rate markets are inaccurate, the consequences to the Fund may leave the Fund in a worse position than if such strategies were not used. Risks inherent in the use of options, foreign currency, swaps contracts, futures contracts and options on futures contracts, swap contracts, securities indices and foreign currencies include: <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Arial, Helvetica, Sans-Serif"> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 0.25in; text-align: right; vertical-align: top"></td> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top">●</td> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; text-align: justify; text-indent: 0in">dependence on the Investment Adviser’s ability to predict correctly movements in the direction of interest rates, securities prices and currency markets;</td> </tr> </table> <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Arial, Helvetica, Sans-Serif"> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 0.25in; text-align: right; vertical-align: top"></td> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top">●</td> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; text-align: justify; text-indent: 0in">imperfect correlation between the price of options and futures contracts and options thereon and movements in the prices of the securities or currencies being hedged;</td> </tr> </table> <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Arial, Helvetica, Sans-Serif"> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 0.25in; text-align: right; vertical-align: top"></td> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top">●</td> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; text-align: justify; text-indent: 0in">the fact that skills needed to use these strategies are different from those needed to select portfolio securities;</td> </tr> </table> <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Arial, Helvetica, Sans-Serif"> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 0.25in; text-align: right; vertical-align: top"></td> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top">●</td> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; text-align: justify; text-indent: 0in">the possible absence of a liquid secondary market for any particular instrument at any time;</td> </tr> </table> <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Arial, Helvetica, Sans-Serif"> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 0.25in; text-align: right; vertical-align: top"></td> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top">●</td> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; text-align: justify; text-indent: 0in">the possible need to defer closing out certain hedged positions to avoid adverse tax consequences;</td> </tr> </table> <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Arial, Helvetica, Sans-Serif"> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 0.25in; text-align: right; vertical-align: top"></td> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top">●</td> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; text-align: justify; text-indent: 0in">the possible inability of the Fund to purchase or sell a security at a time that otherwise would be favorable for it to do so; and</td> </tr> </table> <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Arial, Helvetica, Sans-Serif"> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 0.25in; text-align: right; vertical-align: top"></td> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top">●</td> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; text-align: justify; text-indent: 0in">the creditworthiness of counterparties.</td> </tr> </table> Options, futures contracts, swaps contracts and options thereon and forward contracts on securities and currencies may be traded on foreign exchanges. Such transactions may not be regulated as effectively as similar transactions in the United States, may not involve a clearing mechanism and related guarantees, and are subject to the risk of governmental actions affecting trading in, or the prices of, foreign securities. The value of such positions also could be adversely affected by (i) other complex foreign political, legal and economic factors, (ii) lesser availability than in the United States of data on which to make trading decisions, (iii) delays in the ability of the Fund to act upon economic events occurring in the foreign markets during non-business hours in the United States, (iv) the imposition of different exercise and settlement terms and procedures and margin requirements than in the United States and (v) less trading volume. Exchanges on which options, futures, swaps and options on futures or swaps are traded may impose limits on the positions that the Fund may take in certain circumstances. Many OTC derivatives are valued on the basis of dealers’ pricing of these instruments. However, the price at which dealers value a particular derivative and the price which the same dealers would actually be willing to pay for such derivative should the Fund wish or be forced to sell such position may be materially different. Such differences can result in an overstatement of the Fund’s NAV and may materially adversely affect the Fund in situations in which the Fund is required to sell derivative instruments. Exchange-traded derivatives and OTC derivative transactions submitted for clearing through a central counterparty have become subject to minimum initial and variation margin requirements set by the relevant clearinghouse, as well as possible margin requirements mandated by the SEC or the Commodity Futures Trading Commission. These regulators also have broad discretion to impose margin requirements on non-cleared OTC derivatives. These margin requirements will increase the overall costs for the Fund. While hedging can reduce or eliminate losses, it can also reduce or eliminate gains. Hedges are sometimes subject to imperfect matching between the derivative and the underlying security, and there can be no assurance that the Fund’s hedging transactions will be effective. Derivatives may give rise to a form of leverage and may expose the Fund to greater risk and increase its costs. Under Rule 18f-4 under the 1940 Act, among other things, the Fund must either use derivatives in a limited manner or comply with an outer limit on fund leverage risk based on value-at-risk. See “—Derivatives Transactions Subject to Rule18f-4 Under the 1940 Act” below. Special Risk Considerations Relating to Futures and Options Thereon. The Fund’s ability to establish and close out positions in futures contracts and options thereon will be subject to the development and maintenance of liquid markets. Although the Fund generally will purchase or sell only those futures contracts and options thereon for which there appears to be a liquid market, there is no assurance that a liquid market on an exchange will exist for any particular futures contract or option thereon at any particular time. In the event no liquid market exists for a particular futures contract or option thereon in which the Fund maintains a position, it may not be possible to effect a closing transaction in that contract or to do so at a satisfactory price and the Fund may have to either make or take delivery under the futures contract or, in the case of a written option, wait to sell the underlying securities until the option expires or is exercised or, in the case of a purchased option, exercise the option. In the case of a futures contract or an option thereon which the Fund has written and which the Fund is unable to close, the Fund would be required to maintain margin deposits on the futures contract or option thereon and to make variation margin payments until the contract is closed. Successful use of futures contracts and options thereon and forward contracts by the Fund is subject to the ability of the Investment Adviser to predict correctly movements in the direction of interest and foreign currency rates. If the Investment Adviser’s expectations are not met, the Fund will be in a worse position than if a hedging strategy had not been pursued. For example, if the Fund has hedged against the possibility of an increase in interest rates that would adversely affect the price of securities in its portfolio and the price of such securities increases instead, the Fund will lose part or all of the benefit of the increased value of its securities because it will have offsetting losses in its futures positions. In addition, in such situations, if the Fund has insufficient cash to meet daily variation margin requirements, it may have to sell securities to meet the requirements. These sales may be, but will not necessarily be, at increased prices that reflect the rising market. The Fund may have to sell securities at a time when it is disadvantageous to do so. Additional Risks of Foreign Options, Futures Contracts, Swaps Contracts, Options on Futures Contracts and Forward Contracts. Options, futures contracts, swaps contracts and options thereon and forward contracts on securities and currencies may be traded on foreign exchanges. Such transactions may not be regulated as effectively as similar transactions in the United States, may not involve a clearing mechanism and related guarantees, and are subject to the risk of governmental actions affecting trading in, or the prices of, foreign securities. The value of such positions also could be adversely affected by (i) other complex foreign political, legal and economic factors, (ii) lesser availability than in the United States of data on which to make trading decisions, (iii) delays in the ability of the Fund to act upon economic events occurring in the foreign markets during non-business hours in the United States, (iv) the imposition of different exercise and settlement terms and procedures and margin requirements than in the United States and (v) less trading volume. Exchanges on which options, futures, swaps and options on futures or swaps are traded may impose limits on the positions that the Fund may take in certain circumstances. See “Risk Factors and Special Considerations – Futures Transactions.” Derivatives Transactions Subject to Rule 18f-4 Under the 1940 Act. Rule 18f-4 under the 1940 Act governs the Fund’s use of derivative instruments and certain other transactions that create future payment and/or delivery obligations by the Fund. Rule 18f-4 permits the Fund to enter into Derivatives Transactions (as defined below) and certain other transactions notwithstanding the restrictions on the issuance of “senior securities” under Section 18 of the 1940 Act. Section 18 of the Investment Company Act, among other things, prohibits closed-end funds, including the Trust, from issuing or selling any “senior security” representing indebtedness (unless the fund maintains 300% “asset coverage”) or any senior security representing stock (unless the fund maintains 200% “asset coverage”). In connection with the adoption of Rule 18f-4, the SEC eliminated the asset segregation framework arising from prior SEC guidance for covering Derivatives Transactions and certain financial instruments. Under Rule 18f-4, “Derivatives Transactions” include the following: (i) any swap, security-based swap (including a contract for differences), futures contract, forward contract, option (excluding purchased options), any combination of the foregoing, or any similar instrument, under which the Fund is or may be required to make any payment or delivery of cash or other assets during the life of the instrument or at maturity or early termination, whether as margin or settlement payment or otherwise; (ii) any short sale borrowing; (iii) reverse repurchase agreements and similar financing transactions, if the Fund elects to treat these transactions as Derivatives Transactions under Rule 18f-4; and (iv) when-issued or forward-settling securities (e.g., firm and standby commitments, including to-be-announced (“TBA”) commitments, and dollar rolls) and non-standard settlement cycle securities, unless the Fund intends to physically settle the transaction and the transaction will settle within 35 days of its trade date. Unless the Fund is relying on the Limited Derivatives User Exception (as defined below), the Fund must comply with Rule 18f-4 with respect to its Derivatives Transactions. Rule 18f-4, among other things, requires the Fund to (i) appoint a Derivatives Risk Manager, (ii) maintain a Derivatives Risk Management Program designed to identify, assess, and reasonably manage the risks associated with Derivatives Transactions; (iii) comply with certain value-at-risk (VaR)-based leverage limits (VaR is an estimate of an instrument’s or portfolio’s potential losses over a given time horizon and at a specified confidence level); and (iv) comply with certain Board reporting and recordkeeping requirements. Rule 18f-4 provides an exception from the requirements to appoint a Derivatives Risk Manager, adopt a Derivatives Risk Management Program, comply with certain VaR-based leverage limits, and comply with certain Board oversight and reporting requirements if the Fund’s “derivatives exposure” (as defined in Rule 18f-4) is limited to 10% of its net assets (as calculated in accordance with Rule 18f-4) and the Fund adopts and implements written policies and procedures reasonably designed to manage its derivatives risks (the “Limited Derivatives User Exception”). Pursuant to Rule 18f-4, if the Fund enters into reverse repurchase agreements or similar financing transactions, the Fund will (i) aggregate the amount of indebtedness associated with all of its reverse repurchase agreements or similar financing transactions with the amount of any other “senior securities” representing indebtedness (e.g., bank borrowings, if applicable) when calculating the Fund’s asset coverage ratio or (ii) treat all such transactions as Derivatives Transactions. The requirements of Rule 18f-4 may limit the Fund’s ability to engage in Derivatives Transactions as part of its investment strategies. These requirements may also increase the cost of the Fund’s investments and cost of doing business, which could adversely affect the value of the Fund’s investments and/or the performance of the Fund. Futures Transactions The Fund may make investments in futures and options on futures. Risks include, but are not limited to, the following: <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Arial, Helvetica, Sans-Serif"> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 0.25in; text-align: right; vertical-align: top"></td> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top">●</td> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; text-align: justify; text-indent: 0in">no assurance that futures contracts or options on futures can be offset at favorable prices;</td> </tr> </table> <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Arial, Helvetica, Sans-Serif"> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 0.25in; text-align: right; vertical-align: top"></td> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top">●</td> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; text-align: justify; text-indent: 0in">possible reduction of the yield of the Fund due to the use of hedging;</td> </tr> </table> <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Arial, Helvetica, Sans-Serif"> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 0.25in; text-align: right; vertical-align: top"></td> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top">●</td> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; text-align: justify; text-indent: 0in">possible reduction in value of both the securities hedged and the hedging instrument;</td> </tr> </table> <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Arial, Helvetica, Sans-Serif"> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 0.25in; text-align: right; vertical-align: top"></td> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top">●</td> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; text-align: justify; text-indent: 0in">possible lack of liquidity due to daily limits or price fluctuations;</td> </tr> </table> <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Arial, Helvetica, Sans-Serif"> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 0.25in; text-align: right; vertical-align: top"></td> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top">●</td> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; text-align: justify; text-indent: 0in">imperfect correlation between the contracts and the securities being hedged; and</td> </tr> </table> <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Arial, Helvetica, Sans-Serif"> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 0.25in; text-align: right; vertical-align: top"></td> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top">●</td> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; text-align: justify; text-indent: 0in">losses from investing in futures transactions that are potentially unlimited.</td> </tr> </table> Swap Agreements Swap agreements involve the risk that the party with whom the Fund has entered into the swap will default on its obligation to pay the Fund and the risk that the Fund will not be able to meet its obligations to pay the other party to the agreement. Whether the Fund’s use of swap agreements will be successful in furthering its investment objective will depend on the Investment Adviser’s ability to correctly predict whether certain types of investments are likely to produce greater returns than other investments. Because they are two party contracts and because they may have terms of greater than seven days, some swap agreements may be considered by the Fund to be illiquid. Restrictions imposed by the tax rules applicable to regulated investment companies may limit the Fund’s ability to use swap agreements. The swap market currently is largely unregulated. It is possible that developments in the swap market, including potential significant government regulation as a result of the Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010 (the “Dodd-Frank Act”) or otherwise, could adversely affect the Fund’s ability to enter into or terminate swap agreements or to realize amounts to be received under these agreements. Swap transactions may involve substantial leverage. <p id="xdx_842_ecef--RiskTextBlock_hcef--RiskAxis__custom--ForwardCurrencyExchangeContractsMember_zlck3WRZjLda" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">Forward Currency Exchange Contracts The use of forward currency exchange contracts may involve certain risks, including the failure of the counterparty to perform its obligations under the contract and that the use of forward contracts may not serve as a complete hedge because of an imperfect correlation between movements in the prices of the contracts and the prices of the currencies hedged or used for cover. Risks of Currency Transactions. Currency transactions are also subject to risks different from those of other portfolio transactions. Because currency control is of great importance to the issuing governments and influences economic planning and policy, purchases and sales of currency and related instruments can be adversely affected by government exchange controls, limitations or restrictions on repatriation of currency, and manipulation, or exchange restrictions imposed by governments. These forms of governmental action can result in losses to the Fund if it is unable to deliver or receive currency or monies in settlement of obligations and could also cause hedges it has entered into to be rendered useless, resulting in full currency exposure as well as incurring transaction costs. <p id="xdx_849_ecef--RiskTextBlock_hcef--RiskAxis__custom--InterestRateTransactionsMember_zYpScGp5Xig6" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">Interest Rate Transactions The Fund may enter into an interest rate swap or cap transaction. The use of interest rate swaps and caps is a highly specialized activity that involves certain risks to the Fund including, among others, counterparty risk and early termination risk. Counterparty Risk The Fund will be subject to credit risk with respect to the counterparties to the derivative contracts purchased by the Fund. If a counterparty becomes bankrupt or otherwise fails to perform its obligations under a derivative contract due to financial difficulties, the Fund may experience significant delays in obtaining any recovery under the derivative contract in bankruptcy or other reorganization proceeding. The Fund may obtain only a limited recovery or may obtain no recovery in such circumstances. Dodd-Frank Act Risk Title VII of the Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010 (the “Dodd-Frank Act”) (the “Derivatives Title”) imposed a substantially new regulatory structure on derivatives markets, with particular emphasis on swaps (which are subject to oversight by the CFTC) and security-based swaps (which are subject to oversight by the SEC). The regulatory framework covers a broad range of swap market participants, including banks, non-banks, credit unions, insurance companies, broker-dealers and investment advisers. Prudential regulators were granted authority to regulate margining of swaps and security-based swaps of banks and bank-related entities. Current regulations for swaps require the mandatory central clearing and mandatory exchange trading of particular types of interest rate swaps and index credit default swaps (together, “Covered Swaps”). The Fund is required to clear its Covered Swaps through a clearing broker, which requires, among other things, posting initial margin and variation margin to the Fund’s clearing broker in order to enter into and maintain positions in Covered Swaps. Covered Swaps generally are required to be executed through a swap execution facility (“SEF”), which can involve additional transaction fees. Additionally, under the Dodd-Frank Act, with respect to uncleared swaps (both uncleared swaps and uncleared security-based swaps entered into with banks), swap dealers are required to collect from the Fund both initial and variation margin (comprised of specified liquid instruments and subject to a required haircut). Shares of investment companies (other than certain money market funds) may not be posted as collateral under applicable regulations. As capital and margin requirements for swap dealers and capital and margin requirements for security-based swaps are implemented, such requirements may make certain types of trades and/or trading strategies more costly. There may be market dislocations due to uncertainty during the implementation period of any new regulation and the Investment Adviser cannot know how the derivatives market will adjust to such new regulations. In addition, regulations adopted by global prudential regulators that are now in effect require certain bank-regulated counterparties and certain of their affiliates to include in “qualified financial contracts,” including many derivatives contracts as well as repurchase agreements and securities lending agreements, terms that delay or restrict the rights of counterparties to terminate such contracts, foreclose upon collateral, exercise other default rights or restrict transfers of affiliate credit enhancements (such as guarantees) in the event that the bank-regulated counterparty and/or its affiliates are subject to certain types of resolution or insolvency proceedings. <p id="xdx_84D_ecef--RiskTextBlock_hcef--RiskAxis__custom--SpecialRisksRelatedToFundInvestmentsInPreferredSecuritiesMember_zNKT2XEx71y9" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">Special Risks Related to Fund Investments in Preferred Securities There are special risks associated with the Fund’s investing in preferred securities, including: <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Arial, Helvetica, Sans-Serif"> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 0.25in; text-align: right; vertical-align: top"></td> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top">●</td> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; text-align: justify; text-indent: 0in">Deferral. Preferred securities may include provisions that permit the issuer, at its discretion, to defer dividends or distributions for a stated period without any adverse consequences to the issuer. If the Fund owns a preferred security that is deferring its dividends or distributions, the Fund may be required to report income for tax purposes although it has not yet received such income.</td> </tr> </table> <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Arial, Helvetica, Sans-Serif"> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 0.25in; text-align: right; vertical-align: top"></td> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top">●</td> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; text-align: justify; text-indent: 0in">Non-Cumulative Dividends. Some preferred securities are non-cumulative, meaning that the dividends do not accumulate and need not ever be paid. A portion of the portfolio may include investments in non-cumulative preferred securities, whereby the issuer does not have an obligation to make up any arrearages to its shareholders. Should an issuer of a non-cumulative preferred security held by the Fund determine not to pay dividends or distributions on such security, the Fund’s return from that security may be adversely affected. There is no assurance that dividends or distributions on non-cumulative preferred securities in which the Fund invests will be declared or otherwise made payable.</td> </tr> </table> <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Arial, Helvetica, Sans-Serif"> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 0.25in; text-align: right; vertical-align: top"></td> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top">●</td> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; text-align: justify; text-indent: 0in">Subordination. Preferred securities are subordinated to bonds and other debt instruments in an issuer’s capital structure in terms of priority to corporate income and liquidation payments, and therefore will be subject to greater credit risk than more senior debt security instruments.</td> </tr> </table> <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Arial, Helvetica, Sans-Serif"> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 0.25in; text-align: right; vertical-align: top"></td> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top">●</td> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; text-align: justify; text-indent: 0in">Liquidity. Preferred securities may be substantially less liquid than many other securities, such as common stocks or U.S. government securities.</td> </tr> </table> <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Arial, Helvetica, Sans-Serif"> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 0.25in; text-align: right; vertical-align: top"></td> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top">●</td> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; text-align: justify; text-indent: 0in">Limited Voting Rights. Generally, preferred security holders (such as the Fund) have no voting rights with respect to the issuing company unless preferred dividends have been in arrears for a specified number of periods, at which time the preferred security holders may be entitled to elect a number of directors to the issuer’s board. Generally, once all the arrearages have been paid, the preferred security holders no longer have voting rights.</td> </tr> </table> <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Arial, Helvetica, Sans-Serif"> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 0.25in; text-align: right; vertical-align: top"></td> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top">●</td> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; text-align: justify; text-indent: 0in">Special Redemption Rights. In certain varying circumstances, an issuer of preferred securities may redeem the securities prior to a specified date. For instance, for certain types of preferred securities, a redemption may be triggered by a change in federal income tax or securities laws. A redemption by the issuer may negatively impact the return of the security held by the Fund.</td> </tr> </table> <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Arial, Helvetica, Sans-Serif"> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 0.25in; text-align: right; vertical-align: top"></td> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top">●</td> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; text-align: justify; text-indent: 0in">Phantom Income. Some preferred securities are classified as debt for U.S. federal income tax purposes. If a debt instrument is issued with original issue discount, the Fund could recognize taxable income in advance of the receipt of cash on the investment. This “phantom income” may require the Fund to liquidate other investments (including when it is not advantageous to do so) to meet its distribution requirements or otherwise qualify for treatment as a RIC.</td> </tr> </table> <p id="xdx_847_ecef--RiskTextBlock_hcef--RiskAxis__custom--SpecialRisksForHoldersOfSubscriptionRightsMember_z8AoAgfbspf9" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">Special Risks for Holders of Subscription Rights The issuance of subscription rights to purchase our common shares may substantially dilute the aggregate NAV of the common shares owned by shareholders who do not fully exercise their rights in the offering. Shareholders who do not exercise their rights to purchase common stock will own a smaller proportional interest in the Fund than they did before the offering. In the case of subscription rights for preferred shares, there is a risk that changes in yield or changes in the credit quality of the Fund may result in the underlying preferred shares purchasable upon exercise of the subscription rights being less attractive to investors at the conclusion of the subscription period. This may reduce or eliminate the value of the subscription rights for the preferred shares. Investors who receive subscription rights may find that there is no market to sell rights they do not wish to exercise. If investors exercise only a portion of the rights, the number of preferred shares or common shares issued may be reduced, and the preferred shares or common shares may trade at less favorable prices than larger offerings for similar securities. Management Risk The Fund is subject to management risk because it is an actively managed portfolio. The Investment Adviser applies investment techniques and risk analyses in making investment decisions for the Fund, but there can be no guarantee that these will produce the desired results. Portfolio Turnover The Fund may have a high turnover ratio which may result in higher expenses and lower after-tax return to shareholders than if the Fund had a lower turnover ratio. <p id="xdx_84F_ecef--RiskTextBlock_hcef--RiskAxis__custom--DependenceOnKeyPersonnelMember_z7uiwM5964za" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">Dependence on Key Personnel Mr. Mario J. Gabelli is a portfolio manager of the Fund. The Investment Adviser is dependent upon the expertise of Mr. Gabelli in providing advisory services with respect to the Fund’s investments. If the Investment Adviser were to lose the services of Mr. Gabelli, its ability to service the Fund could be adversely affected. There can be no assurance that a suitable replacement could be found for Mr. Gabelli in the event of his death, resignation, retirement or inability to act on behalf of the Investment Adviser. Coronavirus (“COVID-19”) and Global Health Event Risk An outbreak of a highly contagious novel coronavirus known as “COVID 19” that was first declared in December 2019 developed into a global pandemic that had a devastating impact on the global economy, including the U.S. economy, and resulted in a global economic recession. Many states issued orders requiring the closure of non-essential businesses and/or requiring residents to stay at home. The COVID 19 pandemic and preventative measures taken to contain or mitigate its spread caused business shutdowns, cancellations of events and travel, significant reductions in demand for certain goods and services, reductions in business activity and financial transactions, supply chain interruptions and overall economic and financial market instability both globally and in the United States. The U.S. economy and most other major global economies may continue to experience a substantial economic downturn or recession, and our business and operations, as well as the business and operations of our portfolio companies, could be materially adversely affected by a prolonged economic downturn or recession in the United States and other major markets. The impact of this coronavirus, and other epidemics and pandemics that may arise in the future, could affect the economies of many nations, individual companies and the market in general ways that cannot necessarily be foreseen at the present time. These events could have a significant impact on the Fund’s performance, NAV, income, operating results and ability to pay distributions, as well as the performance, income, operating results and viability of issuers in which it invests. <p id="xdx_842_ecef--RiskTextBlock_hcef--RiskAxis__custom--MarketDisruptionAndGeopoliticalRiskMember_zZNdiQm4s5Di" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">Market Disruption and Geopolitical Risk The consequences of the conflict between Russia and Ukraine, including international sanctions, further impact on inflation and increased disruption to supply chains may impact our portfolio companies, result in an economic downturn or recession either globally or locally in the U.S. or other economies, reduce business activity, spawn additional conflicts (whether in the form of traditional military action, reignited “cold” wars or in the form of virtual warfare such as cyberattacks) with similar and perhaps wider ranging impacts and consequences and have an adverse impact on the Fund’s returns and NAV. The occurrence of events similar to those in recent years, such as localized wars, instability, new and ongoing pandemics (such as COVID-19), epidemics or outbreaks of infectious diseases in certain parts of the world, natural/environmental disasters, terrorist attacks in the United States and around the world, social and political discord, debt crises sovereign debt downgrades, increasingly strained relations between the United States and a number of foreign countries, new and continued political unrest in various countries, the exit or potential exit of one or more countries from the European Union (“EU”) or the Economic and Monetary Union, continued changes in the balance of political power among and within the branches of the U.S. government, government shutdowns, among others, may result in market volatility, may have long term effects on the U.S. and worldwide financial markets, and may cause further economic uncertainties in the United States and worldwide. The current contentious domestic political environment, as well as political and diplomatic events within the United States and abroad, such as the U.S. government’s inability at times to agree on a long-term budget and deficit reduction plan, may in the future result in government shutdowns, which could have a material adverse effect on the Fund’s investments and operations. In addition, the Fund’s ability to raise additional capital in the future through the sale of securities could be materially affected by a government shutdown. Additional and/ or prolonged U.S. government shutdowns may affect investor and consumer confidence and may adversely impact financial markets and the broader economy, perhaps suddenly and to a significant degree. In particular, the escalation of the conflict between Russia and Ukraine, including international sanctions, further impact on inflation and increased disruption to supply chains may impact our portfolio companies. Such unfavorable economic conditions also may also be expected to increase our funding costs, limit our access to the capital markets or result in a decision by lenders not to extend credit to us. The current political climate has intensified concerns about a potential trade war between China and the United States, as each country has recently imposed tariffs on the other country’s products. These actions may trigger a significant reduction in international trade, the oversupply of certain manufactured goods, substantial price reductions of goods and possible failure of individual companies and/or large segments of China’s export industry, which could have a negative impact on our performance. U.S. companies that source material and goods from China and those that make large amounts of sales in China would be particularly vulnerable to an escalation of trade tensions. Uncertainty regarding the outcome of the trade tensions and the potential for a trade war could cause the U.S. dollar to decline against safe haven currencies, such as the Japanese yen and the euro. Events such as these and their consequences are difficult to predict and it is unclear whether further tariffs may be imposed or other escalating actions may be taken in the future. Any of these effects could have a material adverse effect on our business, financial condition and results of operations. On January 31, 2020, the United Kingdom officially left the European Union (“Brexit”), subject to a transitional period that ended December 31, 2020. The United Kingdom and European Union have reached an agreement on the terms of their future trading relationship effective January 1, 2021, which principally relates to the trading of goods rather than services, including financial services. Further discussions are to be held between the United Kingdom and the European Union in relation to matters not covered by the trade agreement, such as financial services. The Fund faces risks associated with the potential uncertainty and consequences that may follow Brexit, including with respect to volatility in exchange rates and interest rates. Brexit could adversely affect European or worldwide political, regulatory, economic or market conditions and could contribute to instability in global political institutions, regulatory agencies and financial markets. Brexit has also led to legal uncertainty and could lead to politically divergent national laws and regulations as a new relationship between the United Kingdom and European Union is defined and the United Kingdom determines which European Union laws to replace or replicate. Any of these effects of Brexit could adversely affect any of the companies to which the Fund has exposure and any other assets that the Fund invests in. The political, economic and legal consequences of Brexit are not yet known. In the short term, financial markets may experience heightened volatility, particularly those in the United Kingdom and Europe, but possibly worldwide. The United Kingdom and Europe may be less stable than they have been in recent years, and investments in the United Kingdom and the European Union may be difficult to value or subject to greater or more frequent volatility. In the longer term, there is likely to be a period of significant political, regulatory and commercial uncertainty as the United Kingdom continues to negotiate the terms of its future trading relationship with the European Union. While the extreme volatility and disruption that U.S. and global markets experienced for an extended period of time beginning in 2007 and 2008 had, until the recent coronavirus (COVID-19) outbreak, generally subsided, uncertainty and periods of volatility still remain, and risks to a robust resumption of growth persist. Federal Reserve policy, including with respect to certain interest rates, may adversely affect the value, volatility and liquidity of dividend and interest paying securities. Market volatility, dramatic changes to interest rates and/or a return to unfavorable economic conditions may lower the Fund’s performance or impair the Fund’s ability to achieve its investment objective. Cybersecurity incidents affecting particular companies or industries may adversely affect the economies of particular countries, regions or parts of the work in which the Fund invests. The occurrence of any of these above events could have a significant adverse impact on the value and risk profile of the Fund’s portfolio. The Fund does not know how long the securities markets may be affected by similar events and cannot predict the effects of similar events in the future on the U.S. economy and securities markets. There can be no assurance that similar events and other market disruptions will not have other material and adverse implications. <p id="xdx_841_ecef--RiskTextBlock_hcef--RiskAxis__custom--EconomicEventsAndMarketRiskMember_zkIWG13muQLb" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">Economic Events and Market Risk Periods of market volatility may continue to occur in the future, in response to various political, social and economic events both within and outside of the United States. These conditions have resulted in, and in many cases continue to result in, greater price volatility, less liquidity, widening credit spreads and a lack of price transparency, with many securities remaining illiquid and of uncertain value. Such market conditions may adversely affect the Fund, including by making valuation of some of the Fund’s securities uncertain and/or result in sudden and significant valuation increases or declines in the Fund’s holdings. If there is a significant decline in the value of the Fund’s portfolio, this may impact the asset coverage levels for the Fund’s outstanding leverage. Risks resulting from any future debt or other economic crisis could also have a detrimental impact on the global economic recovery, the financial condition of financial institutions and our business, financial condition and results of operation. Market and economic disruptions have affected, and may in the future affect, consumer confidence levels and spending, personal bankruptcy rates, levels of incurrence and default on consumer debt and home prices, among other factors. To the extent uncertainty regarding the U.S. or global economy negatively impacts consumer confidence and consumer credit factors, our business, financial condition and results of operations could be significantly and adversely affected. Downgrades to the credit ratings of major banks could result in increased borrowing costs for such banks and negatively affect the broader economy. Moreover, Federal Reserve policy, including with respect to certain interest rates, may also adversely affect the value, volatility and liquidity of dividend- and interest-paying securities. Market volatility, rising interest rates and/ or a return to unfavorable economic conditions could impair the Fund’s ability to achieve its investment objective. <p id="xdx_842_ecef--RiskTextBlock_hcef--RiskAxis__custom--RegulationAndGovernmentInterventionRiskMember_zdVHQaXVKZS9" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">Regulation and Government Intervention Risk Federal, state, and other governments, their regulatory agencies or self-regulatory organizations may take actions that affect the regulation of the issuers in which the Fund invests in ways that are unforeseeable. Legislation or regulation may also change the way in which the Fund is regulated. Such legislation or regulation could limit or preclude the Fund’s ability to achieve its investment objective. In light of popular, political and judicial focus on finance related consumer protection, financial institution practices are also subject to greater scrutiny and criticism generally. In the case of transactions between financial institutions and the general public, there may be a greater tendency toward strict interpretation of terms and legal rights in favor of the consuming public, particularly where there is a real or perceived disparity in risk allocation and/or where consumers are perceived as not having had an opportunity to exercise informed consent to the transaction. In the event of conflicting interests between retail investors holding common shares of a closed-end investment company such as the Fund and a large financial institution, a court may similarly seek to strictly interpret terms and legal rights in favor of retail investors. The Fund may be affected by governmental action in ways that are not foreseeable, and there is a possibility that such actions could have a significant adverse effect on the Fund and its ability to achieve its investment objective. Inflation Risk Inflation risk is the risk that the value of assets or income from investments will be worth less in the future as inflation decreases the value of money. Inflation rates may change frequently and drastically as a result of various factors, including unexpected shifts in the domestic or global economy. As inflation increases, the real value of the Fund’s shares and distributions therefore may decline. In addition, during any periods of rising inflation, dividend rates of any debt securities issued by the Fund would likely increase, which would tend to further reduce returns to common shareholders. Deflation Risk Deflation risk is the risk that prices throughout the economy decline over time, which may have an adverse effect on the market valuation of companies, their assets and their revenues. In addition, deflation may have an adverse effect on the creditworthiness of issuers and may make issuer default more likely, which may result in a decline in the value of the Fund’s portfolio. Leverage Risk The Fund currently uses, and intends to continue to use, leverage for investment purposes by issuing preferred shares. “Leverage” for these purposes means the ratio by which the aggregate amount of senior securities representing indebtedness of the Fund plus the aggregate involuntary liquidation preference of the Fund’s preferred shares bears to the Fund’s total assets. As of December 31, 2023, the amount of leverage represented approximately 22% of the Fund’s total assets. All series of the Fund’s preferred shares have the same seniority with respect to distributions and liquidation preference. Preferred shares have seniority over common shares with respect to distributions and upon liquidation of the Fund. The Fund’s leveraged capital structure creates special risks not associated with unleveraged funds having similar investment objectives and policies. The Fund’s use of leverage, which can be described as exposure to changes in price at a ratio greater than the amount of equity invested, either through the issuance of preferred shares, borrowing or other forms of market exposure, magnifies both the favorable and unfavorable effects of price movements in the investments made by the Fund. The Fund’s leveraged capital structure creates special risks not associated with unleveraged funds having similar investment objectives and policies. The Fund cannot assure that the issuance of preferred shares will result in a higher yield or return to the holders of the common shares. Also, as the Fund is utilizing leverage, a decline in NAV could affect the ability of the Fund to make common share distributions and such a failure to pay dividends or make distributions could result in the Fund ceasing to qualify as a regulated investment company under the Code. <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Arial, Helvetica, Sans-Serif"> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 0.25in; text-align: right; vertical-align: top"></td> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top">●</td> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; text-align: justify; text-indent: 0in">Preferred Share Risk. The issuance of preferred shares causes the NAV and market value of the common shares to become more volatile. If the dividend rate on the preferred shares approaches the net rate of return on the Fund’s investment portfolio, the benefit of leverage to the holders of the common shares would be reduced. If the dividend rate on the preferred shares plus the management fee annual rate of 1.00% (as applicable) exceeds the net rate of return on the Fund’s portfolio, the leverage will result in a lower rate of return to the holders of common shares than if the Fund had not issued preferred shares.</td> </tr> </table> Any decline in the NAV of the Fund’s investments would be borne entirely by the holders of common shares. Therefore, if the market value of the Fund’s portfolio declines, the leverage will result in a greater decrease in NAV to the holders of common shares than if the Fund were not leveraged. This greater NAV decrease will also tend to cause a greater decline in the market price for the common shares. In such a case, the Fund might be in danger of failing to maintain the required asset coverage of the preferred shares or of losing its ratings (if any) on the preferred shares or, in an extreme case, the Fund’s current investment income might not be sufficient to meet the dividend requirements on the preferred shares. In order to counteract such an event, the Fund might need to liquidate investments in order to fund a redemption of some or all of the preferred shares. In addition, the Fund would pay (and the holders of common shares will bear) all costs and expenses relating to the issuance and ongoing maintenance of the preferred shares, including the advisory fees on the incremental assets attributable to such shares. Holders of preferred shares may have different interests than holders of common shares and may at times have disproportionate influence over the Fund’s affairs. Holders of preferred shares, voting separately as a single class, have the right to elect two members of the Board at all times and in the event dividends become two full years in arrears have the right to elect a majority of the Trustees until such arrearage is completely eliminated. In addition, preferred shareholders have class voting rights on certain matters, including changes in fundamental investment restrictions and conversion of the Fund to open-end status, and accordingly can veto any such changes. Restrictions imposed on the declarations and payment of dividends or other distributions to the holders of the Fund’s common shares and preferred shares, both by the 1940 Act and by requirements imposed by any rating agencies, might impair the Fund’s ability to maintain its qualification as a regulated investment company for federal income tax purposes. While the Fund intends to redeem its preferred shares to the extent necessary to enable the Fund to distribute its income as required to maintain its qualification as a regulated investment company under the Code, there can be no assurance that such actions can be effected in time to meet the Code requirements. <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Arial, Helvetica, Sans-Serif"> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 0.25in; text-align: right; vertical-align: top"></td> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top">●</td> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; text-align: justify; text-indent: 0in">Special Risks to Holders of Fixed Rate Preferred Shares</td> </tr> </table> Illiquidity. Prior to the offering, there will be no public market for any additional series of Fixed Rate Preferred Shares. In the event any additional series of Fixed Rate Preferred Shares are issued, prior application may have been, but is not required to be, made to list such shares on a national securities exchange, which would be expected to be the NYSE. If no such application is made, there can be no assurances that any additional series of Fixed Rate Preferred Shares would be liquid at any time. If any additional series of Fixed Rate Preferred Shares are to be listed, during an initial period prior to listing, which would not be expected to exceed 30 days after the date of initial issuance, such shares may not be listed on any securities exchange. During such period, the underwriters may make a market in such shares, though, they will have no obligation to do so. Consequently, an investment in such shares may be illiquid during such period. Market Price Fluctuation. Fixed Rate Preferred Shares that are listed on a national securities exchange may trade at a premium to or discount from liquidation value for various reasons, including changes in interest rates. <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Arial, Helvetica, Sans-Serif"> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 0.25in; text-align: right; vertical-align: top"></td> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top">●</td> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; text-align: justify; text-indent: 0in">Special Risks to Holders of Notes. There may not be an established market for our notes. To the extent that our notes trade, they may trade at a price either higher or lower than their principal amount depending on interest rates, the rating (if any) on such notes and other factors.</td> </tr> </table> <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Arial, Helvetica, Sans-Serif"> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 0.25in; text-align: right; vertical-align: top"></td> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top">●</td> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; text-align: justify; text-indent: 0in">Special Risks to Holders of Notes and Preferred Shares</td> </tr> </table> Common Share Repurchases. Repurchases of common shares by the Fund may reduce the net asset coverage of the notes and preferred shares, which could adversely affect their liquidity or market prices, if such noted or preferred shares are listed on a national securities exchange. Common Share Distribution Policy. In the event the Fund does not generate a total return from dividends and interest received and net realized capital gains in an amount at least equal to its distributions for a given year, the Fund may return capital as part of its distribution. This would decrease the asset coverage per share with respect to the Fund’s notes or preferred shares, which could adversely affect their liquidity or market prices, if such notes or preferred shares are listed on a national securities exchange. See “Risk Factors and Special Considerations — Common Share Distribution Policy Risk.” Credit Quality Ratings. The Fund may obtain credit quality ratings for its preferred shares or notes, if desired; however, it is not required to do so and may issue preferred shares or notes without any rating. If rated, the Fund does not impose any minimum rating necessary to issue such preferred shares or notes. In order to obtain and maintain attractive credit quality ratings for preferred shares or borrowings, if desired, the Fund’s portfolio must satisfy over-collateralization tests established by the relevant rating agencies. These tests are more difficult to satisfy to the extent the Fund’s portfolio securities are of lower credit quality, longer maturity or not diversified by issuer and industry within the meaning of such rating agencies’ over-collateralization tests. These guidelines could affect portfolio decisions and may be more stringent than those imposed by the 1940 Act. With respect to ratings (if any) of the notes or preferred shares, a rating by a ratings agency does not eliminate or necessarily mitigate the risks of investing in our preferred shares or notes, and a rating may not fully or accurately reflect all of the securities’ credit risks. A rating does not address the liquidity or any other market risks of the securities being rated. A rating agency could downgrade the rating of our notes or preferred shares, which may make such securities less liquid in the secondary market. If a rating agency downgrades the rating assigned to our preferred shares or notes, we may alter our portfolio or redeem all or a portion of the preferred shares or notes that are then redeemable under certain circumstances. <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Arial, Helvetica, Sans-Serif"> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 0.25in; text-align: right; vertical-align: top"></td> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top">●</td> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; text-align: justify; text-indent: 0in">Special Risks of Notes to Holders of Common Shares. If the interest rate on the notes approaches the net rate of return on the Fund’s investment portfolio, the benefit of leverage to the holders of the common shares would be reduced. Any decline in the NAV of the Fund’s investments would be borne entirely by the holders of common shares. Therefore, if the market value of the Fund’s portfolio declines, the leverage will result in a greater decrease in NAV to the holders of common shares than if the Fund were not leveraged. This greater NAV decrease will also tend to cause a greater decline in the market price for the common shares. The Fund might be in danger of failing to maintain the required asset coverage of the notes. Holders of notes may have different interests than holders of common shares and at times may have disproportionate influence over the Fund’s affairs. In the event the Fund fails to maintain the specified level of asset coverage of any notes outstanding, the holders of the notes will have the right to elect a majority of the Fund’s trustees.</td> </tr> </table> <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Arial, Helvetica, Sans-Serif"> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 0.25in; text-align: right; vertical-align: top"></td> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top">●</td> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; text-align: justify; text-indent: 0in">Portfolio Guidelines of Rating Agencies for Preferred Shares and/or Credit Facility. In order to obtain and maintain attractive credit quality ratings for preferred shares or borrowings, if desired, the Fund must comply with investment quality, diversification and other guidelines established by the relevant rating agencies. These tests tend to require over-collateralization and may be more difficult to satisfy to the extent the Fund’s portfolio securities are of lower credit quality, longer maturity or not diversified by issuer and industry within the meaning of such rating agencies’ collateralization tests. These guidelines could affect portfolio decisions and may be more stringent than those imposed by the 1940 Act. In the event that a rating on the Fund’s preferred shares or notes is lowered or withdrawn by the relevant rating agency, the Fund may also be required to redeem all or part of its outstanding preferred shares or notes, and the common shares of the Fund will lose the potential benefits associated with a leveraged capital structure.</td> </tr> </table> <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Arial, Helvetica, Sans-Serif"> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 0.25in; text-align: right; vertical-align: top"></td> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top">●</td> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; text-align: justify; text-indent: 0in">Impact on Common Shares. Assuming that leverage will (1) be equal in amount to approximately 22% of the Fund’s total net assets, and (2) charge interest or involve dividend payments at a projected blended annual average leverage dividend or interest rate of 4.32%, then the annual return generated by the Fund’s portfolio (net of estimated expenses) must exceed approximately 1.01% of the Fund’s total net assets in order to cover such interest or dividend payments and other expenses specifically related to leverage. These numbers are merely estimates, used for illustration. Actual dividend rates, interest or payment rates may vary frequently and may be significantly higher or lower than the rate estimated above. The following table is furnished in response to requirements of the SEC. It is designed to illustrate the effect of leverage on common share total return, assuming investment portfolio total returns (comprised of net investment income of the Fund, realized gains or losses of the Fund and changes in the value of the securities held in the Fund’s portfolio) of –10%, –5%, 0%, 5% and 10%. These assumed investment portfolio returns are hypothetical figures and are not necessarily indicative of the investment portfolio returns experienced or expected to be experienced by the Fund. See “Risks.” The table further reflects leverage representing 22% of the Fund’s total assets, the Fund’s current projected blended an-nual average leverage dividend or interest rate of 4.32%, a management fee at an annual rate of 1.00% of the liquidation preference of any outstanding preferred shares and estimated annual incremental expenses attributable to any outstanding preferred shares of 0.04% of the Fund’s net assets attributable to common shares.</td> </tr> </table> <table cellpadding="0" cellspacing="0" style="font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"> <tr style="font-family: Arial, Helvetica, Sans-Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Arial, Helvetica, Sans-Serif; text-indent: -0.125in; padding-left: 0.125in; width: 40%; font-weight: bold; text-align: left">Assumed Return on Portfolio (Net of Expenses)</td> <td style="font-family: Arial, Helvetica, Sans-Serif; width: 1%"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif; width: 9%; text-align: right">(10</td> <td style="font-family: Arial, Helvetica, Sans-Serif; width: 1%; text-align: left">)%</td> <td style="font-family: Arial, Helvetica, Sans-Serif; width: 1%"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif; width: 9%; text-align: right">(5</td> <td style="font-family: Arial, Helvetica, Sans-Serif; width: 1%; text-align: left">)%</td> <td style="font-family: Arial, Helvetica, Sans-Serif; width: 1%"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif; width: 9%; text-align: right">0</td> <td style="font-family: Arial, Helvetica, Sans-Serif; width: 1%; text-align: left">%</td> <td style="font-family: Arial, Helvetica, Sans-Serif; width: 1%"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif; width: 9%; text-align: right">5</td> <td style="font-family: Arial, Helvetica, Sans-Serif; width: 1%; text-align: left">%</td> <td style="font-family: Arial, Helvetica, Sans-Serif; width: 1%"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif; width: 9%; text-align: right">10</td> <td style="font-family: Arial, Helvetica, Sans-Serif; width: 1%; text-align: left">%</td></tr> <tr style="font-family: Arial, Helvetica, Sans-Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Arial, Helvetica, Sans-Serif; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left">Common Shares Total Return</td> <td style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold; text-align: left"> </td> <td id="xdx_985_ecef--ReturnAtMinusTenPercent_dp_c20230101__20231231__cef--RiskAxis__custom--CommonStocksMember_zHXMZVNN6DS1" style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold; text-align: right">(14.51</td> <td style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold; text-align: left">)%</td> <td style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold; text-align: left"> </td> <td id="xdx_987_ecef--ReturnAtMinusFivePercent_dp_c20230101__20231231__cef--RiskAxis__custom--CommonStocksMember_zwReMSoFDW8d" style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold; text-align: right">(8.05</td> <td style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold; text-align: left">)%</td> <td style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold; text-align: left"> </td> <td id="xdx_98A_ecef--ReturnAtZeroPercent_dp_c20230101__20231231__cef--RiskAxis__custom--CommonStocksMember_zcK3siVVafp9" style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold; text-align: right">(1.58</td> <td style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold; text-align: left">)%</td> <td style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold; text-align: left"> </td> <td id="xdx_98A_ecef--ReturnAtPlusFivePercent_dp_c20230101__20231231__cef--RiskAxis__custom--CommonStocksMember_zqAnpM6peJ3b" style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold; text-align: right">4.89</td> <td style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold; text-align: left">%</td> <td style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold; text-align: left"> </td> <td id="xdx_984_ecef--ReturnAtPlusTenPercent_dp_c20230101__20231231__cef--RiskAxis__custom--CommonStocksMember_zkdhinUbmLBb" style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold; text-align: right">11.36</td> <td style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold; text-align: left">%</td></tr> </table> Common share total return is composed of two elements — the common share distributions paid by the Fund (the amount of which is largely determined by the taxable income of the Fund (including realized gains or losses) after paying interest on any debt and/or dividends on any preferred shares) and unrealized gains or losses on the value of the securities the Fund owns. As required by SEC rules, the table assumes that the Fund is more likely to suffer capital losses than to enjoy total return. For example, to assume a total return of 0% the Fund must assume that the income it receives on its investments is entirely offset by expenses and losses in the value of those investments. The Fund’s shares are leveraged and the risks and special considerations related to leverage described in this prospectus apply. Such leveraging of the shares cannot be fully achieved until the proceeds resulting from the use of leverage have been invested in accordance with the Fund’s investment objectives and policies. <p id="xdx_840_ecef--RiskTextBlock_hcef--RiskAxis__custom--PotentialDilutionInRightsOfferingsMember_zAw144YkSssg" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">Potential Dilution in Rights Offerings To the extent that the Fund engages in a rights offering, shareholders who do not exercise their subscription rights may, at the completion of such an offering, own a smaller proportional interest in the Fund than if they exercised their subscription rights. As a result of such an offering, a shareholder also may experience dilution in NAV per share if the subscription price per share is below the NAV per share on the expiration date. Specifically, if the subscription price per share is below the NAV per share of the Fund’s shares on the expiration date of the rights offering, a shareholder will experience an immediate dilution of the aggregate NAV of their shares if the shareholder does not participate in the offering and the shareholder will experience a reduction in the NAV per share of their shares whether or not the shareholder participates in the offering. The Fund cannot state precisely the extent of this dilution (if any) if the shareholder does not exercise his or her subscription rights because the Fund does not know what the NAV per share will be when a rights offering expires or what proportion of the rights will be exercised. There is also a risk that the Fund’s largest shareholders, record date shareholders of more than 5% of the outstanding common shares of the Fund, may increase their percentage ownership of the Fund through the exercise of the primary subscription and any over-subscription privilege. <p id="xdx_84F_ecef--RiskTextBlock_hcef--RiskAxis__custom--CommonShareDistributionPolicyRiskMember_ziEoGAcGLoKf" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">Common Share Distribution Policy Risk The Fund has adopted a policy, which may be changed at any time by the Board, of paying distributions on its common shares of $0.15 per share per quarter. In the event the Fund does not generate a total return from dividends and interest received and net realized capital gains in an amount equal to or in excess of its stated distribution in a given year, the Fund may return capital as part of such distribution, which may have the effect of decreasing the asset coverage per share with respect to the Fund’s preferred shares. Any return of capital should not be considered by investors as yield or total return on their investment in the Fund. Shareholders should not assume that a distribution from the Fund is comprised exclusively of net profits. For the fiscal year ended December 31, 2023, the Fund made distributions of $0.60 per common share, approximately $0.02 of which was deemed a return of capital. The Fund has made quarterly distributions with respect to its common shares since June 2012. A portion of the distributions to holders of common shares during four of the sixteen fiscal years since the Fund’s inception has constituted a return of capital. The composition of each distribution is estimated based on the earnings of the Fund as of the record date for each distribution. The actual composition of each of the current year’s distributions will be based on the Fund’s investment activity through the end of the calendar year. Legislation Risk At any time after the date of this report, legislation may be enacted that could negatively affect the assets of the Fund. Legislation or regulation may change the way in which the Fund itself is regulated. The Investment Adviser cannot predict the effects of any new governmental regulation that may be implemented and there can be no assurance that any new governmental regulation will not adversely affect the Fund’s ability to achieve its investment objective. <p id="xdx_840_ecef--RiskTextBlock_hcef--RiskAxis__custom--RelianceOnServiceProvidersRiskMember_zB5pz7zn1op5" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">Reliance on Service Providers Risk The Fund must rely upon the performance of service providers to perform certain functions, which may include functions that are integral to the Fund’s operations and financial performance. Failure by any service provider to carry out its obligations to the Fund in accordance with the terms of its appointment, to exercise due care and skill or to perform its obligations to the Fund at all as a result of insolvency, bankruptcy or other causes could have a material adverse effect on the Fund’s performance and returns to shareholders. The termination of the Fund’s relationship with any service provider, or any delay in appointing a replacement for such service provider, could materially disrupt the business of the Fund and could have a material adverse effect on the Fund’s performance and returns to shareholders. Cyber Security Risk The Fund and its service providers are susceptible to cyber security risks that include, among other things, theft, unauthorized monitoring, release, misuse, loss, destruction or corruption of confidential and highly restricted data; denial of service attacks; unauthorized access to relevant systems, compromises to networks or devices that the Fund and its service providers use to service the Fund’s operations; or operational disruption or failures in the physical infrastructure or operating systems that support the Fund and its service providers. Cyber attacks against or security breakdowns of the Fund or its service providers may adversely impact the Fund and its shareholders, potentially resulting in, among other things, financial losses; the inability of Fund shareholders to transact business and the Fund to process transactions; inability to calculate the Fund’s NAV; violations of applicable privacy and other laws; regulatory fines, penalties, reputational damage, reimbursement or other compensation costs; and/or additional compliance costs. The Fund may incur additional costs for cyber security risk management and remediation purposes. In addition, cyber security risks may also impact issuers of securities in which the Fund invests, which may cause the Fund’s investment in such issuers to lose value. There can be no assurance that the Fund or its service providers will not suffer losses relating to cyber attacks or other information security breaches in the future. <p id="xdx_848_ecef--RiskTextBlock_hcef--RiskAxis__custom--MisconductOfEmployeesAndOfServiceProvidersRiskMember_zUwJKAN8mdVl" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">Misconduct of Employees and of Service Providers Risk Misconduct or misrepresentations by employees of the Investment Adviser or the Fund’s service providers could cause significant losses to the Fund. Employee misconduct may include binding the Fund to transactions that exceed authorized limits or present unacceptable risks and unauthorized trading activities, concealing unsuccessful trading activities (which, in any case, may result in unknown and unmanaged risks or losses) or making misrepresentations regarding any of the foregoing. Losses could also result from actions by the Fund’s service providers, including, without limitation, failing to recognize trades and misappropriating assets. In addition, employees and service providers may improperly use or disclose confidential information, which could result in litigation or serious financial harm, including limiting the Fund’s business prospects or future marketing activities. Despite the Investment Adviser’s due diligence efforts, misconduct and intentional misrepresentations may be undetected or not fully comprehended, thereby potentially undermining the Investment Adviser’s due diligence efforts. As a result, no assurances can be given that the due diligence performed by the Investment Adviser will identify or prevent any such misconduct. <p id="xdx_844_ecef--RiskTextBlock_hcef--RiskAxis__custom--AntiTakeoverProvisionsOfTheFundsGoverningDocumentsMember_zDi5sp2d1kua" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">Anti-Takeover Provisions of the Fund’s Governing Documents The Fund’s Agreement and Declaration of Trust as amended and supplemented (including the statements of preferences thereto) and bylaws, as amended from time to time, include provisions that could limit the ability of other entities or persons to acquire control of the Fund or convert the Fund to an open-end fund. <p id="xdx_840_ecef--RiskTextBlock_hcef--RiskAxis__custom--StatusAsARegulatedInvestmentCompanyMember_zHjFhFkOrdUe" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">Status as a Regulated Investment Company The Fund has qualified, and intends to remain qualified, for federal income tax purposes as a regulated investment company under Subchapter M of the Code. Qualification requires, among other things, compliance by the Fund with certain distribution requirements. Statutory limitations on distributions on the common shares if the Fund fails to satisfy the 1940 Act’s asset coverage requirements could jeopardize the Fund’s ability to meet such distribution requirements. The Fund presently intends, however, to purchase or redeem preferred shares to the extent necessary in order to maintain compliance with such asset coverage requirements. Temporary Investments During temporary defensive periods and during inopportune periods to be fully invested, the Fund may invest in U.S. government securities, including U.S. Treasury securities, and in money market mutual funds that invest in those securities. Obligations of certain agencies and instrumentalities of the U.S. government, such as the Government National Mortgage Association, are supported by the “full faith and credit” of the U.S. government; others, such as those of the Export-Import Bank of the United States, are supported by the right of the issuer to borrow from the U.S. Treasury; others, such as those of the Federal National Mortgage Association, are supported by the discretionary authority of the U.S. government to purchase the agency’s obligations; and still others, such as those of the Student Loan Marketing Association, are supported only by the credit of the instrumentality. No assurance can be given that the U.S. government would provide financial support to U.S. government-sponsored instrumentalities if it is not obligated to do so by law. Investment Restrictions The Fund has adopted certain investment limitations designed to limit investment risk and maintain portfolio diversification. These limitations are fundamental and may not be changed without the approval of the holders of a majority, as defined in the 1940 Act, of the outstanding common shares and preferred shares voting together as a single class. The Fund may become subject to guidelines that are more limiting than the investment restrictions set forth above in order to obtain and maintain ratings from a credit rating agency on its preferred shares. See “Leverage Risk — Portfolio Guidelines of Rating Agencies for Preferred Shares and/or Credit Facility.” <p id="xdx_84C_ecef--RiskTextBlock_hcef--RiskAxis__custom--IndustryConcentrationRisksMember_zuJDqaMcxOMg" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">Industry Concentration Risks The Fund is concentrated in the healthcare and wellness industries. Under normal market conditions, the Fund will invest at least 80% of its net assets (plus borrowings made for investment purposes) in equity securities (such as common stock and preferred stock) and income producing securities (such as fixed income debt securities and securities convertible into common stock) of domestic and foreign companies in the healthcare and wellness industries. As a result of investing a significant portion of its assets in companies in the healthcare and wellness industries, the value of the Fund’s shares will be more susceptible to factors affecting those particular types of companies, which may include, among others, governmental regulation, changes in government subsidy and reimbursement levels, the governmental approval process, rapid obsolescence of products and services and patent expirations. The Investment Adviser believes that certain healthcare and wellness related companies could experience growth as a result of demographic changes and the Fund intends to focus on companies that will benefit from these demographic trends. However, certain of these companies may be less able to anticipate demographic trends and investments in these companies would not be likely to perform as well as investments in those that do. Long Term Objective The Fund seeks long term growth of capital. The Fund is not meant to provide a vehicle for those who wish to exploit short term swings in the stock market. An investment in shares of the Fund should not be considered a complete investment program. Each shareholder should take into account the shareholder’s investment objectives when considering an investment in the Fund. Tax Status To qualify as a “regulated investment company,” or “RIC,” for purposes of the Internal Revenue Code of 1986, as amended (the “Code”), the Fund has in the past conducted and intends to conduct its operations in a manner that will relieve it of any liability for federal income tax to the extent its earnings are distributed to shareholders. To so qualify as a “regulated investment company,” among other requirements, the Fund will limit its investments so that, at the close of each quarter of the taxable year: <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Arial, Helvetica, Sans-Serif"> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 0.25in; text-align: right; vertical-align: top"></td> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top">●</td> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; text-align: justify; text-indent: 0in">not more than 25% of the market value of its total assets will be invested in the securities (other than United States government securities or the securities of other RICs) of a single issuer, any two or more issuers in which the Fund owns 20% or more of the voting securities and which are determined to be engaged in the same, similar or related trades or businesses or in the securities of one or more qualified publicly traded partnerships (as defined in the Code); and</td> </tr> </table> <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Arial, Helvetica, Sans-Serif"> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 0.25in; text-align: right; vertical-align: top"></td> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top">●</td> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; text-align: justify; text-indent: 0in">at least 50% of the market value of the Fund’s assets will be represented by cash, securities of other RICs, United States government securities and other securities, with such other securities limited in re-</td> </tr> </table> spect of any one issuer to an amount not greater than 5% of the value of the Fund’s total assets and not more than 10% of the outstanding voting securities of such issuer. <p id="xdx_847_ecef--RiskTextBlock_hcef--RiskAxis__custom--MarketValueAndNetAssetValueMember_zC9cpunyccqh" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">Market Value and Net Asset Value The Fund is a diversified, closed-end management investment company. Shares of closed-end funds are bought and sold in the securities markets and may trade at either a premium to or discount from NAV. Listed shares of closed-end investment companies often trade at discounts from NAV. This characteristic of shares of a closed-end fund is a risk separate and distinct from the risk that its NAV may decrease. The Fund cannot predict whether its listed shares will trade at, below or above NAV. The risk of holding shares of a closed-end fund that might trade at a discount is more pronounced for shareholders who wish to sell their shares in a relatively short period of time after acquiring them because, for those investors, realization of a gain or loss on their investments is likely to be more dependent upon the existence of a premium or discount than upon portfolio performance. The Fund’s shares are not subject to redemption. Shareholders desiring liquidity may, subject to applicable securities laws, trade their Fund shares on the New York Stock Exchange (“NYSE”) or other markets on which such shares may trade at the then-current market value, which may differ from the then current NAV. Shareholders will incur brokerage or other transaction costs to sell shares. Equity Risk Investing in the Fund involves equity risk, which is the risk that the securities held by the Fund will fall in market value due to adverse market and economic conditions, perceptions regarding the industries in which the issuers of securities held by the Fund participate and the particular circumstances and performance of particular companies whose securities the Fund holds. An investment in the Fund represents an indirect economic stake in the securities owned by the Fund, which are for the most part traded on securities exchanges or in the OTC markets. The market value of these securities, like other market investments, may move up or down, sometimes rapidly and unpredictably. The NAV of the Fund may at any point in time be worth less than the amount at the time the shareholder invested in the Fund, even after taking into account any reinvestment of distributions. Foreign Securities There is no limitation on the amount of foreign securities, including emerging market securities, in which the Fund may invest. Investments in the securities of foreign issuers involve certain considerations and risks not ordinarily associated with investments in securities of domestic issuers and such securities may be more volatile than those of issuers in the United States. Foreign companies are not generally subject to uniform accounting, auditing and financial standards and requirements comparable to those applicable to United States companies. Foreign securities exchanges, brokers and listed companies may be subject to less government supervision and regulation than exists in the United States. Dividend and interest income may be subject to withholding and other foreign taxes, which may adversely affect the net return on such investments. There may be difficulty in obtaining or enforcing a court judgment abroad. In addition, it may be difficult to effect repatriation of capital invested in certain countries. Also, with respect to certain countries, there are risks of expropriation, confiscatory taxation, political or social instability or diplomatic developments that could affect assets of the Fund held in foreign countries. Dividend income that the Fund receives from foreign securities may not be eligible for the special tax treatment applicable to qualified dividend income. Moreover, certain equity investments in foreign issuers classified as passive foreign investment companies may be subject to additional taxation risk. There may be less publicly available information about a foreign company than a United States company. Foreign securities markets may have substantially less volume than United States securities markets and some foreign company securities are less liquid than securities of otherwise comparable United States companies. A portfolio of foreign securities may also be adversely affected by fluctuations in the rates of exchange between the currencies of different nations and by exchange control regulations. Foreign markets also have different clearance and settlement procedures that could cause the Fund to encounter difficulties in purchasing and selling securities on such markets and may result in the Fund missing attractive investment opportunities or experiencing loss. In addition, a portfolio that includes foreign securities can expect to have a higher expense ratio because of the increased transaction costs on non-United States securities markets and the increased costs of maintaining the custody of foreign securities. The Fund also may purchase sponsored American Depositary Receipts (“ADRs”) or United States dollar denominated securities of foreign issuers, including emerging market issuers. ADRs are receipts issued by United States banks or trust companies in respect of securities of foreign issuers held on deposit for use in the United States securities markets. While ADRs may not necessarily be denominated in the same currency as the securities into which they may be converted, many of the risks associated with foreign securities may also apply to ADRs. In addition, the underlying issuers of certain depositary receipts, particularly unsponsored or unregistered depositary receipts, are under no obligation to distribute shareholder communications to the holders of such receipts, or to pass through to them any voting rights with respect to the deposited securities. Emerging Markets The Fund may invest in securities of issuers whose primary operations or principal trading market is in an “emerging market.” An “emerging market” country is any country that is considered to be an emerging or developing country by the International Bank for Reconstruction and Development (the “World Bank”). Investing in securities of companies in emerging markets may entail special risks relating to potential political and economic instability and the risks of expropriation, nationalization, confiscation or the imposition of restrictions on foreign investment, the lack of hedging instruments and restrictions on repatriation of capital invested. Emerging securities markets are substantially smaller, less developed, less liquid and more volatile than the major securities markets. The limited size of emerging securities markets and limited trading value compared to the volume of trading in U.S. securities could cause prices to be erratic for reasons apart from factors that affect the quality of the securities. For example, limited market size may cause prices to be unduly influenced by traders who control large positions. Adverse publicity and investors’ perceptions, whether or not based on fundamental analysis, may decrease the value and liquidity of portfolio securities, especially in these markets. Other risks include high concentration of market capitalization and trading volume in a small number of issuers representing a limited number of industries, as well as a high concentration of investors and financial intermediaries; overdependence on exports, including gold and natural resources exports, making these economies vulnerable to changes in commodity prices; overburdened infrastructure and obsolete or unseasoned financial systems; environmental problems; potential for sanctions; less developed legal systems, and deficiencies in regulatory oversight, market infrastructure, shareholder protections; differences in regulatory, accounting, auditing and financial reporting and recordkeeping standards; and less reliable securities custodial services and settlement practices. Value Investing Risk The Fund focuses its investments on the securities of companies that the Investment Adviser believes to be undervalued or inexpensive relative to other investments. These types of securities may present risks in addition to the general risks associated with investing in common and preferred stocks. These securities generally are selected on the basis of an issuer’s fundamentals relative to current market price. Such securities are subject to the risk of mis-estimation of certain fundamental factors. In addition, during certain time periods market dynamics may strongly favor “growth” stocks of issuers that do not display strong fundamentals relative to market price based upon positive price momentum and other factors. Disciplined adherence to a “value” investment mandate during such periods can result in significant underperformance relative to overall market indices and other managed investment vehicles that pursue growth style investments and/or flexible equity style mandates. Smaller Companies The Fund may invest in smaller companies that may benefit from the development of new products and services. These smaller companies may present greater opportunities for capital appreciation, and may also involve greater investment risk than larger, more established companies. For example, smaller companies may have more limited product lines, market, or financial resources, and their securities may trade less frequently and in lower volume than the securities of larger, more established companies. As a result, the prices of the securities of such smaller companies may fluctuate to a greater degree than the prices of securities of other issuers. Fixed Income Securities Fixed income securities in which the Fund may invest are generally subject to the following risks: <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Arial, Helvetica, Sans-Serif"> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 0.25in; text-align: right; vertical-align: top"></td> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 0.25in; text-align: left; vertical-align: top">●</td> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; text-align: justify">Interest Rate Risk. The market value of bonds and other fixed-income or dividend paying securities changes in response to interest rate changes and other factors. Interest rate risk is the risk that prices of bonds and other income or dividend paying securities will increase as interest rates fall and decrease as interest rates rise. The Fund may be subject to a greater risk of rising interest rates due to the recent period of historically low interest rates. The Federal Reserve began raising the federal funds rate in March 2022 as part of its efforts to address rising inflation. There is a risk that interest rates will continue to rise, which will likely drive down prices of bonds and other fixed-income securities. The magnitude of these price reductions in the market price of bonds and other fixed-income securities is generally greater for those securities with longer maturities. Fluctuations in the market price of the Fund’s investments will not affect interest income derived from instruments already owned by the Fund, but will be reflected in the Fund’s NAV. The Fund may lose money if short-term or long-term interest rates rise sharply in a manner not anticipated by the Investment Adviser. </td> </tr> </table> <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Arial, Helvetica, Sans-Serif"> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 0.25in; text-align: right; vertical-align: top"></td> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top">●</td> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; text-align: justify; text-indent: 0in">Issuer Risk. Issuer risk is the risk that the value of an income or dividend paying security may decline for a number of reasons which directly relate to the issuer, such as management performance, financial leverage, reduced demand for the issuer’s goods and services, historical and prospective earnings of the issuer, and the value of the assets of the issuer.</td> </tr> </table> <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Arial, Helvetica, Sans-Serif"> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 0.25in; text-align: right; vertical-align: top"></td> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top">●</td> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; text-align: justify; text-indent: 0in">Credit Risk. Credit risk is the risk that one or more income or dividend paying securities in the Fund’s portfolio will decline in price or fail to pay interest/distributions or principal when due because the issuer</td> </tr> </table> of the security experiences a decline in its financial status. Credit risk is increased when a portfolio security is downgraded or the perceived creditworthiness of the issuer deteriorates. <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Arial, Helvetica, Sans-Serif"> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 0.25in; text-align: right; vertical-align: top"></td> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top">●</td> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; text-align: justify; text-indent: 0in">Prepayment Risk. Prepayment risk is the risk that during periods of declining interest rates, borrowers may exercise their option to prepay principal earlier than scheduled. For income or dividend paying securities, such payments often occur during periods of declining interest rates, forcing the Fund to reinvest in lower yielding securities, resulting in a possible decline in the Fund’s income and distributions to shareholders.</td> </tr> </table> <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Arial, Helvetica, Sans-Serif"> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 0.25in; text-align: right; vertical-align: top"></td> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top">●</td> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; text-align: justify; text-indent: 0in">Reinvestment Risk. Reinvestment risk is the risk that income from the Fund’s portfolio will decline if the Fund invests the proceeds from matured, traded or called fixed income securities at market interest rates that are below the Fund portfolio’s current earnings rate.</td> </tr> </table> <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Arial, Helvetica, Sans-Serif"> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 0.25in; text-align: right; vertical-align: top"></td> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top">●</td> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; text-align: justify; text-indent: 0in">Duration and Maturity Risk. The Fund may incur costs in seeking to adjust the portfolio average duration or maturity. In comparison to maturity (which is the date on which the issuer of a debt instrument is obligated to repay the principal amount), duration is a measure of the price volatility of a debt instrument as a result in changes in market rates of interest, based on the weighted average timing of the instrument’s expected principal and interest payments. Specifically, duration measures the anticipated percentage change in NAV that is expected for every percentage point change in interest rates. The two have an inverse relationship. For example, a duration of five years means that a 1% decrease in interest rates will increase the NAV of the portfolio by approximately 5%; if interest rates increase by 1%, the NAV will decrease by 5%. However, in a managed portfolio of fixed income securities having differing interest or dividend rates or payment schedules, maturities, redemption provisions, call or prepayment provisions and credit qualities, actual price changes in response to changes in interest rates may differ significantly from a duration-based estimate at any given time. Actual price movements experienced by a portfolio of fixed income securities will be affected by how interest rates move (i.e., changes in the relationship of long term interest rates to short term interest rates), the magnitude of any move in interest rates, actual and anticipated prepayments of principal through call or redemption features, the extension of maturities through restructuring, the sale of securities for portfolio management purposes, the reinvestment of proceeds from prepayments on and from sales of securities, and credit quality-related considerations whether associated with financing costs to lower credit quality borrowers or otherwise, as well as other factors. Accordingly, while duration maybe a useful tool to estimate potential price movements in relation to changes in interest rates, investors are cautioned that duration alone will not predict actual changes in the net asset or market value of the Fund’s shares and that actual price movements in the Fund’s portfolio may differ significantly from duration-based estimates. Duration differs from maturity in that it takes into account a security’s yield, coupon payments and its principal payments in addition to the amount of time until the security matures. As the value of a security changes over time, so will its duration. There can be no assurance that the Investment Adviser’s assessment of current and projected market conditions will be correct or that any strategy to adjust duration or maturity will be successful at any given time.</td> </tr> </table> <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Arial, Helvetica, Sans-Serif"> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 0.25in; text-align: right; vertical-align: top"></td> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top">●</td> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; text-align: justify; text-indent: 0in">Liquidity Risk. Certain fixed income securities in which the Fund invests may be or become illiquid. See “Certain Investment Practices – Restricted and Illiquid Securities.”</td> </tr> </table> Lower Grade Securities Generally, lower grade securities and unrated securities of comparable quality offer a higher current yield than is offered by higher rated securities, but also (i) will likely have some quality and protective characteristics that, in the judgment of the rating organizations, are outweighed by large uncertainties or major risk exposures to adverse conditions and (ii) are predominantly speculative with respect to the issuer’s capacity to pay interest and repay principal in accordance with the terms of the obligation. The market values of certain of these securities also tend to be more sensitive to individual corporate developments and changes in economic conditions than higher quality securities. In addition, such securities generally present a higher degree of credit risk. The risk of loss due to default by these issuers is significantly greater because such lower grade securities and unrated securities of comparable quality generally are unsecured and frequently are subordinated to the prior payment of senior indebtedness. In light of these risks, the Investment Adviser, in evaluating the creditworthiness of an issue, whether rated or unrated, will take various factors into consideration, which may include, as applicable, the issuer’s operating history, financial resources and its sensitivity to economic conditions and trends, the market support for the facility financed by the issue, the perceived ability and integrity of the issuer’s management, and regulatory matters. In addition, the market value of lower securities is more volatile than that of higher quality securities, and the markets in which such lower grade or unrated securities are traded are more limited than those in which higher rated securities are traded. The existence of limited markets may make it more difficult for the Fund to obtain accurate market quotations for purposes of valuing its portfolio and calculating its NAV. Moreover, the lack of a liquid trading market may restrict the availability of securities for the Fund to purchase and may also have the effect of limiting the ability of the Fund to sell securities at their fair value in response to changes in the economy or the financial markets. Lower grade securities also present risks based on payment expectations. If an issuer calls the obligation for redemption (often a feature of fixed income securities), the Fund may have to replace the security with a lower yielding security, resulting in a decreased return for investors. Also, as the principal value of nonconvertible bonds and preferred stocks moves inversely with movements in interest rates, in the event of rising interest rates the value of the securities held by the Fund may decline proportionately more than a portfolio consisting of higher rated securities. Investments in zero coupon bonds may be more speculative and subject to greater fluctuations in value due to changes in interest rates than bonds that pay regular income streams. See “—Fixed Income Securities—Interest Rate Risk” above. As part of its investment in lower grade securities, the Fund may invest in securities of issuers in default. The Fund will make an investment in securities of issuers in default only when the Investment Adviser believes that such issuers will honor their obligations or emerge from bankruptcy protection under a plan pursuant to which the securities received by the Fund in exchange for its defaulted securities will have a value in excess of the Fund’s investment. By investing in securities of issuers in default, the Fund bears the risk that these issuers will not continue to honor their obligations or emerge from bankruptcy protection or that the value of the securities will not otherwise appreciate. In addition to using recognized rating agencies and other sources, the Investment Adviser also performs its own analysis of issues in seeking investments that it believes to be underrated (and thus higher yielding) in light of the financial condition of the issuer. Its analysis of securities of issuers may include, among other things, current and anticipated cash flow and borrowing requirements, value of assets in relation to historical cost, strength of management, responsiveness to business conditions, credit standing, and current anticipated results of operations. In selecting investments for the Fund, the Investment Adviser may also consider general business conditions, anticipated changes in interest rates, and the outlook for specific industries. Subsequent to its purchase by the Fund, an issuer of securities may cease to be rated or its rating may be reduced. In addition, it is possible that statistical rating agencies may change their ratings of a particular issuer to reflect subsequent events. Moreover, such ratings do not assess the risk of a decline in market value. None of these events will require the sale of the securities by the Fund, although the Investment Adviser will consider these events in determining whether the Fund should continue to hold the securities. The market for lower grade and comparable unrated securities has experienced several periods of significantly adverse price and liquidity, particularly at or around times of economic recessions. Past market recessions have adversely affected the value of such securities as well as the ability of certain issuers of such securities to repay principal and pay interest thereon or to refinance such securities. The market for those securities may react in a similar fashion in the future. <p id="xdx_844_ecef--RiskTextBlock_hcef--RiskAxis__custom--SpecialRisksOfDerivativeTransactionsMember_zkc7GY3WwzUj" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">Special Risks of Derivative Transactions The Fund may participate in derivative transactions. Such transactions entail certain execution, market, liquidity, hedging and tax risks. Participation in the options, futures or swaps markets and in currency exchange transactions involves investment risks and transaction costs to which the Fund would not be subject absent the use of these strategies. If the Investment Adviser’s prediction of movements in the direction of the securities, foreign currency and interest rate markets are inaccurate, the consequences to the Fund may leave the Fund in a worse position than if such strategies were not used. Risks inherent in the use of options, foreign currency, swaps contracts, futures contracts and options on futures contracts, swap contracts, securities indices and foreign currencies include: <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Arial, Helvetica, Sans-Serif"> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 0.25in; text-align: right; vertical-align: top"></td> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top">●</td> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; text-align: justify; text-indent: 0in">dependence on the Investment Adviser’s ability to predict correctly movements in the direction of interest rates, securities prices and currency markets;</td> </tr> </table> <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Arial, Helvetica, Sans-Serif"> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 0.25in; text-align: right; vertical-align: top"></td> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top">●</td> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; text-align: justify; text-indent: 0in">imperfect correlation between the price of options and futures contracts and options thereon and movements in the prices of the securities or currencies being hedged;</td> </tr> </table> <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Arial, Helvetica, Sans-Serif"> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 0.25in; text-align: right; vertical-align: top"></td> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top">●</td> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; text-align: justify; text-indent: 0in">the fact that skills needed to use these strategies are different from those needed to select portfolio securities;</td> </tr> </table> <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Arial, Helvetica, Sans-Serif"> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 0.25in; text-align: right; vertical-align: top"></td> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top">●</td> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; text-align: justify; text-indent: 0in">the possible absence of a liquid secondary market for any particular instrument at any time;</td> </tr> </table> <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Arial, Helvetica, Sans-Serif"> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 0.25in; text-align: right; vertical-align: top"></td> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top">●</td> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; text-align: justify; text-indent: 0in">the possible need to defer closing out certain hedged positions to avoid adverse tax consequences;</td> </tr> </table> <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Arial, Helvetica, Sans-Serif"> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 0.25in; text-align: right; vertical-align: top"></td> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top">●</td> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; text-align: justify; text-indent: 0in">the possible inability of the Fund to purchase or sell a security at a time that otherwise would be favorable for it to do so; and</td> </tr> </table> <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Arial, Helvetica, Sans-Serif"> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 0.25in; text-align: right; vertical-align: top"></td> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top">●</td> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; text-align: justify; text-indent: 0in">the creditworthiness of counterparties.</td> </tr> </table> Options, futures contracts, swaps contracts and options thereon and forward contracts on securities and currencies may be traded on foreign exchanges. Such transactions may not be regulated as effectively as similar transactions in the United States, may not involve a clearing mechanism and related guarantees, and are subject to the risk of governmental actions affecting trading in, or the prices of, foreign securities. The value of such positions also could be adversely affected by (i) other complex foreign political, legal and economic factors, (ii) lesser availability than in the United States of data on which to make trading decisions, (iii) delays in the ability of the Fund to act upon economic events occurring in the foreign markets during non-business hours in the United States, (iv) the imposition of different exercise and settlement terms and procedures and margin requirements than in the United States and (v) less trading volume. Exchanges on which options, futures, swaps and options on futures or swaps are traded may impose limits on the positions that the Fund may take in certain circumstances. Many OTC derivatives are valued on the basis of dealers’ pricing of these instruments. However, the price at which dealers value a particular derivative and the price which the same dealers would actually be willing to pay for such derivative should the Fund wish or be forced to sell such position may be materially different. Such differences can result in an overstatement of the Fund’s NAV and may materially adversely affect the Fund in situations in which the Fund is required to sell derivative instruments. Exchange-traded derivatives and OTC derivative transactions submitted for clearing through a central counterparty have become subject to minimum initial and variation margin requirements set by the relevant clearinghouse, as well as possible margin requirements mandated by the SEC or the Commodity Futures Trading Commission. These regulators also have broad discretion to impose margin requirements on non-cleared OTC derivatives. These margin requirements will increase the overall costs for the Fund. While hedging can reduce or eliminate losses, it can also reduce or eliminate gains. Hedges are sometimes subject to imperfect matching between the derivative and the underlying security, and there can be no assurance that the Fund’s hedging transactions will be effective. Derivatives may give rise to a form of leverage and may expose the Fund to greater risk and increase its costs. Under Rule 18f-4 under the 1940 Act, among other things, the Fund must either use derivatives in a limited manner or comply with an outer limit on fund leverage risk based on value-at-risk. See “—Derivatives Transactions Subject to Rule18f-4 Under the 1940 Act” below. Special Risk Considerations Relating to Futures and Options Thereon. The Fund’s ability to establish and close out positions in futures contracts and options thereon will be subject to the development and maintenance of liquid markets. Although the Fund generally will purchase or sell only those futures contracts and options thereon for which there appears to be a liquid market, there is no assurance that a liquid market on an exchange will exist for any particular futures contract or option thereon at any particular time. In the event no liquid market exists for a particular futures contract or option thereon in which the Fund maintains a position, it may not be possible to effect a closing transaction in that contract or to do so at a satisfactory price and the Fund may have to either make or take delivery under the futures contract or, in the case of a written option, wait to sell the underlying securities until the option expires or is exercised or, in the case of a purchased option, exercise the option. In the case of a futures contract or an option thereon which the Fund has written and which the Fund is unable to close, the Fund would be required to maintain margin deposits on the futures contract or option thereon and to make variation margin payments until the contract is closed. Successful use of futures contracts and options thereon and forward contracts by the Fund is subject to the ability of the Investment Adviser to predict correctly movements in the direction of interest and foreign currency rates. If the Investment Adviser’s expectations are not met, the Fund will be in a worse position than if a hedging strategy had not been pursued. For example, if the Fund has hedged against the possibility of an increase in interest rates that would adversely affect the price of securities in its portfolio and the price of such securities increases instead, the Fund will lose part or all of the benefit of the increased value of its securities because it will have offsetting losses in its futures positions. In addition, in such situations, if the Fund has insufficient cash to meet daily variation margin requirements, it may have to sell securities to meet the requirements. These sales may be, but will not necessarily be, at increased prices that reflect the rising market. The Fund may have to sell securities at a time when it is disadvantageous to do so. Additional Risks of Foreign Options, Futures Contracts, Swaps Contracts, Options on Futures Contracts and Forward Contracts. Options, futures contracts, swaps contracts and options thereon and forward contracts on securities and currencies may be traded on foreign exchanges. Such transactions may not be regulated as effectively as similar transactions in the United States, may not involve a clearing mechanism and related guarantees, and are subject to the risk of governmental actions affecting trading in, or the prices of, foreign securities. The value of such positions also could be adversely affected by (i) other complex foreign political, legal and economic factors, (ii) lesser availability than in the United States of data on which to make trading decisions, (iii) delays in the ability of the Fund to act upon economic events occurring in the foreign markets during non-business hours in the United States, (iv) the imposition of different exercise and settlement terms and procedures and margin requirements than in the United States and (v) less trading volume. Exchanges on which options, futures, swaps and options on futures or swaps are traded may impose limits on the positions that the Fund may take in certain circumstances. See “Risk Factors and Special Considerations – Futures Transactions.” Derivatives Transactions Subject to Rule 18f-4 Under the 1940 Act. Rule 18f-4 under the 1940 Act governs the Fund’s use of derivative instruments and certain other transactions that create future payment and/or delivery obligations by the Fund. Rule 18f-4 permits the Fund to enter into Derivatives Transactions (as defined below) and certain other transactions notwithstanding the restrictions on the issuance of “senior securities” under Section 18 of the 1940 Act. Section 18 of the Investment Company Act, among other things, prohibits closed-end funds, including the Trust, from issuing or selling any “senior security” representing indebtedness (unless the fund maintains 300% “asset coverage”) or any senior security representing stock (unless the fund maintains 200% “asset coverage”). In connection with the adoption of Rule 18f-4, the SEC eliminated the asset segregation framework arising from prior SEC guidance for covering Derivatives Transactions and certain financial instruments. Under Rule 18f-4, “Derivatives Transactions” include the following: (i) any swap, security-based swap (including a contract for differences), futures contract, forward contract, option (excluding purchased options), any combination of the foregoing, or any similar instrument, under which the Fund is or may be required to make any payment or delivery of cash or other assets during the life of the instrument or at maturity or early termination, whether as margin or settlement payment or otherwise; (ii) any short sale borrowing; (iii) reverse repurchase agreements and similar financing transactions, if the Fund elects to treat these transactions as Derivatives Transactions under Rule 18f-4; and (iv) when-issued or forward-settling securities (e.g., firm and standby commitments, including to-be-announced (“TBA”) commitments, and dollar rolls) and non-standard settlement cycle securities, unless the Fund intends to physically settle the transaction and the transaction will settle within 35 days of its trade date. Unless the Fund is relying on the Limited Derivatives User Exception (as defined below), the Fund must comply with Rule 18f-4 with respect to its Derivatives Transactions. Rule 18f-4, among other things, requires the Fund to (i) appoint a Derivatives Risk Manager, (ii) maintain a Derivatives Risk Management Program designed to identify, assess, and reasonably manage the risks associated with Derivatives Transactions; (iii) comply with certain value-at-risk (VaR)-based leverage limits (VaR is an estimate of an instrument’s or portfolio’s potential losses over a given time horizon and at a specified confidence level); and (iv) comply with certain Board reporting and recordkeeping requirements. Rule 18f-4 provides an exception from the requirements to appoint a Derivatives Risk Manager, adopt a Derivatives Risk Management Program, comply with certain VaR-based leverage limits, and comply with certain Board oversight and reporting requirements if the Fund’s “derivatives exposure” (as defined in Rule 18f-4) is limited to 10% of its net assets (as calculated in accordance with Rule 18f-4) and the Fund adopts and implements written policies and procedures reasonably designed to manage its derivatives risks (the “Limited Derivatives User Exception”). Pursuant to Rule 18f-4, if the Fund enters into reverse repurchase agreements or similar financing transactions, the Fund will (i) aggregate the amount of indebtedness associated with all of its reverse repurchase agreements or similar financing transactions with the amount of any other “senior securities” representing indebtedness (e.g., bank borrowings, if applicable) when calculating the Fund’s asset coverage ratio or (ii) treat all such transactions as Derivatives Transactions. The requirements of Rule 18f-4 may limit the Fund’s ability to engage in Derivatives Transactions as part of its investment strategies. These requirements may also increase the cost of the Fund’s investments and cost of doing business, which could adversely affect the value of the Fund’s investments and/or the performance of the Fund. Futures Transactions The Fund may make investments in futures and options on futures. Risks include, but are not limited to, the following: <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Arial, Helvetica, Sans-Serif"> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 0.25in; text-align: right; vertical-align: top"></td> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top">●</td> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; text-align: justify; text-indent: 0in">no assurance that futures contracts or options on futures can be offset at favorable prices;</td> </tr> </table> <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Arial, Helvetica, Sans-Serif"> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 0.25in; text-align: right; vertical-align: top"></td> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top">●</td> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; text-align: justify; text-indent: 0in">possible reduction of the yield of the Fund due to the use of hedging;</td> </tr> </table> <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Arial, Helvetica, Sans-Serif"> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 0.25in; text-align: right; vertical-align: top"></td> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top">●</td> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; text-align: justify; text-indent: 0in">possible reduction in value of both the securities hedged and the hedging instrument;</td> </tr> </table> <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Arial, Helvetica, Sans-Serif"> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 0.25in; text-align: right; vertical-align: top"></td> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top">●</td> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; text-align: justify; text-indent: 0in">possible lack of liquidity due to daily limits or price fluctuations;</td> </tr> </table> <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Arial, Helvetica, Sans-Serif"> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 0.25in; text-align: right; vertical-align: top"></td> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top">●</td> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; text-align: justify; text-indent: 0in">imperfect correlation between the contracts and the securities being hedged; and</td> </tr> </table> <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Arial, Helvetica, Sans-Serif"> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 0.25in; text-align: right; vertical-align: top"></td> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top">●</td> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; text-align: justify; text-indent: 0in">losses from investing in futures transactions that are potentially unlimited.</td> </tr> </table> Swap Agreements Swap agreements involve the risk that the party with whom the Fund has entered into the swap will default on its obligation to pay the Fund and the risk that the Fund will not be able to meet its obligations to pay the other party to the agreement. Whether the Fund’s use of swap agreements will be successful in furthering its investment objective will depend on the Investment Adviser’s ability to correctly predict whether certain types of investments are likely to produce greater returns than other investments. Because they are two party contracts and because they may have terms of greater than seven days, some swap agreements may be considered by the Fund to be illiquid. Restrictions imposed by the tax rules applicable to regulated investment companies may limit the Fund’s ability to use swap agreements. The swap market currently is largely unregulated. It is possible that developments in the swap market, including potential significant government regulation as a result of the Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010 (the “Dodd-Frank Act”) or otherwise, could adversely affect the Fund’s ability to enter into or terminate swap agreements or to realize amounts to be received under these agreements. Swap transactions may involve substantial leverage. <p id="xdx_842_ecef--RiskTextBlock_hcef--RiskAxis__custom--ForwardCurrencyExchangeContractsMember_zlck3WRZjLda" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">Forward Currency Exchange Contracts The use of forward currency exchange contracts may involve certain risks, including the failure of the counterparty to perform its obligations under the contract and that the use of forward contracts may not serve as a complete hedge because of an imperfect correlation between movements in the prices of the contracts and the prices of the currencies hedged or used for cover. Risks of Currency Transactions. Currency transactions are also subject to risks different from those of other portfolio transactions. Because currency control is of great importance to the issuing governments and influences economic planning and policy, purchases and sales of currency and related instruments can be adversely affected by government exchange controls, limitations or restrictions on repatriation of currency, and manipulation, or exchange restrictions imposed by governments. These forms of governmental action can result in losses to the Fund if it is unable to deliver or receive currency or monies in settlement of obligations and could also cause hedges it has entered into to be rendered useless, resulting in full currency exposure as well as incurring transaction costs. <p id="xdx_849_ecef--RiskTextBlock_hcef--RiskAxis__custom--InterestRateTransactionsMember_zYpScGp5Xig6" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">Interest Rate Transactions The Fund may enter into an interest rate swap or cap transaction. The use of interest rate swaps and caps is a highly specialized activity that involves certain risks to the Fund including, among others, counterparty risk and early termination risk. Counterparty Risk The Fund will be subject to credit risk with respect to the counterparties to the derivative contracts purchased by the Fund. If a counterparty becomes bankrupt or otherwise fails to perform its obligations under a derivative contract due to financial difficulties, the Fund may experience significant delays in obtaining any recovery under the derivative contract in bankruptcy or other reorganization proceeding. The Fund may obtain only a limited recovery or may obtain no recovery in such circumstances. Dodd-Frank Act Risk Title VII of the Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010 (the “Dodd-Frank Act”) (the “Derivatives Title”) imposed a substantially new regulatory structure on derivatives markets, with particular emphasis on swaps (which are subject to oversight by the CFTC) and security-based swaps (which are subject to oversight by the SEC). The regulatory framework covers a broad range of swap market participants, including banks, non-banks, credit unions, insurance companies, broker-dealers and investment advisers. Prudential regulators were granted authority to regulate margining of swaps and security-based swaps of banks and bank-related entities. Current regulations for swaps require the mandatory central clearing and mandatory exchange trading of particular types of interest rate swaps and index credit default swaps (together, “Covered Swaps”). The Fund is required to clear its Covered Swaps through a clearing broker, which requires, among other things, posting initial margin and variation margin to the Fund’s clearing broker in order to enter into and maintain positions in Covered Swaps. Covered Swaps generally are required to be executed through a swap execution facility (“SEF”), which can involve additional transaction fees. Additionally, under the Dodd-Frank Act, with respect to uncleared swaps (both uncleared swaps and uncleared security-based swaps entered into with banks), swap dealers are required to collect from the Fund both initial and variation margin (comprised of specified liquid instruments and subject to a required haircut). Shares of investment companies (other than certain money market funds) may not be posted as collateral under applicable regulations. As capital and margin requirements for swap dealers and capital and margin requirements for security-based swaps are implemented, such requirements may make certain types of trades and/or trading strategies more costly. There may be market dislocations due to uncertainty during the implementation period of any new regulation and the Investment Adviser cannot know how the derivatives market will adjust to such new regulations. In addition, regulations adopted by global prudential regulators that are now in effect require certain bank-regulated counterparties and certain of their affiliates to include in “qualified financial contracts,” including many derivatives contracts as well as repurchase agreements and securities lending agreements, terms that delay or restrict the rights of counterparties to terminate such contracts, foreclose upon collateral, exercise other default rights or restrict transfers of affiliate credit enhancements (such as guarantees) in the event that the bank-regulated counterparty and/or its affiliates are subject to certain types of resolution or insolvency proceedings. <p id="xdx_84D_ecef--RiskTextBlock_hcef--RiskAxis__custom--SpecialRisksRelatedToFundInvestmentsInPreferredSecuritiesMember_zNKT2XEx71y9" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">Special Risks Related to Fund Investments in Preferred Securities There are special risks associated with the Fund’s investing in preferred securities, including: <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Arial, Helvetica, Sans-Serif"> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 0.25in; text-align: right; vertical-align: top"></td> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top">●</td> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; text-align: justify; text-indent: 0in">Deferral. Preferred securities may include provisions that permit the issuer, at its discretion, to defer dividends or distributions for a stated period without any adverse consequences to the issuer. If the Fund owns a preferred security that is deferring its dividends or distributions, the Fund may be required to report income for tax purposes although it has not yet received such income.</td> </tr> </table> <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Arial, Helvetica, Sans-Serif"> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 0.25in; text-align: right; vertical-align: top"></td> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top">●</td> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; text-align: justify; text-indent: 0in">Non-Cumulative Dividends. Some preferred securities are non-cumulative, meaning that the dividends do not accumulate and need not ever be paid. A portion of the portfolio may include investments in non-cumulative preferred securities, whereby the issuer does not have an obligation to make up any arrearages to its shareholders. Should an issuer of a non-cumulative preferred security held by the Fund determine not to pay dividends or distributions on such security, the Fund’s return from that security may be adversely affected. There is no assurance that dividends or distributions on non-cumulative preferred securities in which the Fund invests will be declared or otherwise made payable.</td> </tr> </table> <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Arial, Helvetica, Sans-Serif"> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 0.25in; text-align: right; vertical-align: top"></td> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top">●</td> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; text-align: justify; text-indent: 0in">Subordination. Preferred securities are subordinated to bonds and other debt instruments in an issuer’s capital structure in terms of priority to corporate income and liquidation payments, and therefore will be subject to greater credit risk than more senior debt security instruments.</td> </tr> </table> <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Arial, Helvetica, Sans-Serif"> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 0.25in; text-align: right; vertical-align: top"></td> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top">●</td> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; text-align: justify; text-indent: 0in">Liquidity. Preferred securities may be substantially less liquid than many other securities, such as common stocks or U.S. government securities.</td> </tr> </table> <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Arial, Helvetica, Sans-Serif"> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 0.25in; text-align: right; vertical-align: top"></td> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top">●</td> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; text-align: justify; text-indent: 0in">Limited Voting Rights. Generally, preferred security holders (such as the Fund) have no voting rights with respect to the issuing company unless preferred dividends have been in arrears for a specified number of periods, at which time the preferred security holders may be entitled to elect a number of directors to the issuer’s board. Generally, once all the arrearages have been paid, the preferred security holders no longer have voting rights.</td> </tr> </table> <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Arial, Helvetica, Sans-Serif"> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 0.25in; text-align: right; vertical-align: top"></td> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top">●</td> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; text-align: justify; text-indent: 0in">Special Redemption Rights. In certain varying circumstances, an issuer of preferred securities may redeem the securities prior to a specified date. For instance, for certain types of preferred securities, a redemption may be triggered by a change in federal income tax or securities laws. A redemption by the issuer may negatively impact the return of the security held by the Fund.</td> </tr> </table> <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Arial, Helvetica, Sans-Serif"> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 0.25in; text-align: right; vertical-align: top"></td> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top">●</td> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; text-align: justify; text-indent: 0in">Phantom Income. Some preferred securities are classified as debt for U.S. federal income tax purposes. If a debt instrument is issued with original issue discount, the Fund could recognize taxable income in advance of the receipt of cash on the investment. This “phantom income” may require the Fund to liquidate other investments (including when it is not advantageous to do so) to meet its distribution requirements or otherwise qualify for treatment as a RIC.</td> </tr> </table> <p id="xdx_847_ecef--RiskTextBlock_hcef--RiskAxis__custom--SpecialRisksForHoldersOfSubscriptionRightsMember_z8AoAgfbspf9" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">Special Risks for Holders of Subscription Rights The issuance of subscription rights to purchase our common shares may substantially dilute the aggregate NAV of the common shares owned by shareholders who do not fully exercise their rights in the offering. Shareholders who do not exercise their rights to purchase common stock will own a smaller proportional interest in the Fund than they did before the offering. In the case of subscription rights for preferred shares, there is a risk that changes in yield or changes in the credit quality of the Fund may result in the underlying preferred shares purchasable upon exercise of the subscription rights being less attractive to investors at the conclusion of the subscription period. This may reduce or eliminate the value of the subscription rights for the preferred shares. Investors who receive subscription rights may find that there is no market to sell rights they do not wish to exercise. If investors exercise only a portion of the rights, the number of preferred shares or common shares issued may be reduced, and the preferred shares or common shares may trade at less favorable prices than larger offerings for similar securities. Management Risk The Fund is subject to management risk because it is an actively managed portfolio. The Investment Adviser applies investment techniques and risk analyses in making investment decisions for the Fund, but there can be no guarantee that these will produce the desired results. Portfolio Turnover The Fund may have a high turnover ratio which may result in higher expenses and lower after-tax return to shareholders than if the Fund had a lower turnover ratio. <p id="xdx_84F_ecef--RiskTextBlock_hcef--RiskAxis__custom--DependenceOnKeyPersonnelMember_z7uiwM5964za" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">Dependence on Key Personnel Mr. Mario J. Gabelli is a portfolio manager of the Fund. The Investment Adviser is dependent upon the expertise of Mr. Gabelli in providing advisory services with respect to the Fund’s investments. If the Investment Adviser were to lose the services of Mr. Gabelli, its ability to service the Fund could be adversely affected. There can be no assurance that a suitable replacement could be found for Mr. Gabelli in the event of his death, resignation, retirement or inability to act on behalf of the Investment Adviser. Coronavirus (“COVID-19”) and Global Health Event Risk An outbreak of a highly contagious novel coronavirus known as “COVID 19” that was first declared in December 2019 developed into a global pandemic that had a devastating impact on the global economy, including the U.S. economy, and resulted in a global economic recession. Many states issued orders requiring the closure of non-essential businesses and/or requiring residents to stay at home. The COVID 19 pandemic and preventative measures taken to contain or mitigate its spread caused business shutdowns, cancellations of events and travel, significant reductions in demand for certain goods and services, reductions in business activity and financial transactions, supply chain interruptions and overall economic and financial market instability both globally and in the United States. The U.S. economy and most other major global economies may continue to experience a substantial economic downturn or recession, and our business and operations, as well as the business and operations of our portfolio companies, could be materially adversely affected by a prolonged economic downturn or recession in the United States and other major markets. The impact of this coronavirus, and other epidemics and pandemics that may arise in the future, could affect the economies of many nations, individual companies and the market in general ways that cannot necessarily be foreseen at the present time. These events could have a significant impact on the Fund’s performance, NAV, income, operating results and ability to pay distributions, as well as the performance, income, operating results and viability of issuers in which it invests. <p id="xdx_842_ecef--RiskTextBlock_hcef--RiskAxis__custom--MarketDisruptionAndGeopoliticalRiskMember_zZNdiQm4s5Di" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">Market Disruption and Geopolitical Risk The consequences of the conflict between Russia and Ukraine, including international sanctions, further impact on inflation and increased disruption to supply chains may impact our portfolio companies, result in an economic downturn or recession either globally or locally in the U.S. or other economies, reduce business activity, spawn additional conflicts (whether in the form of traditional military action, reignited “cold” wars or in the form of virtual warfare such as cyberattacks) with similar and perhaps wider ranging impacts and consequences and have an adverse impact on the Fund’s returns and NAV. The occurrence of events similar to those in recent years, such as localized wars, instability, new and ongoing pandemics (such as COVID-19), epidemics or outbreaks of infectious diseases in certain parts of the world, natural/environmental disasters, terrorist attacks in the United States and around the world, social and political discord, debt crises sovereign debt downgrades, increasingly strained relations between the United States and a number of foreign countries, new and continued political unrest in various countries, the exit or potential exit of one or more countries from the European Union (“EU”) or the Economic and Monetary Union, continued changes in the balance of political power among and within the branches of the U.S. government, government shutdowns, among others, may result in market volatility, may have long term effects on the U.S. and worldwide financial markets, and may cause further economic uncertainties in the United States and worldwide. The current contentious domestic political environment, as well as political and diplomatic events within the United States and abroad, such as the U.S. government’s inability at times to agree on a long-term budget and deficit reduction plan, may in the future result in government shutdowns, which could have a material adverse effect on the Fund’s investments and operations. In addition, the Fund’s ability to raise additional capital in the future through the sale of securities could be materially affected by a government shutdown. Additional and/ or prolonged U.S. government shutdowns may affect investor and consumer confidence and may adversely impact financial markets and the broader economy, perhaps suddenly and to a significant degree. In particular, the escalation of the conflict between Russia and Ukraine, including international sanctions, further impact on inflation and increased disruption to supply chains may impact our portfolio companies. Such unfavorable economic conditions also may also be expected to increase our funding costs, limit our access to the capital markets or result in a decision by lenders not to extend credit to us. The current political climate has intensified concerns about a potential trade war between China and the United States, as each country has recently imposed tariffs on the other country’s products. These actions may trigger a significant reduction in international trade, the oversupply of certain manufactured goods, substantial price reductions of goods and possible failure of individual companies and/or large segments of China’s export industry, which could have a negative impact on our performance. U.S. companies that source material and goods from China and those that make large amounts of sales in China would be particularly vulnerable to an escalation of trade tensions. Uncertainty regarding the outcome of the trade tensions and the potential for a trade war could cause the U.S. dollar to decline against safe haven currencies, such as the Japanese yen and the euro. Events such as these and their consequences are difficult to predict and it is unclear whether further tariffs may be imposed or other escalating actions may be taken in the future. Any of these effects could have a material adverse effect on our business, financial condition and results of operations. On January 31, 2020, the United Kingdom officially left the European Union (“Brexit”), subject to a transitional period that ended December 31, 2020. The United Kingdom and European Union have reached an agreement on the terms of their future trading relationship effective January 1, 2021, which principally relates to the trading of goods rather than services, including financial services. Further discussions are to be held between the United Kingdom and the European Union in relation to matters not covered by the trade agreement, such as financial services. The Fund faces risks associated with the potential uncertainty and consequences that may follow Brexit, including with respect to volatility in exchange rates and interest rates. Brexit could adversely affect European or worldwide political, regulatory, economic or market conditions and could contribute to instability in global political institutions, regulatory agencies and financial markets. Brexit has also led to legal uncertainty and could lead to politically divergent national laws and regulations as a new relationship between the United Kingdom and European Union is defined and the United Kingdom determines which European Union laws to replace or replicate. Any of these effects of Brexit could adversely affect any of the companies to which the Fund has exposure and any other assets that the Fund invests in. The political, economic and legal consequences of Brexit are not yet known. In the short term, financial markets may experience heightened volatility, particularly those in the United Kingdom and Europe, but possibly worldwide. The United Kingdom and Europe may be less stable than they have been in recent years, and investments in the United Kingdom and the European Union may be difficult to value or subject to greater or more frequent volatility. In the longer term, there is likely to be a period of significant political, regulatory and commercial uncertainty as the United Kingdom continues to negotiate the terms of its future trading relationship with the European Union. While the extreme volatility and disruption that U.S. and global markets experienced for an extended period of time beginning in 2007 and 2008 had, until the recent coronavirus (COVID-19) outbreak, generally subsided, uncertainty and periods of volatility still remain, and risks to a robust resumption of growth persist. Federal Reserve policy, including with respect to certain interest rates, may adversely affect the value, volatility and liquidity of dividend and interest paying securities. Market volatility, dramatic changes to interest rates and/or a return to unfavorable economic conditions may lower the Fund’s performance or impair the Fund’s ability to achieve its investment objective. Cybersecurity incidents affecting particular companies or industries may adversely affect the economies of particular countries, regions or parts of the work in which the Fund invests. The occurrence of any of these above events could have a significant adverse impact on the value and risk profile of the Fund’s portfolio. The Fund does not know how long the securities markets may be affected by similar events and cannot predict the effects of similar events in the future on the U.S. economy and securities markets. There can be no assurance that similar events and other market disruptions will not have other material and adverse implications. <p id="xdx_841_ecef--RiskTextBlock_hcef--RiskAxis__custom--EconomicEventsAndMarketRiskMember_zkIWG13muQLb" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">Economic Events and Market Risk Periods of market volatility may continue to occur in the future, in response to various political, social and economic events both within and outside of the United States. These conditions have resulted in, and in many cases continue to result in, greater price volatility, less liquidity, widening credit spreads and a lack of price transparency, with many securities remaining illiquid and of uncertain value. Such market conditions may adversely affect the Fund, including by making valuation of some of the Fund’s securities uncertain and/or result in sudden and significant valuation increases or declines in the Fund’s holdings. If there is a significant decline in the value of the Fund’s portfolio, this may impact the asset coverage levels for the Fund’s outstanding leverage. Risks resulting from any future debt or other economic crisis could also have a detrimental impact on the global economic recovery, the financial condition of financial institutions and our business, financial condition and results of operation. Market and economic disruptions have affected, and may in the future affect, consumer confidence levels and spending, personal bankruptcy rates, levels of incurrence and default on consumer debt and home prices, among other factors. To the extent uncertainty regarding the U.S. or global economy negatively impacts consumer confidence and consumer credit factors, our business, financial condition and results of operations could be significantly and adversely affected. Downgrades to the credit ratings of major banks could result in increased borrowing costs for such banks and negatively affect the broader economy. Moreover, Federal Reserve policy, including with respect to certain interest rates, may also adversely affect the value, volatility and liquidity of dividend- and interest-paying securities. Market volatility, rising interest rates and/ or a return to unfavorable economic conditions could impair the Fund’s ability to achieve its investment objective. <p id="xdx_842_ecef--RiskTextBlock_hcef--RiskAxis__custom--RegulationAndGovernmentInterventionRiskMember_zdVHQaXVKZS9" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">Regulation and Government Intervention Risk Federal, state, and other governments, their regulatory agencies or self-regulatory organizations may take actions that affect the regulation of the issuers in which the Fund invests in ways that are unforeseeable. Legislation or regulation may also change the way in which the Fund is regulated. Such legislation or regulation could limit or preclude the Fund’s ability to achieve its investment objective. In light of popular, political and judicial focus on finance related consumer protection, financial institution practices are also subject to greater scrutiny and criticism generally. In the case of transactions between financial institutions and the general public, there may be a greater tendency toward strict interpretation of terms and legal rights in favor of the consuming public, particularly where there is a real or perceived disparity in risk allocation and/or where consumers are perceived as not having had an opportunity to exercise informed consent to the transaction. In the event of conflicting interests between retail investors holding common shares of a closed-end investment company such as the Fund and a large financial institution, a court may similarly seek to strictly interpret terms and legal rights in favor of retail investors. The Fund may be affected by governmental action in ways that are not foreseeable, and there is a possibility that such actions could have a significant adverse effect on the Fund and its ability to achieve its investment objective. Inflation Risk Inflation risk is the risk that the value of assets or income from investments will be worth less in the future as inflation decreases the value of money. Inflation rates may change frequently and drastically as a result of various factors, including unexpected shifts in the domestic or global economy. As inflation increases, the real value of the Fund’s shares and distributions therefore may decline. In addition, during any periods of rising inflation, dividend rates of any debt securities issued by the Fund would likely increase, which would tend to further reduce returns to common shareholders. Deflation Risk Deflation risk is the risk that prices throughout the economy decline over time, which may have an adverse effect on the market valuation of companies, their assets and their revenues. In addition, deflation may have an adverse effect on the creditworthiness of issuers and may make issuer default more likely, which may result in a decline in the value of the Fund’s portfolio. Leverage Risk The Fund currently uses, and intends to continue to use, leverage for investment purposes by issuing preferred shares. “Leverage” for these purposes means the ratio by which the aggregate amount of senior securities representing indebtedness of the Fund plus the aggregate involuntary liquidation preference of the Fund’s preferred shares bears to the Fund’s total assets. As of December 31, 2023, the amount of leverage represented approximately 22% of the Fund’s total assets. All series of the Fund’s preferred shares have the same seniority with respect to distributions and liquidation preference. Preferred shares have seniority over common shares with respect to distributions and upon liquidation of the Fund. The Fund’s leveraged capital structure creates special risks not associated with unleveraged funds having similar investment objectives and policies. The Fund’s use of leverage, which can be described as exposure to changes in price at a ratio greater than the amount of equity invested, either through the issuance of preferred shares, borrowing or other forms of market exposure, magnifies both the favorable and unfavorable effects of price movements in the investments made by the Fund. The Fund’s leveraged capital structure creates special risks not associated with unleveraged funds having similar investment objectives and policies. The Fund cannot assure that the issuance of preferred shares will result in a higher yield or return to the holders of the common shares. Also, as the Fund is utilizing leverage, a decline in NAV could affect the ability of the Fund to make common share distributions and such a failure to pay dividends or make distributions could result in the Fund ceasing to qualify as a regulated investment company under the Code. <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Arial, Helvetica, Sans-Serif"> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 0.25in; text-align: right; vertical-align: top"></td> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top">●</td> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; text-align: justify; text-indent: 0in">Preferred Share Risk. The issuance of preferred shares causes the NAV and market value of the common shares to become more volatile. If the dividend rate on the preferred shares approaches the net rate of return on the Fund’s investment portfolio, the benefit of leverage to the holders of the common shares would be reduced. If the dividend rate on the preferred shares plus the management fee annual rate of 1.00% (as applicable) exceeds the net rate of return on the Fund’s portfolio, the leverage will result in a lower rate of return to the holders of common shares than if the Fund had not issued preferred shares.</td> </tr> </table> Any decline in the NAV of the Fund’s investments would be borne entirely by the holders of common shares. Therefore, if the market value of the Fund’s portfolio declines, the leverage will result in a greater decrease in NAV to the holders of common shares than if the Fund were not leveraged. This greater NAV decrease will also tend to cause a greater decline in the market price for the common shares. In such a case, the Fund might be in danger of failing to maintain the required asset coverage of the preferred shares or of losing its ratings (if any) on the preferred shares or, in an extreme case, the Fund’s current investment income might not be sufficient to meet the dividend requirements on the preferred shares. In order to counteract such an event, the Fund might need to liquidate investments in order to fund a redemption of some or all of the preferred shares. In addition, the Fund would pay (and the holders of common shares will bear) all costs and expenses relating to the issuance and ongoing maintenance of the preferred shares, including the advisory fees on the incremental assets attributable to such shares. Holders of preferred shares may have different interests than holders of common shares and may at times have disproportionate influence over the Fund’s affairs. Holders of preferred shares, voting separately as a single class, have the right to elect two members of the Board at all times and in the event dividends become two full years in arrears have the right to elect a majority of the Trustees until such arrearage is completely eliminated. In addition, preferred shareholders have class voting rights on certain matters, including changes in fundamental investment restrictions and conversion of the Fund to open-end status, and accordingly can veto any such changes. Restrictions imposed on the declarations and payment of dividends or other distributions to the holders of the Fund’s common shares and preferred shares, both by the 1940 Act and by requirements imposed by any rating agencies, might impair the Fund’s ability to maintain its qualification as a regulated investment company for federal income tax purposes. While the Fund intends to redeem its preferred shares to the extent necessary to enable the Fund to distribute its income as required to maintain its qualification as a regulated investment company under the Code, there can be no assurance that such actions can be effected in time to meet the Code requirements. <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Arial, Helvetica, Sans-Serif"> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 0.25in; text-align: right; vertical-align: top"></td> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top">●</td> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; text-align: justify; text-indent: 0in">Special Risks to Holders of Fixed Rate Preferred Shares</td> </tr> </table> Illiquidity. Prior to the offering, there will be no public market for any additional series of Fixed Rate Preferred Shares. In the event any additional series of Fixed Rate Preferred Shares are issued, prior application may have been, but is not required to be, made to list such shares on a national securities exchange, which would be expected to be the NYSE. If no such application is made, there can be no assurances that any additional series of Fixed Rate Preferred Shares would be liquid at any time. If any additional series of Fixed Rate Preferred Shares are to be listed, during an initial period prior to listing, which would not be expected to exceed 30 days after the date of initial issuance, such shares may not be listed on any securities exchange. During such period, the underwriters may make a market in such shares, though, they will have no obligation to do so. Consequently, an investment in such shares may be illiquid during such period. Market Price Fluctuation. Fixed Rate Preferred Shares that are listed on a national securities exchange may trade at a premium to or discount from liquidation value for various reasons, including changes in interest rates. <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Arial, Helvetica, Sans-Serif"> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 0.25in; text-align: right; vertical-align: top"></td> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top">●</td> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; text-align: justify; text-indent: 0in">Special Risks to Holders of Notes. There may not be an established market for our notes. To the extent that our notes trade, they may trade at a price either higher or lower than their principal amount depending on interest rates, the rating (if any) on such notes and other factors.</td> </tr> </table> <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Arial, Helvetica, Sans-Serif"> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 0.25in; text-align: right; vertical-align: top"></td> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top">●</td> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; text-align: justify; text-indent: 0in">Special Risks to Holders of Notes and Preferred Shares</td> </tr> </table> Common Share Repurchases. Repurchases of common shares by the Fund may reduce the net asset coverage of the notes and preferred shares, which could adversely affect their liquidity or market prices, if such noted or preferred shares are listed on a national securities exchange. Common Share Distribution Policy. In the event the Fund does not generate a total return from dividends and interest received and net realized capital gains in an amount at least equal to its distributions for a given year, the Fund may return capital as part of its distribution. This would decrease the asset coverage per share with respect to the Fund’s notes or preferred shares, which could adversely affect their liquidity or market prices, if such notes or preferred shares are listed on a national securities exchange. See “Risk Factors and Special Considerations — Common Share Distribution Policy Risk.” Credit Quality Ratings. The Fund may obtain credit quality ratings for its preferred shares or notes, if desired; however, it is not required to do so and may issue preferred shares or notes without any rating. If rated, the Fund does not impose any minimum rating necessary to issue such preferred shares or notes. In order to obtain and maintain attractive credit quality ratings for preferred shares or borrowings, if desired, the Fund’s portfolio must satisfy over-collateralization tests established by the relevant rating agencies. These tests are more difficult to satisfy to the extent the Fund’s portfolio securities are of lower credit quality, longer maturity or not diversified by issuer and industry within the meaning of such rating agencies’ over-collateralization tests. These guidelines could affect portfolio decisions and may be more stringent than those imposed by the 1940 Act. With respect to ratings (if any) of the notes or preferred shares, a rating by a ratings agency does not eliminate or necessarily mitigate the risks of investing in our preferred shares or notes, and a rating may not fully or accurately reflect all of the securities’ credit risks. A rating does not address the liquidity or any other market risks of the securities being rated. A rating agency could downgrade the rating of our notes or preferred shares, which may make such securities less liquid in the secondary market. If a rating agency downgrades the rating assigned to our preferred shares or notes, we may alter our portfolio or redeem all or a portion of the preferred shares or notes that are then redeemable under certain circumstances. <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Arial, Helvetica, Sans-Serif"> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 0.25in; text-align: right; vertical-align: top"></td> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top">●</td> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; text-align: justify; text-indent: 0in">Special Risks of Notes to Holders of Common Shares. If the interest rate on the notes approaches the net rate of return on the Fund’s investment portfolio, the benefit of leverage to the holders of the common shares would be reduced. Any decline in the NAV of the Fund’s investments would be borne entirely by the holders of common shares. Therefore, if the market value of the Fund’s portfolio declines, the leverage will result in a greater decrease in NAV to the holders of common shares than if the Fund were not leveraged. This greater NAV decrease will also tend to cause a greater decline in the market price for the common shares. The Fund might be in danger of failing to maintain the required asset coverage of the notes. Holders of notes may have different interests than holders of common shares and at times may have disproportionate influence over the Fund’s affairs. In the event the Fund fails to maintain the specified level of asset coverage of any notes outstanding, the holders of the notes will have the right to elect a majority of the Fund’s trustees.</td> </tr> </table> <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Arial, Helvetica, Sans-Serif"> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 0.25in; text-align: right; vertical-align: top"></td> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top">●</td> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; text-align: justify; text-indent: 0in">Portfolio Guidelines of Rating Agencies for Preferred Shares and/or Credit Facility. In order to obtain and maintain attractive credit quality ratings for preferred shares or borrowings, if desired, the Fund must comply with investment quality, diversification and other guidelines established by the relevant rating agencies. These tests tend to require over-collateralization and may be more difficult to satisfy to the extent the Fund’s portfolio securities are of lower credit quality, longer maturity or not diversified by issuer and industry within the meaning of such rating agencies’ collateralization tests. These guidelines could affect portfolio decisions and may be more stringent than those imposed by the 1940 Act. In the event that a rating on the Fund’s preferred shares or notes is lowered or withdrawn by the relevant rating agency, the Fund may also be required to redeem all or part of its outstanding preferred shares or notes, and the common shares of the Fund will lose the potential benefits associated with a leveraged capital structure.</td> </tr> </table> <table border="0" cellpadding="0" cellspacing="0" style="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Arial, Helvetica, Sans-Serif"> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 0.25in; text-align: right; vertical-align: top"></td> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; width: 0.25in; text-align: left; text-indent: 0in; vertical-align: top">●</td> <td style="font: 10pt Arial, Helvetica, Sans-Serif; vertical-align: top; text-align: justify; text-indent: 0in">Impact on Common Shares. Assuming that leverage will (1) be equal in amount to approximately 22% of the Fund’s total net assets, and (2) charge interest or involve dividend payments at a projected blended annual average leverage dividend or interest rate of 4.32%, then the annual return generated by the Fund’s portfolio (net of estimated expenses) must exceed approximately 1.01% of the Fund’s total net assets in order to cover such interest or dividend payments and other expenses specifically related to leverage. These numbers are merely estimates, used for illustration. Actual dividend rates, interest or payment rates may vary frequently and may be significantly higher or lower than the rate estimated above. The following table is furnished in response to requirements of the SEC. It is designed to illustrate the effect of leverage on common share total return, assuming investment portfolio total returns (comprised of net investment income of the Fund, realized gains or losses of the Fund and changes in the value of the securities held in the Fund’s portfolio) of –10%, –5%, 0%, 5% and 10%. These assumed investment portfolio returns are hypothetical figures and are not necessarily indicative of the investment portfolio returns experienced or expected to be experienced by the Fund. See “Risks.” The table further reflects leverage representing 22% of the Fund’s total assets, the Fund’s current projected blended an-nual average leverage dividend or interest rate of 4.32%, a management fee at an annual rate of 1.00% of the liquidation preference of any outstanding preferred shares and estimated annual incremental expenses attributable to any outstanding preferred shares of 0.04% of the Fund’s net assets attributable to common shares.</td> </tr> </table> <table cellpadding="0" cellspacing="0" style="font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"> <tr style="font-family: Arial, Helvetica, Sans-Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Arial, Helvetica, Sans-Serif; text-indent: -0.125in; padding-left: 0.125in; width: 40%; font-weight: bold; text-align: left">Assumed Return on Portfolio (Net of Expenses)</td> <td style="font-family: Arial, Helvetica, Sans-Serif; width: 1%"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif; width: 9%; text-align: right">(10</td> <td style="font-family: Arial, Helvetica, Sans-Serif; width: 1%; text-align: left">)%</td> <td style="font-family: Arial, Helvetica, Sans-Serif; width: 1%"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif; width: 9%; text-align: right">(5</td> <td style="font-family: Arial, Helvetica, Sans-Serif; width: 1%; text-align: left">)%</td> <td style="font-family: Arial, Helvetica, Sans-Serif; width: 1%"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif; width: 9%; text-align: right">0</td> <td style="font-family: Arial, Helvetica, Sans-Serif; width: 1%; text-align: left">%</td> <td style="font-family: Arial, Helvetica, Sans-Serif; width: 1%"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif; width: 9%; text-align: right">5</td> <td style="font-family: Arial, Helvetica, Sans-Serif; width: 1%; text-align: left">%</td> <td style="font-family: Arial, Helvetica, Sans-Serif; width: 1%"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif; width: 9%; text-align: right">10</td> <td style="font-family: Arial, Helvetica, Sans-Serif; width: 1%; text-align: left">%</td></tr> <tr style="font-family: Arial, Helvetica, Sans-Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Arial, Helvetica, Sans-Serif; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left">Common Shares Total Return</td> <td style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold; text-align: left"> </td> <td id="xdx_985_ecef--ReturnAtMinusTenPercent_dp_c20230101__20231231__cef--RiskAxis__custom--CommonStocksMember_zHXMZVNN6DS1" style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold; text-align: right">(14.51</td> <td style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold; text-align: left">)%</td> <td style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold; text-align: left"> </td> <td id="xdx_987_ecef--ReturnAtMinusFivePercent_dp_c20230101__20231231__cef--RiskAxis__custom--CommonStocksMember_zwReMSoFDW8d" style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold; text-align: right">(8.05</td> <td style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold; text-align: left">)%</td> <td style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold; text-align: left"> </td> <td id="xdx_98A_ecef--ReturnAtZeroPercent_dp_c20230101__20231231__cef--RiskAxis__custom--CommonStocksMember_zcK3siVVafp9" style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold; text-align: right">(1.58</td> <td style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold; text-align: left">)%</td> <td style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold; text-align: left"> </td> <td id="xdx_98A_ecef--ReturnAtPlusFivePercent_dp_c20230101__20231231__cef--RiskAxis__custom--CommonStocksMember_zqAnpM6peJ3b" style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold; text-align: right">4.89</td> <td style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold; text-align: left">%</td> <td style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold; text-align: left"> </td> <td id="xdx_984_ecef--ReturnAtPlusTenPercent_dp_c20230101__20231231__cef--RiskAxis__custom--CommonStocksMember_zkdhinUbmLBb" style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold; text-align: right">11.36</td> <td style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold; text-align: left">%</td></tr> </table> Common share total return is composed of two elements — the common share distributions paid by the Fund (the amount of which is largely determined by the taxable income of the Fund (including realized gains or losses) after paying interest on any debt and/or dividends on any preferred shares) and unrealized gains or losses on the value of the securities the Fund owns. As required by SEC rules, the table assumes that the Fund is more likely to suffer capital losses than to enjoy total return. For example, to assume a total return of 0% the Fund must assume that the income it receives on its investments is entirely offset by expenses and losses in the value of those investments. The Fund’s shares are leveraged and the risks and special considerations related to leverage described in this prospectus apply. Such leveraging of the shares cannot be fully achieved until the proceeds resulting from the use of leverage have been invested in accordance with the Fund’s investment objectives and policies. -0.1451 -0.0805 -0.0158 0.0489 0.1136 <p id="xdx_840_ecef--RiskTextBlock_hcef--RiskAxis__custom--PotentialDilutionInRightsOfferingsMember_zAw144YkSssg" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">Potential Dilution in Rights Offerings To the extent that the Fund engages in a rights offering, shareholders who do not exercise their subscription rights may, at the completion of such an offering, own a smaller proportional interest in the Fund than if they exercised their subscription rights. As a result of such an offering, a shareholder also may experience dilution in NAV per share if the subscription price per share is below the NAV per share on the expiration date. Specifically, if the subscription price per share is below the NAV per share of the Fund’s shares on the expiration date of the rights offering, a shareholder will experience an immediate dilution of the aggregate NAV of their shares if the shareholder does not participate in the offering and the shareholder will experience a reduction in the NAV per share of their shares whether or not the shareholder participates in the offering. The Fund cannot state precisely the extent of this dilution (if any) if the shareholder does not exercise his or her subscription rights because the Fund does not know what the NAV per share will be when a rights offering expires or what proportion of the rights will be exercised. There is also a risk that the Fund’s largest shareholders, record date shareholders of more than 5% of the outstanding common shares of the Fund, may increase their percentage ownership of the Fund through the exercise of the primary subscription and any over-subscription privilege. <p id="xdx_84F_ecef--RiskTextBlock_hcef--RiskAxis__custom--CommonShareDistributionPolicyRiskMember_ziEoGAcGLoKf" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">Common Share Distribution Policy Risk The Fund has adopted a policy, which may be changed at any time by the Board, of paying distributions on its common shares of $0.15 per share per quarter. In the event the Fund does not generate a total return from dividends and interest received and net realized capital gains in an amount equal to or in excess of its stated distribution in a given year, the Fund may return capital as part of such distribution, which may have the effect of decreasing the asset coverage per share with respect to the Fund’s preferred shares. Any return of capital should not be considered by investors as yield or total return on their investment in the Fund. Shareholders should not assume that a distribution from the Fund is comprised exclusively of net profits. For the fiscal year ended December 31, 2023, the Fund made distributions of $0.60 per common share, approximately $0.02 of which was deemed a return of capital. The Fund has made quarterly distributions with respect to its common shares since June 2012. A portion of the distributions to holders of common shares during four of the sixteen fiscal years since the Fund’s inception has constituted a return of capital. The composition of each distribution is estimated based on the earnings of the Fund as of the record date for each distribution. The actual composition of each of the current year’s distributions will be based on the Fund’s investment activity through the end of the calendar year. Legislation Risk At any time after the date of this report, legislation may be enacted that could negatively affect the assets of the Fund. Legislation or regulation may change the way in which the Fund itself is regulated. The Investment Adviser cannot predict the effects of any new governmental regulation that may be implemented and there can be no assurance that any new governmental regulation will not adversely affect the Fund’s ability to achieve its investment objective. <p id="xdx_840_ecef--RiskTextBlock_hcef--RiskAxis__custom--RelianceOnServiceProvidersRiskMember_zB5pz7zn1op5" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">Reliance on Service Providers Risk The Fund must rely upon the performance of service providers to perform certain functions, which may include functions that are integral to the Fund’s operations and financial performance. Failure by any service provider to carry out its obligations to the Fund in accordance with the terms of its appointment, to exercise due care and skill or to perform its obligations to the Fund at all as a result of insolvency, bankruptcy or other causes could have a material adverse effect on the Fund’s performance and returns to shareholders. The termination of the Fund’s relationship with any service provider, or any delay in appointing a replacement for such service provider, could materially disrupt the business of the Fund and could have a material adverse effect on the Fund’s performance and returns to shareholders. Cyber Security Risk The Fund and its service providers are susceptible to cyber security risks that include, among other things, theft, unauthorized monitoring, release, misuse, loss, destruction or corruption of confidential and highly restricted data; denial of service attacks; unauthorized access to relevant systems, compromises to networks or devices that the Fund and its service providers use to service the Fund’s operations; or operational disruption or failures in the physical infrastructure or operating systems that support the Fund and its service providers. Cyber attacks against or security breakdowns of the Fund or its service providers may adversely impact the Fund and its shareholders, potentially resulting in, among other things, financial losses; the inability of Fund shareholders to transact business and the Fund to process transactions; inability to calculate the Fund’s NAV; violations of applicable privacy and other laws; regulatory fines, penalties, reputational damage, reimbursement or other compensation costs; and/or additional compliance costs. The Fund may incur additional costs for cyber security risk management and remediation purposes. In addition, cyber security risks may also impact issuers of securities in which the Fund invests, which may cause the Fund’s investment in such issuers to lose value. There can be no assurance that the Fund or its service providers will not suffer losses relating to cyber attacks or other information security breaches in the future. <p id="xdx_848_ecef--RiskTextBlock_hcef--RiskAxis__custom--MisconductOfEmployeesAndOfServiceProvidersRiskMember_zUwJKAN8mdVl" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">Misconduct of Employees and of Service Providers Risk Misconduct or misrepresentations by employees of the Investment Adviser or the Fund’s service providers could cause significant losses to the Fund. Employee misconduct may include binding the Fund to transactions that exceed authorized limits or present unacceptable risks and unauthorized trading activities, concealing unsuccessful trading activities (which, in any case, may result in unknown and unmanaged risks or losses) or making misrepresentations regarding any of the foregoing. Losses could also result from actions by the Fund’s service providers, including, without limitation, failing to recognize trades and misappropriating assets. In addition, employees and service providers may improperly use or disclose confidential information, which could result in litigation or serious financial harm, including limiting the Fund’s business prospects or future marketing activities. Despite the Investment Adviser’s due diligence efforts, misconduct and intentional misrepresentations may be undetected or not fully comprehended, thereby potentially undermining the Investment Adviser’s due diligence efforts. As a result, no assurances can be given that the due diligence performed by the Investment Adviser will identify or prevent any such misconduct. <p id="xdx_844_ecef--RiskTextBlock_hcef--RiskAxis__custom--AntiTakeoverProvisionsOfTheFundsGoverningDocumentsMember_zDi5sp2d1kua" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">Anti-Takeover Provisions of the Fund’s Governing Documents The Fund’s Agreement and Declaration of Trust as amended and supplemented (including the statements of preferences thereto) and bylaws, as amended from time to time, include provisions that could limit the ability of other entities or persons to acquire control of the Fund or convert the Fund to an open-end fund. <p id="xdx_840_ecef--RiskTextBlock_hcef--RiskAxis__custom--StatusAsARegulatedInvestmentCompanyMember_zHjFhFkOrdUe" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 0; text-align: center">Status as a Regulated Investment Company The Fund has qualified, and intends to remain qualified, for federal income tax purposes as a regulated investment company under Subchapter M of the Code. Qualification requires, among other things, compliance by the Fund with certain distribution requirements. Statutory limitations on distributions on the common shares if the Fund fails to satisfy the 1940 Act’s asset coverage requirements could jeopardize the Fund’s ability to meet such distribution requirements. The Fund presently intends, however, to purchase or redeem preferred shares to the extent necessary in order to maintain compliance with such asset coverage requirements. Temporary Investments During temporary defensive periods and during inopportune periods to be fully invested, the Fund may invest in U.S. government securities, including U.S. Treasury securities, and in money market mutual funds that invest in those securities. Obligations of certain agencies and instrumentalities of the U.S. government, such as the Government National Mortgage Association, are supported by the “full faith and credit” of the U.S. government; others, such as those of the Export-Import Bank of the United States, are supported by the right of the issuer to borrow from the U.S. Treasury; others, such as those of the Federal National Mortgage Association, are supported by the discretionary authority of the U.S. government to purchase the agency’s obligations; and still others, such as those of the Student Loan Marketing Association, are supported only by the credit of the instrumentality. No assurance can be given that the U.S. government would provide financial support to U.S. government-sponsored instrumentalities if it is not obligated to do so by law. Investment Restrictions The Fund has adopted certain investment limitations designed to limit investment risk and maintain portfolio diversification. These limitations are fundamental and may not be changed without the approval of the holders of a majority, as defined in the 1940 Act, of the outstanding common shares and preferred shares voting together as a single class. The Fund may become subject to guidelines that are more limiting than the investment restrictions set forth above in order to obtain and maintain ratings from a credit rating agency on its preferred shares. See “Leverage Risk — Portfolio Guidelines of Rating Agencies for Preferred Shares and/or Credit Facility.” Effects of Leverage The following information is furnished in response to requirements of the SEC. It is designed to, among other things, illustrate the effects of leverage through the use of senior securities, as that term is defined under Section 18 of the 1940 Act, on Common Share total return, assuming investment portfolio total returns (consisting of income and changes in the value of investments held in a Fund’s portfolio) of -10%, -5%, 0%, 5% and 10%. The table below reflects the Fund’s continued use of preferred shares, as of December 31, 2023 as a percentage of total managed assets (including assets attributable to such leverage), the estimated annual effective preferred shares dividend rate and interest expense rate payable by the Fund on such instruments (based on market conditions as of December 31, 2023), and the annual return that the Fund’s portfolio must experience (net of expenses) in order to cover such costs. The information below does not reflect the Fund’s use of certain other forms of economic leverage achieved through the use of other instruments or transactions not considered to be senior securities under the 1940 Act, such as derivative instruments. The assumed investment portfolio returns in the table below are hypothetical figures and are not necessarily indicative of the investment portfolio returns experienced or expected to be experienced by the Fund. Your actual returns may be greater or less than those appearing below. <table cellpadding="0" cellspacing="0" style="font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"> <tr style="font-family: Arial, Helvetica, Sans-Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Arial, Helvetica, Sans-Serif; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 88%; font-weight: bold; text-align: left">Preferred Shares as a Percentage of Total Managed Assets (Including Assets Attributable to Preferred Shares)</td> <td style="font-family: Arial, Helvetica, Sans-Serif; width: 1%"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif; width: 9%; text-align: right">22</td> <td style="font-family: Arial, Helvetica, Sans-Serif; width: 1%; text-align: left">%</td></tr> <tr style="font-family: Arial, Helvetica, Sans-Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Arial, Helvetica, Sans-Serif; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left">Estimated Annual Effective Preferred Share Dividend Rate</td> <td style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold; text-align: left"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold; text-align: right">4.32</td> <td style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold; text-align: left">%</td></tr> <tr style="font-family: Arial, Helvetica, Sans-Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Arial, Helvetica, Sans-Serif; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left">Annual Return Fund Portfolio Must Experience (net of expenses) to Cover Estimated Annual Effective Preferred Share Dividend Rate</td> <td style="font-family: Arial, Helvetica, Sans-Serif"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">1.01</td> <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">%</td></tr> <tr style="font-family: Arial, Helvetica, Sans-Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Arial, Helvetica, Sans-Serif; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left">Common Share Total Return for (10.00)% Assumed Portfolio Total Return</td> <td style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold; text-align: left"> </td> <td id="xdx_986_ecef--ReturnAtMinusTenPercent_dp_c20230101__20231231_z6hKnjYID4yi" style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold; text-align: right">(14.51</td> <td style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold; text-align: left">)%</td></tr> <tr style="font-family: Arial, Helvetica, Sans-Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Arial, Helvetica, Sans-Serif; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left">Common Share Total Return for (5.00)% Assumed Portfolio Total Return</td> <td style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold; text-align: left"> </td> <td id="xdx_989_ecef--ReturnAtMinusFivePercent_dp_c20230101__20231231_zau1zLYxuCF8" style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold; text-align: right">(8.05</td> <td style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold; text-align: left">)%</td></tr> <tr style="font-family: Arial, Helvetica, Sans-Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Arial, Helvetica, Sans-Serif; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left">Common Share Total Return for 0.00% Assumed Portfolio Total Return</td> <td style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold; text-align: left"> </td> <td id="xdx_982_ecef--ReturnAtZeroPercent_dp_c20230101__20231231_zXSRlKieooTf" style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold; text-align: right">(1.58</td> <td style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold; text-align: left">)%</td></tr> <tr style="font-family: Arial, Helvetica, Sans-Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Arial, Helvetica, Sans-Serif; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left">Common Share Total Return for 5.00% Assumed Portfolio Total Return</td> <td style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold; text-align: left"> </td> <td id="xdx_983_ecef--ReturnAtPlusFivePercent_dp_c20230101__20231231_z45ZuzFTfTkj" style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold; text-align: right">4.89</td> <td style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold; text-align: left">%</td></tr> <tr style="font-family: Arial, Helvetica, Sans-Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Arial, Helvetica, Sans-Serif; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left">Common Share Total Return for 10.00% Assumed Portfolio Total Return</td> <td style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold; text-align: left"> </td> <td id="xdx_984_ecef--ReturnAtPlusTenPercent_dp_c20230101__20231231_zC5ZdTYdfEol" style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold; text-align: right">11.36</td> <td style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold; text-align: left">%</td></tr> </table> Common shares total return is composed of two elements — the distributions paid by a Fund to holders of common shares (the amount of which is largely determined by the net investment income of the Fund after paying dividend payments on any preferred shares issued by the Fund and expenses on any forms of leverage outstanding) and gains or losses on the value of the securities and other instruments the Fund owns. As required by SEC rules, the table assumes that a Fund is more likely to suffer capital losses than to enjoy capital appreciation. For example, to assume a total return of 0%, a Fund must assume that the income it receives on its investments is entirely offset by losses in the value of those investments. This table reflects hypothetical performance of the Fund’s portfolio and not the actual performance of the Fund’s common shares, the value of which is determined by market forces and other factors. Should the Fund elect to add additional leverage to its portfolio, any benefits of such additional leverage cannot be fully achieved until the proceeds resulting from the use of such leverage have been received by the Fund and invested in accordance with the Fund’s investment objectives and policies. As noted above, the Fund’s willingness to use additional leverage, and the extent to which leverage is used at any time, will depend on many factors, including, among other things, the Fund’s assessment of the yield curve environment, interest rate trends, market conditions and other factors. The following information is furnished in response to requirements of the SEC. It is designed to, among other things, illustrate the effects of leverage through the use of senior securities, as that term is defined under Section 18 of the 1940 Act, on Common Share total return, assuming investment portfolio total returns (consisting of income and changes in the value of investments held in a Fund’s portfolio) of -10%, -5%, 0%, 5% and 10%. The table below reflects the Fund’s continued use of preferred shares, as of December 31, 2023 as a percentage of total managed assets (including assets attributable to such leverage), the estimated annual effective preferred shares dividend rate and interest expense rate payable by the Fund on such instruments (based on market conditions as of December 31, 2023), and the annual return that the Fund’s portfolio must experience (net of expenses) in order to cover such costs. The information below does not reflect the Fund’s use of certain other forms of economic leverage achieved through the use of other instruments or transactions not considered to be senior securities under the 1940 Act, such as derivative instruments. The assumed investment portfolio returns in the table below are hypothetical figures and are not necessarily indicative of the investment portfolio returns experienced or expected to be experienced by the Fund. Your actual returns may be greater or less than those appearing below. <table cellpadding="0" cellspacing="0" style="font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"> <tr style="font-family: Arial, Helvetica, Sans-Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Arial, Helvetica, Sans-Serif; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 88%; font-weight: bold; text-align: left">Preferred Shares as a Percentage of Total Managed Assets (Including Assets Attributable to Preferred Shares)</td> <td style="font-family: Arial, Helvetica, Sans-Serif; width: 1%"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif; width: 1%; text-align: left"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif; width: 9%; text-align: right">22</td> <td style="font-family: Arial, Helvetica, Sans-Serif; width: 1%; text-align: left">%</td></tr> <tr style="font-family: Arial, Helvetica, Sans-Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Arial, Helvetica, Sans-Serif; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left">Estimated Annual Effective Preferred Share Dividend Rate</td> <td style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold; text-align: left"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold; text-align: right">4.32</td> <td style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold; text-align: left">%</td></tr> <tr style="font-family: Arial, Helvetica, Sans-Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Arial, Helvetica, Sans-Serif; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left">Annual Return Fund Portfolio Must Experience (net of expenses) to Cover Estimated Annual Effective Preferred Share Dividend Rate</td> <td style="font-family: Arial, Helvetica, Sans-Serif"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: right">1.01</td> <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: left">%</td></tr> <tr style="font-family: Arial, Helvetica, Sans-Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Arial, Helvetica, Sans-Serif; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left">Common Share Total Return for (10.00)% Assumed Portfolio Total Return</td> <td style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold; text-align: left"> </td> <td id="xdx_986_ecef--ReturnAtMinusTenPercent_dp_c20230101__20231231_z6hKnjYID4yi" style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold; text-align: right">(14.51</td> <td style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold; text-align: left">)%</td></tr> <tr style="font-family: Arial, Helvetica, Sans-Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Arial, Helvetica, Sans-Serif; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left">Common Share Total Return for (5.00)% Assumed Portfolio Total Return</td> <td style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold; text-align: left"> </td> <td id="xdx_989_ecef--ReturnAtMinusFivePercent_dp_c20230101__20231231_zau1zLYxuCF8" style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold; text-align: right">(8.05</td> <td style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold; text-align: left">)%</td></tr> <tr style="font-family: Arial, Helvetica, Sans-Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Arial, Helvetica, Sans-Serif; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left">Common Share Total Return for 0.00% Assumed Portfolio Total Return</td> <td style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold; text-align: left"> </td> <td id="xdx_982_ecef--ReturnAtZeroPercent_dp_c20230101__20231231_zXSRlKieooTf" style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold; text-align: right">(1.58</td> <td style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold; text-align: left">)%</td></tr> <tr style="font-family: Arial, Helvetica, Sans-Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Arial, Helvetica, Sans-Serif; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left">Common Share Total Return for 5.00% Assumed Portfolio Total Return</td> <td style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold; text-align: left"> </td> <td id="xdx_983_ecef--ReturnAtPlusFivePercent_dp_c20230101__20231231_z45ZuzFTfTkj" style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold; text-align: right">4.89</td> <td style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold; text-align: left">%</td></tr> <tr style="font-family: Arial, Helvetica, Sans-Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Arial, Helvetica, Sans-Serif; vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left">Common Share Total Return for 10.00% Assumed Portfolio Total Return</td> <td style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold; text-align: left"> </td> <td id="xdx_984_ecef--ReturnAtPlusTenPercent_dp_c20230101__20231231_zC5ZdTYdfEol" style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold; text-align: right">11.36</td> <td style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold; text-align: left">%</td></tr> </table> 0.0432 0.0101 -0.1451 -0.0805 -0.0158 0.0489 0.1136 The following table shows the Fund’s expenses, which are borne directly or indirectly by holders of the Fund’s common shares, including preferred shares offering expenses, as a percentage of net assets attributable to common shares. All expenses of the Fund will be borne, directly or indirectly, by the common shareholders. Amounts are for the current fiscal year. <table cellpadding="0" cellspacing="0" style="font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"> <tr style="font-family: Arial, Helvetica, Sans-Serif; vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left">Annual Expenses</td> <td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; font-weight: bold; text-align: center">Percentages of Net Assets Attributable to Common Shares </td> </tr> <tr style="font-family: Arial, Helvetica, Sans-Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Arial, Helvetica, Sans-Serif; text-indent: -0.125in; padding-left: 0.125in; width: 51%; font-weight: bold; text-align: left">Management Fees(a)</td> <td style="font-family: Arial, Helvetica, Sans-Serif; width: 1%; font-weight: bold"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif; width: 9%; font-weight: bold; text-align: right">1.29</td> <td style="font-family: Arial, Helvetica, Sans-Serif; width: 9%; font-weight: bold; text-align: left">%</td></tr> <tr style="font-family: Arial, Helvetica, Sans-Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Arial, Helvetica, Sans-Serif; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left">Interest Expense(b)</td> <td style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold; text-align: right">1.27</td> <td style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold; text-align: left">%</td></tr> <tr style="font-family: Arial, Helvetica, Sans-Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Arial, Helvetica, Sans-Serif; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left; padding-bottom: 1pt">Other Expenses(c)</td> <td style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; font-weight: bold; text-align: right">0.44</td> <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; font-weight: bold; text-align: left">%</td></tr> <tr style="font-family: Arial, Helvetica, Sans-Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Arial, Helvetica, Sans-Serif; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left; padding-bottom: 1pt">Total Annual Expenses</td> <td style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; font-weight: bold; text-align: right">3.00</td> <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; font-weight: bold; text-align: left">%</td></tr> <tr style="font-family: Arial, Helvetica, Sans-Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-indent: -0.125in; padding-left: 0.125in; font-weight: bold; text-align: left">Total Annual Expenses and Dividends on Preferred Shares(d)</td> <td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; font-weight: bold"> </td> <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; font-weight: bold; text-align: right">3.00</td> <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; font-weight: bold; text-align: left">%</td></tr> </table> 0.0129 0.0127 0.0044 0.0300 0.0300 “Other Expenses” are based on amounts for the year ended December 31, 2023. The following example illustrates the expenses you would pay on a $1,000 investment in common shares, assuming a 5% annual portfolio total return.* <table cellpadding="0" cellspacing="0" style="font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; text-align: left"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">1 Year</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">3 Year</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">5 Year</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">10 Year</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; text-indent: -0.125in; padding-left: 0.125in; width: 56%; font-weight: bold; text-align: left">Total Expenses Incurred</td><td style="text-align: center; width: 1%; font-weight: bold"> </td> <td id="xdx_980_ecef--ExpenseExampleYear01_c20230101__20231231_zMPV7nCY3pLe" style="width: 10%; font-weight: bold; text-align: center">$30</td><td style="text-align: center; width: 1%; font-weight: bold"> </td> <td id="xdx_983_ecef--ExpenseExampleYears1to3_c20230101__20231231_zEcfESgpOxAj" style="width: 10%; font-weight: bold; text-align: center">$93</td><td style="text-align: center; width: 1%; font-weight: bold"> </td> <td id="xdx_983_ecef--ExpenseExampleYears1to5_c20230101__20231231_zJtxDbunTpf1" style="width: 10%; font-weight: bold; text-align: center">$158</td><td style="text-align: center; width: 1%; font-weight: bold"> </td> <td id="xdx_98F_ecef--ExpenseExampleYears1to10_c20230101__20231231_zzmsuYjXuC0a" style="width: 10%; font-weight: bold; text-align: center">$332</td></tr> </table> <div style="font-family: Arial, Helvetica, Sans-Serif; width: 25%"><div style="border-top: Black 1pt solid; font: 1pt Arial, Helvetica, Sans-Serif"> </div></div> <table cellpadding="0" cellspacing="0" style="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"> <tr style="font-family: Arial, Helvetica, Sans-Serif; vertical-align: top; text-align: justify"> <td style="font-family: Arial, Helvetica, Sans-Serif; width: 0in"></td> <td style="font-family: Arial, Helvetica, Sans-Serif; width: 0.25in; text-align: left">*</td> <td style="font-family: Arial, Helvetica, Sans-Serif; text-align: justify">The example should not be considered a representation of future expenses. The example is based on Total Annual Expenses and Dividends on Preferred Shares shown in the table above and assumes that the amounts set forth in the table do not change and that all distributions are reinvested at NAV. Actual expenses may be greater or less than those assumed. Moreover, the Fund’s actual rate of return may be greater or less than the hypothetical 5% return shown in the example.</td> </tr> </table> The above example includes Dividends on Preferred Shares. If Dividends on Preferred Shares were not included in the example calculation, the expenses would be as follows (based on the same assumptions as above). <table cellpadding="0" cellspacing="0" style="font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">1 Year</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">3 Year</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">5 Year</td><td style="text-align: center; font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">10 Year</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; width: 56%; font-weight: bold; text-align: left">Total Expenses Incurred</td><td style="text-align: center; width: 1%; font-weight: bold"> </td> <td id="xdx_98A_ecef--ExpenseExampleYear01_c20230101__20231231__cef--RiskAxis__custom--DividendsOnPreferredSharesNotIncludedMember_zdrzOtqmw2R9" style="width: 10%; font-weight: bold; text-align: center">$18</td><td style="text-align: center; width: 1%; font-weight: bold"> </td> <td id="xdx_982_ecef--ExpenseExampleYears1to3_c20230101__20231231__cef--RiskAxis__custom--DividendsOnPreferredSharesNotIncludedMember_zG7g3PN98cCl" style="width: 10%; font-weight: bold; text-align: center">$55</td><td style="text-align: center; width: 1%; font-weight: bold"> </td> <td id="xdx_988_ecef--ExpenseExampleYears1to5_c20230101__20231231__cef--RiskAxis__custom--DividendsOnPreferredSharesNotIncludedMember_zkJ8jK4leRfl" style="width: 10%; font-weight: bold; text-align: center">$94</td><td style="text-align: center; width: 1%; font-weight: bold"> </td> <td id="xdx_984_ecef--ExpenseExampleYears1to10_c20230101__20231231__cef--RiskAxis__custom--DividendsOnPreferredSharesNotIncludedMember_zVMVjxlOR2N" style="width: 10%; font-weight: bold; text-align: center">$205</td></tr> </table> 30 93 158 332 18 55 94 205 The following table sets forth for the quarters indicated, the high and low closing prices on the NYSE per share of the Fund’s common shares and the NAV and the premium or discount from NAV at which the common shares was trading, expressed as a percentage of NAV, at each of the high and low NYSE closing prices provided. <table cellpadding="0" cellspacing="0" style="font: 8pt Arial, Helvetica, Sans-Serif; border-collapse: collapse; width: 100%"> <tr style="font-family: Arial, Helvetica, Sans-Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold; text-align: left"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold"> </td> <td id="xdx_486_ecef--HighestPriceOrBid_zE1XQrwoY8H6" style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold; text-align: center"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold; text-align: left"> </td> <td id="xdx_481_ecef--LowestPriceOrBid_zmGBe5XpP4jk" style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold; text-align: center"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold; text-align: left"> </td> <td id="xdx_48F_ecef--HighestPriceOrBidNav_zn2OZ9MwNuIe" style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold; text-align: center"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold; text-align: left"> </td> <td id="xdx_48A_ecef--LowestPriceOrBidNav_zhstIyOD8Uv5" style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold; text-align: center"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold; text-align: left"> </td> <td id="xdx_485_ecef--HighestPriceOrBidPremiumDiscountToNavPercent_zV06Bmgdzd77" style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold; text-align: center"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold"> </td> <td id="xdx_48E_ecef--LowestPriceOrBidPremiumDiscountToNavPercent_zUkKE7B1LRb7" style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold; text-align: center"> </td></tr> <tr style="font-family: Arial, Helvetica, Sans-Serif; vertical-align: bottom"> <td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; text-align: left"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">Common Share Market Price</td> <td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">Corresponding Net Asset Value (“NAV”) Per Share </td> <td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; font-weight: bold"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">Corresponding Premium or Discount as a % of NAV</td> </tr> <tr style="font-family: Arial, Helvetica, Sans-Serif; vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; font-weight: bold; text-align: left">Quarter Ended</td> <td style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; font-weight: bold; text-align: center">High</td> <td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; font-weight: bold"> </td> <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; text-align: center">Low</td> <td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; font-weight: bold; text-align: center">High</td> <td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; font-weight: bold"> </td> <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; font-weight: bold; text-align: center">Low</td> <td style="font-family: Arial, Helvetica, Sans-Serif; padding-bottom: 1pt; font-weight: bold"> </td> <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; font-weight: bold; text-align: center">High</td> <td style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font-family: Arial, Helvetica, Sans-Serif; font-weight: bold; text-align: center">Low</td> </tr> <tr id="xdx_411_20220101__20220331__cef--RiskAxis__custom--CommonStocksMember_zrgDWl8pXYP6" style="font-family: Arial, Helvetica, Sans-Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Arial, Helvetica, Sans-Serif; width: 34%; font-weight: bold; text-align: left">March 31, 2022 </td> <td style="font-family: Arial, Helvetica, Sans-Serif; width: 2%; font-weight: bold"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif; width: 9%; font-weight: bold; text-align: center">$13.68</td> <td style="font-family: Arial, Helvetica, Sans-Serif; width: 2%; font-weight: bold; text-align: left"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif; width: 9%; font-weight: bold; text-align: center">$12.00</td> <td style="font-family: Arial, Helvetica, Sans-Serif; width: 2%; font-weight: bold; text-align: left"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif; width: 9%; font-weight: bold; text-align: center">$15.34</td> <td style="font-family: Arial, Helvetica, Sans-Serif; width: 2%; font-weight: bold; text-align: left"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif; width: 9%; font-weight: bold; text-align: center">$13.96</td> <td style="font-family: Arial, Helvetica, Sans-Serif; width: 2%; font-weight: bold; text-align: left"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif; width: 9%; font-weight: bold; text-align: center">(10.82)%</td> <td style="font-family: Arial, Helvetica, Sans-Serif; width: 2%; font-weight: bold"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif; width: 9%; font-weight: bold; text-align: center">(14.04)%</td> </tr> <tr id="xdx_41F_20220401__20220630__cef--RiskAxis__custom--CommonStocksMember_zw2OIKGmyII1" style="font-family: Arial, Helvetica, Sans-Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold; text-align: left">June 30, 2022</td> <td style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold; text-align: center">$13.19</td> <td style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold; text-align: left"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold; text-align: center">$9.84</td> <td style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold; text-align: left"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold; text-align: center">$14.94</td> <td style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold; text-align: left"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold; text-align: center">$11.56</td> <td style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold; text-align: left"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold; text-align: center">(11.71)%</td> <td style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold; text-align: center">(14.88)%</td> </tr> <tr id="xdx_410_20220701__20220930__cef--RiskAxis__custom--CommonStocksMember_zzltKl5BDAM4" style="font-family: Arial, Helvetica, Sans-Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold; text-align: left">September 30, 2022</td> <td style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold; text-align: center">$12.27</td> <td style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold; text-align: left"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold; text-align: center">$9.50</td> <td style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold; text-align: left"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold; text-align: center">$13.38</td> <td style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold; text-align: left"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold; text-align: center">$10.99</td> <td style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold; text-align: left"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold; text-align: center">(8.30)%</td> <td style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold; text-align: center">(13.56)%</td> </tr> <tr id="xdx_414_20221001__20221231__cef--RiskAxis__custom--CommonStocksMember_z1Jl2UFpIagi" style="font-family: Arial, Helvetica, Sans-Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold; text-align: left">December 31, 2022</td> <td style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold; text-align: center">$10.65</td> <td style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold; text-align: left"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold; text-align: center">$9.50</td> <td style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold; text-align: left"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold; text-align: center">$12.53</td> <td style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold; text-align: left"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold; text-align: center">$11.00</td> <td style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold; text-align: left"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold; text-align: center">(15.00)%</td> <td style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold; text-align: center">(13.64)%</td> </tr> <tr id="xdx_410_20230101__20230331__cef--RiskAxis__custom--CommonStocksMember_zkjHHOiMig1" style="font-family: Arial, Helvetica, Sans-Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold; text-align: left">March 31, 2023 </td> <td style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold; text-align: center">$10.56</td> <td style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold; text-align: left"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold; text-align: center">$9.49</td> <td style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold; text-align: left"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold; text-align: center">$12.47</td> <td style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold; text-align: left"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold; text-align: center">$11.38</td> <td style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold; text-align: left"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold; text-align: center">(15.32)%</td> <td style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold; text-align: center">(16.61)%</td> </tr> <tr id="xdx_417_20230401__20230630__cef--RiskAxis__custom--CommonStocksMember_zKkIRLttScY8" style="font-family: Arial, Helvetica, Sans-Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold; text-align: left">June 30, 2023</td> <td style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold; text-align: center">$10.34</td> <td style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold; text-align: left"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold; text-align: center">$9.50</td> <td style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold; text-align: left"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold; text-align: center">$12.55</td> <td style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold; text-align: left"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold; text-align: center">$11.46</td> <td style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold; text-align: left"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold; text-align: center">(17.61)%</td> <td style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold; text-align: center">(17.10)%</td> </tr> <tr id="xdx_41D_20230701__20230930__cef--RiskAxis__custom--CommonStocksMember_z7d7L2TiiOW4" style="font-family: Arial, Helvetica, Sans-Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold; text-align: left">September 30, 2023</td> <td style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold; text-align: center">$10.12</td> <td style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold; text-align: left"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold; text-align: center">$8.57</td> <td style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold; text-align: left"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold; text-align: center">$12.28</td> <td style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold; text-align: left"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold; text-align: center">$10.70</td> <td style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold; text-align: left"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold; text-align: center">(17.59)%</td> <td style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold; text-align: center">(19.91)%</td> </tr> <tr id="xdx_41F_20231001__20231231__cef--RiskAxis__custom--CommonStocksMember_zxMy1DJPiu1h" style="font-family: Arial, Helvetica, Sans-Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold; text-align: left">December 31, 2023</td> <td style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold; text-align: center">$9.35</td> <td style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold; text-align: left"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold; text-align: center">$7.74</td> <td style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold; text-align: left"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold; text-align: center">$11.49</td> <td style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold; text-align: left"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold; text-align: center">$9.81</td> <td style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold; text-align: left"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold; text-align: center">(18.62)%</td> <td style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold"> </td> <td style="font-family: Arial, Helvetica, Sans-Serif; font-weight: bold; text-align: center">(21.10)%</td> </tr> </table> 13.68 12.00 15.34 13.96 -0.1082 -0.1404 13.19 9.84 14.94 11.56 -0.1171 -0.1488 12.27 9.50 13.38 10.99 -0.0830 -0.1356 10.65 9.50 12.53 11.00 -0.1500 -0.1364 10.56 9.49 12.47 11.38 -0.1532 -0.1661 10.34 9.50 12.55 11.46 -0.1761 -0.1710 10.12 8.57 12.28 10.70 -0.1759 -0.1991 9.35 7.74 11.49 9.81 -0.1862 -0.2110 30000 30000 30000 30000 30000 1200000 1200000 1200000 1200000 1200000 25.00 25.00 25.00 25.00 25.00 25.43 25.89 26.12 25.96 25.85 101.31 111.76 105.40 115.04 115.23 37036 37036 37036 35000 35000 1481000 1481000 1481000 1400000 1400000 25.00 25.00 25.00 25.00 25.00 25.83 26.67 26.76 26.09 25.37 101.31 111.76 105.40 115.04 115.23